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P1 Epidemiology of ARDS in a Brazilian ICU
FS Dias, N Almeida, IC Wawrzeniack, PB Nery, JA Froemming, MO Guerreiro
Hospital São Lucas da PUCRS, Av. Ipiranga 6690, CEP 90610-000 Porto Alegre, RS, Brazil
Purpose: To describe the epidemiology of the acute respiratory
distress syndrome (ARDS) in a Brazilian ICU.
Methods: This prospective observational, non-interventional study,
included all consecutive patients with ARDS criteria [1] admitted in
the ICU of a Brazilian tertiary hospital, between January 1997 and
September 2001. Were collected in a prospective fashion the fol-
lowing variables: age, gender, APACHE II score at ICU admission
and at ARDS diagnosis, cause of ARDS, presence of AIDS, cancer
and immunosuppression, occurrence of barotrauma, performance
of traqueostomy, mortality, duration of mechanical ventilation (MV),
length of stay (LOS) in ICU and in hospital. The lung injury score
(LIS) [2] was used to quantify the degree of pulmonary injury in the
first week of ARDS.
Results: There was 2182 patients (P) admitted in ICU during the
study period, of whom 141 (6.46%) had ARDS criteria. Seventy-six
(54%) were men, the mean age was 46±18 years, APACHE II
18±7 and 19±7 at admission and at ARDS diagnosis, respec-
tively. Septic shock accounted for 42% (60P) of the ARDS
causes, sepsis 22% (31P), diffuse pulmonary infection
16% (23P), aspiration pneumonia 11% (15P), non-septic shock
5% (7P) and others 4% (5P). Ten percent (14P) had AIDS,
30% (43P) cancer and 25% (36P) immunosuppression. All
patients were mechanically ventilated with Tidal Volume between
4 and 8ml/kg. Only 3.5% (5P) had barotrauma and 10% (14P)
performed traqueostomy. Mortality rate was 79% in the ICU. The
patients required 12±10 days on MV, ranging from 1 to 55 days.
The LOS in ICU and hospital was 14±13 (1–69) days and
28±32 (1–325) days, respectively. There was a time delay of
3.7±4.5 days between admission in ICU and the onset of ARDS.
The Murray score (mean±SD) was 3.2±0.4, 3±0.5, 3±0.5,
2.9±0.6, 2.8±0.7, 2.7±0.7 and 2.6± 0.8 in the first 7 days,
respectively.
Conclusions: ARDS in our hospital has a similar incidence of
reports in the USA and Europe. There was a higher mortality,
which could be explained by a high incidence of infection causes
of ARDS, mainly septic shock, and elevated combined occurrence
of AIDS, cancer and immunosuppression, along the degree of LIS.
The incidence of barotrauma was low, as a consequence of the
current mechanical ventilation strategies.
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P2 Role of multiple organ dysfunction syndrome in ARDS mortality
FS Dias, N Almeida, IC Wawrzeniack, PB Nery
Hospital São Lucas da PUCRS, Av. Ipiranga 6690, CEP 90610-000 Porto Alegre, RS, Brazil
Purpose: To correlate the occurrence and level of organ dysfunc-
tion in ARDS with mortality.
Methods: This cohort study includes all consecutive patients with
ARDS criteria [1] admitted in the ICU between January 1997 and Sep-
tember 2001. Were collected in a prospective fashion the following
variables: age, gender, APACHE II score at the ARDS diagnosis, the
occurrence of organ dysfunction determined by the multiple organ dys-
function syndrome (MODS) [2] in the first week, and mortality in the
ICU. The occurrence of organ/system dysfunction was considered
with a MODS equal to or greater than 1 in any day. The levels 3 or 4 of
MODS were considered severe organ/system dysfunction. Statistical
analyses were done by Mann–Whitney and chi-square as indicated.
Results: There was 141 patients (P) with ARDS criteria and all
were included in the analysis. Seventy-six (54%) were men, the
mean age was 46±18 years and APACHE II 19±7. Mortality rate
was 79%. In survivors (SV) and nonsurvivors (NSV) mean age was
35±14 years and 49±5 years (P<0.0001), and APACHE II
16±5 and 20±7 (P<0.001), respectively. There was no differ-
ence about gender in mortality. In all groups, there was 4.3±1
organ dysfunction, with 10P (7%) with 2, 20P (14%) 3,
36P (26%) 4, 69P (49%) 5, and 6P (4%) 6 organ/system dys-
function; mortality rate in these groups was, respectively: 50%,
60%, 81%, 87% and 100%. The number of organ/system dys-
function was in SV 3.7±1.1 and in NSV 4.5±0.9 (P<0.01). The
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8.8±3.1*; 5.8±2.6 and 9±3.5*; 5.9±2.8 and 9±3.5*; 4.9±2.6
and 8.8±3.7*; 4.3±2.7 and 8.6±3.7*; 4.3±3.2 and 8.6±3.6*;
5.2±3.6 and 7.2±3.7**, respectively (*P<0.0001; **P=0.035).
Bivariate analysis of each organ of MODS in separate in the first
week vs mortality showed that renal dysfunction was present in
94P (89%) and 12P (11%) (P<0.001) and haematological dys-
function in 96P (86%) and 16P (14%) (P<0.01), in NSV and SV.
Severe cardiovascular dysfunction was present in 79P (85%) NSV
and in 14 (15%) SV (P<0.03). The other variables showed no sta-
tistical differences.
Conclusions: The occurrence, level and number of organ/systems
compromised in the first week after ARDS, estimated by the
MODS, correlated with mortality in our patients. Cardiovascular,
renal and hematological dysfunctions were those more influents in
mortality; the determination of neurological dysfunction was diffi-
cult because patients were sedated for mechanical ventilation. In
our patients, mortality was affected by age and the severity of
organ dysfunction in the first week, estimated by the MODS.
References:
1. Bernard GR, Artigas A, Brigham KL, et al.: Am Respir Crit Care Med
1994, 149:818-824.
2. Marshall JC, Cook DJ, Christou NV, Bernard GR, Sprung CL, Sibbald
WJ: Crit Care Med 1995, 23:1638-1652.
P3 Instrument development to conduct a meta-analysis of mortality from ARDS
T Simpson, EF Bond
University of Washington School of Nursing, Biobehavioral Nursing & Health Systems Department, Box 357266, Seattle, WA 98195-7266,
USA
Recently, randomized clinical trials of ventilatory management
strategies indicate a reduction in mortality associated with acute
respiratory distress syndrome (ARDS). However, there is little
clarity as to whether mortality has changed over time to provide a
benchmark reference for measuring the effects of therapies and for
identifying factors that reduce mortality. In preparation to conduct a
comprehensive meta-analysis of mortality from ARDS, 14 search
terms for ARDS were identified to generate titles from published,
electronic, and unpublished sources. The co-investigators indepen-
dently reviewed a subset of titles (1996–2000) to select abstracts
about investigations of a therapy or pathophysiological mechanism
likely to yield information about mortality from ARDS.
Titles were excluded from further review if the report appeared to
be a single page; single case study; pediatric/neonatal or healthy
subject; review or meta-analysis; study sample with chronic respi-
ratory failure, idiopathic pneumonia syndrome, or pulmonary toxic-
ity; or a methods paper of instrument reliability for patients with
ARDS. Inter- and intra-rater agreements ranged between
98–100% across 5 years of title reviews. The co-investigators
independently reviewed abstracts of acceptable titles to determine
the likelihood that the manuscript would contain useful mortality
data (inter-rater Kappa [corrected for chance agreement]=0.76;
intra-rater Kappa=0.86); clarity of distinct study group(s) with
ARDS (inter-rater Kappa=0.71; intra-rater Kappa=0.94); and
sample size of greater than one subject with ARDS (inter-rater
Kappa=0.78; intra-rater Kappa=0.79).
An instrument is being developed to assess the study quality and
outcomes of each manuscript. The purpose of assessing the
quality of the manuscript is to derive a total and variable-linked
score by which the manuscript can be assessed for the impact of
bias and precision on the meta-analysis. Four areas of the study’s
quality include publication demographics, study methods, statisti-
cal analysis, and presentation of results. Publication demographics
include publication source, geographic location of the study, bio-
statistician involvement, and source of support for the study. Study
methods are assessed for the design, sampling methods, descrip-
tion of conditions, randomization and blinding strategies, and a
priori power analysis. Statistical analysis entails determining the
clarity of analysis, intention to treat, compliance, and monitoring of
adverse effects. Presentation of results is evaluated for the dura-
tion of enrollment, comparison of baseline characteristics and
prognostic variables, and post hoc power analysis.
Inter- and intra-rater agreement of study quality are in process of
being analyzed. An instrument to measure variables associated with
mortality is also being developed to include general variables (ARDS
definition, sample characteristics, groups compared [ARDS versus
non-ARDS]), mortality linked with risk groups (sepsis/nonsepsis,
direct/indirect risk), nominal/ordinal subject characteristics (gender,
ARDS stage, location and cause of death), and interval/ratio subject
characteristics (lung injury, illness severity). Instrument development
will provide a solid methodological foundation for conducting a meta-
analysis of the risks, treatment effects, and mortality associated with
ARDS, using clinical studies from 1967 to the most recent findings.
P4 A novel technique of intra-abdominal pressure measurement: validation of two prototypes
MLNG Malbrain, M Léonard, D Delmarcelle
ICU, Ste-Elisabeth Hospital, 1180 Brussels, Belgium
Introduction: Intra-abdominal pressure (IAP) is an important para-
meter and prognostic indicator of the patient’s underlying physio-
logic status [1]. Correct IAP measurement therefore is crucial. The
gold standard measurement method via a bladder catheter first
described by Kron poses the risk for infection and needle-stick
injury and interferes with urinary output estimations [1]. Cheatham
and Safcsak reported a revision of Kron’s technique limiting these
risks but still interfering with urinary output estimation [2]. All these
measurements also interfere with nursing time and cannot be done
without manipulation of the Foley catheter. A technique for measur-
ing IAP using the patient’s own urine as transmitting medium has
been described previously [1]. The aim of this study is to validate
IAP measurement via two prototypes (Holtech Medical, Kopen-
hagen, Denmark) using this technique. A 50ml container fitted with
a bio-filter for venting is inserted between the Foley catheter and
the drainage bag. The container fills with urine during drainage;
when the container is elevated, the 50ml urine flows back into the
patient’s bladder, and IAP can be read from the position of the
meniscus in the clear manometer tube between the container and
the Foley catheter. The first prototype consisted of a 50ml plastic
bag with a bio-filter, inserted between the Foley catheter and the
urine collection bag; a major drawback was occasional blocking of
the bio-filter, leading to overestimation of IAP in some cases.
Another drawback was the occasional presence of air-bubbles inthe manometer tube, producing multiple menisci leading to mis-
interpretation of IAP. In addition, the volume of urine flowing back
into the bladder was not well defined. Prototype 2 was adapted to
correct for the drawbacks of prototype 1, using a rigid 50ml reser-
voir with a large bio-filter surface.
Methods: In total 60 paired measurements were performed in five
patients with prototype 1, and 119 paired measurements were per-
formed in seven patients with prototype 2. The IAP was calculated
using two different methods: the gold standard via an indwelling
bladder catheter using a pressure transducer (IAPves) and via the
prototypes using the patient’s own urine as transmitting medium
(IAPproto1 and IAPproto2). The M/F ratio was 4/1, age 71.4±6.6,
MODScore 5.4±3.6, SOFA score 8.4±2.9, APACHE-II score
22.6±4.8, SAPS-II score 51.8±14.4 in the five prototype 1
patients and 4/3, 68.4±18.9, 5.9±3, 7±1.9, 16.6±5.2 and
43.4±11.9 respectively in the seven prototype 2 patients. The
number of measurements in each patient was 12±2.7 for proto-
type 1 and 17±9.8 for prototype 2. Calculation of correlation was
done with the Prism GraphPad™ software (version 2.00,
31 October 1995), values are mean±SD.
Results: The values for IAP (mmHg) were 12.6±5.3 (IAPves)
versus 11.1±3.7 (IAPproto1) and 10.1±3.6 (IAPves) versus
10.2±3.3 (IAPproto2). There was a good correlation between
IAPves and IAPproto1: IAPves=0.592×IAPproto1 + 3.666
(R2=0.71, P<0.0001), but the bias was considerable. The analy-
sis according to Bland and Altman showed that IAPproto1 consis-
tently underestimated IAPves with a mean difference or bias of
–1.5±2.9 (SD) mmHg (95% confidence interval –2.2 to –0.7); the
limits of agreement were –7.3 to 4.4 mmHg (95% CI –8.6 to –6
for the LLA and 3.1 to 5.7 for the ULA), these intervals are large
and thus reflect poor agreement. The correlation was better
between IAPves and IAPproto2: IAPves=0.9×IAPproto2 + 1.17
(R2=0.96,  P<0.0001). The analysis according to Bland and
Altman showed that IAPproto2 was almost identical to IAPves with
a mean difference or bias of 0.17±0.8 (SD) mmHg (95% CI 0.03
to 0.3); with small limits of agreement –1.4 to 1.7 mmHg (95% CI
–1.6 to –1.1 for the LLA and 1.5 to 2 for the ULA), these small
intervals thus reflect good agreement. A drawback of prototype 2
was the appearance of urine leakage from the rigid 50ml
container’s bio-filter in 11 out of 13 devices after 16.7±12.3 hours
caused by a technical problem during the assembly of the proto-
types.
Conclusions: We found a good correlation between all IAP mea-
surements using the gold standard and both prototypes.
Prototype 2 represents a major improvement in the quality and
reproducibility of the IAP measurement. With this non-invasive
technique using the patient’s own urine as transmitting medium
nursing time and cost can be significantly reduced. IAP measure-
ment can easily be done at each urine output estimation without
interference. The risk of infection and needle-stick injury is
reduced. The leakage problem of prototype 2 needs to be
corrected.
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P5 An observational study on intraabdominal pressure in 125 critically ill patients
N Pouliart, L Huyghens
AZ-VUB, Laarbeeklaan 101, 1090 Brussels, Belgium
Elevated intraabdominal pressure and the abdominal compartment
syndrome seem to be the recent hype at critical care conferences.
The objective of this longitudinal, observational study is to docu-
ment epidemiologic data on intraabdominal pressure (IAP) in
patients admitted to a mixed medical and surgical intensive care
department (ICU) of an university hospital and to determine the
value of routine monitoring of IAP.
All adult patients admitted for an expected minimum stay of
48 hours in the ICU were included, provided that they needed an
indwelling urinary bladder catheter. Included patients were fol-
lowed until discharge from the ICU or until death, whichever came
first. Final outcome at hospital discharge was determined. The IAP
was measured in a non-invasive manner through the aspiration port
of a standard indwelling bladder catheter, in a modification of the
procedure as originally described by Kron et al. The IAP was mea-
sured twice daily until discharge from the ICU or until there was no
further need of a bladder catheter (i.e. a bladder catheter was not
left in place for the sole purpose of measuring IAP). Furthermore,
demographic, pathologic, and diagnostic data, as well as physio-
logic, hemodynamic, and biochemical parameters were recorded.
Several disease severity scores were calculated.
We present the results of the first 125 patients included. A total
of 1451 measurements were performed. Patients were stratified
into two groups depending on 30-day survival or outcome at dis-
charge from hospital. Forty-one patients (652 measurements) did
not survive. Mean IAP for this group was 8.9 (range –6 to 24, SD
4.5). We recorded 130 IAP-values over 12mmHg (20%) of
which seven IAP-values over 19mmHg (1%) in six patients.
Eighty-four patients (799 measurements) had a favourable
outcome. Mean IAP for this group was 7.6 (range –6 to 30, SD
4.6). We recorded 112 IAP-values over 12mmHg (14%) of
which 10IAP-values over 19mmHg (1%) in five patients. The
two-tailed student’s t-test for the IAP between the two groups
was significant (P<0.0001). However, elevation of IAP-values
did not necessarily coincide with demise. We could not demon-
strate a linear correlation between IAP-values and values of other
parameters.
From our present data we can conclude that IAP is generally
higher in non-survivors than in survivors, but that survivors can have
elevated values of IAP. Routine monitoring of IAP in all patients
admitted to the ICU does not seem warranted.
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P6 Relation between transdiaphragmatic pressure and oxygen consumption in patients with intestinal obstruction
RR Gubaidullin, AV Butrov
Medical Faculty of Russian Peoples’ Friendship University, Tsyurupy 16-1-168, 117418 Moscow, Russia
Background and goals: Dysfunction of the diaphragm generally
causes an additional load on other respiratory muscles [1]. It may
be expressed by the increased oxygen cost of breathing and
oxygen consumption (VO2) [2]. The increased abdominal pressure
in patients with an intestinal obstruction may cause the dysfunction
of the diaphragm.
Materials and methods: We studied the relation between VO2
and the end tidal transdiaphragmatic pressure (PdiET) in 16
patients with the diagnosis of an intestinal obstruction. The investi-
gations were carried out after operation and before extubation. The
average age of the patients was 41±12. The same technique of
anesthesia was performed in all patients. The APACHE II count
was 22±3. The device Capnomac Ultima™ measured VO2.
Results: The relation between PdiET and VO2 are submitted in the
Figure.
Conclusion: The patients with an intestinal obstruction demonstrate
the moderate linear correlation (r=0.63) between PdiET and VO2.
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Introduction: In Systemic Inflammatory Response Syndrome
(SIRS) model in rabbits we aim to investigate the relationship
between increased intraabdominal pressure (IAP) and lung compli-
ance during mechanical ventilation.
Methods: Twenty-four New Zealand rabbits were randomly divided
into three groups (n=8). After sedation with intramuscularly keta-
mine (50mg/kg): In group 1: Laparotomy and single cecum punc-
ture was done and, after insertion of an intraabdominal catheter,
the abdomen was closed. In group 2: Laparotomy was done and
after insertion of an intraabdominal catheter, the abdomen was
closed. In group 3: It was the control group. After sedation, nothing
was done.
In group 1 and 2, after 1 hour of abdomen closure and in group 3
after 1 hour of sedation, tracheostomy was performed and endo-
tracheal tube was inserted. The rabbits were curarized by
atracuriým (0.5mg/kg, intramuscularly), and ventilated with PC
mode for 3 hours and the parameters of ventilation were FiO2=
1.0, PIP=18cmH2O, PEEP=5cmH2O, RR=80breaths/min.
Compliance and IAP values were recorded every 30 min. Data
were compared by Mann–Whitney U test. P<0.05 was consid-
ered to indicate statistical significance.
Results: IAP levels in group 2 were found to be higher than
group 3 (P<0.01). However when lung compliance values were
compared between groups, no significant differences was encoun-
tered. And lung compliance values were found to be significantly
decreased when compared to initial values in all groups at the end
of the study (P<0.05).
Conclusion: In this experimental SIRS model, at the very begin-
ning, increased IAP values does not seem to effect lung compli-
ance measurements during mechanical ventilation.
P8 The effects of increasing levels of PEEP on inflammation markers and oxygenation in rats with unilateral lung injury
T Schreiber, K Schwarzkopf, B Schmidt, W Karzai
Department of Anesthesiology and Intensive Care Medicine, University of Jena, Bachstrasse 18, 07740 Jena, Germany
Introduction: The effects of PEEP on inflammation and oxygena-
tion during acute lung injury are not well known. Accordingly, we
investigated the effect of different PEEP levels on local and sys-
temic parameters of lung injury and inflammatory response in a uni-
lateral in vivo lung injury model.
Methods: Male Wistar rats (350g) underwent left-sided lung injury
using endobronchial instillation of 0.4ml HCl (pH1) (study group)
or endobronchial instillation of 0.1ml NaCl 0.9% (placebo group).
Twenty-four hours after treatment the rats were anesthetized, and
intravascular catheters inserted for fluid infusion and hemodynamic
monitoring. A tracheostomy was performed and the rats were venti-
lated for 4 hours with tidal volume of 6ml/kg body weight and ran-
domly assigned to ZEEP, PEEP=5cmH2O or PEEP=10cmH2O
groups. Oxygenation was measured every 30min and left and right
lung lavage was performed lung after 4 hours of ventilation for cell
and protein determination. An ANOVA was used for statistical
analysis.
ç
P7 Effects of systemic inflammatory response syndrome on intraabdominal pressure and lung compliance
Y Tur, GM Koksal, C Sayilgan, H Oz
IU Cerrahpasa Medical Faculty, Department of Anaesthesiology, 34303 Istanbul, TurkeyTable
Lung injury with HCl Controls
ZEEP PEEP5 PEEP10 ZEEP PEEP5 PEEP10
PaO2 after 4h vent. (mmHg)* 127±26 193±4 203±10 138±14 215±10 197±13
Protein left lung (mg/l)** 2841±146 2867±253 1970±300 80±11 62±17 72±17
Protein right lung (mg/l)*** 343±69 212±69 195±43 69±7 85±13 92±10
Neutrophils left lung (ml–1)** 4082±503 2634±530 1744±453 158±77 157±34 85±29
Neutrophils right lung (ml–1)*** 456±98 449±147 335±148 155±33 214±56 185±58
Mean±SEM; Protein and neutrophils: in lavage fluid. *P<0.05 for effects of PEEP; **P<0.05 for effects of group, PEEP and interaction;
***P<0.05 for effects of group.
Results and conclusion: PaO2 was higher in the PEEP groups as in
the ZEEP groups. Protein and neutrophils in lung lavage fluid of both
sides were higher in injured as in placebo rats. Increasing PEEP
levels reduced neutrophil count in lavage fluid of the damaged lung
in a dose dependent manner. PEEP increases oxygenation and
decreased neutrophil infiltration in this model of lung injury.
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P9 The effects of increasing levels of PEEP on oxygenation and lung perfusion in pigs with unilateral lung injury
T Schreiber*, K Schwarzkopf*, N Preussler*, H Schubert†, E Gaser*, L Hüter*, W Karzai*
*Department of Anesthesiology and Intensive Care Medicine, and †Department of Experimental Animals, University of Jena, Bachstrasse 18,
07740 Jena, Germany
Table
Lung injury with HCl (n=8) Control (n=6)
ZEEP PEEP5 PEEP10 ZEEP PEEP5 PEEP10
PaO2 (mmHg) 407±17* 471±11* 468±22* 470±22 488±12 525±14
MAP (mmHg) 75±8** 65±5** 45±8** 67±11** 61±11** 53±9**
CO (l/min) 3.6±0.2** 2.9±0.2** 2.0±0.1** 3.8±0.4** 3.2±0.2** 2.6±0.2**
Left lung perfusion (% of total) 30±3* 30±4* 30±3* 50±1.6 47±1.1 57±1.8
Left lung TV (% of total) 29±1.6* 32±1.2* 33±1.2* 45±0.8* 47±1* 46±0.6*
Mean±SEM; CO=cardiac output, MAP=mean arterial pressure, TV=tidal volume. *P<0.05 for effects of group. **P<0.05 for effects of PEEP.
Introduction: The effects of PEEP may differ in healthy and dis-
eased parts of the lung. Accordingly, we studied the effects of
increasing PEEP-levels on ventilation, lung perfusion, oxygenation,
and hemodynamics in an animal model with unilateral lung injury.
Methods: In 8 pigs (25–36kg) unilateral lung injury was induced
by bronchoscopic application of HCl 0.1m into the left lung (total:
20–35ml). Twenty-four hours after injury the pigs were anes-
thetized, endotracheally intubated with a double-lumen tube and
mechanically ventilated. Catheters for hemodynamic monitoring
were inserted. Volume controlled ventilation (12ml/kg body weight,
FiO2 1.0) with ZEEP, PEEP 5cmH2O and PEEP 10cmH2O was
performed in random order in each animal. Measurements after
45min of hemodynamic stability in each phase included differential
lung perfusion using colored microspheres and differential lung
ventilation using the double lumen tube. In 6pigs (control group)
the study was performed without preceding lung injury. ANOVA
was used for statistical analysis.
Results and conclusion: After lung injury and in comparison to the
control group, left side lung compliance and left side tidal volumes
were significantly lower (data not shown). With increasing PEEP,
MAP, CO and shunt fraction decreased in both groups.
Compared to the control group, perfusion of the left lung
decreased after lung damage, but was not changed by PEEP. Our
study shows that PEEP depresses the circulation but does not
alter the perfusion of the injured lung during unilateral lung injury.
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P10 The blood shifts during the pressure volume curve
D Chiumello, A Aliverti, R Dellacà, E Carlesso, L Gattinoni
Ist. di Anestesia e Rianimazione, Ospedale Maggiore Policlinico-IRCCS, Milano, Italy; Dipartimento di Bioingegneria, Politecnico di Milano,
Italy; and Centro di Bioingegneria, Fond. Don Gnocchi IRCCS and Politecnico di Milano, Italy
Background and goals: The pressure volume (PV) curve of the
respiratory system is drawn assuming that the gas volume dis-
placements (∆Vgas) are equals to the lung and chest wall changes
(∆Vcw). In this study we compared ∆Vgas and ∆Vcw during static PV
curve obtained by supersyringe (PVgas) and by OEP (PVcw) [1].
Materials and methods: In eight sedated and paralyzed
ALI/ARDS patients (5M/3 F, age 75±13 years, BMI 25.6±
3kg/m2, PaO2/FiO2 222±67mmHg), the PV curves were
obtained by the supersyringe method. A mathematical correction
was applied to the gas volume injected or withdrawn by the syringe
to avoid mistakes due to temperature, humidity, pressure and gas
exchange [2]. To study the deflation phase, avoiding the inflation
effects, for each PV curve the difference between the total static
compliance (TSC) of PVgas and TSC of PVcw, was added to the
deflation limb of PVcw.
Results: (1) Inflation phase: the ∆Vgas was always higher than the
∆Vcw, the discrepancy between ∆Vgas and  ∆Vcw was at TSC
–193.72±145.56ml, which was correlated to airway pressure
product time of inflation (P<0.001,  r2=0.87) and to the ratio
between esophageal and airway pressure variations (∆Pes/∆Paw)
(P<0.01, r2=0.91).
(2) Deflation phase: the ∆Vgas was equal, lower or higher than the
∆Vcw, this discrepancy was correlated to central venous pressure
(P<0.01, r2=0.7) and time to deflation (P<0.05, r2=0.8).
Conclusions: The discrepancy between ∆Vgas and ∆Vcw was cor-
related to time to perform the PV curve, airway pressure reached,
mechanical property of the respiratory system and hemodynamic
conditions. We think that the discrepancy can be due to the blood
shifts (OUT and INTO the thorax).
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P11 Clinical study of sustained inflation on patients with acute respiratory distress syndrome
Y Tan, HB Qiu, SX Zhou, Y Yang, SH Liu, RQ Zheng, YZ Huang, FM Guo
Department of Critical Care Medicine (ICU), Zhong-Da Hospital and Clinical Medical College, Southeast University, Nanjing, PR China
Objective: To evaluate the therapeutic effects of sustained inflation
(SI) combined with lung protective strategy in patients with acute
respiratory distress syndrome (ARDS).
Design: Prospective study.
Setting: Medical intensive care unit, university hospital.
Patients: Twenty mechanically ventilated ARDS patients.
Interventions: SI (30cmH2O, 20 s) was combined with lung pro-
tective strategy in 20 ARDS patients. Hemodynamics, pulmonary
mechanics and gas exchange were monitored continuously.
Measurements and results: SI was well tolerated by every
patient. Four patients were lack of beneficial effects. Arterial
oxygen tension and saturation, mixed venous oxygen tension and
saturation increased after SI, while venous admixture decreased
(P<0.05). Dynamic pulmonary compliance and lung volume
improved markedly. The effects were maintained in 16 patients for
4 hours. Mean arterial pressure, central venous pressure, pul-
monary capillary wedge pressure, mean pulmonary arterial pres-
sure, pulmonary vascular resistance index and right ventricular
stroke work index significantly increased during the 20s inflation
(P<0.05), but reversed rapidly after the inflation was terminated.
Conclusions: Using with lung protective strategy, SI is able to
improve pulmonary compliance, lung volume and oxygenation. It is
a safe and valid lung recruitment maneuver.
P12 The optimal pressure of sustained inflation for alveolar recruitment
HB Qiu, Y Tan, SX Zhou, FM Guo, JH Dai
Department of Critical Care Medicine (ICU), Zhong-Da Hospital and Clinical Medical College, Southeast University, Nanjing, PR China
Objective: To determine the optimal recruitment pressure of sus-
tained inflation (SI) in treatment of rabbits with acute respiratory
distress syndrome (ARDS).
Materials and methods: SI was applied at pressures of 1~6
times of mean airway pressure (Pm) for 20s to saline-lavaged adult
New Zealand rabbits. Hemodynamics, pulmonary mechanics and
gas exchange were observed before SI, during, and 2 min, 5 min
after applying SI. Lung histology was observed after experiment.
Results: When the pressure of SI was higher than 3Pm, arterial
oxygen tension (PaO2) and arterial oxygen saturation were
improved. The difference of PaO2  before and during SI were
(75±39)mmHg and (52±25)mmHg respectively in the 5Pm and
6P m group, which were higher than 1Pm  group significantly
([–5±4]mmHg,  P<0.05). The difference of dynamic pulmonary
compliance before and during SI in 5Pm group was increased
markedly ([1.90±0.20]ml/cmH2O in 5Pm group, [–0.02±
0.04]ml/cmH2O in 1Pm group, P<0.05). 5Pm resulted in immedi-
ate increased significantly in lung volume ([3.1±2.1]ml/kg in the
5P m group, [8.3±0.7]ml/kg in the 1Pm  group). Histologically,
Smith lung injury score was 4.03±1.79 in the 5Pm group, which
was less than the score in the group of ARDS model (6.10±0.77).
SI with 6Pm led to alveolar overdistention. With the increasing of
SI pressure, mean arterial pressure decreased markedly.
Conclusions: 5Pm (25~35cmH 2O) may be the optimal recruit-
ment pressure of SI in rabbits with ARDS.P13 Expiratory pressure–volume curves in pulmonary and extrapulmonary ARDS
G Muñiz Albaiceta, F Taboada, D Parra Ruiz, JA Gonzalo Guerra, A Lopez Morán, A Blanco Vicente
Intensive Care Unit, Hospital Central de Asturias, C/Celestino Villamil s/n. 33006, Oviedo, Spain
Objective: To assess the differences in lung mechanics during
expiration between acute respiratory distress syndrome from pul-
monary (ARDSp) and extrapulmonary (ARDSe) origin.
Methods: The expiratory pressure–volume (PV) curve was
recorded after standardisation of volume history. The ventilator was
switched to CPAP of 35cmH2O and was then reduced in
5cmH2O steps. Volume corresponding to static conditions was
recorded. Esophagic pressure was recorded with a fluid-filled
catheter [1]. The PV curves were fitted to a sigmoid model [2] for
comparing volumes (absolute and percentage to estimated total
lung capacity) at the same pleural and transpulmonary pressures.
All data are expressed as mean±SD. Differences between groups
were performed using a Mann–Whitney U test.
Results:  Patients: Ten patients with early ARDS (5 ARDSp/
5 ARDSe). Mean age was 59±15.5 years. APACHE-II score:
22.8±6.8. Lung injury score: 2.9±0.3. PaO2/FiO2: 124±50.7. No
differences were found between ARDSp and ARDSe in these results.
Compliance (C): ARDSp and ARDSe show similar respiratory
system C (30±8.7ml/cmH2O vs 45±18.1ml/cmH2O respec-
tively, n.s.), but ARDSp has lower lung C (35.9±11.3ml/cmH2O
vs 77.2±50.6ml/cmH2O,  P=0.05) and higher chest wall 
C (199.6±44.4ml/cmH2O vs 125.5±16.5ml/cmH2O, P<0.05).
PV curves (see Fig.): Respiratory system PV curve from ARDSp is
shifted down and right with respect to ARDSe. When fractional
volumes are considered these differences are also significative.
The lung PV curve of ARDSp is shifted in a similar way. However,
when considering fractional volumes, the differences are only signi-
ficative in the low pressure range (0–10cmH2O). The chest wall
PV curve in the ARDSp group is, as expected, shifted to the left.
Conclusions: The ARDSp has a respiratory system PV curve dis-
placed downwards when compared with ARDSe, which suggests
a small amount of reclutable tissue. When the lung PV curve is
considered, these differences are higher. The fractional PV curves
show similar differences for the respiratory system, but not for the
lung. The difference in the latest affects only to the low pressure
range, which suggest a greater airway closure in ARDSe.
References:
1. Karason S, et al.: A simplified method for separate measurements
of lung and chest wall mechanics in ventilator treated patients.
Acta Anesthesiol Scand 1999, 43:308-315.
2. Venegas JG, Harris RS, Simon BA: A comprehensive equation for
the pulmonary pressure–volume curve. J Appl Physiol 1998,
84:389-395.
Figure
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P14 Influence of positive end-expiratory pressure (PEEP) on left ventricular regional wall motion in patients with acute
respiratory distress syndrome (ARDS)
E Huettemann, M Steinecke, C Schelenz, S Thomas, K Reinhart
Department of Anaesthesiology and Intensive Care, Friedrich-Schiller-University, D-07740 Jena, Germany
Regional left ventricular wall motion abnormalities have been
described at a positive end-expiratory pressure (PEEP) level of
20cm H2O [1]. However, no PEEP level has yet been defined,
above which RWMA may occur.
Objective: To assess global and regional LV performance in
response to PEEP by transoesophageal echocardiography (TOE)
in patients with ARDS.
Setting: Surgical ICU in a university hospital.
Patients: Eight critically ill patients with normal systolic LV function
requiring mechanical ventilation (tidal volume 6–8ml/kg, PEEP
12±2cmH 2O) due to ARDS.
Measurements: Regional and global LV performance were
assessed at PEEP levels of 5, 10, 15, 20 and 25cmH2O by means
of TOE by the centerline method on the transgastric short-axis view.
Results: PEEP ≥15cmH2O produced a significant reduction in
systolic septal wall motion (hypokinesia) and a significant augmen-
tation of lateral systolic wall motion (hyperkinesia). Global LV per-
formance — measured as fractional area change — was not
significantly affected.
Conclusion and discussion: PEEP levels ≥15cmH2O may be
associated with an inhomogeneity of regional wall motion. Most
likely, this phenomenon is related to a nonuniform transmission of
the increased intrathoracic pressure on the left ventricular wall
because of its different relation to the pleural space.
Reference:
1. Fellahi JL, Valtier B, Beauchet A, et al.: Does positive end-expiratory
pressure ventilation improve left ventricular function? A compara-
tive study by transesophageal echocardiography in cardiac and
noncardiac patients. Chest 1998, 114:556-562.
Table
Males Females Age ICU stay (hours) MV (hours) Pneumonia Death
9 ml 24 34 54 178 100 17 (29%) 6/58 (10.3%)
14 ml 28 14 57 171 98 14 (32%) 7/44 (16%)
P15 Does the use of large ventilator tidal volume increase the incidence of postoperative complications?
SK Appavu, TR Haley, SR Patel, A Khorasani, K Mbekeani
Department of Surgical Critical Care, Cook County Hospital and the University of Illinois College of Medicine, Chicago, IL, USA
The use of large tidal volumes (LTV) (10–15ml/kg) for mechanical
ventilation (MV) of patients with ARDS has been shown to be detri-
mental. Whether or not the use of LTV for postoperative mechani-
cal ventilation increases the risk of pulmonary complications,
pneumonia, and consequent mortality from pulmonary causes is
unknown. We performed this study with the hypothesis that post-
operative patients receiving MV with large tidal volume would have
an increased incidence of pulmonary complications and mortality.
Postoperative abdominal and thoracic surgical patients receiving
either 9ml/kg or 14ml/kg tidal volumes for mechanical ventilation
were studied. Those with pre-existing atelectasis, pneumonia or
ARDS were excluded. The patients were managed in the SICU and
were weaned and extubated according to standard practice. Extu-
bated patients who later required reintubation were not placed on
study tidal volumes. Data collection included patient demographics,
surgical diagnoses, operations, preoperative chest X-ray results,
the size of tidal volume, duration of MV, incidence of pulmonary
complications, and patient outcome. The data was analyzed using
SPSS statistical soft ware. One hundred and two patients were
studied: 52 males and 50 females. Their mean age was 55.4 years.
The operative procedures included major elective abdominal
surgery, aortic reconstruction, emergency abdominal surgery, and
esophageal resections. Eighty patients had normal preoperative
chest X-ray. Twenty-two patients had COPD or other chronic
pulmonary conditions. Sixty-nine patients had no postoperative
pulmonary complications. Pneumonia developed in 31 (30.4%)
patients, pulmonary edema in one, and pleural effusion in another.
Thirteen of 102 patients (12.7%) died. Fifty-eight patients received
9ml/kg and 44 received 14ml/kg tidal volume. Their characteris-
tics are shown in the Table.
Two patients in the 9ml/kg group and one patient in the 14ml/kg
group died from pneumonia. One of eight patients in the 9ml/kg
group and four of seven patients in the 14ml/kg group died from
septic shock due to gangrene or perforation of the GI tract with
peritonitis.
Conclusion: The use of large tidal volume for postoperative
mechanical ventilation does not increase postoperative complica-
tions or mortality.P16 Lung recruitment manoeuvres decrease gastric mucosal blood flow in ICU patients
SJ Claesson, S Lehtipalo, O Winsö
Department of Surgical and Perioperative Sciences, Anesthesiology and Intensive Care, Umeå University Hospital, S-901 85 Umeå,
Sweden
Introduction: The use of recruitment manoeuvres (RM) has
recently been introduced into clinical practice for treatment of
atelectasis during mechanical ventilation. Transient high airway
pressures, such as those employed in RM, may lead to adverse
general or regional circulatory effects. The aim of this study was to
evaluate effects of RM on gastric mucosal blood flow, systemic
oxygenation and respiratory mechanics.
Methods: Nine ICU patients with acute lung injury, age 60±5,
APACHE II 22±3, were studied. Gastric mucosal blood flow was
measured continuously with laser Doppler flowmetry (LDF). Mean
arterial (MAP), central venous (CVP), oesophageal, abdominal and
airway pressures were also measured continuously. Cardiac output
was measured by arterial pulse contour analysis (PICCO). Three
consecutive RMs separated by a 15 min pause were studied, the
two first were performed with inspiratory pressure (Pinsp)
40cmH2O, inspiratory time (Tinsp) 8s, expiratory pressure (Pexp)
20cmH2O and expiratory time (Texp) 2s for 2 min. The third RM
was performed with Pinsp 50cmH2O, Tinsp 4s, Pexp 20cmH2O, Texp
1s for 2 min. Blood gas measurements were performed before, at
the end of, and 3 min after each RM.
Results: When comparing values before RM1 with values
obtained after RM3 preliminary data indicate that three consecutive
RMs did not significantly change MAP, HR, PaO2 or dynamic com-
pliance. There was a significant decrease in LDF, CI and a signifi-
cant increase in SVRI. Three patients demonstrated a drastic
increase in PaO2 during all RMs, but this increase was not sus-
tained after the RMs were terminated.
Conclusion: Three consecutive recruitment manoeuvres
decreased gastric mucosal perfusion and cardiac index without
any beneficial effect on oxygenation.
Table
Before RM1 After RM3
MAP (mmHg) 86±5 88±4
CI (l/min/m2)( n=4) 4.2±0.2 3.8±0.2*
LDF (PU) (n=8) 504±49 387±28*
PaO2 (kPa) 10.5±0.5 11.4±0.9
n=9. Mean±SEM. *P<0.05.
P17 Asymmetry in lung pathology and short-term effects of independent lung ventilation (ILV) on pulmonary mechanics and
gas exchange in patients with blunt chest trauma
S Milanov, M Milanov, E Giurov
Emergency Institute ‘Pirogov’, Totleben 21, Sofia, Bulgaria
Independent lung ventilation has been used in patients with asym-
metric lung pathology. In this study we applied ILV in 17 consecu-
tive ventilated patients with blunt chest trauma with inclusion
criteria PO2/FiO2<200 without physical or roentgenographic evi-
dence of unilateral pulmonary disease. Eight of the patients (53%)
demonstrated paradoxical PEEP/CPAP effect (worsening of pul-
monary mechanics, gas exchange and increase in shunt with PEEP
application) before institution of ILV. After application of ILV 10 of
the patients (59%) demonstrated pulmonary mechanics asymmetry
between left and right lung. In this group of patients we continued
with ILV and applied differential PEEP levels (3.4±2.2cmH2O for
normal lung and 12±3.7 for diseased lung, optimized with con-
stant flow technique) with different tidal volumes for both lungs and
level of Pplat<30cmH2O. Pulmonary mechanics, gas exchange
and total body oxygen delivery were determined on 1, 6 and
48 hours after ILV application. In patients who did not demonstrate
pulmonary asymmetry we replaced ILV with conventional mechani-
cal ventilation. Patients with continued ILV demonstrated signifi-
cant improvement in oxygenation parameters and total body
oxygen delivery and gradually decreasing asymmetry in pulmonary
mechanics. In this study we found high incidence (59% of
patients) of lung pathology asymmetry in patients with blunt chest
trauma without roentgenographic or physical evidence of such
asymmetry. Our data suggest that ILV can be used in patients with
blunt chest trauma as lung protective ventilatory strategy with
maximal favourable effect on diseased lung and minimal adverse
effect on normal lung.
References:
1. Klingstedt et al.: Ventilation–perfusion relationships and atelecta-
sis formation during conventional mechanical and differential ven-
tilation. Acta Anaesthesiol Scand 1994, 34:421.
2. Baehrendtz S et al.: Differential ventilation in acute bilateral lung
disease. Influence on gas exchange and haemodynamics. Acta
Anaesthesiol Scand 1983, 27:270-274.
P18 Alveolar recruitment improves arterial oxygenation in responders to prone position
J Reutershan, A Schmitt, R Fretschner
Department of Anaesthesiology and Critical Care, University Hospital Tübingen, Hoppe-Seyler-Str. 3, 72076 Tübingen, Germany
Introduction: Although prone position is known as a simple
method to improve arterial oxygenation in patients with acute respi-
ratory distress syndrome (ARDS), the underlying physiological
mechanisms remain poorly understood. This study was performed
to show the effect of prone position on alveolar recruitment.
Methods: After approval by the local ethics committee of the
medical faculty 12 patients with ARDS diagnosed according to the
criteria of the American–European Consensus Conference were
included. Patients were ventilated in volume controlled mode and
the ventilatory settings were kept unchanged throughout the whole
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period of measurements. Patients were kept in prone position for 8
hours. Arterial partial pressure of oxygen (PaO2), airway pressure,
gas flow and functional residual capacity (FRC) were measured
(AMIS 2001 Intensive Care Monitoring System; INNOVISION,
Odense Denmark) and intrapulmonary shunt (Qs/Qt) was calcu-
lated from arterial and mixed venous blood gas analyses. Measure-
ments were performed in supine position (Ts0), immediately after
turning to prone position (Tp0), after 1, 2, 4 and 8 hours in prone
position (Tp1, Tp2, Tp4, Tp8) and immediately after turning back to
supine (Ts1). Patients were defined as responders to prone posi-
tion if the oxygenation quotient (PaO2/FiO2) increased more than
30%. Individual pressure–volume curves (pv-curves) of the respira-
tory system were constructed by means of FRC measurements
and dynamic compliances which were calculated from gas flow
and airway pressure measurements. Then alveolar recruitment
during prone position was identified as volume increase between
pv-curves at a predefined airway pressure of 20cmH2O.
Results: Seven of 12 patients showed a sustained increase of oxy-
genation quotient greater than 30% after prone therapy and were
defined as responders (+100% vs +10% in nonresponders).
There was no statistical difference in biometric data and severity of
ARDS between the two groups. Responders showed a continuous
increase of recruited lung volume during prone position. Total alve-
olar recruitment was significantly greater in responders than in non-
responders (+800±200ml vs –40±180ml; P<0.0001). Time
course of the alveolar recruitment and time of maximal recruitment
differs in all patients. A good correlation was found between total
recruited volume and decrease of intrapulmonary shunt (R2=0.72).
Conclusion: The present results show that alveolar recruitment
increases in responders to prone therapy. An individual time
course of alveolar recruitment was found, indicating that the dura-
tion of prone position has to be selected according to the specific
requirements of each patient. The good correlation between
increased lung volume and decrease of intrapulmonary shunt indi-
cates that the recruited lung spaces are capable of participating in
gas exchange and are not caused by overdistension or dead space
increase.
P19 Rotoprone®: a new and promising way to prone positioning
MG Baacke, T Neubert, M Spies, L Gotzen, RJ Stiletto
Department of Trauma-Surgery and Intensive-Care of the Philipps-University-Marburg, Germany
Introduction: Prone positioning developed to the most hopeful
therapeutical approach in the treatment of severe respiratory
failure. Different types of kinetic therapy are practiced, but not
every method can be used in any patient. Instable pelvic fractures,
aortic rupture, prominent external fixation, obesity, e.g., does some-
times not allow one to turn a patient to the prone position. With a
new kind of kinetic bed (Rotoprone®) more patients can treated in
prone position. First experiences, benefits and problems will be
reported.
Patients and methods: In an open prospective study we observed
from July 1999 until June 2000 eight polytraumatized patients in
the ICU of the Trauma-Center-Marburg with severe post-traumatic
respiratory failure, undergoing prone positioning by using the Roto-
prone®. Severity of injury and clinical course were defined through
the Injury-Severity-Score (ISS), APACHE-II-Score and the Thera-
peutic-Intervention-Scoring-System (TISS). The mean ISS was
39.8 (19/52), the APACHE-II-Score on the time of admission was
20.3 (19/23) and the TISS was 28.3 (43/25). All patients were
male. The mean age was 39.8 (19/66). The average time of begin-
ning the Rotoprone®-therapy was on the 8.8th day (2/21), the
average time of respiratory support was 33.4th day (18/59). The
mean time on ICU was 36.6 (22/62) days. Only one patient died
on ICU due to multiple organ failure.
Results: Using the SOFA-Score/lung (PaO2/FiO2) for measuring
the respiratory function we found a value of 170 (93/228) at the
beginning of prone positioning with the expected improvement to
values of 301 (265/375) at the end of kinetic therapy. Just in one
case we had to discontinue the use of Rotoprone® due to a mal-
function of the security-mechanism.
Edema of face and neck, pressure induced necrosis, hypotension
or arrhythmia never reached such an extent that we had to end
kinetic therapy.
Conclusions: This bed is a new and promising tool in treatment of
severe respiratory failure. Some patients who require kinetic
therapy in the extent of prone positioning who could so far not be
turned — due to different reasons — could now be treated. High
costs, difficult handling and few available beds are so far limiting
factors.
P20 Do we have explanations for the improvement of oxygenation and deterioration of outcome by using prone position in
acute respiratory failure?
JC Lewejohann, E Rieh, E Muhl, HP Bruch
Department of Surgery, Medical University of Lübeck, Ratzeburger Allee 160, 23538 Lübeck, Germany
In acute respiratory failure (ARF), in particular acute lung injury (ALI)
and respiratory distress syndrome (ARDS), change from supine
(SP) to prone position (PP) can improve oxygenation. The efficacy
of this intervention can be demonstrated by the course of oxygena-
tion index. Nevertheless prone position ventilation (PPV) showed no
improvement in survival so far. Endpoint for the assessment of ther-
apeutic effects of an intervention like PPV is generally the mortality
rate. The aim of our study is to attempt to analyze the discrepancy
between positive effects of prone position ventilation on oxygena-
tion index in ARF and the comparatively high mortality rates despite
of this intervention. We studied 110 consecutive patients with ALI
(n=18) and ARDS (n=92) at mean age 66±13 [SE] years in a
clinical follow-up design at a surgical ICU in a university hospital,
who met the criteria of the American European consensus defini-
tion. All patients were ventilated intermittent in SP and in PP (135°
left/right-side-position) for at least 6 hours/day. Data collection
included apart from baseline characteristics individual oxygenation
index and underlying diseases of the patients, in particular if of
benign or malignant nature. We compared individual oxygenation
index (PaO2/FiO2) before and after start of prone position (SPSS®
T-test) and the data set of each patient with outcome. PPV was well
tolerated in all n=110 patients and showed an significant increase
of PaO2/FiO2 in n=106 within the first 6 hours (SP 149±0.52 vs
PP 230±0.73mmHg [mean±SEM]). In the remaining four casesthere was a positive effect within the first 24 hours. Sixty-seven
(61%) of the patients died in the course of intensive care therapy
and 43 (39%) survived. Seven died with an oxygenation index
below 100, another 36 with a ratio below 200, 17 below 300 and
seven above 300mmHg. Patients with a malignant underlying
disease as cofactor had a 1.8 times higher and those with sepsis a
3.15 times higher risk to die during their ICU-stay despite of PPV.
Despite of positive effects of PPV on oxygenation in our patients a
considerable part of them died. To our amazement oxygenation
index previous to death was not the main problem for most part of
the patients in that phase. Malignant diseases in history and sepsis
during the ICU-stay seem to increase the risk to die in the course of
ALI or ARDS regardless the use of PPV conspicuously. Our results
show that for the assessment of a therapeutic intervention in acute
respiratory failure not only mortality as an endpoint seems to be suit-
able, but also important clinical cofactors.
P21 Lung protective strategy for ventilation in acute lung failure with pECLA (pumpless extracorporal lung assist)
K Magnusson*, T Othman†, NA Cicco*, EG Vester*
*Department of Cardiology, and †Department of Internal Medicine, Evangelisches Krankenhaus Duesseldorf, Germany
Introduction: The morphological changes in the lungs in acute
lung injury (ALI) often lead to high elevated inspiratory pressures
and the use of high dosed toxic inspiratory O2-concentration. This
requires an appropriate adaptation of the mechanical ventilation to
reduce ventilation associated complications. In our department we
use the pumpless extracorporal lung assist (pECLA; Jostra Mediz-
intechnik, Germany) to bridge these ventilation problems till the
main lung injuries, which led to the ALI, have been healed.
Methods: In three patients the pECLA-procedure was performed
after exhausting all possible ventilation strategies to avoid respira-
tor associated complications. In these patients the femoral vein
and artery were cannulated with tubes with diameters between
15 and 19Fr. Comparable to the continuous arterio-venous dialysis
the bloodstream passes a special unit. In this case an oxygenator
in which oxygen is inflated with flow of 15l/min. The high oxygen
partial pressure in the oxygenator displaces the carbon dioxide out
of its bond to the haemoglobin.
Results: The pECLA-procedure was performed in three patients
with a mean age of 55±15 (SD) years. The lung injury score was
3.7±0.4. In two patients the ALI was caused by pneumonia and
severe sepsis. In one patient it was caused by a cardiogenic shock.
The pECLA-procedure led at the latest after 3 days to lungprotec-
tive ventilation (Table). One of the three patients survived and has
been discharged from hospital. The two others died. One due to
an intracerebral bleeding and the other one due to a prolonged
mesenteric ischemia which led to his severe sepsis.
Conclusion: With the usage of the pECLA it seemed to be possi-
ble to achieve a lungprotective ventilation also in nearly hopeless
cases. To find evidence that morbidity and mortality can be
reduced by this approach further trials should be conducted.
Table
pO2 (mmHg) pCO2 (mmHg) FiO2 PaO2/FiO2
Patient Before pECLA After pECLA Before pECLA After pECLA Before pECLA After pECLA Before pECLA After pECLA
1 70 60 74 35 1.0 0.35 70 171
26 79 33 33 11 . 0 0 . 46 7 2 3 3
3 57 65 113 40 0.7 0.45 88 144
P22 Does evolution of pre-ECMO conventional therapies affect the use of ECMO over the past decade in the regional ECMO
centre in UK?
N Najafi, RK Philip, AP Goldman
Paediatric Intensive Care Unit, Great Ormond Street Hospital for Children, Great Ormond Street, London WC1N 3JH, UK
Introduction: Extracorporeal membrane oxygenation (ECMO) has
been recognised as effective in supporting newborn infants with
acute hypoxemic respiratory failure due to pulmonary hypertension.
The aim of this retrospective study was to document changing
trends in the use of pre-ECMO novel therapies (surfactant, high-
frequency oscillatory ventilation and inhaled nitric oxide) over the
past decade in one of the regional ECMO centre in UK.
Methods and patients: All neonatal ECMO patients treated
between October 1992 and August 2001 were retrospectively
reviewed. Pre-ECMO treatments were analysed separately during
1992–1995, 1995–1998 and 1998–2001.
Results: A total of 128 neonates received ECMO. Thirty-two
patients were excluded due to major associated congenital anom-
alies. Of the remaining 96 patients, 64 had meconium aspiration
Table 1
1992–1995 1995–1998 1998–2001
Numbers of ECMO patients 12 28 24
Surfactant (%) 50 75 83.3
High-frequency oscillatory 58.3 89.3 95.8
ventilation (%)
Inhaled nitric oxide (%) 41.7 92.9 100
Time on ECMO (hours) 113.9 151.4 125.2
Survival (%) 91.7 92.9 83.3
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syndrome and 32 had other causes. Table 1 shows the distribution
of pre-ECMO therapies in meconium aspiration syndrome group
and patients’ outcome received ECMO.
Conclusion: This data suggests a steady increase in the use of
pre-ECMO conventional therapies over the past decade in our
regional ECMO centre. However, this has not been associated
with a significant reduction in the use of ECMO nationally nor in
the ventilated time pre-ECMO, length of time or patient outcome
on ECMO.
P23 The effect of lateral positioning on gas exchange and respiratory mechanics in mechanically ventilated patients with
unilateral lung disease
N Markou*, P Myrianthefs†, P Malamos*, B Ilieskou‡, I Alamanos*, E Paulou‡, L Gregorakos*, H Apostolakos*
*ICU-B, Athens University School of Nursing, †ICU, and ‡ICU-A, KAT Hospital, Athens, Greece
Objective: To study the influence of lateral positioning with the
involved side upwards, on gas exchange and respiratory mechan-
ics in intubated patients with unilateral lung disease.
Materials and methods: Mechanically ventilated patients with
unilateral lung disease. Of the 15 patients studied, seven had
pneumonia and eight atelectasis with no response to routine
physicotherapy. All patients were sedated and paralyzed for the
study. All patients were ventilated in the A/C mode.
We performed measurements of gas exchange and respiratory
system compliance and resistance (interrupter technique) with the
patient supine. Immediately afterwards the patient was placed at
lateral decubitus position with the involved side upwards. After
10 min at the new position, measurements were repeated. We
searched for differences with positioning for the parameters mea-
sured. We also tried to correlate changes in oxygenation with a
score expressing the radiographic extend of lung disease on the
basis of portable anterolateral X-rays. Statistical analysis was per-
formed with t-test and Pearson correlation. All measurements are
expressed as mean±SEM.
Results: With lateral positioning there was a statistically significant
increase in PaO2/FiO2 (from 132.5±19.4 to 162.5±18.9mmHg,
P<0.000) and PaCO2 (from 41.7±2.6 to 43.7±2.5mmHg,
P<0.01). At the same time a significant decrease in compliance
(from 44.9±3.1 to 39.4±2.9l/cmH2O, P<0.000) and an increase
in resistance (from 0.223±0.02 to 0.255±0.02cmH2O l–1 s,
P<0.000), were observed. PaO2/FiO2 was significantly (P<0.01)
correlated with the radiographic score (r=0.76).
Conclusion: Placement in lateral decubitus positioning with the
involved side upwards, results in immediate improvement of oxy-
genation in the majority of cases of unilateral lung disease. This
improvement is correlated with the radiographic extend of disease.
At the same time a statistically significant deterioration in respira-
tory mechanics is observed.
P24 Surfactant phospholipids in the bronchoalveolar lavage fluid (BALF) of children who develop acute lung injury (ALI)
DA Todd*, S Sebastian*, S Gupta*, O Ross*, S Watkins*, G Clarke†, AD Postle†, MJ Marsh*
*Paediatric Intensive Care Unit, and †Child Health, Southampton General Hospital, Tremona Road, Southampton SO16 6YD, UK
Introduction: Children with ALI represent 5% of admissions to our
Paediatric Intensive Care Unit [1]. Although there has been much
research in adults with ALI, little is known about the pathophysiol-
ogy in children [2]. More specifically there is a paucity of informa-
tion on the pulmonary phospholipid (PL) changes during ALI
children.
Methods: All children without pre-existing lung pathology who
developed ALI (defined as PaO2/FiO2<300mmHg [39.5kPa] and
bilateral infiltrates seen on frontal chest X-ray [2]) were eligible for
the study within 18 hours of the diagnosis. Following parental
consent, BALF was collected on days 1–4, then weekly and imme-
diately prior to extubation. BALF was filtered to remove debris, cen-
trifuged at 400×g and 4°C for 10 min to remove cells and the
supernatant stored at –80°C prior to analysis. Molecular species
compositions of phosphatidylcholine (PC), were determined by
electrospray ionisation mass spectrometry of lipid extracts of BALF
supernatants. Children without any pulmonary pathology who were
intubated following surgical procedures acted as controls. The
study was approved by the local research ethics committee.
Results: Over 9 months, 40 (8.8%) children of 452 admissions
developed ALI. Ten of 26 eligible children were enrolled in the
study; six parents declined consent and 10 children were either
too unstable for BALF collection or were not recruited in time. In
the study group, the dipalmitoyl PC (DPPC) content in BALF
decreased from control values (42.8±6.5% of total PC) to a
minimum of 23.1±11.9% (P<0.01) between days 2–3, but
increased to 37.8±4.8% pre-extubation. These changes were
accompanied by reciprocal increases in the concentrations of
monounsaturated PC species characteristic of inflammatory cells.
Conclusion: Changes in the PC profile of BALF samples in chil-
dren with ALI indicate that there is an increase in the cellular break-
down products. We speculate that this alteration in the PC profile
with a lowering of DPPC may contribute to the disease process of
ALI in children.
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1994, 149:818-824.P25 Treatment of status asthmaticus in children: is there a place for sodium bicarbonate?
CMP Buysse, M de Hoog
Sophia Children’s Hospital, Department of Pediatric Intensive Care, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands
Introduction: Status asthmaticus is frequently associated with
metabolic acidosis and acidosis reduces the effectiveness of
β-agonists. In January 1999 we initiated a new protocol for the
treatment of status asthmaticus in which the use of intravenous
sodium bicarbonate was added if the pH is below 7.15 in patients
with refractory status asthmaticus. This was based upon previous
reports in the literature. It was postulated that refractory status
asthmaticus could benefit from treating acidosis, although others
have pointed out the risk of hypercapnia.
Objective: To investigate the effect of the administration of sodium
bicarbonate on carbon dioxide levels in children with status asth-
maticus and to evaluate the clinical effect of this treatment modality
in reducing the number of ventilated patients.
Methods: We retrospectively studied the children with status asth-
maticus admitted to the pediatric intensive care unit (PICU) that
received sodium bicarbonate. The following data were collected from
the charts: demographic data (age, sex), weight, severity of asthma,
duration of admission, treatment of the status asthmaticus and blood
gas before and after the administration of sodium bicarbonate.
Measurements and results: During the 2.5-year period reviewed,
42 patients with status asthmaticus were admitted to the PICU.
Sodium bicarbonate was given in six patients with a mean total
dose of 1.2mmol/kg (0.57–4mmol/kg). One patient received two
doses of sodium bicarbonate during the same admission. Five of
these patients that received sodium bicarbonate, were not
mechanically ventilated. It is very likely that all five patients would
have been intubated and mechanically ventilated if there had been
no improvement of the respiratory distress after the administration
of sodium bicarbonate. In the patient who was already mechani-
cally ventilated, sodium bicarbonate was given after intubation.
There was a significant decrease of pCO2 after sodium bicarbon-
ate infusion (P=0.009). Also there was a decrease of the respira-
tory distress. We did not observe adverse effects such as
hypokalemia, hypernatremia or aggravation of the altered mental
status. Since the initiation of the new protocol four patients were
mechanically ventilated, but they were all intubated in the referring
hospital prior to admission to the PICU. All patients survived.
Conclusion: Since the initiation of a treatment protocol for status
asthmaticus in which sodium bicarbonate was added, sodium
bicarbonate was administered in six patients. In these patients
there was a significant decrease in pCO2 and an amelioration of
the respiratory distress. No adverse effects were observed. Also
since then no patient required intubation after admission to the
PICU.
P26 Effect of helium–oxygen mixture on time constant inequalities in COPD patients during controlled ventilation
JM Arnal, M Gainnier, A Grandfond, S Donati, L Papazian, JM Sainty
Service de réanimation médicale, Hôpital Ste Marguerite, 13009 Marseille, France
The respiratory system of the COPD patients is characterised by
regional differences in mechanical properties. When mechanical ven-
tilation is applied, this inhomogeneous lung causes regional dynamic
hyperinflation. The aim of the present study was to compare the time
constant inequalities obtained with air–oxygen and helium–oxygen
mixtures in 14 COPD patients. The local ethic committee approved
the protocol and consent was obtained from next of kin. The patients
were sedated and paralysed for the duration of the protocol. Con-
trolled mechanical ventilation was performed with constant flow. A
Fleisch pneumotachograph calibrated for the use of helium and a dif-
ferential pressure transducer were inserted between the endotra-
cheal tube and the Y piece. The patients were ventilated
successively with air–oxygen and helium–oxygen mixture in a random
order. The time constant inequalities at the end of inspiration were
calculated by the difference between P1 and plateau pressure
(obtained by an occlusion of 5s). The time constant inequalities at
the end of expiration were calculated by the difference between
static intrinsic PEEP (PEEPistat) and dynamic intrinsic PEEP
(PEEPidyn). A Wilcoxon test was used to compare the data.
The time constant inequalities at end inspiration and end expiration
were reduced (Figs 1 and 2) with the helium-oxygen mixture
(15 and 40% respectively).
A modification of the viscoelastic behaviour of the system could
explain these results. The inspired volume is distributed more
homogeneously to the different unit, with helium–oxygen mixture.
During expiration, the regions with long time constant empty faster
which could explain the decrease in regional dynamic hyperinfla-
tion. In conclusion, helium–oxygen mixture reduces the time con-
stant inequalities of the respiratory system in COPD patient during
controlled ventilation.
Figure 1
3
2
1
0
P1 
–
 P
p
la
t (c
m
H
O)
2
Air – Oxygen Helium – Oxygen
*
* < 0.01 P Average
Figure 2
14
12
10
8
6
4
2
0
PEEPi
st
at
 
–
 PEEPi
dyn (
c
mH
O)
2
Air – Oxygen Helium – Oxygen
*
* < 0.01 P Average
Available online  http://ccforum.com/supplements/6/S1Critical Care    Vol 6 Suppl 1 22nd International Symposium on Intensive Care and Emergency Medicine
P27 Impact of aerosol particle size on drug deposition during mechanical ventilation: an in vitro evaluation
JB Fink, A McCall, P Uster
Aerogen, Inc., 1310 Orleans Drive, Sunnyvale, CA 94089, USA
Aerosol particle size is thought to impact drug deposition in the
lung during controlled mechanical ventilation (CMV). The
Aeroneb™ Professional Nebulizer System (Aeroneb Pro, in devel-
opment), designed for continuous aerosolization with mechanical
ventilators, utilizes a micro-pump with domed aperture plate that
can be modified to generate fine particle, low-velocity aerosols of
specific particle sizes. Thus, the effect of a range of aerosol parti-
cle sizes on drug deposition can be studied without changing
other nebulizer characteristics.
Methods: To better understand the effect of particle size on drug
deposition, six Aeroneb Pro nebulizers were modified to generate
aerosols ranging from 3.4 to 5.4µm volume median diameter
(VMD), as determined by laser diffraction (Spraytech™; Malvern).
Albuterol sulfate (0.5ml of 0.5% solution) was aerosolized using an
Aeroneb Pro placed in the humidified inspiratory limb of a Puritan
Bennett 760 Ventilator (tidal volume of 500ml, peak flow 40l/min,
ramp flow pattern, I:E ratio 1:3, rate 15/min) attached to an intu-
bated adult lung model. The amount of drug deposited on an
absolute filter distal to an 8mm ID endotracheal tube was deter-
mined for each aerosol particle size (n=3). Drug was eluted from
the filter and determined by reverse phase HPLC with isocratic
elution and UV detection at 275nm.
Results: The percent of the total dose administered±standard
deviation (SD) which was deposited in the test lung for each VMD
tested is shown in the Table.
Summary: There was an inverse correlation (P<0.05, least
squares analysis) between deposition of drug and aerosol particle
size across the range of particle sizes tested. The efficient deposi-
tion (19–40%) of the 0.5ml dose of albuterol is due, in part, to the
low residual volume of the Aeroneb Pro.
Conclusion: Smaller aerosol particles resulted in greater drug
delivery in vitro when using the modified Aeroneb Pro during CMV.
Further studies are warranted to better understand this relation-
ship, and to confirm this relationship in vivo.
Table
VMD (µm) 3.4 4.0 4.6 4.9 5.4
Deposition (%±SD) 39.6±3.9 37.6±4.5 36.0±2.3 26.5±4.5 19.0±4.1
P28 Ultrasound diagnosis of pneumothorax
D Lichtenstein, G Mezière, P Biderman, A Gepner
Medical ICU, Hôpital Ambroise-Paré, F-92100 Boulogne (Paris-Ouest), France
Introduction: Diagnosis of pneumothorax needs radiographic con-
firmation, which has numerous drawbacks in emergency (time-con-
suming, poor sensitivity, irradiation) or even CT. Can lung
ultrasound play a role?
Methods: Eighty-five pneumothoraces were studied in 78 consec-
utive ICU patients (mean age 43 years, range 17–99, 60 men,
18 women). The diagnosis was radiologic in 71 cases and only
scanographic (radioccult cases) in 14. The control group included
254 lungs in 127 consecutive patients (mean age 57 years, range
20–85, 87 men, 40 women) who required CT and were free of
pneumothorax. Three signs were assessed: (1) absence of ‘lung
sliding’, (2) absence of pathologic ‘comet-tail artifacts’, (3) fleeting
inspiratory visualization of ‘lung sliding’ or pathologic ‘comet-tails’
at the limit of the pathologic area, a sign called ‘lung point’. Inten-
sivists trained in emergency ultrasound used a Hitachi-405 with a
5MHz probe in strictly supine patients.
Results: Ultrasound analysis was prevented in eight cases (parietal
emphysema in six cases). In 79 analyzable cases, ‘lung sliding’ was
always absent, at least at the lower anterior half, with complete
absence of pathologic ‘comet-tails’ at the same location. A ‘lung
point’ was present in 53 cases. In 249 controls with anterior aerated
pattern, ‘lung sliding’ was present in 190 cases, pathologic ‘comet-
tails’ in 158 cases, and the ‘lung point’ was visible in no case.
By considering only absent ‘lung sliding’, ultrasound had a sensitiv-
ity of 100% and a specificity of 78%. By considering absent ‘lung
sliding’ plus absence of pathologic ‘comet-tails’, sensitivity was
100%, specificity 95%. By considering ‘lung sliding’ plus absence
of pathologic ‘comet-tails’ plus ‘lung point’, sensitivity was 67% but
specificity 100%. For radioccult cases only, ‘lung point’ sensitivity
was 80% and specificity 100%.
Conclusions: Anterior ‘lung sliding’ or pathologic ‘comet-tails’
allow pneumothorax to be discounted. The presence of a ‘lung
Table
Pneumothorax
Radiologic Radiooccult Controls
Lung sliding plus 0 0 79
absence of comet-tails
Lung sliding plus 0 0 111
comet-tails
Lung sliding absent 0 0 47
plus comet-tails
Lung sliding and 69 10 12
comet-tails absent
TOTAL 69 10 249
Lung point 45 8 0point’ indicates pneumothorax. Ultrasound proved more sensitive
than bedside radiography. Ultrasound use may therefore obviate
the need for CT in a majority of cases.
P29 Bedside fiberoptic bronchoscopy can be safely performed under conscious sedation
NSP Ngiam, DYT Goh, CPP Hia, SY Chng
Paediatric Pulmonary and Critical Care Service, The Children’s Medical Institute, National University Hospital, 5, Lower Kent Ridge Road,
Singapore 119074
Bedside fiberoptic bronchoscopy aids in the diagnosis and treat-
ment of various respiratory conditions in critically ill patients. Ade-
quate sedation is of paramount importance to ensure the success
and safety of the procedure. In our institution, flexible fiberoptic
bronchoscopy is done under conscious sedation with a benzodi-
azepine in the majority of cases in the paediatric intensive care unit.
We retrospectively reviewed 107 procedures performed on
48 patients in the period between March 2000 and November
2001. The median age was 29 months (range 1–306 months).
Fifty-five percent (n=59) were done via the endotracheal tube,
40% (n=43) transnasally while 5% (n=5) were done via a tra-
cheostomy. The Olympus fiberoptic bronchoscope (model no.
BFXP40) with a 2.8mm outer diameter was used.
Forty-six percent (n=49) of procedures were done with intravenous
midazolam sedation with a dose of 0.2–0.4mg/kg. Twenty-six
percent (n=28) were performed with no parenteral sedation as
these were mostly comatosed intubated patients. Eight percent
(n=8) of procedures required sedation with a combination of intra-
venous midazolam, pethidine and chlorpromazine. The remaining
patients underwent the procedure with their existing sedative infu-
sions. Topical anaesthesia was used in all procedures. All patients
were continuously monitored with cardiorespiratory and pulse oxime-
try monitors. Only 5.6% (n=6) developed transient desaturation.
One patient had transient hypotension probably related to sedation,
one developed airway bleeding because of underlying thrombocy-
topenia and one developed transient post-procedure stridor. 3.7% (n
=4) had their sedation reversed with flumazenil or naloxone.
In conclusion, bedside flexible fiberoptic bronchoscopy under intra-
venous conscious sedation in children in the paediatric intensive
care unit is safe. Proper monitoring and trained personnel are
however important to avoid potential complications.
P30 Hypoxaemia during tracheal suctioning; comparison of closed versus open techniques at varying PEEP
DG Pogson, PJ Shirley
Intensive Care Unit, Royal Adelaide Hospital, North Terrace, Adelaide SA5000, Australia
Introduction: Suctioning of artificial airways is a necessary proce-
dure but is not without risk. Hypoxaemia is a recognised complica-
tion. Several small studies have suggested that closed suction
catheters offer benefits over open suction because disconnection
from the ventilator circuit is not required [1], thereby maintaining
ventilation, FIO2 and PEEP. Other studies have sought to prove the
maintenance of lung volume and cardiovascular stability with
closed suction [2]. There is little evidence that closed suction
systems offer clinical advantage over open suction in terms of arte-
rial oxygenation. No published study had compared changes in
PaO2/FIO2 post suction. We performed a study in critically ill
adults to identify any differences in PaO2/FIO2 between closed and
open suction for a given PEEP.
Methodology: We obtained local ethical approval for a prospec-
tive, randomised, crossover study. Adult ventilated patients with
6.5 tracheal tubes or larger and arterial catheter were randomised
by sealed envelope to receive closed or open suction first, then the
converse. Head injured patients were excluded. The two standard-
ised suction episodes were separated by 2 hours. Ventilatory para-
meters, PEEP and position were unchanged. After baseline ABGs,
subjects received FIO2 1.0 (hyperoxygenation) for 3 min prior to
suctioning. The authors performed suctioning at 100mmHg nega-
tive pressure. 14F Ballard Trach-Care and Indoplas suction
catheters were used. Two suction passes were made, timed to
less than 30s total. The patients were re-commenced on pre-
suction ventilator settings and FIO2. ABGs were drawn at 3,
15 and 30 min post suction and analysed immediately.
Results: Twenty-three patients were recruited. Thirteen subjects
were receiving PEEP 10cmH2O or greater and 10 less than
10cmH2O. Arterial oxygenation data was expressed as PaO2/FIO2
and compared using a paired t-test. One high PEEP subject was
withdrawn from the study after developing hypoxaemia after open
suctioning. No critical incidents were noted. In all patients sedation
scores were the same for both episodes.
Hyperoxygenation produced an expected significant increase in
PaO2/FIO2  at time zero. At 3 min the sustained increase
approached significance. At 15 and 30 min, in both high and low
PEEP groups, there were no statistically significant differences from
baseline with either closed or open suction (P=0.140–0.763). No
comparison is therefore possible between the two suction methods.
Discussion: Three minutes of 100% oxygen prior to tracheal
suction would seem to prevent hypoxaemia and provide increased
oxygenation for up to 3 min after suctioning. This period of hyper-
Figure
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oxygenation is longer than that recommended by the AARC. After
3 min, oxygenation returned to baseline in both high and low PEEP
patients and as there was no difference demonstrated, the two
methods of suctioning cannot be compared. If hyperoxygenation is
performed properly before suctioning, it is unlikely there would be
any clinically significant differences between suction methods in
terms of hypoxaemia.
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P31 Bacterial filters in breathing circuits: an unnecessary cost?
L Lorente*, M Lecuona†, J Málaga*, C Revert†, M Llavador†, ML Mora*
*Department of Intensive Care, and †Department of Microbiology, Hospital Universitario de Canarias, Tenerife, Spain
Objective: To analyze the utility of bacterial filters (BF) to prevent the
incidence of pneumonia (PN), tracheobronchitis (TB) and tracheal
colonization (TC) in patients undergoing mechanical ventilation.
Methods: From 1 July 2000 until 31 March 2001 a prospective
and randomized study was realized. Included were all patients
admitted in ICU and who required mechanical ventilation for
24 hours or more. At admission to the ICU patients were random-
ized in two groups (one group ventilated with BF, and another one
without them). A throat swab on admission and afterwards twice
weekly were taken. Infections were diagnosed according to CDC
criteria and classified based on throat flora in endogenous and
exogenous. The statistical analysis was realized by chi-square test
and Student t-test, and we took values P<0.05 to consider a sig-
nificant difference.
Results: Included were 230 patients (59.13% male). Mean age
was 57.60±17.21 years. APACHE-II was 15.88±5.18. Mortality
was 28.26%. Both groups of patients (114 with BF and 116
without BF) were similar in age, sex, mortality and APACHE-II. No
significant diferences were found in the percentage of patients
who developed PN (24.56% with BF and 21.55% without BF),
combined PN or TB (34.21% vs 28.44%), combined PN or TB or
TC (42.10% vs 43.96%). Neither in the number of infectious
events per 1000 mechanical ventilation-days: PN (17.41 with BF
and 16.26 without BF), PN or TB (24.62 vs 20.88), PN or TB or
TC (36.63 vs 34.98). Neither in the the percentage of patients who
developed infectious events and in the number of infectious events
per 1000 mechanical ventilation-days in each group of mechanical
ventilation-days. Neither in the number of exogenous events per
1000 mechanical ventilation-days (4.20 with BF and 3.95 without
BF).
Conclusions: Bacterial filters in breathing circuits do not reduce
the incidence of respiratory infections, neither exogenous events.
The employment of bacterial filter may be an unnecessary cost.
P32 Are periodic changes of ventilator circuits necessary?
L Lorente*, M Lecuona†, R Galván*, J Málaga*, MJ Ramos†, ML Mora*
*Department of Intensive Care, and †Department of Microbiology, Hospital Universitario de Canarias, Tenerife, Spain
Objective: To analyze the utility of periodic change of ventilator cir-
cuits (PCVC) to prevent the incidence of pneumonia (PN), tracheo-
bronchitis (TB) and tracheal colonization (TC) in patients
undergoing mechanical ventilation.
Methods: From 1 April 2001 until 30 August 2001 a prospective
and randomized study was realized. Included were all patients
admitted in ICU and who required mechanical ventilation for
72 hours or more. At admission to the ICU patients were random-
ized in two groups: one group ventilated with PCVC each
48 hours, and another one without change. A throat swab on
admission and afterwards twice weekly were taken. Infections were
diagnosed according to CDC criteria and classified based on
throat flora in endogenous and exogenous. The statistical analysis
was realized by chi-square test and Student t-test, and we took
values P<0.05 to consider a significant difference.
Results: Included were 87 patients (62.06% male). Mean age was
59.52±18.23 years. APACHE-II was 16.01±6.24. Mortality was
18.39%. Both groups of patients (39 with PCVC and 48 without
change) were similar in age, sex, mortality and APACHE-II. No sig-
nificant diferences were found in the percentage of patients who
developed some infectious events (PN 20.68%, PN or TB 31.03%,
PN or TB or TC 48.27%), nor in the number of infectious events
per 1000 mechanical ventilation-days (PN 12.42, PN or TB 21.92,
PN or TB or TC 37.28). Neither in the the percentage of patients
who developed infectious events and in the number of infectious
events per 1000 mechanical ventilation-days in each group of
mechanical ventilation-days. Neither in the number of exogenous
events per 1000 mechanical ventilation-days (PN 2.92, PN or
TB 4.38, PN or TB or TC 6.57).
Conclusions: The periodic change of ventilator circuits do not
reduce the incidence of respiratory infections, neither exogenous
events. This may be an unnecessary practice.
P33 Evaluation of early and late complications of percutaneous dilatational tracheostomy in 86 ICU patients
E Efstathiou, M Zaka, M Farmakis, S Evangelatos, A Denaxa, D Pragastis
Intensive Care Unit of METAXA Hospital, Piraeus, Greece
Introduction: Due to the prolonged stay of the critically ill under
mechanical ventilation in ICU often stomatotracheal intubation
should be replaced by tracheostomy. In our ICU for over the last
18 months we are practicing percutaneous dilatational tra-
cheostomy as described by Griggs. The aim of our study is to esti-
mate the safety of the method by evaluating the early and late com-
plications that occurred.
Method: In a retrospective study including 86 patients that have
been trachiostomised by the above method we registered all com-plication that occurred for a period of 40 days after the procedure.
In all of the cases the procedure was carried out in the ICU. The
average time for the procedure varied between 2–10 min depend-
ing mainly on the experience of the performing surgeon.
Results: In all cases per-operative mortality was 0%. The compli-
cations registered were grouped in Minor (A): Bleeding up to 20ml
in eight cases, rapture of the cuff in four cases, difficulty in advanc-
ing the tube into the trachea in four cases, minor subcutaneous
emphysema in the region in two cases, and Major (B): Bleeding
20–150ml in four cases, prolonged oxygen desaturation to 80% in
two cases, extended subcutaneous emphysema in one case.
In group A complications did not request any specific treatment, in
contrast with group B that all complication necessitated specific
treatment.
Early post-operatively in two cases we had suppuration of the
stoma. In two cases we had minor lung atelectasias possibly due
to bleeding. Evaluation on the 40th day was possible only in
55 cases that survived. Among these cases we had kelloid forma-
tions at the wound site in two cases.
Conclusions: The performance of tracheostomy by the above
method is quick and effective in experienced hands in spite of the
low possibility of major bleeding. However, the whole procedure
should be performed in the presence of surgeon. Post operative
scars were minimal.
Table
Age APACHE II Duration of PCT (min) Days intubated
COPA (n=23) 52.96±17.29 18.70±9.97 4.17±1.11 12.78±6.49
LMA (n=24) 48.79±18.14 15.08±7.17 4.71±1.97 10.42±2.95
P35 The percutaneous dilatational tracheostomy, a comparative clinical trial
MG Baacke, I Roth, RJ Stiletto, M Rothmund, L Gotzen
Department of Trauma-Surgery and Intensive-Care of the Philipps-University-Marburg, Germany
Introduction: The dilatational tracheostomy becomes more and
more a standard procedure in many ICU. Several systems for the
procedure are available. Few clinical experiences are published
about this procedure, even less about a comparison of the different
kind of systems. On the bases of the experience of 96 self-prac-
ticed dilatational tracheostomies we critically report our experi-
ences with two different kind of tracheostomy-sets.
Methods: Between December 1998 to September 2001 we initi-
ated a prospective, comparing observational study on 96 patients
on a surgical 12-bed ICU who were undergoing a percutaneous
dilatational tracheostomy (PDT). In 36 patients the multi-step-
dilatation-procedure, following Ciaglia (Cook®) was used, the
Criggs–Method (Portex®), a one-step-dilatation with a certain
dilatation-forceps was practiced 59 times. We documented opera-
tion-time, costs and complications in the daily practice at a univer-
sity-teaching-ICU. As complications we considered all transfusion
or surgical intervention requiring bleedings, infections which
needed surgical treatment or antibiotics or intraoperative lowering
of the SpO2-pressure. The operation teams were classified follow-
ing their surgical experience: Team 1: senior-resident/resident,
Team 2: resident/resident, Team 3: resident/house-man.
ç ç
P34 Comparison of the laryngeal mask airway (LMA) and cuffed oropharyngeal airway (COPA) during percutaneous
tracheostomy (PCT) in ICU patients
SF Kahveci, N Kelebek, B Yavascaog
vlu, O Kutlay
Uludag
v University School of Medicine, Department of Anaesthesiology and Intensive Care, Bursa, Turkey
ç
Introduction: PCT is frequently used in ICU patients. Recent
studies suggest that the use of a LMA has achieved good control
of airway during PCT [1]. The COPA is a modification of the
Guedel airway which allows manual ventilation by directly connect-
ing to the breathing system [2]. We designed a prospective ran-
domized study to compare the COPA and LMA devices during
PCT in ICU patients.
Methods: In this study, a COPA or a LMA device was inserted
prior to performing PCT following propofol, fentanyl and mivac-
urium anaesthesia. A size 9–10 COPA or size 4–5 LMA used in all
patients. After oxygenation and ventilation had been adequate,
PCT was performed (Sims Portex Ltd, Kent, UK). If patent airway
was not provided in COPA or LMA, the devices was removed and
endotracheal intubation was performed. All occuring events were
documented, such as hypoxia, airway manipulations during this
procedure.
Results: Patient’s demographic data are in the Table. No proce-
dure-related deaths occurred. The COPA failed in three of
23 patients (13%), the LMA failed in two of 24 patients (8%) to
maintain patent airway. The number of airway interventions such as
chin lift were higher in COPA group (48%). Three patients in
COPA group and four patients in LMA group developed minor
bleeding in peristomal area.
Conclusion: Both of COPA and LMA were inserted easily with a
high success rate, but airway manipulations in order to maintain
patent airway were higher in COPA group. Our data suggest that
COPA can be used as an alternative to LMA during PCT.
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Results: The operation-time for the Ciaglia-procedure was
25 (SD±14) min, with the Criggs-procedure 20 (SD±13) min.
Considering the costs was the Criggs-system with 127.–E clearly
cheaper than the Ciaglia-system with 165.–E. We found the
Criggs-system easy to learn and to handle, which explains the dif-
ferent durations of operation-times in the different qualified teams:
Team 1 needed with a mean operation-time of 36.4 min
(n=11/SD 14 min) significantly longer than Team 2 with a mean
operation-time of 27.3 min (n=24/SD 14.7 min) and Team 3 with a
operation-time of 29.2 min (n=36/SD 18.6). A short-time lowering
of the SpO2-pressure down to 70% occurred in five patients, rele-
vant bleedings were not observed. Dependent on the age of the
patients we found fractures of the tracheal cartilage in 25% of the
patients but just in one patient further interventions following
decannulation were necessary.
Conclusion: The PDT – independent of the used system —
became a safe, cheap and fast standard-procedure on our ICU. So
far we prefer the Criggs-procedure due to the lower risk of damag-
ing the posterior wall of the trachea, the shorter operation-time and
the lower costs. Nevertheless we practice both methods because
each surgeon achieves best results with the system of it’s own
convenience. No difference was found in the incidence of compli-
cations.
P36 Evaluation of the mobility of the vocal folds after percutaneous translaryngeal tracheostomy intervention (Fantoni
technique) on ICU patients
A Di Pastena, U Schloderer, M Delli Muti, G Virtuoso, M Radici, D Celleno
ICU Ospedale S. Giovanni Calibita Fatebenefratelli Roma, Isola Tiberina, 00186 Rome, Italy
The treatment of a critical respiratory insufficiency during a decom-
pensated phase can cause a prolonged period of mechanical ven-
tilation. So a tracheostomic access may be necessary in order to
continue the weaning process from the ventilator.
In our study we wanted to evaluate the mobility of the true vocal
chords and occurrence of the dyslocation of cricoarytenoid carti-
lage after the percutaneous tracheostomy with the Fantoni tech-
nique, which we applied on 70 patients from 1997 until 2001. All
70 patients were treated with the same tracheal access method in
the space between the first and the second tracheal ring.
Our study required an endoscopic evaluation protocol with a direct
fibrolaringoscopic access to the patient. So we evaluated the con-
formation of the upper respiratory-digestive ways and the mobility
of the larynx and of the vocal chords (precisely: symmetric move-
ment in adduction and abduction of vocal folds) and occurrence of
cricoarytenoid cartilage lesion. We repeated the measurements
7 days after the intervention when we substituted the endotracheal
cannule (Time 1) and after 20 days (Time 2).
In the follow up we controlled our patients 2 months after the tra-
cheostomy (Time 3) to find out about eventual anatomic and func-
tional changes of the larynx. Considering the patient’s condition we
then decided about the possible weaning from the tracheostomic
cannule.
Exclusion criteria from patient enrollment were:
1. Patients affected by severe neurologic pathology in which the
damage of the central nervous system could eventually inter-
fere with the mobility of the upper respiratory-digestive ways.
2. Patients affected by severe peripheral neuropathy.
3. Patients with previous surgery of the larynx, the thyroid gland
and the latero-cervical areas (lymphadenectomy, carotid endar-
teriectomy, etc.)
Conclusions: We found no change of mobility of the vocal folds in
any patient nor dislocation of the cricoarytenoid cartilage at any time.
The complicances we observed were due to the percutaneous
technique that consisted in initial lesions like edema (four patients
at Time 1, one patient at Time 2) and hematoma (two patients at
Time 2) which were not visible anymore after 20 days and cartilage
fracture in three patients. On the long run we observed synechie
(three patients at Time 2, four patients at Time 3) and cicatric
stenosis (three patients at Time 2 and 3).
P37 Over-inflation of the tracheal tube cuff: a case for routine monitoring
S Sathish Kumar, PJ Young
Department of Anaesthesia, The Queen Elizabeth Hospital, King’s Lynn, PE30 4ET, UK
Introduction: Excessive tracheal tube cuff pressure can cause
mucosal ischaemia leading to tracheal stenosis or tracheo-
oesophageal fistulae [1] and under-inflation of the cuff has been
associated with an increased risk of ventilator-associated pneumo-
nia [2]. High-volume low-pressure (HVLP) cuffs were introduced in
the early 1970s to enable tracheal wall pressure control. The use
of a HVLP cuff does not however guarantee an acceptable
mucosal pressure (MP) unless the intra-cuff pressure (CP) is main-
tained lower than 30cmH2O. CP was measured regularly in only
13% of intensive care units (ICU) in one region of England [3]. This
prospective observational study examines the CP recorded after
induction of anaesthesia and in two critical care facilities.
Method: The CP was measured in 30 sequential anaesthetised
patients and 30 critically ill patients in each of two critical care
facilities in one region of England. The anaesthetised group had
their cuffs inflated by the operating department practitioner (ODP).
The cuffs of the critically ill patients were surreptitiously checked
once per patient on the ICU. The ODP and ICU nurses were
unaware that the audit was taking place. If the CP was high it was
reduced to 30cmH2O. If a leak was detected after reducing the
CP then the cuff was re-inflated to just seal and the patient docu-
mented as appropriately high CP.
Results:  Anaesthetised patients: The mean CP was 62cmH2O
(range 20–120cmH2O, n=30). There were six (20%) CPs above
100cmH2O.
Critically ill patients: The mean CP was 46cmH2O (range
13–120cmH2O, n=60). There was no difference in CP between
the two ICUs (mean CP was 43 and 48cmH2O respectively).
There were three (5%) CPs above 100cmH2O. Eight patients had
appropriately high CPs (mean CP 52cmH2O) as reducing the CP
caused an audible air leak to occur.Conclusion: Over-inflation was more frequent than under-inflation
and pressures far exceeding the capillary perfusion and even
exceeding the systolic arterial pressure were recorded. We recom-
mend that formal protocols of cuff pressure measurement should
be implemented or constant pressure cuff inflators used, especially
in those who are undergoing prolonged intubation.
References:
1. Stauffer JL, Olson DE, Petty TL: Complications and consequences
of endotracheal intubation and tracheostomy. A prospective study
of 150 critically ill adult patients. Am J Med 1981; 70:65-76.
2. Rello J, Sonora R, Jubert P, Artigas A, Rue M, Valles J: Pneumonia in
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P38 Does the method of humidification within a CPAP circuit affect the work of breathing? A pilot study
JS Wills, KJ Girling
Intensive Care, University Hospital, Nottingham, UK
Introduction: It has been shown (for example [1]) that heat and
moisture exchange filters (HME) can be as effective in humidifica-
tion of a breathing circuit as a heated humidification (HH) system.
Before considering the replacement of the present HH system with
HME filters in the high-flow CPAP circuits, we wished to examine
whether they would affect the work of breathing (WOB) through
the circuit. We found no evidence in the medical literature that
such an investigation had been carried out.
Method: Six healthy male volunteers were studied. They were
asked to breathe via a facemask through a high flow CPAP circuit
at three different levels of CPAP: 0, 5 and 10cmH2O. Either a HH
system (MR210; Fisher-Paykel Healthcare, NZ) or a HME (Ven-
talink; Pennine Healthcare, UK) was used in the circuit. During tidal
breathing over a 20s period, the airflow through the circuit was
measured with a Fleisch no.2 pneumotachograph and the pres-
sure drop across the circuit was simultaneously recorded, both at
200Hertz. The work of breathing for inspiration and expiration was
calculated as the product of volume and pressure. Repeated-mea-
sures ANOVA was used for analysis.
Results: The work of breathing per unit tidal volume attributable to
the breathing circuit, shown in the Table, was not significantly
affected by method of humidification for inspiration (P=0.058) or
for expiration (P=0.343) although it increased for each level of
CPAP (inspiration, P=0.004 and expiration, P=0.001).
Conclusion: This pilot study suggests a hypothesis that the use of
a HME filter, compared to a HH system, may increase the WOB
associated with a CPAP circuit. The results are not statistically sig-
nificant and 25 subjects will be required to test this hypothesis
according to power analysis. This study will be carried out on
patients on the Intensive Care Unit.
Reference:
1. Martin et al.: Heat and moisture exchange and vaporizing humidi-
fiers in the intensive care unit. Chest 1990, 97:144-145.
Table
Level of CPAP (cmH2O)
WOB mean (SD) (J/l) 0 5 10
Inspiration
HME 0.20 (0.07) 0.29 (0.09) 0.37 (0.10)
HH 0.19 (0.07) 0.21 (0.06) 0.31 (0.09)
Expiration
HME 0.14 (0.04) 0.20 (0.10) 0.25 (0.07)
HH 0.12 (0.13) 0.17 (0.04) 0.21 (0.03)
P39 Comfort levels of six CPAP delivery systems
RG Roberts*, JS Mecklenburgh†, A Saayman*, H Rinka‡, GP Findlay
*Critical Care Directorate, Univesity Hospital of Wales, Cardiff CF14 4XW, UK; †Department of Anaesthetics andIntensive Care, UWCM,
Cardiff CF14 4XN, UK; ‡Emergency and Critical Care, Osaka General Hospital, Japan
Objectives: Not all CPAP systems have similar performance char-
acteristics [1]. We aimed to assess comfort levels using six differ-
ent CPAP delivery systems.
Methods: Six healthy blinded volunteers subjectively ranked each
system for ease of breathing and comfort. The CPAP systems were
set to 5cmH2O CPAP via standardised tubing, mouthpiece and
Table
Pressure deviation (cmH2O) from CPAP level at 25 l/min flow
CPAP delivery system Subjective ranking Inspiration Expiration Overall
Respironics Vision 1 –0.8 –0.1 0.6
Respironics S/T 2 –0.6 0.1 0.8
Drager Evita 4 (NIV) 3 –1.1 1.3 2.4
Drager Evita 4 4 –1.1 1.3 2.5
Drager CF 800 5 –1.3 0.7 2.0
Siemens Servo 300 6 –1.1 2.3 3.4
Spearman Correlation with –0.76 0.83 0.89
ranking P value 0.084 0.04 0.017
NIV, new non-invasive software.
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nasal clips. Pressure, flow and volume at the mouthpiece were
measured using an Datex AS3 monitor and logged to PC.
Results: The pressure fluctuations between inspiration and expira-
tion at 25l/min correlated well with the subjective ranking
(P = 0.017), with differences most evident in the expiratory phase
of the cycle (P=0.04).
Conclusions: CPAP systems that minimise pressure fluctuations
are more comfortable. Patient comfort can be improved by choos-
ing and setting CPAP systems to minimise pressure fluctuations.
References:
1. Austin PN, et al.:  Work of breathing characteristics of seven
portable ventilators. Resuscitation 2001, 49:158-167.
P40 Hypercapnia and respiratory drive in obstructive sleep apnea patients before and after CPAP treatment
A Tasiou, S Nanas, A Prekates, P Tselioti, Ch Roussos
Pulmonary and Critical Care Medicine, Evgenidio Hospital, University of Athens, Greece
Objective: To investigate the respiratory drive and the response to
CPAP treatment in obstructive sleep apnea patients.
Methods: Twenty-one consecutive patients (19 males/2 females)
with newly diagnosed disease with polysomnography were
enrolled in this study. Blood gases, body mass index measurement
(BMI) and spirometry were performed in all patients. Respiratory
drive was evaluated by using the P0.1 technique and the mean
inspiratory flow (VT/TI). P0.1 was also measured during sub maximal
exercise by using the same technique. All parameters of the respi-
ratory cycle were measured during the P0.1 procedure (VT, f, VE, TI,
TTOT, TI/TTOT). We evaluated all the parameters before and 2 days
after CPAP treatment.
Results: There was no significant difference in BMI, PO2, FEV1,
FVC, respiratory cycle indices and P0.1 at rest. PCO2 was signifi-
cantly reduced (44±5 vs 42±6mmHg) after treatment. At exer-
cise P0.1 and VT/TI were significantly reduced (6.6±2.7 vs
4.9±1.6cmH2O,  P<0.01 and 72±16 vs 64±10, P<0.05,
respectively).
Conclusion: The unchanged respiratory drive at rest may not
explain the PCO2 reduction in our population. The significantly
reduced respiratory drive and mean inspiratory flow during exercise
could possibly explain change of ventilatory control, which may not
be detected at rest.
P41 Very early extubation and non invasive ventilation after lung transplantation
C Coccia, G Della Rocca, L Pompei, MG Costa, P Di Marco, F Pierconti, P Pietropaoli
Istituto di Anestesiologia e Rianimazione, University of Rome ‘La Sapienza’, Viale del Policlinico 155, 00161 Rome, Italy
In recent years non invasive mechanical ventilation (NIV), delivered
through facial or nose mask, has been successfully used as an
effective treatment for acute respiratory failure and as a technique
for weaning [1–3]. The aim of this study was to evaluate the use of
NIV after very early extubation in lung transplanted patients.
Methods: Twelve patients (two single and 10 bilateral sequential
lung transplantation), affected by cystic fibrosis (10) and emphy-
sema (two) were early tracheal extubated, in the operating room.
After tracheal extubation, five patients with PaO2/FiO2
<180mmHg and/or PaCO2  ≥70mmHg and/or respiratory rate
>30, were assisted with delivery of artificial, non invasive ventila-
tion (NIV). NIV was intermittently applied for a period of 30-40 min,
through a full face mask. Pressure support ventilation and ventila-
tory settings were adjusted based on continuous pulse-oximetry
and on measurement of arterial blood gases analysis.
Results: Hemodynamics and oxygenations collected during
mechanical ventilation at the end of surgery (FINAL), in sponta-
neous breathing 30 min after extubation (SB), 30 min after NIV
application (NIV) and in spontaneous breathing 120 min after extu-
bation (POST-NIV) are described in the Table.
Discussion: During NIV we observed an improvement in pul-
monary gas exchange with a decreasing in respiratory rate and an
increasing in tidal volume. No patients were reintubated in ICU.
Conclusion: NIV permitted very early extubation after lung trans-
plantation avoiding tracheal reintubation.
References:
1. Meduri GU, et al.: Chest 1996, 109:179-193.
2. Wysocki M, et al.: Chest 1995, 107:761-768.
3. Antonelli M, et al.: JAMA 2000, 283:235-241.
Table
FINAL SB NIV POST-NIV
mAP 66±9 81±7 80±6 81±13
mPAP 19±3 22±5 18±5 20±6
CI 3.9±1.2 4.6±0.9 4.3±0.6 4.7±0.3
PaO2/FiO2 483±83 155±55 261±88 185±43
PaCO2 47±5 72±13 65±6 63±4
ITBVI 838±93 811±85 784±46 786±61
EVLWI 13.5±4.0 12.5±2.7 11.7±1.5 11.6±1.6
MAP=mean arterial pressure (mmHg), mPAP=mean pulmonary
arterial pressure (mmHg), CI=cardiac index (ml⋅min–1⋅m–2), ITBVI=
intrathoracic blood volume index (ml⋅m–2), EVLWI=extra vascular lung
water index (ml⋅kg–1⋅m–2).P42 Non invasive mechanical ventilation delivered by a new ‘helmet’ versus a standard face mask
D Chiumello, E Carlesso, A Cadisco, S Paganini, L Gattinoni
Institute of Anesthesia and Intensive Care, Policlinico Hospital-IRCCS, Milan, Italy
We compared in six healthy subjects non invasive mechanical ven-
tilation delivered by a new ‘helmet’ (large [L] and small [S] size)
and by a standard face mask (FM). We tested three different venti-
latory setting: a continuous flow CPAP (CPAPCF), a CPAP deliv-
ered by a ventilator (CPAPVent) and a pressure support ventilation
(PSV). The level of PEEP and PSV were 5cmH2O while FIO2 was
21%. Tidal volume VT, respiratory rate (RR), work of breathing
(WOB L), pressure time product (PTP) were measured.
Our results suggest that during CPAP the three systems are
equals while during PSV the FM is better.
Table
VT (l) RR (bpm) WOB L (J/l) PTP (cmH2O*s/m)
CPAPCF
Helmet L 0.42±0.05 14.4±4.1 0.36±0.06 81±16
Helmet S 0.44±0.14 14.8±4.3 0.34±0.06 71±14
FM 0.50±0.07 14.9±4.1 0.39±0.09 84±17
CPAPVent
Helmet L 0.56±0.16 14.8±3.6 0.35±0.12 105±52
Helmet S 0.63±0.12 13.5±2.7 0.31±0.18 85±45
FM 0.55±0.10 14.8±4.3 0.26±0.17 81±49
PSV
Helmet L 0.68±0.15 12.5±3.3 0.12±0.1 28±24
Helmet S 0.68±0.18 13.1±3.7 0.13±0.1 30±21
FM 0.62±0.15 15.6±3.6 0.01±0.01* 2±1*
*P<0.05 vs helmet L and helmet S.
P43 Comparison of efficacy of different ventilators to administer NIV in healthy subjects
S Chatterjee*, GD Perkins*, S Giles*, D McAuley*, M Roland†
*Department of Intensive Care, and †Department of Respiratory Medicine, Birmingham Heartlands Hospital, Bordesley Green East,
Birmingham B9 5SS, UK
Background: Patient compliance and efficacy of the ventilator
used for non-invasive ventilation (NIV) are important determinants
of successful treatment.
Method: In this pilot study, healthy volunteers were requested to
breathe normally for 10 min through a close fitting facemask. Each
volunteer was ventilated using three ventilators, Galileo (Hamilton
Medical, Germany) - pressure support ventilation (PSV), Harmony
S/T (Respironics, USA) - pressure ventilation and Breas PV403
(Breas Medical, Germany) - volume control ventilation (VCV), for a
duration of 10 min in a random order. The CO2SMO Plus respira-
tory profile monitor (Novametrix Medical, USA) linked to a com-
puter was used to measure minute alveolar ventilation (MValv),
intrinsic positive end expiratory pressure (PEEPauto), imposed
work of breathing (WOBimp), end-tidal Carbon dioxide (ETCO2) in
the second 5 min of each episode of ventilation. Visual analogue
scale (VAS) for comfort during NIV from seven volunteers was
recorded. Repeated measures ANOVA was used to analyse multi-
ple comparisons.
Table 1
Comparison of Harmony, Galileo and Breas (mean [SD], median [interquartile])
Baseline Harmony Breas Galileo
MValv 7.48 (0.90) 9.42 (2.08)‡ 6.72 (1.83) † 7.11(1.74)
PEEPauto 0.00 0.44 (0.13–1.36)* 3.58 (3.06–4.04)*†‡ 1.23 (0.73–1.36)*
WOBimp 0.00 0.00 0.25 (0.10-0.37)*†‡ 0.00
Vd/Vt 0.30 (0.03) 0.33 (0.05) 0.31 (0.06) 0.32 (0.06)
VCO2 /kg 2.74 (0.45) 2.28 (0.40) 2.50 (0.55) 2.49 (0.49)
ETCO2 5.19 (0.38) 4.25 (0.62)* 4.55 (0.66)* 4.02 (0.55)*
*P<0.05 compared with baseline. † P<0.05 compared with Harmony. ‡ P<0.05 compared with Galileo.
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Results: Thirteen healthy adult volunteers (five male, eight female)
aged 22–48 years were studied. Data obtained from the study are
displayed in Tables 1 and 2.
Conclusion: In normals, VCV with the Breas was less comfortable
than the pressure ventilation modes tested. The increased
autoPEEP and WOBimp may reflect this. There is also a sugges-
tion that the auto-track triggering on the harmony may have
enhanced comfort in normals when compared to the preset flow
triggering on the Galileo.
Table 2
Comfort VAS scores (0–10) for normal ventilation, Galileo,
Harmony and Breas
Baseline Galileo Harmony Breas
Median 7.8 6.9‡ 8 2.3*†‡
*P<0.05 compared with baseline, † P<0.05 compared with Galileo, ‡
P<0.05 compared with Harmony.
P44 Non-invasive ventilation (PS-IMV) in patients with acute respiratory failure in common wards away from ICU
A Bekridelis, E Antoniadou, A Kiparissi, M Stougianni, S Vasiliagou, J Galatianos, R Manoulidou, T Georgiadou
ICU ‘G. Gennimatas’, Gen. Hospital, Ethnikis Aminis 41, Thessaloniki 54635, Greece
Objective: Trial of non-invasive ventilation (NIV) in two groups of
patients (pts) with postoperative acute respiratory failure (ARF)
and acute on chronic respiratory failure, in common hospital wards.
Patients and methods: Two groups of pts (age 50–78). Group A:
Surgical (n=24) with ARF, after major abdominal surgery.
Group B: Medical (n=11) with ARF post COPD, sleep apnea syn-
drome and stroke. The pts fulfilled at least three of the following cri-
teria: (1) dyspnea-tachypnea (RR>28/min), (2) the use of the
accessory respiratory muscles, (3) abdominal pattern of breathing,
(4) PaO2/FiO2<200 receiving O2  (Venturi mask), (5) abnormal
0.25 thorax X-ray findings. NIV was used by using the Bi PAP
apparatus with nasal mask, with the following settings:
PEEP=5–10cmH2O, PS level 10–15cmH2O, and IMV breaths
5–12/min, FiO2=0.4–0.5. The application protocol was as
follows: first 24 hours — continuous ventilation with short pauses
for physical therapy, then with pauses of up to 30 min of sponta-
neous breathing for the evaluation of the pts respiratory reserve.
Pts were monitored with pulse oximeter, BP, CVP, ABG. All the pts
were under proper medical treatment (bronchodilators, etc.). The
improvement criteria were: sufficient TV, no use of accessory respi-
ratory muscles, FiO2<0.4, PaO2 > 70mmHg (FiO2≤0.4).
Results: Group A: 16/24 pts (67%) showed significant improve-
ment of ABG values, SaO2 and respiratory mechanics. They were
all cured and left hospital. 8/24 (33%) failed to respond and were
intubated and transferred to ICU, owning to bad compliance due
to, nasal mask discomfort (n=4), ARDS (n=3), acute pulmonary
edema (n=1). Group B: 9/11 pts (82%) were successfully discon-
nected, 2/11 (18%) failed to be disconnected owning to severe
respiratory infection in a COPD, patient (n=1) and deterioration of
mental status in a stroke pts (n=1). NIV duration: approximately
72 hours.
Conclusions: The application of NIV is very attractive and promis-
ing with easy use of the BiPAP in common ward pts with ARF. The
majority of our pts responded well and had significant benefit
avoiding endotracheal intubation, mechanical ventilation and ICU
admission.
Reference:
1. Kramer N, Meyer TJ. Mehang J, Cece RD, Hill NS: Randomized
prospective trial of noninvasive positive pressure ventilation in
acute respiratory failure. Am J Resp Crit Care Med 151:1799-1806.
P45 Maintaining ventilatory settings in seven home ventilators during leaks
JM Sab, QV Lê, JY Poy
Service de Reanimation, Centre Hospitalier, 71321 Chalon sur Saône, France
Using home ventilators (HV) may be an alternative for non-invasive
ventilation in intensive care patients with respiratory failure. Air
leaks are frequent in such patients and may be deleterious for the
efficacy of ventilation. Few data are available about performances
of HV. We analyse the adequacy of ventilatory settings in seven
HV during ventilation with increasing leaks on respiratory system.
Study of seven HV on testing bench (SODEREL®):
1: Hélia®(SAIME); 2: Respicaire CV®(DRAGER); 3: O’Nyx®+
(NELLCOR PB); 4: VPAP2 ST® (SULLIVAN); 5: PV 102 (BREAS);
6: Synchrony (RESPIRONICS); 7: Neftis (TAEMA).
Settings: Pep: 6cm, PS: 15cm, RR: 12/min, minimal slope, Expi-
ratory Trigger minimal, Inspiratory Trigger maximal (ITmax) and
minimal (ITmin).
Three periods have been studied: A: no additional air leak, B: one
and C: two calibrated leaks (4mm diameter each).
Parameters analysed: RR with ITmin, Pep and Paw with ITmax,
iFmax, eFmax, I/E with Itmin.
Results: See Table overleaf.
Conclusions: These seven HV are heterogeneous. Only two HV
(4 and 6) are able to maintain the major parameters (RR, PEEP
level and PS level). Two (1–3) are unable to maintain Pep level
with maximum leaks and two (2-7) cannot even reach pressure
support level.
Inspiratory time is systematically increased with inverse I/E in two
cases. Auto triggering occurs with ITmin in three HV (1–2–5) and
is independent of maintaining PEEP level.
It is probably important to consider performances of home ventila-
tors before starting non-invasive ventilation in critically ill patients.Table
1A 1C 2A 2C 3A 3C 4A 4C 5A 5C 6A 6C 7A 7C
Pep 6.27±0.5 1.49±0.0 5.92±0.0 5.79±1.3 5.89±0.1 4.62±0.2 5.88±0.0 5.67±0.0 5.84±0.0 5.70±0.1 5.71±0.0 5.73±0.0 4.43±0.0 4.43±0.0
Paw 21.9± 0.1 22±0.05 22.9±0.1 17.7±6.6 21.3±0.1 20.2±0.1 20.9±0.0 20.4±0.0 21.7±0.1 20.7±0.0 21.7 ±0.2 21.8±0.1 22.5±0.2 18.2±0.4
RR 12.1±0.17 28.6±0.86 11.3±2.9 44±1.2 12.4±0.7 12.3±0.5 12.1±0.3 12.0±0.1 12.1±0.1 24.5±1.1 12.1 ±0.1 12.1±0.1 12.3±0.3 12.3±0.3
iF 1.57 ±0.0 1.61±0.0 1.11±0.0 0.9±0.34 1.15±0.0 1.24±0.0 1.5±0.05 1.22±0.0 1.20±0.0 1.02±0.0 1.28 ±0.0 1.25±0.0 1.54±0.2 1.24±0.2
eF –1.4±0.1 –1.4±0.0 –1.5±0.0 –1.3±0.5 –1.1±0.0 –0.7±0.0 –1.7±0.0 –1.7±0.0 –1.5±0.0 –1.5±0.0 –1.4±0.0 –1.5±0.0 –1.2±0.0 –1±0.1
I/E 0.13±0.1 0.63±0.1 0.19±0.1 1.1±0.0 0.16±0.2 0.16±0.1 0.26±0.1 0.4±0.0 0.3±0.0 1.94±0.1 0.45±0.0 0.46±0.0 0.29±0.0 0.45±0.1
Triggering level automatically adjusted for 4 and 6.
P46 Effect of noninvasive ventilation on pulmonary gas exchange in chronic obstructive pulmonary disease
HK Nagi, AM Habib, SH Omar, AY Zakaria
Critical Care Medicine Department, Cairo University, Egypt
Background: In patients with acute exacerbation of chronic
obstructive pulmonary disease, noninvasive ventilation may be
used in an attempt to avoid endotracheal intubation and complica-
tions associated with mechanical ventilation.
Method: We conducted a prospective, randomized study compar-
ing noninvasive ventilation delivered through a face mask with stan-
dard treatment in patients admitted to ICU.
Results: A total of 23 patients were recruited from a large group
of 63 patients with chronic obstructive pulmonary disease admit-
ted to critical care department. A total of 12 patients were ran-
domly assigned to noninvasive ventilation (group I) and 11 to
standard treatment (group II). The two groups had similar demo-
graphic characteristics with (mean age 51.8±10 vs 58.7±8.4,
P=0.082 and weight 74.8±13.8 vs 74.9±8.9, P=0.97) and
clinical characteristics on admission to the hospital. The use of
noninvasive ventilation significantly improved some of the final
arterial blood gases and oxygenation parameters in successful
cases (Table 1).
However other blood gases and oxygenation parameters showed
no improvement or deterioration (Table 2).
Conclusion: In selected cases with acute exacerbation of chronic
obstructive pulmonary disease, noninvasive ventilation can reduce
the need for endotracheal intubation, and can improve the
hypoventilation associated with the disease.
Table 1
PH PCO2 PO2 Sat PAO2
Initial 7.26±0.029 67.1±5.9 50.0±9.5 76.3±12.2 65.9±7.74
Final 7.38±0.028 60.2±5.4 85.8±7.6 93.9±4.7 164.1±28.3
P value 0.000* 0.041* 0.000* 0.004* 0.000*
*significant with improvement.
Table 2
HCO3 PaO2/FIO2 P(A-a)O2 PaO2/PAO2 Shunt
Initial 31.5± 5.0 238.2± 45.1 15.8±12.9 0.770±0.172 0.93± 0.75
Final 34.3± 6.4 257.7± 31.8 78.3±26.3 0.534±0.089 4.50± 1.40
P value 0.375* 0.368* 0.000** 0.007** 0.000**
*insignificant, **significant with deterioration.
P47 Neuroprotective efficacy of magnesium sulphate in experimental traumatic brain injury
T Erden*, D Aktan*, R Kalayci†, N Çakar*, M Imer‡, F Esen*, L Telci*
*Department of Anesthesiology & Reanimation, †Department of Physiology, and ‡Department of Neurosurgery, University of Istanbul Medical
Faculty, Capa-Istanbul, Turkey
Objective: Traumatic brain injury (TBI) results in brain damage
either by early cell death or by delayed cell death due to secondary
injury factors such as blood–brain barrier breakdown, brain edema,
and cerebral ischemia. Studies have demonstrated that magne-
sium (Mg) salts given after traumatic brain injury improve neurologi-
cal outcome. We aimed to examine the neuroprotective effects of
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magnesium on brain edema and blood–brain barrier breakdown
after experimental traumatic brain injury in rats.
Method: Experimental closed head trauma was induced on
Sprague–Dawley rats by allowing 450 g weight falling from a 2 m
height onto a metallic disc fixed to the intact skull. The animals
were randomly assigned to receive an intraperitoneal bolus of
either 750µmol/kg magnesium sulphate or 1ml saline 30 min after
the induction of TBI. Brain water content (BWC) and brain tissue
specific gravity (SG), as indicators of brain edema, were measured
24 hours after traumatic brain injury. Blood–brain barrier integrity
was evaluated quantitatively 24 hours after injury by fluorometric
assay of Evans Blue dye (EBD) extravasations.
Results: In magnesium group, brain tissue specific gravity was sig-
nificantly increased and brain water content was significantly
reduced. Evans blue dye content in the brain tissue was signifi-
cantly decreased in the magnesium group (Table 1).
Conclusion: These experimental results have demonstrated the
neuroprotective effects of magnesium sulphate on secondary injury
factors like brain edema and blood–brain barrier breakdown after
traumatic brain injury.
Table 1
Brain water content, specific gravity and Evans blue dye content in the brain tissue
BWC (% brain tissue) SG EBD (µg/mg brain tissue)
Groups Left Right Left Right Left Right
Control (n=6) 81.7±0.82 81.2±0.49 1.044±0.002 1.044±0.001 0.0053±0.0004 0.0054±0.005
Magnesium (n=6) 77.82±0.68 78.02±0.33 1.047±0.0007 1.045±0.001 0.0016±0.0002 0.0017±0.0002
P < 0.01 < 0.01 < 0.05 < 0.01 < 0.01 < 0.01
P48 Is continued aggressive care justified in patients requiring mechanical ventilation after a stroke following cardiovascular
surgery?
AA Rabinstein, EFM Wijdicks
Mayo Clinic, Rochester, MN, USA
Background and purpose: Ischemic stroke after cardiovascular
surgery is a major postoperative event that further complicates ICU
care. In many disabled patients who remain ventilated the need for
aggressive care is reconsidered. However, the prognosis of
patients who survive the acute postoperative phase but require
extended ventilatory support due to a stroke is unknown.
Methods: We identified 44 patients with acute ischemic stroke diag-
nosed after cardiovascular surgery resulting in prolonged endotra-
cheal intubation (>14 days). We collected data on surgical
indication, presurgical comorbid conditions, stroke mechanism and
location, reason for prolonged intubation, pulmonary complications
requiring therapeutic intervention, and duration of ventilatory support
and ICU stay. Clinical outcome was defined using the Glasgow
outcome scale (GOS). Proportions were compared using the Fisher
exact test and continuous variables using the paired t-test.
Results: Coronary revascularization, valvular replacement/repair,
and aortic surgery accounted for nearly one-third of the interven-
tions each. Sixty-four percent of the strokes had purely embolic
features and 29% had a combination of embolic and hemodynamic
features. Most patients (75%) remained intubated due to inability
to protect the airway, whereas weaning failure was less common
(25%). Thirty-seven failed extubation attempts were recorded and
35% of them resulted in serious complications. Pulmonary compli-
cations occurred in 59% of patients, including pneumonia in 52%
and ARDS in 12%. In-hospital mortality was 46% and only 9% of
patients were functionally independent (GOS 4–5) upon dis-
charge. History of lung disease and smoking was associated with
poor functional recovery (P=0.04). The presence of pulmonary
complications was associated with longer ICU stay (34±17 days
versus 26±11 days; P=0.02) and a trend towards longer duration
of mechanical ventilation (38±39 days versus 22±11 days;
P=0.16).
Conclusion: Prolonged mechanical ventilation is an important poor
prognostic factor in patients who suffer a stroke after cardiovascu-
lar surgery. Patients with perioperative stroke who cannot be extu-
bated within the first 2 weeks have a very poor outcome, especially
those with pre-existing lung disease. Almost half of the patients die
in the hospital and less than one in 10 patients achieve meaningful
functional recovery.
P49 Pulmonary complications in patients with stroke requiring mechanical ventilation
AA Rabinstein, EFM Wijdicks
Mayo Clinic, Rochester, MN, USA
Background and purpose: Prior studies have suggested that the
outcome of patients with acute stroke who require mechanical ven-
tilation is poor. In most patients swelling of ischemic tissue deter-
mines outcome but pulmonary complications may be equally
important. Our purpose was to assess the impact of pulmonary
complications on the outcome of patients with stroke who need
prolonged mechanical ventilatory support.
Methods: We reviewed data on 50 patients with acute stroke who
were mechanically ventilated for 5 days or more. We collectedinformation on stroke type and location, time to intubation, reason
for intubation, length of ventilatory support, duration of ICU stay. All
pulmonary complications requiring therapeutic intervention were
recorded. We defined outcome using the Glasgow outcome scale
(GOS). Proportions were compared using the Fisher exact test
and continuous variables using the paired t-test.
Results: Fifty-two percent of the strokes were ischemic and 58%
of them involved the posterior circulation. Sixty-two percent of
the hemorrhagic strokes were intraparenchymal hematomas and
more than half were infratentorial. The reason for initial intubation
was airway protection in 58% of patients, respiratory distress in
24% (usually due to aspiration or pulmonary edema), and respira-
tory arrest in 18%. Intubation was performed within 48 hours of
stroke onset in 88% of cases. All patients received a tra-
cheostomy. The mortality rate was 20% upon discharge and
32% among patients available for follow up at 1 year. Meaningful
functional recovery (GOS 4–5) was achieved by 16% of patients
both upon discharge and at 1 year. Pulmonary complications
occurred in 70% of patients, including 62% of patients with
pneumonia and 8% with ARDS. Presence of pulmonary compli-
cations was associated with longer duration of ventilatory
support (24±26 days versus 14±9 days; P=0.05) and ICU
stay (27±17 days versus 13±6 days; P=0.004), but not with
clinical outcome.
Conclusions: Pulmonary complications are very common and
serious among patients with stroke who require prolonged
mechanical ventilation and need a tracheostomy. Although pul-
monary complications lead to prolonged duration of ventilatory
support and ICU length of stay and cost, mortality is not increased.
Long-term ventilation in patients with stroke is not futile; recovery
of functional independence is possible and continuation of full level
of care seems warranted.
P50 Stroke treatment and outcome in ICU
G Consales, V Natale, A Sardu, S Grechi, P Angiolini, AR De Gaudio
Department of Critical Care Medicine, ICU Division, University of Florence, Italy
Introduction and methods: There is no general agreement about
the opportunity of ICU admission of patients with severe stroke
due to high morbidity and mortality. In order to clarify the therapeu-
tic perspective of these patients, is essential to identify some ele-
ments that could give early prognostic information. Aim of the
present study was to analyze patients with severe stroke admitted
to our ICU in order to assess the indications of ICU admission,
prognostic value of SAPS II, morbidity and mortality. Clinical sheet
of stroke patients admitted to ICU from 15 January 1995 to
31 December 2000 were retrospectively analyzed obtaining the
following data: cause of admission, SAPS II, length of stay and
mortality in ICU. SAPS II has been related to outcome. (Student’s
t-test).
Results and discussion: Twenty-seven patients were studied:
16 (59.3%) had intracerebral hemorrhage (ICH), 5 (18.5%) had
subarachnoid hemorrage (SAH), and 6 (22.2%) had an ischemic
stroke (IS). The necessity of tracheal intubation and mechanical
ventilation was the leading cause of admission in ICU. Mean length
of mechanical ventilation was 5±2 days. Mean length of stay in
ICU was 7±2 days. Mortality rate was 59.25%. Relationship
between mortality, functional outcome and nature of stroke, is
shown in Table 1. SAPS II on admission was significantly higher
(P<0.001) in non survivors. The relationship between expected
and observed mortality, in patients with ICH and IS, is shown in
Figure 1. We have noted a similar course of observed and
expected mortality, although observed mortality was slightly higher
than the expected one. We conclude that although high incidence
of poor outcome in severe stroke patients admitted to ICU, a good
functional outcome is possible in survivors. Moreover the SAPS II
may allow a prognostic evaluation of patients on admission.
Reference:
1. Lancet 1975, 1:480-484.
Table 1
Glasgow Outcome
Scale score ICH (n=16) IS (n=6) SAH (n=5)
1 death 10 3 3
2 vegetative state 1 0 1
3 severe disability 3 2 1
4 moderate disability 2 1 0
5 good recovery 0 0 0
5 good recovery 0 0 0
Figure 1
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P51 Medical specific characteristics of brain dead patients related to etiology
M Giannakou, A Efthimiou, G Tsaousi, M Kyparissa, E Anastasiou, E Geka, C Skourtis
Department of Anaesthesiology and Intensive Care, AHEPA General University Hospital, S. Kyriakidi 1, Thessaloniki, Greece
Introduction: Understanding the progressively changing patho-
physiology of brain death (BD) allows expedient diagnosis and
implementation of rapid therapeutic measures that maximize suc-
cessful application of transplantation. The present study investi-
gates whether time course to BD and the incidence of subsequent
homeostatic complications differed in patients with traumatic brain
injury (TBI) and those with non traumatic intracranial pathology
(intracerebral haemorrhage, brain tumor, post cardiac arrest
anoxia-IP) and influenced source of organ donation.
Design: Retrospective chart review in a multidisciplinary ICU from
January 1992 to November 2001.
Method: Patients were analyzed as to demographics, time to BD,
medical complications and their incidence (diabetes insipidus
[D.I.], hypotension, hypothermia, hypokalaemia). The patients were
divided in two categories, those with TBI and those with IP.
Estimation of data was performed using the Mann–Whitney test
and χ2 analysis.
Results: One hundred patients i.e. 2.03% of total admissions
(n = 4150) developed BD. Solid organ donors represented 24%
of brain dead patients and 0.7% of admissions. Patients’ demo-
graphics, medical complications and their incidence are men-
tioned in the Table. Incidence of donation was equal in both
categories (Table).
Conclusion: Age, previous severity of illness (APACHE II score),
GCS and abnormal pupil reactivity, time to BD and hypothermia
constitute the most important factors that differentiate the two cat-
egories. Early donor recognition, rapid and accurate declaration of
BD according to standing law are common practice in our ICU.
Nevertheless the percentage of organ donation remains low com-
pared to international standards.
Table
TBI (n = 50) IP (n = 50) P
Age* (years) 32.5 ± 20.15 48.73 ± 15.87 < 0.001
APACHE II* 21.13 ± 7.93 18.09 ± 6.35 < 0.005
Admission abnormal pupil reactivity (%) 40 25 < 0.02
GCS* upon admission 5.86 ± 2.9 7 ± 3.79 < 0.05
Time to B.D. (days)* 1.71 ± 1.31 2.69 ± 2.43 < 0.02
Hypothermia (%) 28 16 < 0.03
DI (%) 43 36 n.s
Hypotension (%) 34 32 n.s.
Hypokalaemia (%) 15 13 n.s.
* Mean ± SD
P52 BIS for recognition of brain-death in potential organ donors
T Gaszynski, A Wieczorek, W Krupowczyk, W Gaszynski
Department of Anaesthesiology and Intensive Therapy, Medical University of Lodz, Barlicki Hospital, Kopcinskiego 22, 90-153 Lodz, Poland
Background and aim of study: BIS is based on EEG monitoring.
Although it has been created for assessing depth of sedation or
anaesthesia it can give information on damaged brain activity. The
aim of study was to check out whether BIS index can indicate
brain-death and what kind of BIS record is observed in patients
with clinical symptoms of brainstem death.
Methods: Five BIS records of patients with clinically defined symp-
toms of brain-death were analysed. In all patients’ CT scans
showed deep and irreversible damage of brain (massive intracere-
bral haemorrhage). Tests for absence of brainstem reflexes and
persistent apnoea had been carried out and patients were qualified
for transplantation procedure. BIS was monitored before and
during apnoea test and pain stimuli.
Results: In two cases the range of BIS was initially 0 (0–3). BIS
monitor alarmed of EEG flat line. No response on pain stimuli nor
on apnoea test were observed in one case. In the second patient
BIS increased during apnoea test to 90. In the other three cases
initially BIS was over 0 (15–45) and during apnoea test increased
to over 90. No reaction on pain stimuli was observed. In those
cases where reaction on apnoea test was recorded, BIS signifi-
cantly decreased after apnoea test.
Discussion: The attempts for using BIS in patients with a severely
damaged brain as prediction of brain-death have been already
described. However there were no investigations on BIS records in
patients with diagnosed brain-death. It is underlined in many guide-
lines for recognition of brain-death that such investigation as EEG
must be assessed by highly trained specialists. Therefore the use
of a more simple device for recognition of brain-death could be
helpful and might increase the number of organ donations. It is
especially needed in haemodynamically unstable patients in whom
the apnoea test is difficult to perform because it may cause rapid
decrease in blood pressure to an unmeasurable level and even cir-
culatory arrest. Although in two cases BIS confirmed diagnosis ofbrain-death, in three other patients BIS was significantly higher
than 0 and device did not recognise EEG flat line. Probably strong
artefacts were the cause of it: the electrical activity of heart,
autonomous nervous system impulsation and transmissible trem-
bling of upper half of corps caused by heart work, which can be
especially observed in non ventilated patients.
Conclusion: These observations all together make the use of BIS
for diagnosis of brain-death in potential organ donors impossible
and in our opinion unreliable. Too many factors can influence BIS
record and this is unacceptable when used for defining the
patient’s death.
P53 Apnea test for brain death determination: an alternative approach
MD Sharpe*, GB Young†, C Harris‡
*Department of Anesthesia, †Department of Clinical Neurological Sciences, and ‡Department of Respiratory Therapy, London Health
Sciences Center — University Campus, 339 Windermere Rd, London, Ontario, Canada N6A 5A5; Program in Critical Care Medicine,
University of Western Ontario
Introduction: Complications that may occur during the ‘classical’
apnea test include severe respiratoy acidosis causing hemody-
namic instability, hypoxemia and an inadequate increase in CO2
requiring repeat testing. We present our experience administering
carbon dioxide (CO2) during mechanical ventilation as a means of
raising arterial CO2 (PaCO2).
Methods: An arterial blood gas and end-tidal CO2 (EtCO2) were
measured at baseline and hemodynamic monitoring and pulse
oximetry were monitored throughout. Using the formula: PaCO2 of
10 mmHg = pH of 0.8, it was predicted what EtCO2 was required
to achieve a PaCO2 sufficient to cause a pH 7.20. A gas mixture of
3% CO2:97% O2 was then administered through the ventilator
adjusting an IMV rate of 2–4 according to the rise in EtCO2. Once
the predicted EtCO2 was reached, an blood gas was repeated.
The PaCO2–EtCO2 gradient was also calculated pre and post
testing. Respiratory movements were monitored by both the respi-
ratory flow loops and by direct visualization by a physician.
Results: Sixteen patients aged 49 ± 15 years were studied. There
were no incidences of hemodynamic instability or arterial desatura-
tion during the studies. At the end of the apnea test, the predicted
and measured EtCO2 were 52 ± 9 and 56 ± 10 torr, respectively,
and the predicted and measured PaCO2 were 60 ± 10 and
67 ± 10 torr, respectively. All patients achieved an adequate arterial
pH and there was no change in the PaCO2–EtCO2 gradient during
the testing (P = 0.195, Student’s t-test). (Table; mean ± SD).
Conclusions: Advantages of this technique over the previous
method include: 1. allows for continuous measurement of EtCO2
during the apnea test (EtCO2 is predictive of rises in PaCO2); 2.
eliminates the likelihood of desaturation episodes; 3. better monitor-
ing for respiratory effort than provided by visual inspection alone.
Table
Baseline End of apnea test
pH 7.36 ± 0.05 7.19 ± 0.02
EtCO2 (torr) 32 ± 5 56 ± 10
PaCO2 (torr) 41 ± 5  67 ± 10
PaCO2–EtCO2 gradient 9 ± 4 11 ± 5
P54 High serum protein S100B levels in brain-dead patients
S Korfias*, I Dimopoulou†, A Anthi‡, C Psachoulia§, L Kiriou§, C Roussos†, DE Sakas*
*Department of Neurosurgery, and †Department of Critical Care Medicine, Evangelismos Hospital, 4 Marasli Street, 106 75 Athens, Greece;
‡Department of Critical Care Medicine, Hellenic Red Cross Hospital; §Department of Biochemistry, Evangelismos Hospital, Medical School,
National & Kapodistrian University of Athens, Athens, Greece
S100B is a protein synthesized in astroglial and Schwann cells in
the central nervous system (CNS). Only very low concentrations
of this protein are normally present in serum, whereas high levels
of S100B have been found in the blood of patients suffering from
a variety of CNS disorders, including tumors, cerebrovascular
insults or traumatic brain injury (BI). Data on S100B in patients
with brain-death are sparse. To clarify this issue, 48 brain-dead
(BD) patients (34 men, 14 women) with a mean (± SD) age of
48 ± 21 years (range 14–85 years) were studied. Brain-death
was due to trauma (n = 35), spontaneous intracerebral hemor-
rhage (n = 11), intracerebral thrombosis (n = 1) and intracerebral
aneurysm (n = 1). For comparison, 36 patients (32 men,
4 women), with severe traumatic BI who did not develop brain-
death, having a mean age of 33 ± 15 years (range 17–70 years)
were also studied. All patients were intubated and mechanically
ventilated. In BD patients, blood samples for S100B determina-
tion were obtained after clinical diagnosis of brain-death. In BI
patients, blood samples were collected upon admission in the
hospital and every 24 hours thereafter, for a maximum of seven
consecutive days; in these patients peak and average values of
S100B were used for analysis. Protein S100B levels in BD
patients (median 7.68 µg/l, interquartile range 4.06–14.10 µg/l)
were significantly higher compared to the peak (median 1.30 µg/l,
interquartile range 0.60–1.90 µg/l, P < 0.001, Mann–Whitney U
test) or to the average (median 0.60 µg/l, interquartile range
0.36–0.97 µg/l,  P < 0.001, Mann–Whitney U test) values of
S100B in BI patients. In conclusion, serum concentrations of
protein S100B are high in brain-death victims. Further prospective
studies are required to determine the predictive value of S100B
levels in the early diagnosis of brain-death.
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P55 Quality of life after severe head injury correlates to S100B serum level
RD Rothoerl, R Meyer, C Woertgen, A Brawanski
Department of Neurosurgery, University of Regensburg, 93042 Regensburg, Germany
Objective: S100B protein is a new possible indicator of brain
damage after severe head injury. Peak values of S100B serum
concentrations during the first days after trauma were significantly
correlated to survival after severe head injury. In outcome assess-
ment there is an increasing focus on measures of health outcome
incorporating the patients own perspective. Therefore the aim of
our study was to investigate the correlation of early S100B serum
level to the quality of life and outcome after severe head injury.
Methods: We included 51 patients with severe head injury (GCS
< 9), who had been admitted between 1 and 6 hours after injury, in
a prospective study. Blood samples were taken on admission
(mean 2.5 hours). The serum was analyzed for S100B concentra-
tions by using a RIA (Byk-Sangtec). S100B serum values above
0.5 µg/l were defined to be elevated. The outcome was assessed
at follow-up (mean 11.9 months after trauma, follow-up rate 100%)
using the Glasgow Outcome Scale (GOS 1–3 = unfavourable,
GOS 4–5 = favourable) and a questionnaire to assess the quality
of life (QOL) according to Blau consisting of 10 items (job, leisure,
eating, sleeping, friends, money, family, partnership, health and self
assessment). A quality of life index was calculated.
Results: Patients with unfavourable outcome had significantly
higher serum concentrations of S100B compared to the patients
with favourable outcome (4.9 µg/l versus 1.6 µg/l, P < 0.0008). In
the evaluation of all patients the QOL concerning all items is signif-
icantly lower in the group with S-100B serum concentrations
above 2 µg/l on admission (19.6 versus 51.2 points, mean,
P < 0.0007). The overall rating of QOL was in the same range in
these groups (15.2 versus 50.4 points, mean, P < 0.0002). Con-
cerning the survivors the quality of life index and the overall quality
of life is significantly higher in the group of patients with S100B
concentrations ≤ 0.5 µg/l on admission (71.4 versus 55.4 points,
mean, P < 0.05)
Conclusion: Thus S100B seems not only to be able to predict sur-
vival but also to assess the extent of primary brain damage after
trauma.
P56 Serum S100B as a biochemical marker of neurological complications in intensive care patients
A Raabe, O Kopetsch, A Woszcyk, V Seifert
Department of Neurosurgery, Johann Wolfgang Goethe University Frankfurt am Main, Germany
Objective: There is growing evidence that S100B protein may be
used as a novel biochemical marker of brain cell damage, mea-
sured by a simple blood test. Several studies have found increased
values in acute neurological diseases such as stroke, head injury,
intracerebral haemorrhage or cerebral hypoxia. The objective of our
study was to investigate whether measurement of serum S100B is
useful to diagnose an acute neurological complication in the
analgo-sedated and intubated intensive care patient.
Methods: One hundred and fifty neurointensive care patients with
different intracranial diseases were included in our study. Serum
S100B protein was measured daily using an immunoluminometric
assay (LIAISON, Byk-Sangtec Diagnostica, Dietzenbach,
Germany). The result of the test was usually available at the
bedsite within 3 hours. S100B levels and temporal course were
investigated for the sensitivity and specificity to diagnose a neuro-
logical complication occurring during the intensive care course.
Results: One hundred and twelve patients (75%) showed primarily
increased values due to their neurological disease or after surgery.
In 22 patients a complication with neurological deterioration was
observed such as vasospastic infarction, brain haemorrhage, or
contusion/oedema enlargement. In all of these patients, a signifi-
cant rise of S100B (> 0.5 µg/l) was found. There was no major
complication without S100B increase. In three cases, the increase
in S100B was the first sign of neurological complication and
prompted emergency computed tomography scanning. In two
cases, increasing S100B values changed management towards a
surgical intervention.
Conclusion: Serial measurement of S100B protein is suitable to
diagnose neurological complications with a high sensitivity and
specificity and to have an impact on management decisions in
intensive care patients.
P57 The influence of ventricular tapping on S100 and NSE serum concentrations: preliminary results
R Meyer*, M Gutsche†, A Rzepecki†, R Rothoerl*, C Woertgen*, A Brawanski*
*Department of Neurosurgery,and †Department of Anaesthesiology, University Regensburg, 93042 Regensburg, Germany
Objective: Serum markers, e.g. the protein S100 and neuron spe-
cific enolase (NSE), are recognized to give additional information
about the extension and prognosis of brain damage. In some of
these patients, e.g. after SAHs and ICBs, it is necessary to insert a
ventricular drainage. Whether the cannulation of the ventricle and
the insertion of a ventricular drainage falsifies the serum concentra-
tions of S100 and NSE is not known. The aim of this study was to
get further information in this field.
Methods: In this prospective study we included 10 patients
(5 women, 5 men, mean age 53.7 years) suffering from SAH (n = 5),
ICB (n = 2), hydrocephalus (n = 2) and ischemia (n = 1). All
patients underwent a ventricular tapping and an insertion of a ven-
tricular drainage. Serum samples for estimation of S100 and NSE
were collected before, directly after and 6 hours after insertion of
the drainage. In addition we investigated the liquor directly after
and 6 hours after insertion for S100 and NSE concentrations. The
samples were analyzed by using the Liaison kits (Byk-Sangtec,
Dietzenbach, Germany). For statistical work up we used the t-test.
Results: None of the patients showed a significantly increased
S100 or NSE serum concentration after insertion of the drainage.
The mean serum value of S100 before insertion was 0.49 µg/l,
directly after 0.42 µg/l and 6 hours later 0.49 µg/l. The mean
serum concentration of NSE before insertion was 18 µg/l, directly
after 13.9 µg/l and 6 hours later 9.8 µg/l. The concentration ofNSE in the cerebrospinal fluid directly after insertion were signifi-
cantly higher compared to the serum concentration (85 µg/l versus
13.9 µg/l, mean, P < 0.05). The S100 concentration in the liquor
was also higher, but failed to be statistically significant (418.8 µg/l
versus 0.42 µg/l, mean).
Conclusion: Due to our preliminary results, the serum values of
S100 and NSE seem not to be falsified by insertion of a ventricular
drainage. So the prognostic value of these serum markers seems
to be preserved despite the surgical manipulation. In addition the
concentrations of these markers in the cerebrospinal fluid seem to
be exceedingly higher compared to the serum concentrations,
probably reflecting an intact blood–brain barrier.
P58 Serum S100B as a marker of brain damage in the trauma intensive care unit
LE Pelinka*, H Redl†, A Kröpfl‡, W Mauritz*
*Department of Anesthesia and Critical Care Medicine, Lorenz Böhler Trauma Center, Vienna, Austria; †Ludwig Boltzmann Institute of
Experimental and Clinical Traumatology, Vienna, Austria; ‡Salzburg Trauma Center, Salzburg, Austria
Introduction: Though computer tomography (CT) is a reliable and
accurate method of assessing brain damage after trauma, it also
exposes the critically ill patient to considerable stress and is thus
unsuitable for frequent follow-ups. The intensivist managing severe
traumatic brain injury requires a marker which is reliable, repeatable
and non-invasive. Our aim was to determine whether S100B could
be such a marker in the intensive care setting, both for isolated
traumatic brain injury and for traumatic brain injury with additional
multiple trauma.
Methods: Ninety-five critically injured patients have been included
in this ongoing multi-center prospective study and assigned to one
of three groups, according to their pattern of injury:
Group 1: Isolated traumatic brain injury (n = 50)
Group 2: Traumatic brain injury in combination with multiple trauma
(n = 35)
Group 3 (controls): Multiple trauma without traumatic brain injury
(n = 10).
All patients are examined by CT on admission. S100B values are
determined during the first hours after trauma and daily thereafter
for a maximum of 3 weeks and compared to clinical, neurological
and laboratory findings and to CT.
Results: S100B is elevated during the first hours after trauma,
regardless of whether patients are suffering from traumatic brain
injury or not, but drops to normal after 48 hours if patients do
not have traumatic brain injury. The further course of S100B
differs markedly between survivors and non-survivors. In
survivors with traumatic brain injury, S100B decreases post-
traumatically and remains normal. In non-survivors with traumatic
brain injury, S100 remains elevated and/or increases prior to
death. This pattern is most clearly visible in patients with
isolated traumatic brain injury.
Conclusion: We consider S100B to be a useful marker in the
intensive care setting, both for patients with isolated traumatic
brain injury and for patients with additional multiple trauma. S100B
is a reliable, repeatable and non-invasive marker and does not
expose patients to any additional stress. It provides the intensivist
with valuable information regarding the effect of therapy on the one
hand and regarding prognosis on the other.
P59 Is procalcitonin a new surrogate marker for hypoxic brain damage?
M Fries*, D Kunz†, AM Gressner†, R Rossaint*, R Kuhlen*
*Department of Anesthesiology, and †Department of Clinical Chemistry and Pathobiochemistry, University Hospital of RWTH Aachen,
Pauwelsstr. 30, 52074 Aachen, Germany
Objective: Procalcitonin is so far known as a marker of severe
sepsis mostly caused by Gram-negative bacteria. But recent litera-
ture provided hints for its elevation after mechanic or hypoxic tissue
damage, too. In a pilot study we therefore investigated the possibil-
ity whether PCT could serve as a neurological outcome marker
after out-of-hospital cardiac arrest.
Methods: S100 protein and PCT serum levels were serially ana-
lyzed on hospital admission and on the following 3 days in 23
patients resuscitated after out-of-hospital cardiac arrest. At day 14
patients were divided in two groups applying the Glasgow
Outcome Scale (GOS): 16 patients in the group with bad neuro-
logical outcome (GOS 1–3); seven patients in the group with good
neurological outcome (GOS 4–5). If present signs of sepsis or
systemic inflammatory response syndrome (SIRS) were docu-
mented at the different time points. The diagnostic performance of
S100 and PCT levels to differentiate between the both groups was
performed with the use of receiver operating characteristics
(ROC). Both parameters were measured on the LIA-mat using the
assays from Byk-Sangtec and Brahms.
Results: Patients with bad neurological outcome had significantly
higher S100 levels than those with a good neurological outcome at
all time points and significantly elevated PCT levels at days 1–3.
Highest levels for S100 were found immediately after hospitaliza-
tion and for PCT at day 1. The brain-originated S100 showed best
performance immediately after hospitalization with an area under
the curve of 0.89 (sensitivity of 62.5% and specificity of 100% at a
cut-off value of 1.25 µg/l), while the non-brain-originated PCT was
the best predictor for bad neurological outcome at day 1
(AUC = 0.98; sensitivity of 92% and specificity of 100% at a cut-
off value of 0.5 µg/l). None of the patients revealed signs of sepsis
or SIRS at the investigated time points.
Conclusion: Although we only investigated a small number of
patients our results are promising and show that PCT is not only
induced in severe bacterial infection, SIRS, septic shock or multi-
organ dysfunction syndrome. Further investigations on larger
patient populations have to follow. Nevertheless we recommend
that S100 and PCT serum levels in the case of patients with out-of
hospital cardiac arrest can be used as reliable and, because of
their different liberation kinetics, to each other complementary
parameters for the prediction of neurological outcome in success-
fully resuscitated patients.
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P60 Cerebral blood flow in critically ill cardiac patients: effects of vasoactive drug therapy
H El-Atroush, A El-sherif, HK Nagi, N Abed, H Mowafy, S Mokhtar
Critical Care Medicine Department, Cairo University Hospitals, Egypt
The introduction of the thermodilution technique (TD) in measuring
cardiac output (CO) and coronary sinus blood flow has suggested
the application of the same technique into measuring CBF which
has been validated by several methods using transcranial Doppler
and Xenon inhalation clearance curves.
The present work is intended to assess the effect of two vasoac-
tive drugs on CBF in 20 critically ill patients (12 males, 8 females,
mean age: 5.86 ± 9.46) all having CHF due to dilated cardiomy-
opathy. Following clinical examination all patients were subjected
to haemodynamic evaluation including central venous line, arterial
cannulation and jugular vein catheterization. The latter was per-
formed using Baim coronary sinus catheter directed towards the
right jugular vein under fluroscopic guidance up to the bulb of
internal jugular vein. Jugular blood flow (JBF) was measured by
constant infusion of ice cold (5%) dextrose solution and recorded
digitally on a Baim coronary sinus computer. Haemodynamic mea-
surements including CBF were made at rest and repeated follow-
ing infusion of noradrenaline (NA) in incremental doses sufficient to
raise BP by one third of the basal reading. An average of three
readings were taken. NA was discontinued and after 20 min the
same method was repeated after dobutamine infusion given in a
dose of 10 µg/kg/min for 20 min.
Compared to basic measurements, NA significantly reduced CBF
by 22.4 ± 4.79% in 13 patients with simultaneous increase in CVR
by 106.73 ± 29.0%, NA increased CBF by 40.46 ± 12.0% in
seven patients with simultaneous decrease of CVR by 13.7 ± 6.2%.
It also increased systemic vascular resistance by 24.9 ± 2.76%,
P < 0.0001. On the other hand dobutamine has led to an increase
in CBF by 56 ± 12% in 11 patients with simultaneous decrease in
CVR by 22 ± 6.31%. It decreased the CBF by 38.1 ± 11.8% in
four patients with simultaneous increase in CVR by
130.68 ± 70.01%, and a decrease SVR by 21 ± 5%, P < 0.0359.
In conclusion, vasoactive drugs commonly used in critically ill
cardiac patients have different effects on cerebral blood flow.
Despite the beneficial effects obtained from using NA in increasing
perfusion pressure and cardiac output, the adverse effects on CBF
are an obvious limitation to its use as a monotherapy, compared to
dobutamine which besides augmenting CO improves dramatically
CBF.
P61 Validity of cerebral blood flow measurements by the thermodilution technique in critically ill cardiac patients
H El-Atroush, HK Nagi, A El-sherif, N Abed, H Mowafy, S Mokhtar
Critical Care Medicine Department, Cairo University Hospitals, Egypt
Despite the importance of cerebral blood flow (CBF) in determin-
ing the natural history and hospital course of critically ill cardiac
patients (pts), the qualitative determination of the CBF has been
rarely resorted to, because of technical limitations with resultant
lack of information about cerebral oxygen consumption and cere-
bral metabolic rate of oxygen when compared to other organs. The
introduction of the thermodilution technique (TD) in measuring
cardiac output (CO) and coronary sinus blood flow has led to the
suggestion of applying the same technique in measuring CBF. The
present work describes the use of TD to measure CBF in a group
of critically ill cardiac patients in comparison with the golden stan-
dard technique of transcranial Doppler. The group studied
included 20 critically ill cardiac pts (12 males, 8 females, mean age
58.6 ± 9.4 years), all having congestive heart failure due to dilated
cardiomyopathy, and were candidates for inotropic treatment.
Following clinical examination, all pts were subjected to haemody-
namic evaluation including central venous line insertion, arterial
cannulation and internal jugular vein catheterization. The latter was
performed using Baim coronary sinus catheter directed towards
the right jugular vein under fluoroscopic guidance up to the bulb of
internal jugular vein. Jugular blood flow (JBF) was measured by
constant infusion of ice cold dextrose solution and JBF was
recorded digitally on a Baim coronary sinus computer and CBF
was calculated from the equation: (JBF × 2 × 100/Brain weight).
Following the procedure CBF was measured by application of
Doppler technique and expressed as middle cerebral artery flow
velocity with the Doppler transducer over the zygomatic arch
window. Doppler parameters included: mean velocity, maximum
velocity, minimum velocity.. Assessed by TD, CBF averaged
22.32 ± 15.75 ml/min/100 g and was closely correlated in a linear
relationship with middle cerebral artery flow velocity measured by
the transcranial Doppler technique (45.9 ± 20.25 cm/s, r = 0.85,
P < 0.0001).
In conclusion, CBF can be measured in critically ill cardiac patients
by applying the TD principle. Our data have shown the validity of
this technique for assessing the course of critical illness and effect
of therapeutic interventions with the patient serving as a control for
himself.
P62 Correlation of transcranial doppler (TCD) parameters with jugular bulb venous oxygen saturation (SjO2)
S Voulgaris*, M Partheni*, T Vrettos†, A Lefkaditi†, K Kokkinis†
*Department of Neurosurgery, and †Department of Critical Care and Anesthesia, University Hospital of Patras, Greece
Introduction: Disturbances of the cerebral circulation play a key
role in the pathophysiology of head injury. TCD ultrasonography, a
non invasive bedside technique, and SjO2 monitoring, an invasive
technique which has some risk factors, are methods of assessing
cerebral hemodynamics. The purpose of the study was to examine
the relationships between TCD parameters and SjO2 measure-
ments in patients with head injury.
Methods and materials: Forty patients (35 ± 18 years) with
severe head injury (Glasgow coma scale < 8) were included in the
study. All patients were mechanically ventilated, sedated and para-
lyzed. Continuous monitoring of intracranial pressure (ICP), arterial
pressure, pulse oximetry and SjO2 were performed in every patient.
Multiple TCD examinations (total 150) were performed during the
first five ICU days. The TCD parameters were: maximum velocity(Vmax), minimum velocity (Vmin), and pulsatility index (PI). The find-
ings from TCD were compared with SjO2 values using the method
of Pearson’s product moment coefficient of correlation and linear
regression analysis.
Results: Among TCD parameters PI was found to be correlated
with SjO2. There was a leak correlation between PI and SjO2, for
SjO2 values below 75% (r = –0.51, P < 0.01). A breakpoint SjO2
value of 75% was demonstrated above which there was no corre-
lation between PI and SjO2 (r = –0.59, P > 0.05). With the same
method Vmax and Vmin were unable to provide more information.
Conclusion: The pulsatility index (PI) cannot predict changes of
SjO2 values. Therefore a combination of TCD and SjO2 monitoring
can provide better access to cerebral hemodynamics.
P63 Intracranial pressure monitoring in two district general hospital ICUs
JJ Paddle
Intensive Care Unit, Royal Cornwall Hospital, Truro TR1 3LJ, UK
There is a growing consensus that, in selected patients, intracranial
pressure (ICP) monitoring is an appropriate intervention in district
general hospitals. It improves outcome in patients with traumatic
brain injury [1] and is safe [2]. In the Southwest region two district
general hospitals without on-site neurosurgical facilities have been
inserting Camino fibreoptic transducers in their ICUs since
1997.
I conducted a retrospective case note audit of ICP monitored
patients at the two centres. Fifty-one patients had monitors
inserted between 6 October 1997 and 28 February 2001. Data
were collected on: sex, age, initial Glasgow coma score (GCS),
diagnosis, duration of ICP monitoring and incidence and nature of
complications. Sixty-nine percent of patients were male, with a
median age of 29 (range 1–71 years). Median GCS was 6 and
76% had an initial GCS of 8 or less. The most common indication
for ICP monitoring was traumatic brain injury (72%). Other diag-
noses were anoxic coma (12%), meningitis (8%), subarachnoid
haemorrhage (4%), intracerebral bleed (2%) and encephalitis
(2%). Median duration of monitoring was 3 days. Only two patients
were monitored for more than 5 days; both these patients received
two monitors.
The complication rate was low. One (2%) patient had a minor
scalp haemorrhage. One (2%) patient had a small intracerebral
haemorrhage, detected as an incidental finding on CT scan; it had
no clinical sequelae. One (2%) monitor developed a fault and had
to be resited. No infectious complications were seen. The data
from this audit adds to the weight of evidence that ICP monitoring
in selected patient groups is safe in district general hospitals.
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P64 CSF-cytokines (IL-6, IL-12, and IL-13): the right marker for shunt reimplanation after infections?
S Mukodzi*, C Müller*, N Ahrens†, S Kuno*, R-D Stenger*
*Department of Paediatrics, and †Department of Neurology, Ernst-Moritz-Arndt-University Greifswald, Soldmannstr. 15, D-17487 Greifswald,
Germany
Introduction: It is very difficult to determine the optimal time for
shunt re-implantation after cerebrospinal fluid (CSF) shunt infec-
tion. Total white blood cell count, neutrophil, eosinophil granulo-
cyte and plasma cell counts in CSF do not always provide
adequate information for the right decision to re-implant a shunt
after an infection. Re-infections have been frequently observed.
We therefore decided to examine the contribution the three
cytokines IL-6, IL-12 and IL-13 (CSF) could bring in deciding on
shunt re-implantation.
Methods: Three patients (2 boys, 1 girl, age: 4 months to 17.5
years) with external CSF drainage and shunt infections due to
Staphylococcus epidermidis had their CSF examined by ELISA for
IL-6, IL-12, and IL-13 over a period of 3–50 days. A simultaneous
examination of the cytograms was done and compared with the
cytokine results.
Results: The Table shows the similarity in behaviour of the inflam-
matory cells (IC) and the patients’ CSF cytokines.
Conclusion: Whereas the CSF inflammatory cytokines IL-6 and
IL-12 decrease in concentration, the anti-inflammatory cytokine
IL-13 concentration increases. This means that the cytokines could
be a good indicator for the course of CSF infections and hence an
Table
Patient 1 Patient 2 Patient 3
Period (days) 1 4 1 3 1 46
IL-6 (pg/ml) 108.3 74.4 184.9 86.0 111.9 12.3
IL-12 (pg/ml) 7.7 6.2 22.5 4.3 8.7 0.7
IL-13 (pg/ml) 39.5 45.5 58.8 78.8 13.0 51.3
IL-12/IL-13 0.19 0.13 0.05 0.05 0.7 0.01
IC (%) 10 3 10 2 65 1
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indicator for the optimal timing for shunt re-implantation. CSF leu-
cocyte count and its differentiation depends on the examiner and
on the quality of cell preparation. Thus the quantitative determina-
tion of the cytokines is more objective. Regrettably, the cytokine
values are very variable, meaning that only trends can be esti-
mated. Further studies are needed for reliable information concern-
ing the CSF infection status.
P65 Propofol attenuates the neuroprotective effects of magnesium in experimental traumatic brain injury
D Aktan*, T Erden*, M Kaya†, N Çakar*, L Telci*, F Esen*
*University of Istanbul Medical Faculty Department of Anesthesiology & Reanimation, and †University of Istanbul Medical Faculty Department
of Physiology, Capa Istanbul, Turkey
Objectives: Propofol is a popular nonbarbiturate anesthetic agent.
Its neuroprotective effects are controversial. The neuroprotective
effects of magnesium salts have been documented. We aimed to
examine the neuroprotective effects of propofol alone and with
magnesium on brain edema and blood–brain barrier (BBB) break-
down after experimental traumatic brain injury (TBI) in rats.
Method: Experimental closed head trauma was induced on
Sprague–Dawley rats by allowing 450-g weight falling from a 2-m
height onto a metallic disc fixed to the intact skull. Rats were
assigned into four groups to receive intraperitoneally 1 ml/kg saline
in the control group (C, n = 10), 10 mg/kg propofol in the propofol
group (P, n = 10), 750 µmol/kg magnesium sulphate (MgSO4) in the
magnesium group (M, n = 10), 10 mg/kg propofol and 750 µmol/kg
MgSO4 in the magnesium-propofol group (PM, n = 10) 30 min after
TBI. Brain water content (BWC) and specific gravity (SG), as indica-
tors of brain edema were measured 24 hours after TBI. BBB break-
down was evaluated quantitatively 24 hours after TBI by fluorometric
assay of Evans blue dye (EBD) extravasations.
Results: The increase in BWC, the reduction in SG and EBD
content in the group P was statistically significant when compared
to the group C. In the group PM, BWC was significantly higher and
SG was significantly lower than group M. EBD content in the brain
tissue was also significantly increased in the group PM when com-
pared to group M (Table 1).
Conclusions: These experimental data have shown that although
propofol has neuroprotective effects on TBI, it is not as effective as
magnesium, and it attenuates the neuroprotective effects of mag-
nesium sulphate on secondary injury factors following traumatic
brain injury.
Table 1
Statistical significance (P) comparison of BWC, SG, and EBD content between the groups
BWC SG EBD
Left Right Left Right Left Right
C vs M < 0.001 < 0.001 < 0.001 < 0.001 < 0.001 < 0.001
C vs P < 0.01 < 0.01 < 0.05 < 0.05 < 0.05 < 0.05
C vs PM > 0.05 > 0.05 > 0.05 > 0.05 > 0.05 > 0.05
M vs P > 0.05 > 0.05 > 0.05 > 0.05 > 0.05 > 0.05
M vs PM < 0.05 < 0.05 < 0.05 < 0.05 < 0.01 < 0.01
P vs PM > 0.05 > 0.05 > 0.05 > 0.05 > 0.05 > 0.05
P66 Respiratory effects of sufentanil and remifentanil in spontaneously ventilated patients after major abdominal surgery
F Occhigrossi*, E Cavaciocchi*, A Martinotti*, P Assisi*, M Traversa†, R Calimici†, R Salvatori*
*San Giacomo Hospital, and †San Giovanni Hospital, Rome, Italy
Introduction: Opioids as analgosedative agents are commonly
used in intensive care units but they are not performed in sponta-
neously breathing patients because of the potential risks of
adverse respiratory events. The aim of this study was to assess the
respiratory effects of sufentanil and remifentanil in postsurgical crit-
ically ill patients during spontaneous ventilation since the drugs
show pharmacokinetic and pharmacodynamic properties which
make them attractive for intensive care use.
Patients and methods: Twenty-seven patients requiring mechani-
cal ventilatory support were admitted in the general Intensive Care
Unit of the San Giacomo Hospital after major abdominal surgery.
They were randomised to receive either sufentanil (group S = 13
patients) or remifentanil (group R = 14 patients) variable continu-
ous infusion in order to obtain pain control and to maintain a
Ramsay Sedation Score of 2–3 as the target point. Rescue seda-
tion was provided, when needed, with Midazolam boluses. Respira-
tory rate (RR), VE, TV, EtCO2, pH, PaO2, PaCO2 and SpO2 were
measured in the two groups of patients during the continuous infu-
sion of the opioids before and 1 hour after the beginning of sponta-
neous ventilation (Pressure Support Ventilation) and then every
6 hours, even after extubation. Statistical differences were scored
using the Mann–Whitney U test and ANOVA test for repeated
measures.
Results: Adequate analgesia and sedation were achieved with
sufentanil and remifentanil administration. Midazolam mean dosage
was significantly higher in the remifentanil group. There were nostatistically significant differences between the two groups for RR,
TV, TE, EtCO2, pH, PaO2, PaCO2, SpO2 at the different times. No
adverse respiratory events were seen during the study.
Discussion: The present results show that sufentanil and remifen-
tanil continuous infusion at the appropriate dosage appear to have
no important adverse effects on respiratory drive and gas exchange
in spontaneously breathing critically ill patients after surgery.
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P67 Postoperative morphine clonidine analgesia in high-risk patients
SV Bernikova, MN Bogatyr
ICU, City Hospital N26, N2 Kostyushko Street, St. Peterburg, Russia
Intramuscular injections of the opiates in some cases cannot
provide effective analgesia in patients after traumatic abdominal
surgery. The purpose of our research was clinical evaluation of the
efficiency of postoperative morphine clonidine epidural analgesia in
high-risk patients (ASA III–IV). Epidural analgesia — morphine
hydrochloride 4 mg in combination with clonidine 0.05 mg — was
applied in 80 patients aged from 44 to 77 during 3 days of the
postoperative period, patients with unstable hemodynamics inclu-
sively. The epidural space was identified at the level Th5–6 with the
following insertion of the catheter by 3–4 cm into the epidural
space. Sufficient analgetic effect was observed in 20–30 min after
administration of morphine and clonidine and lasted for
10–12 hours. Hemodynamic state remained stable provided suffi-
cient intravenous ‘preload’ infusion had been performed before the
procedure, while the effect of arteriodilatation and hemodilution
was observed — CVP went down by 15% (P > 0.01), hemoglobin
and hematocrit dropping by 7–9% (P > 0.01). At the same time
slower heart rate and breath rate were observed. Analgetic effect
was scored individually in conformity with the rating scale coming
from 0 points (the best effect) to 10 points (the worst effect). The
average score before the injection was at 7.2 ± 2.1, with the fol-
lowing decrease to 3.1 ± 1.2 one hour after the injection. It is
necessary to admit that scores depended on an individual
patient.
Advantages of the postoperative morphine clonidine epidural anal-
gesia were that sufficient pain relief was not accompanied by a
long lasting sedation effect, which enabled patients to remain
active enough to move in bed, breath deeply, and secure effective
cough.
Therefore, postoperative morphine clonidine epidural analgesia
may be regarded as an alternative method of analgesia in high-risk
patients after abdominal surgery.
P68 BIS monitoring in ICU: advantages of the new XP generation
F Coluzzi, C Di Filippo, E Rossetti, D Summonti, C Mattia
Institute of Anaesthesiology and Intensive Care Medicine, University La Sapienza, Roma, Italy
Background: Bispectral Index (BIS) has been used to measure the
level of sedation in critically ill patients [1]. The biggest problems
were the artefacts raising from facial muscle or eye movements,
and the wide variability of analysed clinical conditions [2]. BIS-XP
is a new available device (Aspect, USA), with one more frontal
electrode, that should minimise the movement related artefacts.
The aim of our study was to compare the new and the old BIS
measurement on the same patient in ICU.
Materials and methods: Thirty critically ill patients, admitted to our
intensive care unit, were studied. Head-trauma patients were
excluded. SAPS II and Ramsay Sedation Scale (RSS) were used to
assess physiological impairment and sedation depth. Sedative agents
were administered at the following maintenance doses: Propofol
(1–3 mg/kg/hour) and Midazolam (0.025–0.033 mg/kg/hour), to
achieve a sedation level of 3–4. Sufentanil was administrated
(0.01–0.02 µg/kg/min), as needed, to ensure analgesia. Every patient
was simultaneously monitored with both the BIS and the BIS-XP,
along a period of 3–6 hours. BIS values were continuously recorded
and their variations after painful stimuli were relieved.
Results: Both systems well correlated with the level of sedation in
every single patient. The BIS-XP was able to eliminate anecdotal
rise in BIS value unrelated with depth modifications. Higher vari-
ability in BIS monitoring made the range wider than in BIS-XP
(coefficient of variation 72% vs 55%). After painful stimuli, BIS-XP
was shown to record variations with a mean advance of 42 s
(30–67 s), compare to BIS (both BIS and BIS XP have been set
with the same smoothing rate). Progress in electrode fixation on
the skin were observed with BIS-XP, avoiding repeated installation
and allowing long-term monitoring. Sedation level oscillations,
undetected by BIS, were revealed by BIS-XP value variations.
Conclusion: The BIS-XP showed sedation monitoring improve-
ment. The added electrode in BIS-XP was likely to improve the
number validity, by eliminating patient related artefacts, though the
higher sensitivity makes the BIS-XP trend less stable than the BIS
one. Moreover the advance in relieving depth variations could be
an useful improvement in guiding the administration of sedative-
hypnotic agents to titrate adequate sedation.
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P69 ‘Diprifusor’ TCI for sedation of ventilated adult ICU patients: target blood propofol concentration settings
TJ McMurray*, JR Johnston*, KR Milligan†, IS Grant‡, SJ Mackenzie§, S Beloucif¶, J Janvier**
*Royal Victoria Hospital, Belfast, UK; †Belfast City Hospital, UK; ‡Western General Hospital, Edinburgh, UK; §Royal Infirmary, Edinburgh,UK;
¶Hopital Bichat, Paris, France;**CHU Hopitaux de Bordeaux, France
The principal objective of this multicentre, non-comparative study
was to determine the range of target blood propofol concentration
settings required when ‘Diprifusor’ TCI systems are used to admin-
ister propofol for sedation in ventilated, adult, ICU patients. Follow-
ing local ethics approval, data were obtained from 122 patients.
Informed consent was obtained from patients or their next of kin.
Three categories of ICU patients were studied: 57 post-cardiac
surgery, 18 brain injured and 47 general ICU. Mean ages were
60.7, 41.1 and 60.7 years and mean APACHE II scores 9.2, 17.8
and 19 in the three groups respectively. The mean duration of
sedation was 15 hours in the post-cardiac surgery patients, 47.6
hours in the brain injured group and 63.3 hours in the general ICU
group. All post-cardiac surgery patients had received propofol by
Diprifusor TCI for surgery and the same TCI system continued in
use for sedation. Patients were excluded if they had received
propofol by conventional modes of administration within 4 hours of
the start of the study, had an established regimen of sedation with
agents other than propofol for more than 24 hours, or a regional
anaesthetic block persisting into the period of sedation. Depth of
sedation was assessed with a modified Ramsay Score (UK Inten-
sive Care Society National Guideline, 1999) and was also graded
as light (L), desired level (D) or excessive (E). The ‘Diprifusor’
target blood propofol setting was titrated as required to obtain the
depth of sedation desired in each patient. A desired level of seda-
tion was obtained, after a mean time of 9.9 min, in all but one
patient in whom sedation was ‘excessive’ throughout. For each
patient, the time-weighted average target setting over the entire
period of sedation, from the time when a desired level was first
obtained, was calculated. Median, 10th and 90th percentile values
are presented in Table 1.
Table 1
Time-weighted average Diprifusor target blood propofol
settings (µg/ml)
10th 90th
ICU patient category n Median percentile percentile
Post-cardiac surgery 57 1.33 0.79 1.92
Brain injured 18 0.98 0.58 2.53
General ICU 47 0.41 0.16 1.19
All patients 122 0.99 0.25 1.87
P70 Analgesia and sedation for ventilated newborn infants of low dose remifentanyl infusion
F Stoppa, C Cecchetti, C Tomasello, MA Barbieri, D Perrotta, M Marano, M Prosperi, N Pirozzi
ICU — Emergency Department, Bambino Gesù Paediatric Hospital, P.zza S. Onofrio n° 4, Rome, Italy
Introduction: The aim of our study is to verify the usefulness of
remifentanyl (R) in ventilated newborn (nw) evaluating the anal-
gesic effect and how variation of R infusion maintains a level of
analgesia according to different modality of ventilation (MV).
Materials and methods: Eighteen nw were admitted in ICU for
RDS, GA > 32, mean weight 2.250 ± 450 g. A modified scale,
according to PIPP and Comfort, was used to evaluate ‘comfort’.
According to the score (S) all patients were divided in three
groups: A < 5; B = 5; C > 5. Data were collected at T0 (basal
value), T1 (30 min after start infusion), Tn (every 4 hours), T-est
(extubation time), and T post-est (30 min after extubation). R infu-
sion was started at 0.25 µg/kg/min to obtain an ‘ideal’ S 5 ± 1;
and was modified to obtain an adequate analgesia during PCV.
After ‘critical’ phase R was reduced, evaluating the mean t to reach
an adequate RD (respiratory drive) for weaning. S at this moment
was < 5 (max 7). Finally R was stopped and the mean t for extuba-
tion was calculated. For all parameters median value and SD were
calculated. For HR, BP, PSO2 in A, B, C a Student t test was
adopted for the significance (P < 0.005) through the single value
at T0 (T0 vs A, T0 vs B, T0 vs C) and also A, B, C (A vs B, A vs C,
B vs C).
Results: The mean t of R (T1–Tstop) was 66.94 ± 22 hours, with a
mean dose of R 0.146 ± 0.038 µg/kg/min. The mean t to reach
comfort (5 ± 1) was 20 ± 13.11 hours (T1–T5) with R
0.17 ± 0.14 µg/kg/min. R was 0.18 ± 0.04 µg/kg/min in PCV with
a S of 4 ± 0.63.The mean t, to obtain a RD to change PCV to PAV,
was 2.30 ± 0.56 hours with R 0.09 ± 0.04 µg/kg/min, comfort S
5 ± 0.53 referred to all the period of PAV. Stop-Test was
15 ± 3.4 min. The S at Tpost-est was 5.5 ± 1.03. Statistically sig-
nificant is the fall of HR at T0 vs A (P=0.003) and T0 vs B
(P = 0.002) as a confirmation that an adequate level of analgesia
brings a stabilization of hemodynamic changes to pain stimuli.
SpO2 increased from T0 vs A (P = 0.005) and T0 vs B (P = 0.001)
due to synchronization of the patients to MV since the good level of
analgesia was reached.
Conclusion: No adverse effects were observed: low dose of R
maintained an analgesia with an assessment of patients to MV.
Infusion t did not influence time of extubation. Although the S 5 ± 1
is an hypothetic ‘ideal’ level of analgesia, we can assess that R
could permit, in newborn, to reach a state of comfort during all ‘MV
therapy’ until extubation, when pain stimulus is removed.
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3. Reid JE: Br J Anaesth 2000, 84:422-423.P71 Pain relief in major trauma patients: an Israeli perspective
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Background: The pain of major trauma patients remains often
unrelieved while in the Emergency Department. Our objective was
to examine pain management in several trauma units, and to evalu-
ate the impact of implementation of a trauma pain management
protocol.
Methods: Current status was evaluated from questionnaires filled
by trauma unit personnel of nine medical centers. In one, a pain
management protocol was introduced. Staff and patients evaluated
pain management before and after the protocol was instituted.
Results: About 80% of staff respondents from various centers
were not aware of guidelines for pain management in trauma. The
belief that pain assists diagnosis was the main reason (78.6%) for
withholding analgesia. Large variability existed on what contraindi-
cates analgesia, with the majority withholding analgesia in abdomi-
nal and multiple injuries. When administered, analgesia was
delayed, and most commonly intramuscular Meperidine was given.
After the protocol’s implementation, the personnel’s awareness of
analgesia increased, and consequently it was administered earlier
and to more patients, mostly as intravenous morphine.
Patients appreciated the timely analgesia (38% after vs 14%
before, P = 0.01), with fewer receiving none. Analgesia was con-
sidered beneficial by more patients (70% after vs 23% before,
P < 0.001). This was reflected in increases in overall satisfaction
with pain relief during the entire hospitalization.
Conclusion: The importance of pain management protocols in
major trauma was demonstrated by the response of personnel and
patients. The attitudes of the personnel regarding pain and its relief
have changed and this resulted in improved patient perception and
cooperation. This suggests that similar protocols should be tested
and introduced throughout the country.
P72 Salient beliefs towards the application of an algorithm for pain relief in ICU
D Beaulieu
University Hospital of Geneva, Micheli-du-Crest 24, CH-1211 Geneva 14, Switzerland
Introduction: The negative effects of pain on ICU patients’ recu-
peration has been reported in many studies, prolonging their length
of stay and increasing the cost of hospitalisation. It was demon-
strated that the application of an algorithm reduced pain scores.
Objective: The aim of this study was to identify the salient beliefs
of ICU nurses toward the application of an algorithm for pain relief.
Methods: This information was assessed using a questionnaire
answered by 24 ICU nurses recruited during work, as a convenience
sample. Ajzen’s theoretical framework was used as a basis for the
questionnaire and as a guide for the qualitative analysis of the data.
Results: The respondents found that the application of an algo-
rithm for pain relief increased autonomy and efficacy, ensured a
better follow-up and was easy to use. However, it was found to be
time consuming and not adapted to all patients, was a rigid frame-
work and did not take into consideration the subjectivity of pain.
The main barriers were lack of time, fear of side effects, inaccessi-
bility of the algorithm, the morphine or the pain scale. Also,
patients’ fear of the drug and refusal of the analgesia offered,
physicians’ fear of side effects and unwillingness to adhere to the
algorithm, the inability of patient to use or understand the pain
scale and the chart not adapted were mentioned as barriers.
Conclusion: Although the application of an algorithm seems to be
successful in pain relief, this study has identified numerous objec-
tives of intervention to be considered before the official implemen-
tation of an algorithm as a protocol for pain relief in ICU. Specific
points have been identified to facilitate its integration and reduce
workload for nurses already burdened with many aspects of patient
care. Information concerning pain is the first steep towards its relief
but a more integrated psychosocial approach such as increasing
the feeling of self-efficacy of the nursing and medical team needs
to be considered in order to improve the quality of care and cut
down on health expenses.
P73 Preoperative assessment of carbohydrate-deficient transferrin (CDT) in surgical patients and a prevention of abstinence
syndrome
T Grosmanova*, F Kouril†, V Kral*, T Bohanes*, M Hrabalova*, L Meznikova*
*The 1st Clinic of Surgery, and †Department of Clinical Biochemistry, Palacky University Teaching Hospital Olomouc, Czech Republic
Complications are much more frequent in chronic alcoholics than
in the remaining population after an elective operation or in some
other case, like trauma or acute abdomen. In the postoperative
period, alcoholics, suffering frequently from a liver disease, malnu-
trition etc., are threatened with infection, vegetative and metabolic
dysregulation, heard ischemia, liver dysfunction and also with a rise
of acute abstinence syndrome.
Treatment of the syndrome is mostly based on sedation of the
patient to suppress anxiety, agitation or aggressiveness and also to
control vegetative manifestations. The drugs, which are mostly
used, are able to sedate the patient, on the other hand they make
the postoperative care difficult and increase the complication rate.
Therefore, improvement of the results demands first of all to identify
all risky patients (including secret alcoholics) and to find a suitable
medication to suppress the abstinence with minimal sedation of
the patient.
It has been known since 1976 that pathological carbohydrate-defi-
cient fraction of transferrin (CDT) occurs in blood plasma of people
who are used to consuming more than 60 g of alcohol daily during
14 days, and disappears again after abstinence. The authors have
used detection of CDT according to Boehringer–Mann in their hos-
pital since 1998. The results are very precise and reliable.
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The test was performed in 228 surgical patients till 30 April 2001,
it was positive in 146 patients. In prevention of the abstinence syn-
drome, the authors obtained the best results by administering
clonidine. It reduces the sympathetic reaction to abstinence and
surgery. The drug was used in 42 patients with proven preopera-
tive elevation of CDT in dosage 2 × 0.150 mg i.v. Neither absti-
nence syndrome nor side effects were observed.
The authors suppose the described management, i.e. detection of
chronic alcoholics and prevention of the abstinence syndrome in
them, to be the most reliable and very effective method.
P74 Accidental withdrawal of catheters in 400 patients in ICU
L Lorente, J Málaga, R Galván, MM Martín, ML Mora
Department of Intensive Care, Hospital Universitario de Canarias, Tenerife, Spain
Objective: To determine the accidental withdrawal of catheters for
an assistance quality control.
Methods: It is a prospective study in a 20-bed medical surgical
ICU. Included were all patients admitted from 1 May 2000 to 31
December 2000.
Results: Included were 400 patients (233 males). Mean age was
56.80 ± 17.27 years, APACHE-II was 13.23 ± 5.25. Mortality was
16.50%. Patients distribution was: 185 cardiac surgery, 35 cardio-
logic, 23 pulmonary, 16 digestive, 51 neurologic, 43 traumathol-
ogy, 13 intoxication, 32 sepsis and two others. Patients
percentage with catheter and the accidental withdrawals per
100 days of catheter were: 86% orotracheal tube (0.70), 98%
central venous catheter (0.23), 29% central venous catheter by
peripheral access (0.18), 67% jugular vein catheter (0.33), 35%
subclavian vein catheter (0.17), 13% femoral vein catheter (0.17),
90% artery catheter (1.26), 82% radial artery catheter (1.35), 13%
femoral artery catheter (1.10), 2% pedal artery catheter (0), 2%
humeral artery catheter (0), 91% gastric catheter (6.4), 96% Foley
catheter (0.02), 7% thoracic drainage tube (0), 7% abdominal
drainage tube (0), 3% intracraneal pressure catheter (0.55).
Conclusions: According to the literature we have an acceptable
rate of accidental withdrawal of catheters. This is an important
aspect, not very studied, of an assistance quality control. More
studies are necessary to establish the standards.
P75 Which is worse, a repeated short time ischemia or a continuous long time ischemia? An effect of intermittent reperfusion
on tissue damage due to ischemia-reperfusion
Y Moriwaki, S Yamagishi, H Toyoda, T Kosuge, T Yamamoto, M Sugiyama
Department of Critical Care and Emergency Medicine, Yokohama City University, School of Medicine, Yokohama Citizen Medical Center
Hospital, 4-57 Urafune-cho, Minami-ku, Yokohama, Japan
Objective: The aim of this study is to clarify the effect of repeating
ischemia-reperfusion on the tissue damage or which is worse, con-
tinuous long time ischemia before reperfusion or repeated short
time ischemia-reperfusion before definitive reperfusion.
Materials and methods: Small intestinal segments of Wister male
rats were clamped with its mesenterial vessels. In group A, the
clamped segment was released 60 min after the clamp; in group
B, clamped segment was released 30 min after the clamp (for
10 min), re-clamped, and definitively released 60 min after the first
clamp; and in group C, the procedure of clamp-intermittent
release-definitive release was similar to that of group B and super-
oxide dismutase and catalase were given during the period of inter-
mittent release. Tissue lipid peroxide (LPO) and the activity to
produce oxygen free radicals of neutrophils in the draining vein
from involved intestinal segment (chemiluminescence [CL]) were
measured 10 min after definitive release.
Results: In group A, LPO and CL were increased from 19 to
43 nmol/g and from 30 to 43 counts per cell (cpc), respectively; in
group B, those were increased to 118 nmol/g and 64 cpc, respec-
tively, and in group C, 78 nmol/g and 31 cpc, respectively.
Conclusion: In some condition, tissue damage due to reperfusion
injury derived from oxygen free radicals is more severe in repeat of
short time ischemia with intermittent release than in long continu-
ous ischemia.
Recent experimental studies have described the protective effect
of ischemic preconditioning (IPC) on ischemia-reperfusion (I/R)
injury of the intestine [1,2]. In order to reach a new point of view in
the effect of IPC on the intestinal barrier function, the relationship
between I/R-induced mucosal injury and apoptosis must be clari-
fied. The present study was undertaken to investigate the relation
between IPC and Bcl-2 expression immunohistochemically and
apoptosis (by using conventional light microscopy, immunohisto-
chemical staining for cytokeratin 18 [M30 cytodeath Ab], DNA
agarose gel electrophoresis) in the intestine. Furthermore, we also
investigated the effect of intestinal IPC on serum nitrite/nitrate
levels.
With approval of the Ethical Committee, 33 male Wistar rats
weighing 250–300 g were randomized into three groups. A control
group of rats (n = 11) was subjected laparotomy. In an ischemic
group (n = 11), laparotomy was performed and the superior
mesenteric artery (SMA) was occluded by an atraumatic clamp for
30 min. In the preconditioned group (n = 11), before the ischemia-
reperfusion period, rats were subjected to initial 10 min of intestinal
ç
P76 Ischemic preconditioning reduces intestinal apoptosis in rodents
I Cinel, D Avlan, L Cinel, G Polat, S Atici, H Serinol, S Aksoyek, U Oral
Department of Anesthesiology and Reanimation, Pediatric Surgery, Pathology and Biochemistry, Mersin University School of Medicine,
Mersin, Turkeyischemia and 10 min of reperfusion. Twenty-four hours later, ileum
and blood samples were collected. Nitrite/nitrate levels were mea-
sured in the blood samples. Serum nitrate level was found to be
increased in the I/R group (16.2 ± 0.9 vs 34.3 ± 4.1) but not in the
IPC group (11.3 ± 5.9) (P < 0.05). The numbers of apoptotic cells
at 24 hours after I/R were significantly lower in IPC-treated rats.
Diminished Bcl-2 expression observed on the ileal specimens of
the I/R group was found to be prevented by IPC.
Our results indicate that IPC provides a significant protective effect
on ileum against I/R injury and that its effect is evidenced by a sig-
nificant increase in the expression of Bcl-2 following the insult. This
study shows that intestinal IPC may block the cascade of events
that cause apoptosis that can lead to multiorgan failure. In the
future, the use of agents causing Bcl-2 upregulation against the
spontaneous I/R attacks as a preservative measure in criticial
patients could be seriously considered.
References:
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preconditioning ameliorates ischemia- and reperfusion-induced
hyperpermeability in rats. Shock 2000, 14:429-434.
2. Aksöyek S, Cinel I, Avlan D, Cinel L, Oztürk C, Polat G, Nayci A, Oral
U: Intestinal ischemic preconditioning protects the intestine and
reduces bacterial translocation. Shock 2002, June: (in press).
P77 Sepsis: pro-apoptotic and anti-apoptotic signals in liver cells
EV Chatzigianni, E Messaris, N Memos, S Katsaragakis, G Legakis, E Menenakos, M Konstadoulakis, G Androulakis
Laboratory of Surgical Research, A’ Department of Propaedeutic Surgery, University of Athens, ‘Hippokration’ Hospital, Athens, Greece
Objective: Our aim was to investigate the role of the expression of
pro-apoptotic genes: Bax, Cytochrome-C, Caspase-8 and anti-
apoptotic gene bcl-2 in liver cells of septic rats.
Materials and methods: Sepsis was induced using the cecal liga-
tion and puncture model in 62 adult Wistar rats. The rats were sac-
rificed at 6, 12, 24, 36, 48 and 60 hours after the induction of
sepsis. A control group of 20 rats was used. Liver tissue was
obtained from each rat and the expression of Bax, Cytochrome-C,
Caspase-8 and Bcl-2 proteins was detected using the immunohis-
tochemical streptavidin–biotin method.
Results: The expression of both Bcl-2 and Bax proteins was found
decreased in liver cells of septic rats (50% and 50.8%, respec-
tively) compared to the controls (80%, P = 0.02 and 85%,
P = 0.008, respectively), while cytochrome-c (P = 0.9) and
caspase-8 (P = 0.05) expression did not differ significantly
between septic and control rats. In addition, the expression of all
the pro-apoptotic genes: Bax, caspase-8 and cytochrome-c was
maximum in liver cells of septic rats in the hyperdynamic phase of
sepsis (first 12 hours) and gradually decreased in the hypodynamic
phase (P < 0.05).
Conclusion: We demonstrate that the expression of regulating of
apoptosis genes: bcl-2 and bax, is inhibited in liver cells sepsis and
that the expression of executors of programmed cell death in liver
cells: caspase-8 and cytochrome-c genes is time dependent in
sepsis, with maximum values in the hyperdynamic phase.
Background and goals: Fever is a common problem in intensive
care unit (ICU) [1]. Fever is a cardinal feature of both infective and
non-infective inflammatory process [2].
Material and methods: We studied 50 patients between July and
October 2000 in the ICU. Core temperatures were determined
with the use of a rectal thermometer probe. Determination of the
APACHE-II score was made of all patients. Blood cultures were
obtained on all febrile patients. On each occasion at least two
blood cultures from different sites were obtained. Fever was
defined as a core temperature of ≥ 38.4°C.
Results: The mean APACHE-II score was (16 ± 0.6). The isolation
of Enterobacter aerogenes, Pseudomonas aeroginosa, coagulase-
negative staphylococcus, pseudomanas spp. and Staphylococcus
epidermitidis.
Conclusions: Fever is common and that caused by infective and
non-infective processes in approximately equal number. For this
reason, in treatment, the empirical coverage of all fevers in the ICU
with antibiotics is not necessary [3].
References:
1. Marik P: Chest 2000, 117:855-859.
2. Circiumaru B: Intensive Care Med 1999, 25:668-673.
3. Cunha BA: Intensive Care Med 1999, 25:648-651.
Table
The patients’ cause of admission
Febrile Non-febrile
Blood culture
Diagnoses Number (+) (–)
Organophosphate intox. 5 1 1 3
Multiple trauma 9 3 4 2
Myocardial infarction 3 – 2 1
Major abdominal surgery 7 4 2 1
Pneumonia 9 3 3 3
Renal insufficiency 2 – – 2
Drug intoxications 7 – 3 4
Neurological events 6 2 1 3
HELLP syndrome 2 1 – 1
50 14 16 20
ç
P78 Determination of fever in intensive care unit
M Kizilkaya, M Sahin, N Dogan, D Kursad
Ataturk University of Medical Faculty, Erzurum, Turkey
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P79 Leucocytosis in critically ill patients is not always a sign of infection!
G Izbicki, B Rudensky, M Naamad, M Hersch
Department of Anesthesiology Intensive Care, Clinical Laboratories, Shaare Zedek Medical Center, Jerusalem 91031, Israel
Background: We observed a post-transfusion (PT) leucocytosis in
several ICU patients, without showing other signs of sepsis. To
prevent unnecessary investigations prompted by leucocytosis, and
to understand the phenomenon, a prospective study was
conducted.
Methods: Forty-five non-septic patients receiving a non-filtrated
packed cells (NFPC) had a complete blood count (CBC) pre, and
2, 4, 6, 12 and 24 hours PT. Eleven patients multiply transfused,
were randomly given NFPC or prestorage filtrated packed cells
(PFPC), and CBC taken as above. IL-8, a leucocytes-chemoattrac-
tant, was measured in NFPC and PFPC stored for 1, 2, 3 and
4 weeks and in 16 NFPC just pre transfusion.
Results: White blood cell count (WBC) (× 109/l) significantly
increased 2 hours PT (19.5 ± 7.0 vs 14.3 ± 4.8 at baseline)
(P < 0.05), and returned to baseline in 24 hours. In patients requir-
ing more than one PC, WBC significantly increased 2 hours PT of
a NFPC compared to baseline (24.2 ± 7.8 vs 16.8 ± 4.7)
(P < 0.05), while when the same patients received PFPC, there
was no such increase (14.9 ± 5.2 vs 13.9 ± 5.4). There was no
change in IL-8 levels in PFPC stored for 1, 2, 3 and 4 weeks (mean
54 pg/ml) while there was a significant increase in IL-8 levels in
NFPC (61, 59, 161, and 745 pg/ml, respectively). IL-8 levels were
significantly higher in NFPC given to patients developing leucocy-
tosis compared to patients who did not develop leucocytosis
(408.4 ± 202 vs 70.4 ± 54.1 pg/ml) (P < 0.05).
Conclusions: Transfusion of packed cells may cause an acute and
transient leucocytosis in critically ill non-septic patients. Leucocyto-
sis occurred after transfusion of NFPC but not after transfusion of
PFPC. We suggest that IL-8 may contribute to this phenomenon.
P80 Transfer in ICU of febrile neutropenic patients: identification of risk factors and prospective validation of a prognostic score
J Larché*, F Alla†, P Maurer*, A Gérard*
*Service de Réanimation Médicale, CHU Nancy Brabois 54500 Vandoeuvre les Nancy, France; †Service d’Epidémiologie et d’Evaluation
Cliniques, CHU Nancy Hôpital Marin, 54000 Nancy, France
Objective: Optimal strategy of referral for neutropenic patients
from hematology ward to intensive care unit is not yet well defined.
Different severity-of-illness scores used in ICU have been recently
tested in hematology wards and have failed to predict accurately
patients at ‘high risk’, who could require a pre-emptive transfer in
ICU. We performed a case–control study in post-chemotherapy
neutropenic patients (for leukaemia or lymphoma), aimed at identi-
fying early risk factors for ICU transfer.
Design: Monocentric, retrospective, case–control (equilibration on
age, sex, and type of hemopathy) study comparing febrile neu-
tropenic patients admitted or not in ICU.
Results and measurements: Eighty-two patients have been
included (41 cases, 41 controls). Patients included were 51% men,
were aged 43 ± 17 years. The majority were hospitalized for an
acute myeloblastic leukaemia (56%), the others for acute lym-
phoblastic leukaemia (30%) or lymphoma (13%). Most of the
patients had clinical manifestations of infection (62%) but only 31%
a microbiologically demonstration of infection. 61.7% of the patients
were not in remission at time of admission in ICU. Mortality in ICU
was 65.8%. We compared data between neutropenic patients
(referred or not referred in ICU) during their stay in hematology
ward. We distinguished an early period (within 72 hours after the
onset of febrile neutropenia) and a later period (72 hours before
transfer in ICU or before discharge from hospital). Comparing data
between these patients during the early period highlighted that
urea, creatinin, protein C-reactive, and fibrinogen levels significantly
increased whereas hematocrit, platelets and lymphocytes levels
were significantly decreased, in patients referred in ICU. Using
these ‘early’ independent risk factors, we define a prognostic score
identifying patients who could benefit of an early transfer in ICU. A
multicenter, prospective study is now being performed on a second
cohort to validate accuracy, adequacy and reliability of this score.
Conclusion: Nowadays, no prognostic score focused on identifi-
cation of ‘high-risk’ neutropenic patients has been yet validated.
This study allowed the identification of early risk factors indepen-
dently associated with transfer in ICU. The clinical use in haematol-
ogy wards of such a prognostic score should allow earlier
pre-emptive transfers in ICU, resulting in better management and
possibly a better outcome for these patients.
P81 Septic shock etiology in kidney transplant recipients
FVC De Marco, A Higa, RG Silva, JOM Pestana, OFP Santos
Intensive Care Unit, Kidney and Hypertension Hospital ‘Oswaldo Ramos Foundation’, Rua Borges Lagoa 960, Vila Clementino, CEP
04038-002, São Paulo, Brazil
Introduction: Septic shock carries a high mortality in kidney trans-
plant recipients. Therefore, early institution of empiric antimicrobial
therapy is critical in the management of these patients. There are
few data about septic shock etiology in kidney transplant recipients.
Objectives: The aim of this study is to determine the most common
septic shock etiologic agents in kidney transplant recipients.
Setting: A kidney transplant specialized ICU in a 90-bed public
hospital.
Methods: We prospectively followed (from May 2000 to Decem-
ber 2001) kidney transplant recipients admitted to ICU with diag-
nosis of septic shock according to SCCM/ACCP criteria. ICU
resource utilization, microbiological identification and 28-day mor-
tality were recorded. Apache II score for each patient was calcu-
lated within 24 hours of admission.
Results: We studied 14 (10 M/4 F) consecutive patients admitted
to ICU with septic shock diagnosis. The mean age was 43 ± 9.5
years and mean Apache II was 23.7 ± 7.3. All patients were receiv-ing immunosuppression therapy at ICU admission and 11 (78,5%)
were in the first year of transplantation. The sources of infection
were: lungs (n = 6), intra-abdominal (n = 4), endocarditis (n = 2),
central venous catheter (n = 1) and central nervous system (n = 1).
The most common isolated microorganisms were: Candida (n =5 ) ,
cytomegalovirus (n = 4), Staphylococcus aureus (n = 3), Acineto-
bacter baumanii (n = 2), Escherichia coli (n = 2), Pneumocystis
carinii (n = 2), Klebsiella (n = 1) and Mycobacterium tuberculosis
(n = 1). In only three (21%) patients just one agent was isolated
and in another three (21%) patients we were not able to identify
the etiologic agent. The mean length of ICU stay was 15 ± 15.7
days and of mechanical ventilation was 12.5 ± 16 days. In 10
(71%) of these patients a pulmonary artery catheter was inserted
and there was need for renal replacement therapy in 13 (93%)
patients. The 28-day mortality was 71% and overall ICU mortality
was 78.5%.
Conclusions: Although kidney transplant recipients are suscepti-
ble to opportunistic infections due to immunosuppressive therapy,
bacteria remain a frequent septic shock etiologic agent in these
patients.
P82 Colistin in the treatment of infections from multiresistant Gram (–) bacilli
N Markou*, P Malamos*, D Hroni*, I Alamanos*, A Damianos†, H Apostolakos*
*ICU-B, KAT Hospital, Athens, Greece; †Department of Pulmonary Medicine, Hospital ‘A Fleming’, Athens, Greece
Objective: To present our experience with i.v. colistin in the treat-
ment of infections with multiresistant Gram (–) bacilli.
Materials and methods: Fourteen patients aged 20–81 years old,
with severe infection from multiresistant Gram (–) bacilli, sensitive
only to colistin. Of the patients, 11 were critically ill and mechani-
cally ventilated, with an APACHE II score 8–22, and the other
three were non-intubated patients with acute respiratory failure,
treated in the ward. All patients received intravenous colistin
(150,000 U/kg i.v., adjusted for creatinine clearance). A second
antibiotic (in 11 cases high-dose b-lactam in continuous intra-
venous infusion) was added in the regimen. In total 16 courses of
i.v. colistin were given, for the following infections: ventilator-asso-
ciated pneumonia (VAP) (nine cases), nosocomial pneumonia in
non-intubated patients (three), sepsis of unknown primary origin
(one), urosepsis (one), catheter-related sepsis (two). In all cases, in
spite of documented resistance, was included in the therapeutic
regimen. The bacteria responsible were P. Aeruginosa (14 cases)
or Acinetobacter baumanii (two cases). All patients had serum cre-
atinine < 2.5 g/dl and none was oliguric.
Results: Clinical response was observed in 12 cases. Thirty day
survival was 71.4%. As regards VAP, six of nine cases had a good
response. A slight deterioration in renal function was observed in
three cases.
Conclusion: The small number of patients and the absence of a
control group does not allow any definite conclusions on the clini-
cal effectiveness of colistin. On the other hand we did not notice
the daunting complications attributed to colistin in studies from the
1960s. Therefore, pending a definite controlled trial, intravenous
colistin use should be considered in severe infections with multi-
resistant Gram (–) bacilli, when it remains the only sensitive in vitro
antibiotic.
P83 Clinical outcome in ICU patients with Enterobacter bacteremia
S Blot, K Vandewoude, F Colardyn
Intensive Care Department, Ghent University Hospital, De Pintelaan 185, B-9000 Gent, Belgium
Purpose and methods: To investigate the clinical impact of Enter-
obacter bacteremia in ICU patients, a retrospective (January
1992–December 2000), matched cohort study was performed. All
ICU patients with Enterobacter bacteremia were defined as cases
(n = 67). Matching of the controls (1:2-ratio) (n = 134) was based
on the APACHE II system: an equal APACHE II score (± 1 point)
and admission diagnosis.
Results: There was a high rate of appropriate antibiotic therapy in
patients with Enterobacter bacteremia (96%). The mean delay in
the start of antibiotic therapy was short (0.5 ± 0.9 days). Following
the matching procedure cases and controls had nearly equal
APACHE II scores (23 ± 8.3 vs 23 ± 8.3; P = 0.890) and related
expected mortality rates (41 ± 24.1% vs 40 ± 24.1%; P = 0.805).
Patients with Enterobacter bacteremia had more hemodynamic
instability (78% vs 60%; P = 0.015). They also had a longer ICU
stay (36 ± 32.1 vs 15 ± 18.7 days; P < 0.001) and a longer venti-
lator dependence (32 ± 26.8 vs 12 ± 17.0 days; P  < 0.001).
There was no difference between cases and controls in age
(52 ± 19.8 vs 53 ± 19.3 years; P  = 0.831), acute respiratory
failure (93% vs 84%; P = 0.079) and acute renal failure (16.4% vs
15.8%; P = 0.892). Hospital mortality was not different between
cases and control patients (34.3% vs 38.8%; P = 0.536). A multi-
variate survival analysis showed the APACHE II related expected
mortality as the only independent predictor of mortality (HR, 3.7;
95% CI, 2.0–6.7; P < 0.001).
Conclusion: After accurate adjustment for severity of underlying
disease and acute illness, no difference in mortality was found
between ICU patients with Enterobacter bacteremia (34.3%) and
their matched cohort subjects (38.8%). In the presence of accu-
rate and prompt antibiotic therapy, bacteremia involving Enterobac-
ter species does not adversely affect the outcome in ICU patients.
P84 Screening and isolation of methicillin-resistant Staphylococcus aureus (MRSA) colonized patients is widely practiced in UK
critical care units but little benefit is perceived
MA Carter, MC Blunt
Queen Elizabeth Hospital, King’s Lynn, Norfolk PE30 4ET, UK
Colonization with MRSA has been shown to be associated with
increased length of ICU stay and increased nursing workload in the
critically ill patient [1]. Screening and isolation of colonized
patients have been recommended [2], but this is becoming
Available online  http://ccforum.com/supplements/6/S1Critical Care    Vol 6 Suppl 1 22nd International Symposium on Intensive Care and Emergency Medicine
increasingly difficult [3]. Furthermore this practice derives from rec-
ommendations of cohort isolation of general ward patients rather
than individual isolation of the critically ill [2]. We therefore decided
to assess practice in ICU and CCU by postal survey.
Postal surveys were sent to 193 units across England and Wales.
Replies were received from 98 units (51%). A follow-up survey
was then sent out and replies received from 57 (30%). National
guidelines were used alone in 70% (70/98). MRSA colonization
was flagged up in 73% (72/98). Colonization was perceived to be
increasing in 37% (21/57) and decreasing in 11% (6/57). Routine
screening of patients was performed in 54% (53/98). This was
performed immediately in 51% (22/43); within 24 hours in 44%
(19/43) and on designated days in 5% (2/43). A policy for screen-
ing of elective admissions existed in 49% (48/98), however this
was felt to help rates of colonization in only 23% (9/38). Routine
staff screening was performed in only 2% (2/98). Isolation of
MRSA colonized patients occurred in 69% (68/98). This was
thought to be effective or to eliminate cross infection in 42%
(29/68) and not effective in 15% (14/68). Isolation was not used
because it was not felt necessary in 37% (11/30) or because of a
lack of resources in 60% (18/30). In units using isolation 19%
(11/57) felt this decreased colonization. Increases in inter-hospital
transfers were felt to be a cause of increased colonization in 44%
(25/57).
National guidelines were widely used, however despite recom-
mended routine screening in certain patients this only occurred in
half the units sampled. Despite the frequent use of isolation only
42% of these felt it effective and only 19% had seen a reduction in
colonization rates associated with the use of isolation. 37% of
those not using isolation did not believe it of value, but 60% did
not use isolation due to lack of resources. Overall these figures
help suggest that there are considerable resource implications
from isolating MRSA colonized patients, but whilst this is common
practice its efficacy is not universally perceived and is only rarely
associated with reduced colonization.
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P85 Patient-to-patient antibiotic rotation
L Lorente, J Málaga, R Galván, C García, MM Martín, ML Mora
Department of Intensive Care, Hospital Universitario de Canarias, Tenerife, Spain
Objective: To evaluate ICU-acquired infections, germs responsible
and sensibility to antibiotics in an ICU using a patient-to-patient
antibiotic rotation. We have compared our dates with EPIC study.
Methods: It is a prospective study in a 20-bed medical-surgical
intensive care unit. Included were all patients admitted in ICU
during 19 months in two periods of time (first period from 1
January 1999 to 30 July 1999, second period from 1 May 2000 to
30 April 2001), with a length of stay in ICU longer than 24 hours.
The infections were diagnosed according to CDC criteria.
Results: Studied were 978 patients (371 and 607 patients in
respective periods of time), 601 males and 377 females. Mean age
was 57.01 ± 17.80 years. APACHE-II was 13.76 ± 6.31. Mortality
was 14.21%. Patients distribution was: 46% cardiac surgery, 11%
cardiologic, 10% neurologic, 10% traumathology, 8% pulmonary,
5% digestive, 10% others. We diagnosed 315 UCI-acquired infec-
tions in 182 patients. Distribution infections was: respiratory 39%,
urinary tract infection 28%, central venous catheter 12%, primary
bloodstream 12%, wound surgical 5%, nervous central system
4%. We isolated 322 germs: 47% Gram negative, 43% Gram
positive, 10% fungi. We found the following differences between
EPIC and our data: (a) rate infections for Pseudomonas
aeruginosa 28–7.1%, for acinetobacter 9–0.3%, for fungi
17–9.9%; (b) rate resistance of pseudomonas to gentamicin
46–25%, to ureidopenicillin 37–14%, to ceftazidime 27–18%, to
ciprofloxacin 26–5%, to imipenem 21–13%; (c) rate resistance of
Staphylococci aureus to methicillin 60–17%; (d) rate resistance of
coagulase-negative staphylococci to vancomycin 3–0%.
Conclusions: In our ICU, with a patient-to-patient antibiotic rota-
tion, we had no serious problems of resistance to antibiotics.
P86 Appropriateness of antibiotic prescribing after transition from an open to a closed intensive care unit
JW Zwaal, S Gupta
Kingston Hospital, Kingston upon Thames, Surrey KT2 7QB, UK
The main aim of the study was to investigate whether transition
from an open to a closed intensive care unit would improve
outcome in critically ill patients through more appropriate antibiotic
prescribing.
A retrospective chart survey was performed of all sputum and
blood cultures taken after more than 48 hours of ICU stay over a
3-month period before (period 1) and a 3-month period after
(period 2) transition from an open to a closed intensive care unit.
Populations in both periods were compared for age, sex, APACHE
scores and the following outcome variables: ICU mortality, average
length of stay, percentage appropriate and inappropriate changes
in antibiotic therapy, percentage appropriate and inappropriate
non-changes in antibiotic therapy, average reporting delays of
culture results. Antibiotic therapy was deemed appropriate when
the patients showed signs of sepsis, severe sepsis or septic shock
according to the ACCP/ACCM criteria and were prescribed anti-
biotics to which the cultured organisms were fully sensitive. Differ-
ences between means of continuous variables were tested by the
Student  t-test and between percentages by the method as
described by Armitage [1]. A P value of less than 0.05 was consid-
ered statistically significant.
There was a trend towards an increased percentage of inappropri-
ate decisions in period 2 vs period 1 (13% vs 9%) although this
did not reach statistical significance (see Table).There were no dif-
ferences in APACHE scores, length of stay or mortality between
period 1 and 2.Statistically significant increased reporting delays prior to inappro-
priate decisions not to change antibiotic therapy compared to
reporting delays prior to appropriate decisions to change antibiotic
therapy were found in period 1 but not in period 2 (see Table).
Transition from an open to a closed intensive care unit did not lead
to better antibiotic prescribing or outcome in ICU patients.
Whereas in the open ICU period inappropriate antibiotic therapy
was due to a combination of delays in reporting of culture results
as well as inappropriate decisions, in the closed period this was
solely due to inappropriate decisions not to change antibiotics.
Reference:
1. Armitage P: Statistical Methods in Medical Research. Oxford: Black-
well Scientific Publications; 1971.
Table
Period 1 (n = 81) Period 2 (n = 37) P value
% Appropriate decisions 90.10% 87.00% ns
% Inappropriate decisions not to change antibiotic therapy 9.90% 13.00% ns
% Antibiotics changed appropriately 30.90% 29.60% ns
% Appropriate non-change 59.20% 57.40% ns
Reporting delay prior to appropriate antibiotic change 2.1 days 2.3 days ns
Reporting delay prior to appropriate non-change of antibiotics 3.66 days 3.9 days ns
Reporting delay prior to inappropriate non-change of antibiotics 3.63 days 3.2 days ns
ns, non-significant result.
P87 Audit of therapeutic drug monitoring of dosing of vancomycin on an intensive care unit
P Mason, C Bradley
Pharmacy Department, St George’s Hospital, Blackshaw Road, London SW17 OHQ, UK
Introduction: Vancomycin is used to treat infections in critically ill
patients. Although serum levels are often measured, the relation-
ship between high plasma levels and renal and ototoxicity is not
proven [1]. Doses of 1 g achieve peaks of around 25–40 µg/ml
and toxicity is unlikely in this range. Troughs of between
5–10 µg/ml are thought to be necessary to ensure efficacy [2].
Due to age and renal function, patients on the general ICU at St
George’s are routinely prescribed 1 g once a day at 6.00 pm and
levels are taken the next morning which permits reporting before
the next dose is due. The next dose will only be administered if the
level is less than 10 µg/ml. There is no data supporting this practice.
Method: Data was collected over a 6 month period for patients
who received once a day dosing of vancomycin for at least 3 days.
A pharmacokinetic computer program used the measured plasma
vancomycin level at 12 hours post dose to predict the level at 24
hours post dose. Renal function and whether a further dose was
administered at 24 hours were recorded.
Results: Twenty-one patients (13 male: 8 female with an average
age of 65 years) were audited. Ten patients had some degree of
renal impairment (Cr > 110 mmol/l). One hundred and seventy-one
doses were audited and results are shown in Table 1.
All levels predicted within 5–10 µg/ml at 24 hours were above
10 µg/ml at 12 hours, resulting in only one of the 23 doses being
given. All levels within 5–10 µg/ml at 12 hours were sub-therapeu-
tic at 24 hours.
Conclusion: When monitoring vancomycin levels at 12 hours the target
concentration should be above 10 µg/ml to prevent sub-therapeutic
plasma level occurring in the later part of the dosing period.
References:
1. Saunders NJ: Why monitor peak vancomycin concentrations?
Lancet 1994, 344:1748-1750.
2. Kucers A, et al.:  The Use of Antibiotics, 5th edition. Butterworth-
Heinemann; Oxford, 1997.
Table 1
Measured vancomycin  Predicted vancomycin 
plasma level at 12 hours post dose plasma level at 24 hours post dose
Level > 10 µg/ml 5–10 µg/ml < 5 µg/ml > 10 µg/ml 5–10 µg/ml < 5 µg/ml
Number of samples 63 (37%) 82 (48%) 26 (15%) 12 (7%) 23 (13%) 136 (80%)
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Background: The oral form of moxifloxacin (MXF) has been used in
9 million patients and has been demonstrated to be an effective
and well tolerated treatment for respiratory tract infections in exten-
sive clinical trials. An IV formulation of MXF has been developed
and recently was approved in the US for the treatment of commu-
nity-acquired pneumonia, acute bacterial sinusitis, acute bacterial
exacerbations of chronic bronchitis, and uncomplicated skin and
skin structure infections. The efficacy and safety of IV/PO MXF
compared with IV/PO comparator (CMP) in CAP was examined in
two randomized, controlled studies; a pooled analysis of the
patients with severe CAP is reported here.
Methods: In both studies, MXF-treated patients received
7–14 days IV/PO MXF 400 mg QD. In study 1, CMP-treated
patients received IV/PO alatrofloxacin/trovafloxacin 200 mg QD or
IV/PO levofloxacin 500 mg QD; in study 2, CMP-treated patients
received IV/PO amoxicillin clavulanate 1200/625 mg TID ± IV/PO
clarithromycin 500 mg BID. Severe CAP was defined as the pres-
ence of at least one of the following conditions: respiratory rate
> 30 breaths/min; PaO2/FIO2 ratio < 250 mmHg or PO2 ≤ 8 kPa
(60 mmHg); requirement for mechanical ventilation; chest radi-
ograph indicating bilateral or multilobe involvement; increase in the
size of opacity by ≥ 50% within 48 hours of admission; or shock
(systolic blood pressure < 90 mmHg or diastolic pressure
< 60 mmHg).
Results: One hundred and ninety MXF-treated and 186 CMP-
treated patients comprised the clinically valid population. Treat-
ment groups were similar with respect to demographic and
baseline medical characteristics. Bilateral or multilobar involvement
was present in 44% of MXF-treated and 54% of CMP-treated
patients, and was the most common reason for categorizing CAP
as severe. Clinical resolution was achieved in 88% (167/190) of
MXF-treated and 83% (155/186) of CMP-treated patients (95%
CI = –1.9%, 12.2%). A switch from IV to PO therapy was made by
day 5 of therapy for 73% (139/190) of MXF-treated vs 60%
(112/186) of CMP-treated patients (P < 0.01). Similar durations of
therapy and time of IV to PO switch were observed for the ITT and
microbiologically valid populations. Serious drug-related adverse
events occurred in 7% (16/241) of MXF-treated and 6% (14/238)
of CMP-treated patients.
Conclusions: Sequential IV/PO MXF is as effective as the standard
IV/PO fluoroquinolone or IV/PO beta-lactam/beta-lactamase inhibitor
± macrolide regimens for the treatment of severe CAP. IV/PO MXF
is an excellent choice for empiric therapy of severe CAP.
P89 Adult varicella pneumonia requiring intensive care
BCH Ho, DYH Tai
Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, Singapore 308433, Singapore
Introduction: Varicella pneumonia is the most common severe
complication of chickenpox in adults.
Method: In this retrospective case series, we reviewed the clinical
presentation and outcomes of all adult varicella pneumonia
patients who were admitted to the Medical Intensive Care Unit of a
university-affiliated general hospital from 1997 to 2000.
Results: The 10 patients had a mean ± SD age of 44 ± 20 (range:
26–86) years; two patients were above 65 years old (ages 73 and
86). All but one were male. None had previous varicella vaccina-
tion. Five patients had direct exposure to persons with chickenpox
infection. Four patients had underlying pulmonary pathology: past
pulmonary tuberculosis (two), emphysema (one) and recurrent
right pleural effusion from autoimmune serositis (one). Two patients
had a background history of immunocompromised states (systemic
lupus erythematosus and acute myeloid leukaemia). There were
four cigarette smokers, two ex-smokers, two non-smokers and two
did not have their smoking history documented. The mean respira-
tory rate was 30 ± 8 breaths per minute (range: 18–42). The mean
Acute Physiology and Chronic Health Evaluation II score was
15.7 ± 6.2 (range: 7 to 26). Two patients had acute respiratory dis-
tress syndrome and five had acute lung injury. The mean ratio of
the partial pressure of arterial oxygen to the fraction of inspired
oxygen was 261 ± 60 (range: 171–351). The median duration of
stay in the ICU was 15 days (range: less than 1 day to 76 days).
Eight patients (80%) required mechanical ventilation. The median
duration of mechanical ventilation was 16.5 days (range: less than
1 day to 79 days). All patients were started on acyclovir and empir-
ically treated with cloxacillin and ceftriaxone. There were three
deaths (30%); two were above 65 years old and the third had
acute myeloid leukaemia on chemotherapy. Two patients had acute
renal failure and both died.
Conclusion: Varicella pneumonia carries a high mortality. Old age,
an immunocompromised state and acute renal failure appear to be
associated with increased mortality in our series.
P90 Respiratory Herpes simplex virus at the intensive care unit: a prospective study
P Bruynseels*, P Jorens†, M Elsevier*, H Demey†, H Goossens*, G Ieven*
*Department of Microbiology, and †Department of Intensive Care Medicine, University Hospital of Antwerp, Wilrijkstraat 10, 2650 Edegem, Belgium
Background: Herpes simplex virus (HSV) can cause a variety of
diseases including respiratory infections. A retrospective study per-
formed at our hospital did not clarify the clinical and prognostic sig-
nificance of HSV in the respiratory tract of critical care patients.
Objectives: A prospective study was conducted between Novem-
ber 1999 and July 2001 in order to evaluate the incidence and sig-
nificance of respiratory HSV in ICU patients, to identify risk factors
for the development of lower respiratory tract (LRT) infections with
HSV and to study the origin of the virus.
P88 Efficacy and safety of sequential IV/PO moxifloxacin for the treatment of severe community-acquired pneumonia
H Lode*, S Choudhri†, D Haverstock†, P Jackson†, D Church†
*Lungenklinik Heckeshorn, Berlin, Germany; †Bayer Corp, West Haven, CT, USAMethods: Seven hundred and sixty-four patients admitted to our
30 bed ICU in a tertiary care hospital were examined for the pres-
ence of HSV in the upper (URT) and lower respiratory tract (LRT).
Results: One hundred and sixty-nine patients (22%) had HSV in
the URT. The reactivation of the virus occurred within 10 days for
89% of all positive patients and followed a period of more severe
disease as was indicated by SOFA max. In 58 (16.2%) of the 361
patients who had their LRT sampled, the virus was isolated from
bronchusaspirate (BA) of broncho-alveolar lavage fluid (BAL). HSV
in the throat was a highly significant risk factor (RR 11.6; 95% CI
5.51–23.84) for the development of LRT infections with the virus.
Patients with more debilitating disease on admission and during
ICU stay were more susceptible for HSV reactivation as was
shown by APACHE II and SOFA scores. There was a significant
association between HSV reactivation and ARDS (RR 2.94; 95%
CI 1.6–5.41). The association between intubation and HSV reacti-
vation was probably due to disease severity although patients with
a long intubation (> 7 days) had a RR of 2.77 (95% CI 1.79–4.30)
for reactivation of HSV, even when controlled for SOFA max.
Patients with HSV reactivation had a longer ICU as compared to
those without the virus.
Conclusion: HSV reactivation in ICU patients is more frequent
than previously assumed. Reactivation of the virus in the throat is a
major risk factor for the development of LRTI with the virus.
Patients with HSV reactivation have a longer ICU stay as com-
pared to controls. Further study on the effect of pre-emptive
aciclovir therapy in these patients needs to be performed.
P91 The clinical stages and prognostic factors of children with enterovirus type 71 infection developing pulmonary edema and
hemorrhage
JJ Chang*, SH Hsia*, LY Chang†, TY Lin†
*Division of Pediatric Critical Care Medicine, and †Division of Infectious Disease, Pediatric Department, Chang-Gung Children’s Hospital, 
5 Fu-Hsing St. Kweishan, Taoyuan, Taiwan 333, ROC
Pulmonary edema/hemorrhage was the most severe complications
of EV 71 associated hand–foot–mouth disease and usually led to
cardiopulmonary failure. The mortality rate was 92% in the 1998
outbreak (11/12). During 2000 and 2001 outbreaks, the mortality
rate had been reduced to 33% (8/24). This report was an observa-
tion of the clinical stages, risk factors and outcomes. There were
24 children brought to our PICU from May 2000 to June 2001.
There were 10 females and 14 males. The age ranged from 5 to
93 months old (mean = 19.8).
The EV 71 infections were confirmed by either positive virus isola-
tion (71%, 17/24) or elevated serum neutralization antibody (> 1:8,
96%, 23/24). We found most of the patients (58%, 14/24) pre-
sented five clinical stages: (1) hand–foot–mouth disease; 
(2) meningoencephalitis; (3) cardiopulmonary failure; and (4) conva-
lescence stage. The third stage was divided into two substages,
(3A) hypertension stage and (3B) hypotension stage.
The risk factors associated with mortality/morbidity were age, CSF
leukocytosis, increased troponin I, episodes of cardiac arrest,
decreased ejection fraction, need of high dosage inotropes
support, lack of hypertension stage which might mean delayed
hospital visit, initial very high serum glucose and very low worst
PaO2–FiO2 ratio. Fifty percent of survivors (8/16) had moderate to
severe neurological sequelae and needed long-term respiratory
care.
P92 Surveillance urine cultures in the ICU: prospective markers for the phenotypic and genotypic drift of emerging yeast
pathogens?
G Dimopoulos*, O Kostoula†, M Logotheti†, A Stratis*, A Rasidakis*, NJ Legakis†, A Velegraki†
*Respiratory and Critical Care Department, Athens Chest Hospital ‘SOTIRIA’, Greece; †Mycology Reference Laboratory, Department of
Microbiology, Medical School, University of Athens, Greece
Surveillance for yeast infections in the ICU is essential to define
their burden and trends, to provide the infrastructure needed for
epidemiological studies, to evaluate therapeutic interventions and
to detect new pathogens. The present 12-month prospective
observational study was conducted on a defined ICU population
including 56 (24%) patients among 240 (100%) ICU admissions
with distinct predisposing factors [1], mean age 52 ± 6 years,
mean length of ICU stay 9 ± 6 days, APACHE II score 14 ± 5 and
SOFA score 5 ± 2. Urine samples were tested by microscopy and
culture on selective media. Each isolate was identified to species
level, tested for phenotypic characteristics, such as susceptibility
to current and novel antifungal agents and studied for genotypic
similarities through identifying DNA subtypes with PCR followed by
restriction fragment length polymorphism analysis (RFLP) [2] and
with minisatellite length polymorphism analysis (MLP), to distin-
guish epidemic isolates.
Among the patient population, only 18/56 had negative urine cul-
tures, whereas candiduria (> 1000 CFU/ml) was detected in
38/56 patients and two different yeast species were isolated
from 7/38 patients. Candida albicans was the main aetiology for
candiuria (27%), followed by C. parapsilosis (20%), C. tropicalis
and C. famata (11.3%) respectively. Emerging yeast pathogens,
such as C. lusitaniae, C. dubliniensis, Trichosporon asahii and
T. mucoides were isolated from 18/38 patients, while C. krusei
was isolated from only 2/38 patients. All isolates were suscepti-
ble to amphotericin B, except T. asahii, for which the lowest
minimum inhibitory concentrations (MICs) were recorded for itra-
conazole (Janssen) and voriconazole (Pfizer). Resistance to flu-
conazole (Pfizer) was only detected in C. krusei, in two C. famata
isolates and in a subpopulation of one C. lusitaniae strain, which
however were susceptible to both itraconazole and voriconazole.
Identical DNA subtypes were identified among C. albicans, 
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C. parapsilosis,  C. famata,  C. dubliniensis and  Trichosporon
species, whereas intense genetic heterogeneity was recorded
among C. lusitaniae isolates.
Additional fixed-time surveillance studies in the ICU, using specific
markers linked with phenotypic and genotypic analyses, may be
employed to recognize outbreaks, to formulate emerging pathogen
case definition and exclusion criteria leading to prevention of
further cases, and to evaluate azole-based pre-emptive or targeted
treatment when such criteria are fulfilled.
References:
1. Karabinis A, Hill C, Leclerq B, Tancrede C, Baume D, Andremont A:
Risk factors for candidaemia. A case control study. Am J Med
1988, 87:614-620.
2. Velegraki A, Kambouris M, Skiniotis G, Savala M, Mitroussia-Ziouva A,
Legakis NJ: Identification of medically significant fungal genera by
polymerase chain reaction followed by restriction enzyme analy-
sis. FEMS Immun Med Microbiol 1999, 23:303-312.
P93 5000 days of central venous catheterization: complications
L Lorente, R Galván, J Málaga, C García, MM Martín, ML Mora
Department of Intensive Care, Hospital Universitario de Canarias, Tenerife, Spain
Objective: To analyze complications of central venous catheteriza-
tion in Critical Care.
Methods: It is a prospective study in a 20-bed medical surgical
ICU. Included were all patients admitted from 1 May 2000 to 31
December 2000.
Results: Included were 400 patients (233 males). Mean age was
56.80 ± 17.27 years, APACHE-II was 13.23 ± 5.25. Mortality was
16.50%. Patients distribution was: 185 cardiac surgery, 35 cardio-
logic, 23 pulmonary, 16 digestive, 51 neurologic, 43 traumathol-
ogy, 13 intoxication, 32 sepsis and two others. The number of
catheter and length stay of catheter (days) were: global 706 and
4980, peripheral access 145 and 949, jugular 306 and 1806, sub-
clavian 190 and 1694, femoral 65 and 531. Central venous
catheter related infections per 100 catheter and per 1000 days of
catheterization were: general 3.40 and 4.81, peripheral access
1.64 and 2.52, jugular 3.6 and 6.20, subclavia 1.68 and 1.88,
femoral 11.11 and 13.55. Bloodstream infections secondary to
central venous catheter per 1000 days of catheterization were:
general 1.44, peripheral site 0.84, jugular 0.88, subclavian 1.41,
femoral 4.51. Pneumothorax secondary to central venous catheteri-
zation: general 1.29% (8/619), subclavian 1.68% (4/237), jugular
1.04% (4/382). The groups of microorganisms found were: 62.4%
Gram positives, 25.2% Gram negatives and 12.4% fungi. The
microorganisms isolated were: staphylococcus coagulase negative
58.33%, bacillus 4.16%, Escherichia coli 8.33%, serratia 4.16%,
Pseudomonas aeruginosa 4.16%,  Morganella morganii 4.16%,
Candida albicans 8.33%, Candida tropicalis 4.16%, enterobacter
4.16%.
Conclusions: We have a low rate of central venous catheter com-
plications. Femoral venous catheterization is the site with more
catheter related infections.
P94 Central venous catheter-related infection
M Mer, AG Duse, J Galpin, R Taylor, GA Richards
ICU, Johannesburg Hospital; University of the Witwatersand, South Africa
Introduction: Central venous catheters (CVCs) account for an
estimated 90% of all catheter-related bloodstream infections
(CRBSI). The duration of use of CVCs remains controversial and
the length of time such devices can safely be left in place has not
been fully and objectively addressed in the critically ill ICU patient.
As a consequence, scheduled replacement remains widely prac-
ticed in many ICUs. Over the past few years, antimicrobial impreg-
nated catheters have been introduced in an attempt to limit
catheter-related infection (CRI) and increase the time that CVCs
can safely be left in place. A recent meta-analysis concluded that
chlorhexidine-silver sulfadiazine (CSS) CVCs appear to be effec-
tive in reducing CRI [1].
Materials and methods: This was a prospective randomized
double-blind study performed in the adult multidisciplinary ICU at
Johannesburg Hospital between 1996 and 1999. The study
entailed comparison of a 14-day placement of standard triple-
lumen versus antimicrobial impregnated (CSS) CVCs on the rate
of CRI. Our aim was to determine whether we could safely
increase the duration of catheter insertion time from our standard
practice of 7 days to 14 days, to assess the influence of the antimi-
crobial impregnated catheter on the incidence of CRI, and to eluci-
date the epidemiology of CRI. One hundred and eighteen critically
ill patients were included in the study.
Results: Sixty-two patients received a standard triple-lumen
catheter and 56 patients a CSS impregnated triple-lumen catheter.
The study spanned 34,951.5 catheter hours (3.99 catheter years).
The mean duration of placement for the full sample of 118 CVCs
was 12.3 days (range, 1–14). No statistically significant difference
in CRI rates between the two types of catheters could be demon-
strated. The most common source of primary CRBSI was skin, fol-
lowed by hub and infusate. The site of CVC insertion (internal
jugular vein versus subclavian vein) and the use of parenteral nutri-
tion were not noted to be risk factors for catheter infection.
Conclusions: In this study, we were unable to demonstrate that
the CSS catheter provides any significant benefit over standard
catheters, which we feel can safely be left in place for up to 12
days and probably 14 days. The most common source of CRI was
the skin. The administration of parenteral nutrition and the site of
catheter insertion were not noted to be risk factors for CRI.
Reference:
1. Veenstra DL, et al.: JAMA 1999, 281:261-267.P95 Multi-lumen central venous catheters increase the risk of bloodstream infection: evidence from a systematic review
M Zürcher*, MR Tramèr†, B Walder*
*Division of Surgical Intensive Care, and †Division of Anaesthesiology, Department APSIC, Geneva University Hospitals, CH-1211 Geneva
14, Switzerland
Background and aim: Infections due to central venous catheters
(CVC) contribute to hospital morbidity [1]. There is a controversy
as to whether there is a particularly high risk of infection with multi-
ple lumen CVCs. The aim of this systematic review of randomised
trials was to test the evidence that multi-lumen CVCs, compared
with single-lumen catheters, increase the risk of bloodstream infec-
tion, catheter colonisation, and insertion site infection.
Materials and methods: Systematic search (Medline, Embase,
Cochrane Library, bibliographies, to 12.2001, any language) for
published full reports of randomised comparisons of multi-lumen
versus single-lumen CVCs in adults, reporting data on the inci-
dence of infection according to published criteria [2]. Two authors
independently screened all retrieved reports and extracted data.
Methodological validity of the reports was assessed by all authors
using the Oxford scale. Data were combined using a fixed effect
model and reported as relative risk (RR) with 95% confidence
interval (CI).
Results: Fourteen potentially relevant reports were retrieved; nine
were subsequently excluded (not randomised, invalid endpoints).
Settings were ICU or surgical ward. In five studies (530 CVCs),
bloodstream infection was increased with multi-lumen CVCs com-
pared with single-lumen CVCs (9.5% vs 3.5%, RR 2.62 [95% CI
1.25–5.49]). In four studies (353 CVCs), there was no difference
in colonisation (13.1% with multi-lumen vs 14.7% with single-
lumen, RR 0.93 [95% CI 0.56–1.55]). In two studies (125 CVCs),
there was no difference in insertion site infection (53.1% with
multi-lumen vs 39.3% with single-lumen, RR 1.35 [95% CI
0.91–2.01]).
Conclusions: There is evidence from randomised trials that on
average one in 17 multi-lumen CVCs will lead to a bloodstream
infection which would not have been the case had single-lumen
CVCs been used. These data may have clinical implications.
References:
1. Pittet, et al.: JAMA 1994, 271:1598-1601.
2. Maki, et al.: N Engl J Med 1977, 296:1305-1309.
Table
CVCs Double-lumen HDCs Three-lumen HDCs
Rate infections 2 1 6
Rate colonizations 10 10 12
Ratio infections/colonization 0.2 0.1 0.5
Total duration of catheterization 356 154 412
Infection incidence rates per 1000 days of catheter use 28/1000 64/1000 29/1000
Colonization incidence rates per 1000 days of catheter use 5.6/1000 6.49/1000 14.5/1000
P96 Dialysis with perfusion lumen catheter in intensive care unit
PL Carron, MF Mamzer-Bruneel, JP Rerolle, A Delprat, N Boigne, E Morelon, MN Peraldi, H Kreis
Department of Transplantation and Intensive Care Unit, Hopital Necker, Paris, France
Objective: To evaluate dialysis with or without perfusion lumen
catheter-related infections, and to compare with central venous
catheter in an intensive care unit.
Methods: Catheters inserted and extracted at least 2 days after, in
the intensive care unit, are cultured using the quantitative tip cul-
tures technique described by Brun-Buisson. Colonization is
defined by a quantitative tip culture yielding ≥ 103 colony-forming
units/ml, site infection by catheter colonization with presence of
pus at the insertion site, catheter-related bacteremia by catheter
colonization and blood culture positive for the same organism.
Findings: Between May 2000 and May 2001, 112 catheters were
inserted in 59 patients: 40 central venous catheters, 21 double-
lumen dialysis catheters, and 51 three-lumen dialysis catheters
with perfusion lumen. The mean disease severity assessed by
SAPS II at the ICU admission do not differ for the three groups
(48 ± 22, 47 ± 20, and 54 ± 20.9). The mean duration of catheteri-
zation was 8.1 days for CVCs, 8.9 for HDCs without perfusion
lumen, and 8.9 for HDCs with perfusion lumen (non significant).
There was no difference between the two types of DCs and CVCs
in catheter colonization and catheter-related bacteremia incidence
rates, whatever the insertion site.
Six site infections and three bacteremia happened during the
study. As for the local infections, two concern the CVCs (jugular
site), four concern the HDCs with perfusion lumen (two jugular
sites and two femoral sites). Bacteremia concern one HDC
(femoral site) and two HDCs with perfusion lumen (femoral and
jugular sites).
Interpretation: The frequency of DC-related infection on CVC-
related infection were similar in the ICU patients. There is no
increase of the infectious risk due to the use of catheters associat-
ing perfusion lumen and dialysis lumen in the ICU patient.
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P97 Catheter-related infections in a medical cardio-pulmonary ICU: trends after the implementation of a nosocomial infection
surveillance system (KISS)
J Graf*, S Lemmen†, P Gastmeier‡, E Karassimos*, U Janssens*
*Medical Clinic I, and †Department of Infection Control, University Hospital, Aachen, Germany; ‡Institute for Medical Microbiology, University
Hospital, Hannover, Germany
Background: Central venous catheters are routinely used in criti-
cally ill patients and represent a source of nosocomial infections
(NI). NI concern 5–15% of hospitalised patients and can lead to
complications in 25–50% of those admitted to the ICU [1].
Methods: All patients with devices such as endotracheal tubes
(ET), central venous lines (including pulmonary artery catheter)
(CV) and/or urinary-tract catheters (UC) were prospectively
enrolled during the first quarter of the years 1999 to 2001 accord-
ing to a standardised protocol (KISS). Device-days, infections and
infection rate were recorded. Data were analysed with regard to
patients’ severity of illness (SAPS II) and length of stay (LOS).
Results: Six hundred and twenty-seven patients with a mortality
rate of 12.3% were enrolled in the study. The 31 patients (5%)
who acquired a NI had significantly higher SAPS II score (42 ± 17
vs 31 ± 15, P < 0.001), hospital (33 ± 37 vs 13 ± 18, P < 0.001)
and ICU LOS (18 ± 16 vs 4 ± 15, P < 0.001), proportion of venti-
lation (45% vs 12%, P < 0.001), and mortality (42% vs 11%,
P < 0.001). NI occurred after 15 ± 11 days, median 14 days.
Despite a significant decrease in device-days and ventilatory-days
observed from 1999 to 2001, the absolute number of NI remained
unchanged.
Conclusion: Patients at risk to acquire a NI in our ICU are obvi-
ously sicker. Whether increased LOS is due to the underlying
disease or a result of the NI remains unclear. Implementation of a
prospective surveillance protocol of NIs (KISS) led to a significant
reduction in device-days and ventilatory-days, but did not reduce
the absolute number of NIs. Thus, device-reduction appeared to be
most effective in the less severely ill patients only.
Reference:
1. Bates DW, et al.: Arch Intern Med 1999, 159:2553.
P98 Nosocomial infection: main cause in development of septic complications during postoperative period
E Gyurov, M Milanov, S Milanov, P Neichev
Emergency Institute ‘Pirogov’ – ICU, 21 Totleben, 1606 Sofia, Bulgaria
Objective: To study the frequency of emergence of nosocomial
infection in ICU.
Design: Retrospective study of data from case records and flow
sheets. One thousand four hundred and fifty-one postoperative
patients admitted to ICU during 1999–2000.
Measurements and main results: Of 1451 patients in our ICU
during 2 years, we include those 613 (42.2%) who stayed for
more than 72 hours. According to results from cultures we divided
them to three groups. Group 1 included 355 (57.9%) patients
without bacterial growth. Group 2 included patients with proved
nosocomial infections (NCI). We obtained samples: 898 from
urinary catheters (376 positive — 41.9%), 552 from tracheal tube
(457 positive — 82.8%), 597 from blood (282 positive — 47.2%),
64 intradermal segments from central venous lines (34 positive —
53.1%), and 17 from sputum (15 positive — 88.2%). The most
common place for development of NCI in our ICU is respiratory
tract. On 5th ICU day the tract became infected in almost 56% of
the patients. The major role among pathogens played Acinetobac-
ter spp. (27.4%), Citrobacter spp. (20.3%), P. aeruginosa (12%
and Serratia spp. (10%). The second place for NCI development is
reserved for blood-stream infections. Almost the half of the cultures
(47.2%) showed bacterial growth. The isolated pathogens were
the same: Acinetobacter spp. (19%), Serratia spp. (16%), but
there was substantial rise in emergence of S. epidermidis during
the last year. Its frequency almost equalized that of Acinetobacter
spp. The other two main sources for NCI were urine and CV
catheters. They remained on 3rd and 4th places. Group 3 included
patients with endogenous surgical infections. In this group we
obtained samples from surgical wounds and drainages. In 1999
25.6% of cultures showed bacterial growth. During next 2000 this
figure rose nearly twice (48.3%). The leading role played the same
Acinetobacter spp., Citrobacter spp., P. aeruginosa, Enterococcus
spp. and E. coli. The role of S. epidermidis increased greatly
during this period.
Conclusions: There was a rise in frequency of nosocomial and
secondary endogenous surgical infection in 1999–2000. The fre-
quency of Gram-positive pathogens, namely S. epidermidis, nearly
equalized that of Gram-negative flora as a cause of nosocomial
infection. Nosocomial infection remained the main cause of septic
complications in postoperative ICU patients.
Reference:
1. E Gyurov, M Milanov, S Milanov: Nosocomial infection: main cause
in development of septic complications in surgical postoperative
patients. Crit Care 1999, 3(suppl 1):P54.
P99 Comparative analysis of patients with early-onset versus late-onset nosocomial lower respiratory tract infections in
medical ICU
S Nseir*, C Di Pompéo†, P Pronnier*, T Onimus*, S Beague*, F Saulnier*†‡§, B Grandbastien‡, M Erb‡, D Mathieu*, 
M Roussel-Delvallez§, A Durocher*†‡§
*Intensive Care Department, ‡Hygiene Unit, and §Microbiology Laboratory, Calmette Hospital, bd du Pr Leclercq, 59037 Lille cedex, France;
†Medical Assessment Laboratory, Lille II university, Lille, France
Objective: To compare risk factors and pathogens between early-
onset (occurring 48–96 hours after ICU admission) nosocomial
lower respiratory tract infections (NLRTI) and late-onset (occurring
after 96 hours of ICU admission) NLRTI.Table
Early-onset NLRTI/no NLRTI (n = 68/3164) Late-onset NLRTI/no NLRTI (n = 449/3164)
Multivariate analysis OR 95% CI P OR 95% CI P
Stress ulcer prevention 6.48 3.64–11.55 < 0.001 – – –
Digestive failure 3.26 1.33–7.98 0.009 – – –
Tracheotomy 2.69 1.22–5.91 0.014 – – –
Renal failure 2.17 1.14–4.13 0.018 – – –
Corticotherapy 1.81 1.06–3.09 0.028 1.64 1.20–2.25 0.002
Ranitidine – – – 6.36 3.23–12.53 < 0.001
Omeprazole – – – 3.77 1.34–10.58 0.012
Sucralfate – – – 2.11 1.57–2.84 < 0.001
Number of antibiotics – – – 1.45 1.23–1.69 < 0.001
Duration of MV – – – 1.13 1.11–1.14 < 0.001
Patients and methods: From March 1993 to September 1999, all
patients admitted in our 30-bed medical ICU were included in this
study, their characteristics were prospectively collected. CDC cri-
teria were employed to define nosocomial pneumonia and tracheo-
bronchitis.
Patients with early-onset NLRTI and those with late-onset NLRTI
were compared to patients without NLRTI by univariate and multi-
variate analysis.
Results: Three thousand six hundred and eighty-one patients were
hospitalized (age 58 ± 18 years, SAPS II 37 ± 17, length of ICU
stay 12 ± 15 days, mechanical ventilation [MV] 85%, duration of
MV 11 ± 13 days, ICU mortality 36%, secondary hospitalization
82%, antimicrobial therapy before ICU admission 49%).
Five hundred and seventeen (14%) patients developed at least one
episode of NLRTI, late-onset NLRTI were more frequent than early-
onset NLRTI (87% and 13% respectively).
Multidrug resistant bacteria were isolated in the major part of
NLRTI (respectively for early-onset and late-onset NLRTI):
Pseudomonas aeruginosa (21%, 24%), Staphylococcus aureus
(16%, 12%) and Acinetobacter baumannii (12%, 30%).
Conclusion: The risk factors associated with either early-onset or
late-onset NLRTI are similar to those identified by other studies. In
our population, length of ICU stay before NLRTI occurrence does
not seem to have an impact on the nature of causing organism;
these data could be helpful to improve initial empiric antimicrobial
therapy in our ICU.
P100 Compartmentalized cytokine production during mechanical ventilation and ventilator-associated pneumonia
J Millo*, MJ Schultz†‡, GJ Weverling§, T van der Poll‡¶, CS Garrard*
*Intensive Care Unit, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK; †Department of Intensive Care Medicine,
‡Laboratory of Experimental Internal Medicine, §Clinical Epidemiology and Biostatistics, and ¶Infectious Diseases, Tropical Medicine and
AIDS, Academic Medical Center, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
Introduction: Ventilator associated pneumonia (VAP) is a common
and serious complication of mechanical ventilation (MV). In pneu-
monia, host defense is considered to be dependent upon the
expression of pro-inflammatory cytokines (e.g., tumor necrosis
factor-α (TNF), and interleukin (IL)-6), anti-inflammatory cytokines
(e.g., IL-10), and cytokines with chemotactic abilities (e.g., IL-8).
Aim and methods: We hypothesized that during VAP the inflam-
matory response is restricted to the side of infection, i.e., to the
lung, and may raise before the diagnosis of VAP is clinically made.
Non-directed bronchial lavage (NBL) was performed on alternate
days in patients expected to require MV for longer than 5 days.
Prior to the NBL, blood samples were drawn. The diagnosis of
VAP was standardized using a Clinical Pulmonary Infection Score.
Results: VAP occurred in nine patients and the 19 patients who
did not develop VAP were considered controls. There were no dif-
ferences between patients with VAP and controls with respect to
age, gender, initial APACHE II score, and primary diagnosis. Levels
of TNF, IL-10, IL-6 and IL-8 did not change in control patients in
either plasma or NBL-fluid. Furthermore, the diagnosis of VAP was
not associated with changes in plasma cytokines. However, serial
changes in TNF, IL-10, IL-6 and IL-8 in NBL-fluid strongly corre-
lated with the diagnosis of VAP. A rise of TNF in NBL-fluid above
200 pg/ml predicted a 4.0 (95% CI: 1.1–15.1) times increased
risk for developing VAP (P = 0.04, time-dependent Cox propor-
tional hazard analysis). An increase of IL-10, IL-6 and IL-8 levels in
NBL-fluid above 100 pg/ml, 1 ng/ml, and 15 ng/ml, respectively,
was associated with a relative risk of 5.6 (95% CI: 1.5–20.9), 9.0
(95% CI: 1.1–72.1), and 4.6 (95% CI: 0.9–22.6), respectively, for
developing VAP.
Conclusion: Local, but not systemic, cytokine levels increase
before VAP is clinically diagnosed.
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P101 Monocyte normal immune response to LPS stimulation
P Myrianthefs, K Venetsanou, E Grouzi, E Boutzouka, P Evagelopoulou, G Fildissis, I Spiliotopoulou, G Baltopoulos
Athens University School of Nursing ICU at ‘KAT’ Hospital, Athens, Greece
Introduction: Monocyte stimulation with LPS has been used to
evaluate adequacy of immune response in immunocompromised
patients (monocyte deactivation) with severe sepsis. The aim of the
study was to investigate the dose response curve of maximum
monocyte TNF-α production after LPS stimulation.
Methods: Peripheral blood was obtained from 16 volunteers and
the absolute number of monocytes per 100 µl was measured. The
same quantity was stimulated by different doses (50, 100, 250,
500, 1000 pg) of LPS for 4 hours. TNF-α levels were measured at
baseline and after stimulation and were converted per monocyte.
Stimulation with 500 pg of LPS was found to best stimulate mono-
cytes. Then, 100 µl of the same specimens were stimulated with
500 pg of LPS for 4, 8 and 24 hours.
Results: Baseline levels of TNF-a were undetectable. After different
doses of LPS stimulation for 4 hours TNF-a levels were as follows:
(a) 50 pg/ml LPS: 995.8 ± 60.6 totally and 9.5 ± 1.6/monocyte,
(b) 100 pg/ml LPS: 1084.6 ± 62.2 totally and 10.8 ± 1.9/monocyte
(c) 250 pg/ml LPS: 1214.7 ± 73.1 totally and 13.9 ± 2.6/monocyte
(d) 500 pg/ml LPS: 1307.1 ± 68.4 totally and 16.6 ± 2.8/monocyte
(e) 1000 pg/ml LPS: 1214.2 ± 67.2 totally and 16.8 ± 2.1/monocyte
Timeframe for TNF-α production after stimulation with 500 pg of
LPS is shown in Table 1
Conclusions: Maximum monocyte TNF-α production was
observed after stimulation with 500 pg of LPS which was not sta-
tistically different compared to 1000 pg. Also, maximum response
with 500 pg of LPS was observed after 24 hours of stimulation.
These findings are in contrast with the literature which suggests
stimulation using 100 pg of LPS for 4 hours for the evaluation of
monocyte immune competency.
Table 1
24 hours 
Baseline 4 hours 8 hours 24 hours w/o LPS
Totally ND 344.3 ± 39.1 414.6 ± 39.6 499.1 ± 60.3 37.6 ± 15.1
Per monocyte ND 9.8 ± 1.2 11.8 ± 1.3 13.8 ± 1.4 1.9 ± 0.6
P102 Pro-inflammatory cytokines decrease the expression of tight junction proteins in Caco-2 intestinal epithelial cells through
a process that is dependent on peroxynitrite formation and PARP activation
PL Sappington, X Han, RL Delude, MP Fink
Department of Critical Care Medicine, University of Pittsburgh Medical School, 616 Scaife Hall, 3550 Terrace Street, Pittsburgh, PA 15261, USA
Rationale: We sought to test the hypotheses that cytomix-induced
hyperpermeability is mediated by changes in the expression of the
tight junction proteins, ZO-1 and occludin, secondary to ONOO–
formation and/or activation of the enzyme, poly (ADP-ribosyl) poly-
merase (PARP).
Methods: Caco-2 monolayers grown on permeable filters for 21
days in bicameral Transwell chambers were incubated with control
medium, medium containing cytomix (CM), a cocktail containing
the pro-inflammatory cytokines, IL-1β (1  µg/ml), TNF (10 ng/ml)
and IFN-γ (1000 U/ml), or medium containing CM and one of these
other pharmacologic agents: ethyl pyruvate (EP; H2O2 scavenger;
10 mM): PJ34 (PARP inhibitor; 5 µM): 3-aminobenzamide (3-AB;
PARP inhibition; 3 µM): FeTPPS (ONOO– decomposition catalyst;
50 µM): C-PTIO (NO• scavenger; 100 µM): PDTC (NF-κB
inhibitor; 100 µM) or L-NIL (selective iNOS inhibitor; 20 µM). Per-
meability was expressed as the apical-to-basolateral clearance
(nL cm–1 h–1) of fluorescein-labelled dextran (FD4) during the last
48 hours of incubation. Expression of occludin and ZO-1 were
assessed by Western blot and immunohistochemistry.
Results: Western blot showed that after 48 hours of incubation with
cytomix the intensity of the bands were significantly decreased as
compared with the control group. After incubation with the various
pharmacological agents with cytomix the intensity of the bands have
significantly increased. Immunohistochemistry showed that ZO-1
and occludin were localized to the cell boundaries in control Caco-2
monolayers. Staining was continuous and 48 hours after treatment
with CM, ZO-1 and occludin immunostaining was more diffuse. Co-
incubating cells with CM and agents that interrupted the NF-κB →
iNOS → NO• → ONOO– → PARP pathway prevented and these
alterations in the immunostaining of ZO-1 and occludin.
Table
Condition Permeability Nitrate/nitrite
Control 5.23 ± 0.49 6.6 ± 1.09
CM 99.3 ±7.83* 30.8 ± 1.05*
PDTC + CM 34.1 ± 2.23† 18.3 ± 0.79†
C-PTIO + CM 13.3 ± 1.53† 11.2 ± 0.86†
L-NIL + CM 27.3 ± 2.33† 13.2 ± 0.69†
PJ34 + CM 20.9 ± 2.46† 21.0 ± 0.88†
FeTPPS+ CM 31.0 ± 1.91† 20.7 ± 0.32†
3-AB + CM 19.1 ± 1.73† 21.3 ± 0.90†
EP + CM 22.9 ± 1.64† 17.1 ± 0.82†
*P < 0.05 versus control; †P < 0.05 versus cytomix.Conclusion: Taken together, our data support the view that CM
increases the permeability of Caco-2 monolayers by activating
NF-κB and initiating a chain of events that ultimately leads to PARP
activation and decreased expression of the tight junction proteins,
ZO-1 and occludin.
P103 The effect of surgery followed by endotoxin on the unspecific cell mediated immunity
P Toft, F Dagnaes-Hansen, MS Petersen, E Tonnesen, HS Jørgensen
Intensive Care Unit, Aarhus University Hospital, DK-8000 Aarhus C, Denmark
Introduction: It is especially the cell mediated immunity that is
affected in the course of sepsis and following surgical stress. The
NK cells, the granulocytes and the monocytes constitute the imme-
diate unspecific cells mediated immunity. We therefore investi-
gated the effect on NK cells, granulocytes and monocytes of
surgery, endotoxin induced sepsis and a two-hit model composed
of surgery followed by administration of endotoxin.
Methods: Three groups of 40 mice. Each group was divided into
four groups of 10 in each. All the animals were anaesthetized and
subjected to either (1) laparotomy, (2) treatment with E. coli endo-
toxin i.p., (3) subjected to laparotomy followed 20 min later by i.p.
endotoxin or (4) left untreated as a control group. In the first 40
mice the NK cell activity in spleens and number of NK cells in livers
were measured, in the second the oxidative burst of granulocyte
and in the third the antigen presentation capacity of monocytes.
Results: Endotoxin stimulated the NK cell activity and up-regulated
the antigen presentation on monocytes. In contrast, surgical stress
reduced the NK cell activity, the number of NK cells in tissues and
down-regulated the antigen presentation on monocytes. After
surgery, followed by administration of endotoxin, the oxidative burst
of granulocytes was stimulated while antigen presentation on
monocytes was down-regulated. Endotoxin prevented or reverted
the postoperative suppression of NK cell activity.
Conclusion: Our two-hit model shows that some cell types of the
unspecific immune system exhibit an anti-inflammatory response
(monocytes) while others at the same time show an excessive
inflammatory response (NK cells, granulocytes). This diversity
makes a potential therapeutic immunomodulation very complex, as
some cell types would need to be down-regulated while others
need to be stimulated.
P104 p22phox-containing microparticles from plasma of septic patients are related to reactive oxygen species production and
apoptosis of vascular cells in culture
MA Pedro*, AO Carmo*, M Janiszewski*†, E Silva*, E Knobel*, FRM Laurindo†
*Intensive Care Unit — Basic Research Laboratory, Hospital Israelita Albert Einstein, Av Albert Einstein, 627 CTI A - Sao Paulo SP 05651
901, Brazil; †University of São Paulo, Medical School, Av Eneas C Aguiar, 44 S/S - São Paulo SP 05403 900, Brazil
Reactive oxygen species (ROS) are related to vascular dysfunction
in several pathologies and may be related to the pathophysiology
of sepsis and multiple organ dysfunction.
To investigate their role and sources we evaluated the effects of
plasma of septic patients (SPP) on reactive ROS production and
apoptosis of rabbit endothelial (REC) and aortic smooth muscle
(RASM) cells in culture through NAD(P)H (0.3 mM)-driven luci-
genin (5 µM) luminescence and annexin V assay respectively.
SPP alone showed intrinsic luminescence when compared to
plasma from healthy controls (HCP) (51.4 ± 9.5 cpm/min/mg
protein vs 7.0 ± 1.2, n = 5, P < 0.05). After incubation with REC
and RASM cells SPP induced a two-fold increase in ROS produc-
tion (n = 5, P < 0.05) when compared to incubation with HCP. This
enhancement of ROS production by REC and RASM cells were
paralleled by increase in apoptosis rates induced by SPP. The frac-
tion responsible for ROS production and apoptosis induction was
determined through filtration and ultracentrifugation to be over
50 kD and to contain microparticles (MP), similar to those from acti-
vated platelets. MP showed similar luminescence (60.6 ± 4.4 vs
32.9 ± 3.1, n = 11), blocked by DPI (60%), a flavoenzyme inhibitor,
and by SOD (80%). Addition of MP from SPP to REC and RASM
also induced increased luminescence when compared to the effect
of MP from HCP; These signals were also inhibitable by SOD and
DPI. Incubation of REC and RASM with MP from SPP doubled
apoptosis rates when compared to incubation with MP from HCP.
Apoptosis was also inhibited by addition of SOD or DPI. After lipid
extraction, western-blot analysis of the MP was positive for the
p22phox and gp91 subunits of the NAD(P)H oxidase.
Thus, SPP has intrinsic and enhances REC and RASM ROS pro-
duction, due to NAD(P)H oxidase activity. It causes apoptosis of
REC and RASM, also inhibited by SOD and DPI. These effects
may be attributable to MP containing the p22phox and gp91 sub-
units of NAD(P)H oxidase. ROS derived from microparticles may
represent a new signaling pathway involved in the pathophysiology
of severe sepsis.
P105 LPS activation of leukocytes attenuates adhesion to endothelial cells under shear stress
B Nohé, V Schmidt, A Hientz, C Zanke, HJ Dieterich, K Unertl
Department of Anaesthesiology and Critical Care, University Hospital, Hoppe-Seyler-Str 3, 72076 Tübingen, Germany
Leukocyte adhesion is triggered by upregulation of cell surface
adhesion molecules and counteracted by the shear forces of the
flowing blood. Since both factors, inflammatory response and flow
dynamics are severely altered during endotoxemia, we studied the
effects of endotoxin on leukocyte–endothelial interactions under
different levels of shear stress in vitro. In order to perform the
experiments at precisely adjustable levels of shear stress, we used
a parallel plate flow chamber as has been employed in a number of
adhesion studies previously. Within this chamber, endothelial cells
(HUVEC) could be perfused with neutrophils (PMN) at
0.25–3 dynes/cm2. FACS analysis of adhesion molecules, trypan
blue exclusion and PMN migration showed that the cells were not
altered during cell separation. To determine the effects of
lipopolysaccharide (LPS) on shear-dependent adhesion, we
studied HUVEC and PMN in a native state and following activation
with LPS at 100 ng/ml and 10 ng/ml. All flow experiments were
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videotaped and the results were analysed by the paired t-test
(P < 0.05). The effects of LPS on leukocyte–endothelial interac-
tions strongly depended on the site of activation. Whereas LPS
pretreatment of HUVEC increased PMN adhesion by 5–10 fold,
pre-activation of the PMN resulted in a 50% reduction of adherent
cells. In addition, after pre-activation of PMN, adhesion became
increasingly dependent on shear stress and, thus, inhibition by LPS
was most pronounced at a normal, postcapillary shear stress of
2–3 dynes/cm2. As demonstrated by addition of antibodies against
selectins, the effect of LPS was due to a functional loss of
L-Selectin and P-Selectin mediated interactions. In addition, inte-
grin-mediated adhesion was impaired despite upregulation of
CD11b on activated PMN. In summary, our results show that
leukocyte–endothelial interactions become increasingly dependent
on shear stress as soon as PMN are activated. Once PMN have
undergone LPS activation, leukocyte tethering to the endothelium
becomes entirely dependent on endothelial E-Selectin. Further-
more, adhesion efficiency decreases despite upregulated expres-
sion of CD11b. Since LPS increased the rigidity of PMN, it seems
that the increased stiffness attenuated PMN adhesion by hamper-
ing PMN flattening and, thereby, reducing the number of available
bonds to the endothelium.
P106 Incidence and risk factors of reactive histiocytic hyperplasia with hemophagocytosis in medical intensive care patients
R Strauss*, D Neureiter†, M Wehler*, B Westenburger*, Th Kirchner†, EG Hahn*
*Department of Medicine I, and †Department of Pathology, Friedrich-Alexander Universität Erlangen-Nuremberg, Krankenhausstrasse 12, 
D-91054 Erlangen, Germany
Introduction: Reactive histiocytic hyperplasia with hemophagocy-
tosis (HHH) is characterised by a systemic proliferation of non-
neoplastic histiocytes with phagocytosis of hemopoietic cells.
HHH is mainly associated with virus infections, sepsis, hematologic
malignancies or carcinomas.
Objective: To determine incidence and risk factors of HHH in
patients dying in the intensive care unit (ICU).
Methods: We retrospectively analyzed clinical data and autopsy
findings of patients (n = 107), who died in our medical ICU. Data
included age, sex, medical history, reason for last admission, diag-
nosis, APACHE II-score, TISS-score and SOFA-score, transfusion
requirements, complications, relevant laboratory findings as well as
the cause of death. Bone marrow samples obtained at autopsy
were histochemically stained with hematoxylin–eosin and prussian
blue reaction. Immunohistochemistry with monoclonal antibodies
against CD68, CD61 and myeloperoxidase (all DAKO, Hamburg/
Germany) was done to identify and quantify the hemopoietic cell
lines mainly affected by the HHH. The hemophagocytic activity was
graded from mild to severe HHH according to Suster et al. [1].
Cases showing moderate to severe hemophagocytic activity were
classified as having HHH. Statistical analysis was performed using
chi-square-test, correlational and logistic regression analysis.
Results: At autopsy HHH was present in the bone marrow of 69
out of 107 (64.5%) patients: 35/107 (32.7%) had mild, 27/107
(25.2%) moderate, 7/107 (6.5%) severe HHH. The HHH corre-
lates with the iron store and not with the cellularity of the bone
marrow. In univariate analysis HHH was associated with higher
APACHE II-score, SOFA-score and TISS-score, mechanical venti-
lation, recent blood transfusion, DIC and sepsis (P  < 0.05). At
autopsy histology of pneumonia and respiratory cause of death
were more frequent in patients with HHH (P < 0.05).
Conclusions: HHH is frequent in patients dying in the ICU. HHH
may contribute to the blood cytopenia often seen in ICU patients.
Severity of illness, infections and blood transfusions are predictors
of HHH.
Reference:
1. Suster, et al.: Hum Pathol 1988, 19:705-712.
P107 Decreased monocyte surface expression of HLA-DQ is associated with prolonged duration of septic shock
SJ Voglic, G Fischer, E Barth, T Weckmann, M Georgieff, M Weiss
University Clinic of Ulm, Department of Anesthesia, Steinhoevelstr. 9, 89075 Ulm, Germany
There is increasing evidence for a protective role of Human-Leuko-
cyte-Antigen (HLA)-DQ in response to infection. This study was
performed: (1) to investigate the kinetics of monomorphic (m)HLA-
II (HLA-DR,-DP,-DQ) and HLA-DQ expression on monocytes
during septic shock; (2) to clarify whether maintaining mHLA-II and
HLA-DQ expression within normal range (NR) could predict
improved recovery and survival. In total, 16 patients (11 males, 5
females) in septic shock have been investigated. mHLA-II and
HLA-DQ median fluorescence intensity (MFI) on monocytes have
been monitored daily using flow cytometry. Normal range was
determined in 19 healthy volunteers. MFI of mHLA-II and HLA-DQ
expression throughout septic shock was significantly reduced
when compared to control (P < 0.05). All patients showed median
mHLA-II expression below normal range regardless of duration of
septic shock and survival. In contrast, median HLA-DQ expression
demonstrated negative correlation with the duration of septic
shock (Phi-square = 0.73). Patients with HLA-DQ below normal
range showed almost a three-fold prolonged term of septic shock
as compared to patients with HLA-DQ expression within normal
range (15.2 ± 6.3 days versus 5.5 ± 1.7 days; P < 0.015).
Although, there was no correlation between median HLA-DQ and
survival, all non-survivors showed HLA-DQ expression below
normal range. In conclusion, HLA-DQ expression below normal
range may predict prolonged duration of septic shock and
increased mortality and could be an indicative marker of immune
surveillance in critically ill patients.P108 Complement activation in relation to age in patients with severe sepsis
G Marx*, B Vangerow†, H Rueckoldt‡, M Cobas Meyer†, D Fromann‡, T Schuerholz‡, M Leuwer*
*University Department of Anaesthesia, University of Liverpool, L69 3GA, UK; †Eli Lilly GmbH, Germany; ‡Department of Anaesthesia,
Hannover Medical School, Germany
Objectives: Severe sepsis is still associated with a mortality of
29% [1]. Sepsis mortality is highest in elderly patients [1]. Another
factor, which is related to outcome in sepsis is the extent of com-
plement activation [2]. The aim of this study was to evaluate com-
plement activation in relation to age in severe septic patients.
Methods: This observational study was performed in 20 patients
with severe sepsis (SOFA-Score = 9 ± 3) and grouped according
to age: ≤ 60 years (‘adult’, n = 10) and > 65 years (‘elderly’,
n = 10). Complement proteins Bb, C3a, C4d were performed by
ELISA technique. C1-Inhibitor (C1-Inh) activity was measured by
Berichrom® C1-Inactivator, and C1-Inh protein concentration by
NOR-Partigen®. To compare values at onset of severe sepsis with
those on the 8th day Friedman test with post-hoc Wilcoxon test
was performed. Data are presented as median and range.
*P < 0.05 was considered significant.
Results: See Table 1.
Conclusions: Activation of the classical pathway of complement
was found to be more marked in adult patients than in elderly.
Thus, our results suggest age-related differences in the comple-
ment activation in severe sepsis.
References:
1. Angus DC, et al.: Crit Care Med 2001, 29:1303-1310.
2. Hack CE, et al.: Intensive Care Med 1993, 19(suppl 1):19-28.
Table 1
Adult Elderly
Sepsis day 1 Sepsis day 8 Sepsis day 1 Sepsis day 8
C4d (µg/ml) 2.4 (2.0–3.3) 1.7* (3.8–8.3) 3.2 (2.5–7.3) 5.4 (3.9–7.0)
C1-Inh activity (%) 105 (72–132) 148* (128–163) 122 (85–133) 132 (107–156)
C1-Inh protein (%) 136 (107–148) 196* (158–211) 123 (100–154) 147 (120–165)
Bb (µg/ml) 0.55 (0.32–2.74) 0.79 (0.41–1.15) 0.90 (0.68–1.05) 1.03 (0.88–1.25)
C3a (ng/ml) 118 (65–370) 524 (212–689) 204 (102–1129) 372 (187–1154)
*P < 0.05, sepsis day 1 vs sepsis day 8 (Friedman test with post-hoc Wilcoxon).
P109 Comparing C-reactive protein, procalcitonin, and interleukin-6 for the diagnosis of bacterial infection in adult atraumatic
patients in a medical center emergency department
YL Chan, FL Wong, SS Chang
Emergency Department, Chang Gung Memorial Hospital. 199, Tung Hwa North Road, Taipei, Taiwan
Introduction: Procalcitonin (PCT) has been proposed as a marker
of sepsis in the critically ill patients. Its level is related to the sever-
ity of sepsis. We investigated the value of PCT, comparing with C-
reactive protein (CRP) and interleukin (IL)-6, in the detection of
infection in the emergency department (ED).
Methods: Ninety adult atraumatic patients admitted through the
ED of a tertiary university hospital in June 2001 were consecutively
enrolled. Forty-five were infected, and 31 were not infected. The
serum levels of CRP (mg/l), PCT (ng/ml) and IL-6 (pg/ml) were
compared between the infected and noninfected groups of
patients. Mann–Whitney U test and chi-square test were employed
to compare independent and group data, and the receiver operat-
ing characteristics (ROC) curve and the respective areas under the
curve were calculated.
Results: The best cut-off level for CRP, PCT and IL-6, identified
using Youden’s Index, was 60 mg/l, 0.6 ng/ml and 24 pg/ml,
respectively. Compared with CRP and IL-6, PCT had a comparable
sensitivity, a lower specificity, and a lower area under the ROC
curve. Bacteremic patients had higher PCT and IL-6 concentrations
than those without bacteremia, but similar CRP concentrations.
PCT and IL-6 levels were particularly high in septic shock patients.
Conclusions: PCT is not a better marker of infection than CRP
and IL-6 in the adult ED patients, but it is a useful marker of the
severity of infection.
Table
Sens. Spec. PPV NPV
Parameters (%) (%) (%) (%) AUC
CRP (cut-off 60 mg/l) 73.3 93.5 94.3 70.7 0.896
PCT (cut-off 0.6 ng/ml) 77.8 64.5 76.1 66.7 0.724
IL-6 (cut-off 24 ng/ml) 89.2 75.0 89.2 75.0 0.829
Sens., sensitivity; Spec., specificity.
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P110 Effects of granulocyte-colony stimulating factor (G-CSF) prophylaxis in high risk patients (ASA III and IV) with colorectal
cancer on perioperative cytokine levels, complications and global quality of life
A Torossian*, M Middeke†, U Plaul‡, I Celik†, W Lorenz†, H Wulf*, A Bauhofer†
*Clinic of Anesthesiology and Intensive Care Medicine, †Institute of Theoretical Surgery, and ‡Clinic of Visceral-, Thorax- and Abdominal
Surgery, Philipps-University Marburg, Germany
Aim: The effects of a prophylaxis with G-CSF on postoperative
outcome was examined in high risk patients with colorectal carci-
noma. In a pilot study we examined whether changes in cytokine
levels and leukocyte count correlate with the onset of complica-
tions and influence global quality of life.
Material and methods: Patients (ASA class III and IV) with col-
orectal cancer were randomized in a double-blinded pilot study to:
prophylaxis with G-CSF (12 hours before surgery, 12 and 36 hours
after surgery) versus placebo. Measurements of G-CSF, IL-6,
IL-18, Procalcitonin (PCT) in plasma, leukocyte count, percentage
of polynuclear granulocytes (PMNs) and their phagocytic activity
were started before operation and continued till day 6 after
surgery. TNF-α release was determined after LPS in vitro stimula-
tion of whole blood. All complications were documented as well as
quality of life (QL) at discharge, 2 and 6 months after surgery using
the EORTC QLQ 30 questionnaire and for global QL the index-
points of the area under the curve (AUC) were calculated.
Results: In one patient of the placebo group surgery was can-
celled after randomization (withdrawal). In all measurements IL-6
and IL-18 levels and the leukocyte count of the G-CSF group were
above placebo and normal values. Only in the placebo group
phagocytic activity of granulocytes fell below normal values. There
was no difference between the groups regarding IL-8, PCT and
TNF-α release. All values were within normal range besides PCT.
PCT values were elevated on day 1 after operation on average up
to 1.9 and at day 3 on 1.2 ng/ml (normal <0.5 ng/ml). Patient 2
developed fever on day 5 after surgery and leukocytosis on the
basis of an anastomotic leakage. Patient 4 had the highest IL-6
levels of all patients on day 6 and on day 8 a duodenal ulcer perfo-
ration. Patient 5 developed a bowel atony on day 5 and showed
the highest IL-18 levels of all patients on day 6.
Conclusions: The development of postoperative early phase compli-
cations is accompanied by changes of cytokine- and bloodcell pat-
terns. Prophylactic treatment with G-CSF elevated IL-6 and IL-18
levels and improved phagocytic activity of granulocytes. The expected
influence on global quality of life could not be demonstrated in the
pilot study. The correlations found are being further examined in an
ongoing randomized, double-blinded trial with 80 patients.
Reference:
1. Lorenz et al.: Inflamm Res 2001, 50:115-122.
Table
Patient Age Tumor stage G-CSF Hospital stay ICU/ward TISS QL-AUC Indexpoints Complications
1 63 pT4pN1 Mx Yes 1/12 days 31 133 Ileus, rezidiv (month 5)
2 58 pT1pN0 M0 Yes 1/24 days 21 308 Anastomotic leakage (day 5)
Disturbed micturation (day 12)
3 80 pT3pN2 Mx No 1/14 days 26 92 Nausea/vomiting (day 3)
Urinary tract infection (month 2)
4 71 pT2pN0 Mx Yes 45/22 days 582 333 Duodenal ulcer perforation, OP 
(day 8), pleural effusion, pneumothorax
(day 30)
5 47 pT2pN0 M0 No 1/21 days 21 442 Bowel atony (day 5)
P111 Effects of intravenous and intratracheal pentoxifylline on histopathologic changes and wet–dry ratio in HCl acid-induced
acute lung injury in rabbits
GM Koksal*, E Askin*, S Erdamar†, H Oz*
*Department of Anesthesiology, and †Department of Pathology, I.U Cerrahpasa Medical Faculty, 34303 Istanbul, Turkey
Introduction: The aim of this study was to compare the effects of
intravenous (IV) and intratracheal (IT) pentoxfylline (PTX) on
histopathologic changes and wet/dry ratio in acute lung injury in
rabbits.
Methods: Twenty-one New Zealand rabbits were randomly divided
into three groups (n = 7). After rabbits were sedated with IM keta-
mine, tracheostomy was performed and endotracheal tube was
inserted. Anesthesia was maintained with continuous infusion of
ketamine and atracurium. All animals were ventilated with PC mode
for 3 hours and the parameters of ventilation were FiO2: 1.0, PIP:
15 cmH2O, PEEP: 5 cmH2O. RR was adjusted to produce initial
PaCO2 of 35–40 mmHg. IT HCl (2 ml/kg) was given following tra-
cheostomy in all animals. Five minutes after the application of HCl;
Group 1, received IV PTX (20 mg/kg, bolus); Group 2, received IT
PTX (20 mg/kg, bolus); Group 3, no treatment. At the end of
3 hours, the rabbits were sacrificed for histopathologic examination
to evaluate lung injury and to measure wet/dry ratio. Tissue
sections were examined for light microscopy with HE stain. The
pathologic lesions were classified ranging from 0 to 4. Right lung
was dried at 60°C for 24 hours. These conditions remove virtually
all gravimetrically detectable water. The lung wet and dry weights
were measured, and wet-to-dry weight ratio was calculated to
asses pulmonary edema. Data were compared by Mann–Whitney
U test. P < 0.05 was considered to indicate statistical significance.
Results: Significant changes in histopathologic findings on
bronchial epithelial injury, neutrophil infiltration-density, hemorrhage
and hyalen membrane were encountered in group 3 when com-
pared with other groups (P < 0.01). There was no significance dif-ference for septum injury and atelectasia. Wet/dry ratio of group 3
was higher than the other groups (P < 0.01).
Conclusion: PTX given after the 5 min of HCl application via IT
route might have beneficial effects on histopathologic changes and
wet/dry ratio in HCl induced-ALI model.
P112 Correlation between plasma peroxides and procalcitonin levels in patients with severe streptococcal community acquired
pneumonia
E Borrelli*, M Mencarelli†, P Giomarelli*
*Institute of Thoracic and Cardiovascular Surgery, and †Institute of Infectious Disease, University of Siena Policlinico Le Scotte, 
53100 Siena, Italy
Introduction: During lower respiratory tract infection, massive influx
and activation of phagocytes and release of reactive oxygen species
(ROS) is observed. As a consequence, the lipid peroxidation in
plasma may increase. The aim of this study was to estimate the
plasma concentration of lipid peroxides in combination with a bio-
chemical indicator of inflammation and to assess a possible correla-
tion between infection and oxidative stress. Plasma procalcitonin
(PCT) and peroxides (PEROX) concentrations were measured in
15 patients hospitalised for radiologically confirmed severe strepto-
coccal community acquired pneumonia (CAP). As control values,
PCT and PEROX were also measured in 10 healthy subjects.
Methods: Plasma samples for PCT and PEROX were obtained the
first day of hospitalisation. PCT was determined by immunolumi-
nescence method (LUMITEST PCT, Brahms Diagnostica, Berlin,
Germany). PEROX were analysed by a colorimetric assay
(OXYSTAT, Biomedica, Wien, Austria).
Results: All control subjects showed a PCT level below 0.5 ng/ml
(mean value: 0.32 ± 0.1 ng/ml). Mean patients PCT values was
4.9 ± 2.9 ng/ml (P< 0.01 vs control). Plasma peroxides were higher
in patients respect to controls (860 ± 130 µmol/l vs 278 ± 46 µmol/l,
P< 0.01). A good correlation was found between PCT and PEROX
values (r2 = 0.91) in patients.
Conclusion: Process of lipid peroxidation seems to correlate with
the degree of infection as indicate by PCT levels.
P113 Lipopolysaccharide binding protein: a poor parameter for the differentiation of SIRS and sepsis but useful as determinant
of outcome in septic patients
M Prucha*, R Zazula†, I Herold‡, L Dubska*, M Dostal*
*Department of Clinical Biochemistry, Haematology and Immunology, Hospital Na Homolce, Czech Republic; †Department of
Anaestheziology and Intensive Care, Institute of Experimental Medicine, Prague, Czech Republic; ‡Department of Anaestheziology and
Intensive Care, Klaudian’s Hospital, Mlada Boleslav, Czech Republic
Lipopolysaccharide binding protein (LBP) is an acute phase
hepatic glycoprotein immediately involving in the process of
immune response to endotoxin. Elevation of LBP appears to be an
important marker associated with release of endotoxin and/or bac-
teriemia. In our study we investigated serum LBP levels as a prog-
nostic marker for sepsis and Systemic Inflammatory Response
Syndrome (SIRS). Also we assessed the correlation of LBP with
procalcitonin (PCT), expression HLA-DR on monocytes and the
production of TNF-α ex vivo by monocytes stimulated by
lipopolysaccharide (markers of immunoparalysis).
Methods: The serum levels of lipopolysaccharide binding protein
(LBP) and procalcitonin (PCT), the expression of HLA-DR on
monocytes and the production of tumor necrotizing factor by
monocytes stimulated ex vivo by lipopolysaccharide were mea-
sured in a group of 68 patients with Systemic Inflammatory
Response Syndrome (SIRS), sepsis or septic shock (diagnosed
according to ACCP consensus criteria).
Results: We have found that LBP levels:
1. Were elevated in 98% of patients over normal value of
7.3 ng/ml.
2. Were significantly higher in nonsurvivors than in survivors
(mean 39.1 ng/ml and 26.1 ng/ml) — the difference being due
to group of septic patients — their lethality was significantly
increased when LBP levels exceeded 24.1 ng/ml.
3. Were significantly higher in patients with sepsis or septic
shock than in patients with SIRS (mean (SD) — 40.5 (18.6)
versus 29.8 (17.9) ng/ml).
4. The specificity and sensitivity of LBP levels to differentiate
patients with SIRS versus patients with sepsis was low — 50%
and 74.3%, respectively.
5. Did not differ between the groups of patients with and without
immunoparalysis (37.1 ng/ml to 31.1 ng/ml).
6. Did not correlate with the serum levels of procalcitonin, expres-
sion of HLA-DR on monocytes or production of TNF after stim-
ulation by lipopolysaccharide.
Conclusions: Lipopolysaccharide binding protein may be a useful
marker for the prediction of outcome in patients with sepsis but its
ability to discriminate patients with SIRS to patients with sepsis is
low. Further studies are needed to elucidate its possible prognos-
tic significance.
P114 Changes in plasminogen activator inhibitor-1 (PAI-1) in patients with severe sepsis or septic shock
T Ikeda*, K Ikeda*, T Onizuka*, K Ohshima*, N Matsuno†
*Division of Critical Care and Emergency Medicine, and †5th Department of Surgery, Hachioji Medical Center, Tokyo Medical University,
1163 Tate-machi, Hachioji, Tokyo 193-0998, Japan
Introduction: For septic shock, especially that caused by infection
with Gram-negative bacteria, endotoxin adsorption (direct hemop-
erfusion using polymyxin B fixed fiber: PMX-DHP) is regarded as
an effective method of treatment in Japan. In 27 patients who were
admitted to ICU and underwent PMX-DHP for severe sepsis or
septic shock, the kinetics of PAI-1 were determined, and com-
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pared between the group with a high endotoxin level of 10 pg/ml
or more just before the initiation of PMX-DHP and the group with a
normal endotoxin level of less than 10 pg/ml. Furthermore, the rela-
tions between PAI-1 and other mediators were examined.
Method: Hemoperfusion using polymyxin B fixed fiber was per-
formed by inserting a double-lumen catheter into the femoral or
subclavian vein, at a blood flow rate of 80–100 ml/min. Determina-
tions of PAI-1 and various cytokines including interleukin-6 (IL-6),
interleukin-10 (IL-10) and interleukin-1 receptor antagonist (IL-1ra)
were performed by enzyme linked immunosorbent assay (ELISA)
just before the initiation, just after the completion, and 24 hours
after the completion of PMX-DHP.
Subjects’ backgrounds and underlying diseases: The number of
patients was 12 in the normal level endotoxin group (Group N) and
15 in the high level endotoxin group (Group H). No significant dif-
ference was found in age. Regarding sex difference, females were
dominant in Group N, while males were dominant in Group H. For
other items including the number of pertinent items, septic severity
score, APACHE-II score and MOF score, Group H had higher
values in general. Most of the patients the underlying disease was
sepsis caused by abdominal infection. Concerning the outcome
after 4 weeks, nine (75%) out of 12 patients in Group N survived
and 11 (73%) out of 15 patients survived in Group H, without sig-
nificant difference.
Results: Changes in PAI-1 corresponding to endotoxin level:
PAI-1 before the initiation of PMX-DHP was 416 ± 500 ng/ml in
Group H, while that in Group N was 172 ± 141 ng/ml, showing a
2.4-fold higher tendency in Group H than in Group N. However,
the correlation between PAI-1 and endotoxin level before the initia-
tion, just after completion, and 24 hours after completion of PMX-
DHP was not significant. PAI-1 level just after completion of
PMX-DHP was 104 ± 12 and 362 ± 559 ng/ml in Group N and
Group H, respectively, showing a decreasing tendency and a
greater decrease in Group H after 24 hours.
Relations between PAI-1 and other cytokines: At any period
before the initiation, just after completion, and 24 hours after the
completion of PMX-DHP, a significant positive correlation was
found between PAI-1 and IL-6, indicating the possible role of IL-6
in controlling the kinetics of PAI-1. As in the case of IL-6, a signifi-
cant positive correlation was also found, at any period, between
PAI-1 and IL-10, an anti-inflammatory cytokine. A significant posi-
tive correlation was found, at periods before initiation and just at
completion of PMX-DHP, but not after 24 hours.
Conclusion: Septic-shock patients who underwent endotoxin
adsorption treatment were subjected to examination focusing on
the changes in PAI-1. PAI-1 level was apt to be higher in the high
endotoxin level group, and had a tendency to decrease in patients
with successful PMX treatment.
P115 Antithrombin prevents proinflammatory activation via NFκ κ and MAPK signaling pathways
C Oelschläger, A Staubitz, J Römsich, H Tillmanns, H Hölschermann
Department of Int. Medicine, Division of Cardiology, University of Giessen, Klinikstraße 36, 35392 Giessen, Germany
Background: The serpin Antithrombin III (AT) is reported to have
anticoagulatory as well as anti-inflammatory properties. AT inhibits
cytokine secretion, leukocyte activation and neutrophil migration and
it has been shown to be efficacious in treatment of septic disorders.
The molecular mechanism underlying the anti-inflammatory effects
of AT III is still unclear. We investigated the influence of AT on
NFκB- and MAPK-signaling, both well known proinflammatory sig-
naling pathways in endothelial cells (EC) and monocytes (MO).
Methods: EC or MO were incubated with TNF-α (40 ng/ml) or
LPS (10 µg/ml), respectively, in presence or absence of AT (0–30
IU/ml). Activation of the transcription factors NFκB and AP-1
(EMSA), the phosphorylation and degradation of the NFκB
inhibitory protein IκBα, JNK/SAPK activation (Western Blot), as
well as NFκB regulated protein- and gene expression (Tissue
Factor [TF], TNF-α, IL-6) (ELISA, rtPCR) were analysed under influ-
ence of AT III, AT III isoforms and binding-modified AT.
Results: AT inhibited activation of NFκB in a dose-dependent
manner by preventing phosphorylation and degradation of the
inhibitor protein IκBα. AT prevented the activation of the p54
subunit of JNK/SAPK. TF and cytokine production were markedly
reduced by AT III (20% of control). The b-isoform of AT, reported
to have a higher affinity for glycosaminoglycans (GAGs), was more
effective in preventing this proinflammatory activation than the ATα
isoform. AT without heparin-binding site had no effect.
Conclusion: AT prevents NFκB- and MAPK-activation in EC and
MO when given in therapeutical doses. The anti-inflammatory prop-
erties of AT III seem to depend on the interaction of the heparin-
binding site of AT with GAGs on cell surface.
P116 Cost effectiveness analysis of drotrecogin alfa (activated) as a treatment for severe sepsis in hospitalised patients
R Launois*, L Riou Franca*, B Guidet†, P Aegerter‡, X Huet§, P Meshaka§, P Pinton§
*REES France, Réseau d’Evaluation en Economie de la Santé, 28 rue d’Assas, 75006 Paris, France; †Hôpital Saint Antoine, 184 rue du fb
Saint Antoine, 75012 Paris, France; ‡Biostatistique et Informatique médicale, Hôpital Ambroise Paré, 9 avenue Charles de Gaulle, 92100
Boulogne, France; §Laboratoire Lilly France, 203 bureau de la colline, 92213 St Cloud, France
Introduction: Drotrecogin alfa (activated) significantly reduced
severe sepsis (SevSep) mortality at 28 days [1]. According to the
French budget environment, it is mandatory to evaluate its cost
effectiveness ratio on a pragmatic basis.
Methods: All SevSep patients in the Cub-Réa database
(1997–1999 period) defined according to PROWESS [1] and
with a hospital length of stay (LOS) ≥ 24 hours (n = 10,459) were
included. The baseline patients’ characteristics are similar to those
of the PROWESS criteria study: age (61 years vs 60 years), < 60
years (42% vs 44%), and number of organ failure (2.1 vs 2.4). Key
patient data recorded: age, gender, type of admission (medical or
surgical), admission mode (direct or transfer), number (1, 2, 3),
duration and type of support (respiratory, renal, circulatory) and
SAPS II. Stratification according to these criteria and loading of the
observed frequencies into a decision-tree for conditional probabili-
ties. Relative risk of death with drotrecogin alfa (activated) esti-
mated according to the observed classification into 11 néoGHM
[2] groups (28 days survival represented by the parametric func-
tion of Weibull). SevSep impact on long-term mortality estimatedby the McCabe score with three hypotheses for life expectancy
(LE): unique LE of 5 years, McCabe > 0 (2 years of survival),
McCabe = 0 (4 years LE reduction or half LE reduction versus
whole population). Costs estimated by subgroups and by a linear
equation (nursing workload, LOS, SAPS II, living or dead status).
Calculation of a differential cost effectiveness ratio (drotrecogin
alpha (activated) price: 7836.95 € for 4 days treatment and a
mean patient’s weight of 70 kg) and analysis of Monte Carlo’s
type.
Results: The expected cost in the model of a SevSep patient
treated by standard care is 26,983.3 €FF96 vs 26,373.6 €FF96
observed from Cub-Réa. The expected cost predicted in the model
of a SevSep patient treated by drotrecogin alfa (activated) is
34,605.90 €FF96. The survivors LE according to the above
hypotheses are 5.0, 10.6, and 6.9 years. Corresponding effective-
ness differences in favor of drotrecogin alfa (activated) are 0.33,
0.63, and 0.41 years. The cost per additional year of life saved
amounts of 18,446.3 €FF96 including all degrees of severity and
co-morbidity. The sensitivity analysis model shows that with an
expected threshold of 53,357.1 €FF96, 96.3% of the bootstrap
samples are cost-effective.
Conclusion: The predicted cost effectiveness ratio of drotrecogin
alfa (activated) in adult SevSep patients is much lower than the
international range considered as acceptable (53,357.10 €).
Drotrecogin alfa (activated) is cost-effective when including
patients with all degrees of co morbidity.
References:
1. Bernard G. N Engl J Med 2001, 344:699-670.
2. Misset B. Réan Urg 1998, 7:367-374.
P117 Marked reductions of protein C and antithrombin in post-trauma DIC have close relations with MODS and poor outcome
S Gando, T Kameue, Y Morimoto, N Matsuda, O Kemmotsu
Division of Acute and Critical Care Medicine, Department of Anesthesiology and Critical Care Medicine, Hokkaido University Graduate
School of Medicine, Sapporo, Japan
Objective: Disseminated intravascular coagulation (DIC) associ-
ated with marked reductions of protein C and antithrombin in post-
trauma patients have close relations with multiple organ
dysfunction syndrome (MODS) and their outcome.
Design: Prospective cohort study.
Setting: General intensive care unit of a tertiary care emergency
department.
Patients: Seventy-six trauma victims, 26 with DIC and 50 without
DIC.
Materials and methods: Protein C antigen concentration (protein
C antigen), protein C activity, and antithrombin were measured on
the day of the injury, and on the 1st, 3rd, and 5th days after admis-
sion. The results of these measurements, demographic data, mor-
tality and incidence of acute respiratory distress syndrome
(ARDS), MODS, and sepsis were compared between the patients
with and without DIC. DIC patients were further classified into sub-
groups of survivors and nonsurvivors.
Results: Incidence of ARDS and MODS were significantly high in
the DIC patients. The mortality rate of the DIC patients was signifi-
cantly higher than that of the non-DIC patients. Protein C antigen
and activity, and antithrombin decreased significantly in the DIC
patients compared with those in the non-DIC patients, which con-
tinued to be low up to the 5th day of admission. Clear intergroup
differences of the time course were also noted in the levels of
protein C antigen and activity, and antithrombin between the sur-
vivors and nonsurvivors in the DIC group.
Conclusion: Our findings suggest that DIC involving suppression
of the physiologic anticoagulant pathways is an important contribu-
tor of MODS and poor outcome in post-trauma patients.
P118 Antithrombin reduces the ischemia/reperfusion-induced hepatic injury by increasing hepatic levels of prostacyclin through
activation of capsaicin-sensitive sensory neurons in rats
N Harada*, K Okajima†, M Uchiba†
*Department of Pharmacology, School of Medicine, Fukuoka University, Fukuoka 814-0180, Japan; †Department of Laboratory Medecine,
Kumamoto University School of Medicine, Kumamoto 860-0811, Japan
We have previously demonstrated that antithrombin (AT) reduces
ischemia/reperfusion (I/R)-induced liver injury by inhibiting leuko-
cyte activation through the promotion of hepatic production of
prostacyclin (PGI2) [1]. However, AT does not directly promote the
endothelial production of PGI2 in cultured endothelial cells [2].
Capsaicin-sensitive sensory neurons (CSSN) are nociceptive
neurons that release calcitonin gene-related peptide (CGRP) upon
activation. Since CGRP increases the endothelial production of
PGI2, it is possible that AT may increase the hepatic PGI2 produc-
tion in rats subjected to I/R through the activation of CSSN.
Recent studies have demonstrated that CGRP increases the
endothelial production of nitric oxide (NO). Since NO has been
shown to activate endothelial cyclooxygenase-1 (COX-1) activity,
we further examined whether AT-induced increase in hepatic level
of PGI2 can be mediated by nitric oxide synthase (NOS) activation.
Male Wistar rats were subjected to 60-min ischemia and subse-
quent reperfusion. Both tissue levels of CGRP and the expression
of immunohistochemical CGRP in the liver were significantly
increased in rats subjected to I/R 1 hour after reperfusion. AT
(250 U/kg, i.v.) significantly enhanced the I/R-induced increase in
both hepatic levels of CGRP and the expression of immunohisto-
chemical CGRP. AT-induced increase in hepatic level of CGRP
and CGRP expression were completely inhibited by capsazepine
(CPZ), a vanilloid receptor-1 antagonist. Furthermore, AT-induced
increase in hepatic level of 6-keto-PGF1α, a stable metabolite of
PGI2, were significantly inhibited by CPZ, CGRP (8-37), a CGRP
receptor antagonist, and L-nitro-arginine-methyl-ester (L-NAME), a
non-selective inhibitor of NOS. AT reduced the I/R-induced liver
injury by inhibiting the I/R-induced increase in hepatic tumor necro-
sis factor (TNF)-α. Pretreatment of rats with CPZ, CGRP (8-37),
and L-NAME completely abrogated such preventive effects of AT.
Administration of rat α-CGRP produced effects similar to those of
AT. These results strongly suggest that AT might reduce the I/R-
induced liver injury by increasing the hepatic level of PGI2 through
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the activation of CSSN. Thus, AT might sensitize hepatic CSSN in
rats subjected to hepatic I/R, leading to the increase in the hepatic
tissue level of PGI2. In this process, CGRP-induced activation of
endothelial NOS and COX-1 could be critically involved.
References:
1. Harada N, et al. Blood 1999, 93:157-164.
2. Uchiba M, Okajima K: Thromb Haemost 2001, 86:722-723.
P119 Inhibition of proliferation and induction of differentiation of endothelial cells by antithrombin
CM Reinisch, NC Kaneider, AM Djanani, J Römisch, CJ Wiedermann
Divison of General Internal Medicin, Department of Internal Medicine, University of Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
Anti-angiogenic and anti-tumor activities of latent and cleaved
antithrombin has been described, and in vitro, the serpin inhib-
ited proliferation of endothelial cells. We have recently observed
that direct cellular effects of antithrombin are mediated by synde-
can-4, a heparan sulfate proteoglycan known to bind to the
heparin-binding site of antithrombin. Syndecan-4 is known to
affect proliferation and differentiation of a variety of cell types.
We have, therefore, studied direct effects of intact antithrombin
on endothelial cells. Human umbilical vein and calf pulmonary
artery endothelial cells were studied in the presence or absence
of antithrombin concentrate or monoclonal antibody purified
antithrombin with and without concomitant presence of synthetic
pentasaccharide. Proliferation was assessed in BrDU incorpora-
tion and MTT assays. For testing endothelial cell differentiation,
capillary tube formation was investigated in matrigel assays. Pro-
liferation of the two types of endothelial was significantly inhib-
ited by 1–10 U/ml of both antithrombin concentrate and
antibody-purified antithrombin. Capillary tube formation induced
by matrigel was augmented by the presence of 1–10 U/ml of
antithrombin concentrate which was partly reversed with pen-
tasaccharide. Results show that in vitro effects of antithrombin
on angiogenesis-related endothelial cell functions may be directly
exerted by the intact serpine and can be antagonised by
pentasaccharide
P120 Syndecan-4 on human peripheral blood lymphocytes and monocytes mediates effects of antithrombin on chemotaxis
NC Kaneider, CM Reinisch, S Dunzendorfer, J Römisch, CJ Wiedermann
Divison of General Internal Medicin, Department of Internal Medicine, University of Innsbruck, Anichstrasse 35, A 6020 Innsbruck, Austria
Antithrombin inhibits chemokine-induced migration of neutrophils
by activating heparan sulfate proteoglycan-dependent signaling.
Whether antithrombin affects migration of other types of leuko-
cytes is unknown. We investigated the effects of antithrombin on
spontaneous and chemokine-triggered migration of lymphocytes
and monocytes from human peripheral blood in modified Boyden
chamber micropore filter assays. Lymphocyte and monocyte popu-
lations from human peripheral blood were purified using magnetic
antibody cell sorting. Signaling mechanisms in antithrombin-depen-
dent migration were studied by Western blot analyses of protein
kinases and Rho activation, or were tested functionally by using
signaling enzyme blockers. Expression of heparan sulfate proteo-
glycan core protein was studied by RT-PCR and flow cytometry.
As antithrombins, the concentrate Kybernin®P from human plasma
and a monoclonal antibody-purified preparation therefrom were
used. Pretreatment of lymphocytes and monocytes with antithrom-
bin inhibited chemotaxis toward optimal concentrations of inter-
leukin-8 or Rantes at concentrations of antithrombin as low as
10 nU/ml; in the absence of the chemokines, direct exposure of
cells to gradients of antithrombin stimulated migration. Effects of
antithrombin were abolished by pretreating cells with heparinase-1,
chondroitinase, sodium chlorate and anti-syndecan-4 antibodies.
Expression of syndecan-4 mRNA and protein in monocytes and
lymphocytes was demonstrated in RT-PCR and anti-syndecan-4
immunoreactivity assay, respectively. In the presence of pentasac-
charide, antithrombin lost its activity on the cells. Antithrombin
induced chondroitinase- and heparinase I-dependent phophoryla-
tion of protein kinase C-alpha and dissociation of Rho-GTPase.
Data indicate that antithrombin directly inhibits chemokine-stimu-
lated migration of monocytes and lymphocytes via effects of its
heparin-binding site on cell surface syndecan-4 by activation of
protein kinase C and Rho signaling.
P121 Abstract withdrawnP122 Effect of unfractionated and low molecular weight heparin on microcirculatory antithrombin effects during endotoxemia
JN Hoffmann, B Vollmar, M Laschke, D Inthorn, FW Schildberg, MD Menger
Klinikum Grosshadern Ludwig Maximilians University of Munich, Marchioninistr. 15, 81377 Munich, Germany
Objective: A recent prospective randomized clinical sepsis trial
(Kybersept study) shows a reduction in 90-day mortality by
antithrombin (ATIII) only in the prospectively defined subgroup of
patients without simultaneous heparin treatment. To investigate
whether this clinically observed heparin-ATIII antagonism is caused
by a heparin-related reversal of ATIII effects on the microcirculation
during endotoxemia, experimental ATIII administration was com-
bined with administration of different heparins at a clinically rele-
vant dose.
Methods: In skin fold preparations of the Syrian hamster, normo-
tensive endotoxemia was induced by i.v. administration of 2 mg/kg
endotoxin (LPS, E. coli, 2 mg/kg), whereby intravital video fluores-
cence microscopy allowed determination of venular adherent
leukocyte count (VALC) and functional capillary density (FCD),
which served as a measure of capillary perfusion. ATIII (ATIII group,
n = 6, Kybernin, 250 IU/kg i.v.) was substituted 5 min before LPS
administration. Another group simultaneously received intravenous
unfractionated heparin (ATIII + Hep, n = 5, sodium heparin,
100 IE/24 hours, i.v.), whereas additional animals received low
molecular weight heparin (ATIII + LMWH, n = 5, fraxiparin, 5 µl/kg,
2 hours before LPS, s.c.).
Controls: Saline-treated animals receiving only LPS.
Results: LPS induced a massive increase in VALC with a maximum
at 8 hours and a decrease in FCD (P < 0.01 vs baseline). Both LPS
effects were effectively prevented by ATIII (P < 0.01), whereas ATIII
+ Hep and ATIII + LMWH animals showed microcirculatory distur-
bances comparable to that observed in endotoxemic controls. In
accordance with the clinical finding that beneficial AT III effects
during sepsis are antagonized by concomitant heparin administra-
tion, our study indicates a relevant in-vivo adverse effect of heparins
on microcirculatory AT III effects.
P123 Evaluation of anti-inflammatory and anti-adhesive effects of heparins in human endotoxemia
U Derhaschnig*, T Pernerstorfer†, B Jilma†
*Department of Emergency Medicine, and †Department of Clinical Pharmacology, University of Vienna, Austria
Introduction: Sepsis results from a generalized inflammatory and
pro-coagulant response to an infectious agent. Adhesion mole-
cules and cytokines are of utmost importance for the development
of early symptoms as well as the late sequela of endotoxemia.
Heparin is widely known as an antithrombotic agent. But beyond
its well-understood anticoagulant activity heparin is able to influ-
ence immunologic responses. In addition, in vitro experiments and
animal studies have shown that heparin inhibits P-selectin and
L-selectin mediated adhesion.
Intravenous infusion of LPS into human volunteers provides a stan-
dardized model to study activation of inflammatory, pro-coagulant
and adhesive cascades in humans.
It was recently demonstrated that heparin blunts endotoxin-
induced coagulation activation in a human LPS-model. As pro-
coagulant and inflammatory processes are intricately linked in
sepsis, we used this LPS-model to elucidate whether clinically
applied doses of unfractionated (UFH) or low-molecular weight
heparin (LMWH) are able to affect early inflammatory responses in
low grade human endotoxemia.
Methods: The trial was a randomized, double-blind, placebo-
controlled study in three parallel groups of 30 healthy male subjects.
A bolus of LPS 2 ng/kg was given i.v. to all subjects. Ten minutes
later, study subjects received either 80 IU/kg heparin followed by a
continuous infusion of 18 IU/kg/hour for 6 hours, 40 IU/kg
dalteparin, followed by a continuous infusion of 15 IU/kg/hour for
6 hours, or placebo.
Results: Following LPS infusion, TNF-α levels increased 
> 350-fold in the LMWH and placebo groups but only 150-fold in
the UFH group (P < 0.01 vs LMWH group). Yet, IL-6, IL-8 and
CRP levels were not different between treatment groups.
Plasma levels of sE-selectin increased by approximately 500% and
sP-selectin levels doubled 6 hours after LPS infusion in all groups.
Similarly, platelet leukocyte aggregates increased in all groups
(P > 0.05 between treatments).
The changes in differential and absolute blood counts were not
modified by any treatment. As expected, CD11b expression
increased by 100% while L-selectin decreased by 41% 6 hours
after LPS-infusion. Interestingly, both heparins (in particular UFH)
decreased L-selectin down-modulation as compared to placebo
(P < 0.01).
Conclusion: Heparin displayed little anti-inflammatory actions in
low grade endotoxemia as measured by cytokine levels or endothe-
lial/platelet activation markers. The heparin induced mitigation of
L-selectin down-regulation on neutrophils is in good agreement
with the blockade of L-selectin function observed in vitro and
deserves further investigation.
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P124 Measurement of carboxypeptidase R by colorimetric assay
H Komura*†, K Obata‡, W Campbell†, M Yumoto*, Y Shimomura†, H Katsuya*, N Okada†, H Okada†
*Department of Anesthesiology and Resuscitology Intensive and Critical Care, and †Department of Molecular Biology, Nagoya City
University School of Medicine, Nagoya, Aichi 467-8601, Japan; ‡Division of Anesthesiology, National Cancer Center Hospital, 
Tokyo 104-0045, Japan
Carboxypeptidases (CP), carboxypeptidase N (CPN) and car-
boxypeptidase R (CPR), have been reported as a protease, which
can cleave carboxy-terminal arginine or lysine residues from biologi-
cally active peptides, such as C3a and C5a, and regulate their activ-
ity. CPN is present in the active form in plasma, but CPR is
generated from its zymogen during coagulation. CPR (identical to
carboxypeptidase U [CPU], plasma carboxypeptidase B [plasma
CPB]) has also been described as an inhibitor of fibrinolysis, and
termed TAFI (thrombin activatable fibrinolysis inhibitor). ProCPR is
activated by thrombin, thrombin–thrombomodulin complex (T-TM),
plasmin, and trypsin. Today, the T-TM complex pathway has been
taken notice because of effectiveness of Protein C for sepsis.
Protein C has been recognized as a mediator between inflammation
and coagulation. About CPR, some recent clinical studies have
been shown that CPR is an acute phase protein and proCPR have
been reduced in DIC. Similar to Protein C, CPR may be a mediator
between inflammation and fibrinolysis. Colorimetric assay is one of
the methods for measuring CP activity. Although it is convenient for
determining CP activity, we noticed that some anticoagulants, such
as citrate, interfere with the color development of the reagents used.
Therefore, concentration of citrate in samples should be controlled
to be constant for background subtraction. If one will pay attention
to this point, colorimetric assay will be a good method for measur-
ing CP activity and give us further findings.
P125 The role of natural coagulation inhibitors in correlation with clinic scores in critical patients with obstetric diseases
A Giarratano*, M Raineri*, C Di Giacinto*, S Siragusa†, L Lo Coco†
*Department of Anesthesiology, Intensive Care and Emergency, and †Thrombosis and Hemostasis Department, University of Palermo, Italy
Aims: To validate the correlation among the most significant inflam-
matory cytokines and the coagulation inhibitors system (AT III,
Protein C and TFPI), used as markers, and the levels of organ dys-
function in patients with severe pre-eclampsia and HELLP syndrome.
Materials and methods: Patients involved in the study were those
admitted (more than 48 hours) in ICU from 1 January 2000 to 30
September 2001). Two groups of patients were studied according
with diagnostic and clinic criteria: (NP) normal pregnancy as
control group; (SPH) Severe Pre-eclampsia and HELLP syndrome
as study group. We have registered inflammatory cytokines plasma
levels (IL 6, TNF-α, IL 10) by an ELISA assay; Antithrombin III
(ATIII), Protein C (PC) and Tissue Factor Pathway Inhibitor (TFPI)
as coagulation inhibitor markers are assessed via functional (activ-
ity) and immunological (antigen). We have also monitored the
organ dysfunction score with a SOFA modified score 
(ODS: 0 = no organ dysfunction; 16 = max organ dysfunction).
Results: We have included 18 patients aged from 17 to 41 years
in the SPH group and we have compared these patients with 18
normal pregnancies, aged from 17 to 41 years, before and after
the cesarean section. Table 1 shows synthetically our data.
Conclusions: These data confirm our hypothesis about the role of
well known markers as IL6 and TNF-α in the inflammatory response
associated with severe pre-eclampsia and HELLP syndrome [1]. This
is also true for some natural coagulation inhibitors and specially for
AT III [2]. Protein C and TFPI show, in these data, a new significant
role and contribute to confirm a multiple genesis for the coagulation
disorders and the organ dysfunction associated to this obstetric
disease. In addition to the well known endothelial dysfunction there is
a systemic activation of maternal inflammatory cell responses in
association with clotting alterations and this is supported by the cor-
relation between the high levels of the pro-inflammatory cytokines
and the low levels of coagulation inhibitors. The inhibitory substitutive
treatment with AT III, that we have experienced, and with these
natural inhibitors (specially Protein C) could modulate the excessive
and altered inflammatory response and might restore a normal coag-
ulation and a good organ function reducing the admission and/or the
permanence of these patients in ICU.
References:
1. Redman CWG, Sacks GP, Sargent IL: Preeclampsia: an excessive
maternal inflammatory response to pregnancy. Am J Obstet
Gynecol 1999, 180:499-506.
2. Giarratano A, Capogna G, Celleno D, Mangione S: A new appproach
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3):s321(417).
Table 1
Markers NP SPH
IL-6 (pg/ml) 60.4 (18) 127.4* (24)
IL-10 (pg/ml) 10.2 (12) 18.6 (72)
TNF-α (pg/ml) 25.9 (8) 46.9 (6)
AT III (%) 92 (14) 56* (18)
PC (%) 98 (16) 53* (9)
TFPI (u/l) 1.14(0.2) 2.34* (0.6)
ODS 1 (1) 10 (4)
Data are presented as median concentration (SD). * P < 0.05
compared with levels at admission (Mann–Witney) U test.
P126 Prophylactic anticoagulation with low dose enoxaparin: is the subcutaneous route appropriate in the critically ill?
U Priglinger*, G Delle Karth*, A Geppert*, C Joukhadar†, R Berger*, M Hülsmann*, I Pabinger‡, G Heinz*
*Department of Cardiology, †Department of Clinical Pharmacology, and ‡Department of Hematology, University Hospital of Vienna, Austria
Introduction: Subcutaneously administered LMW heparins are
widely used for prophylactic anticoagulation. The appropriateness
of the SC route in critically ill patients who require vasopressors
and mechanical ventilation has never been established.Methods: The anti-Xa kinetic (0, 1, 3, 6, 12 hours) following 40 mg
of enoxaparin SC was investigated in 16 ICU patients (group 1;
age 61.1 ± 16 years; m/f 7/9, APACHE II 20.9 ± 7, mechanical
ventilation  n = 15, vasopressors n = 13) and 13 non critically ill
patients on the general ward (group 2; age 61.7 ± 9 years, m/f
7/6) requiring prophylactic anticoagulation. Patients with impaired
renal function or requiring hemofiltration and those requiring thera-
peutic anticoagulation were not eligible.
Results: Mean anti-Xa levels were consistently lower in group 1 vs
group 2 on ANOVA (P = 0.001 between groups and over time) as
was the AUC0–12 hours (2.6 ± 1 vs 4.2 ± 1.7 U/ml*h, group 1 vs 2,
P = 0.008). BMI (25.7 ± 5 vs 24 ± 6 kg/m2) and creatinine clear-
ance (67.5 ± 31 vs 67.7 ± 27 mg/dl) were comparable in both
groups (P = ns). The peak anti-Xa level 3 hours after administration
was negatively correlated to the BMI (r = –0.41, P < 0.03) and the
norepinephrine dose (r = –0.36, P = 0.056).
Conclusion: It is cautiously concluded that the SC administration
of established doses of prophylactic enoxaparin might not be
appropriate in the critically ill patient requiring vasopressor support
and mechanical ventilation.
P127 Follow up study in the assessment of rVlla as a universal haemostatic agent in a model of haemodilution
S Chillala*, KJ Pasi†, PA Evans*
*Department of Accident & Emergency Medicine, Leicester Royal Infirmary, Leicester, UK; †Division of Haematology, University of Leicester,
Leicester, UK
Introduction: Large volume fluid replacement to treat haemor-
rhagic shock can result in haemostatic failure due both to a dilution
effect [1] and an intrinsic effect [2,3]. Recombinant factor Vlla
(rVlla) is seen increasingly as a possible universal haemostatic
agent that could act to reverse or even prevent the dilution and
intrinsic effects of fluids used within the ‘golden’ hour of haemor-
rhagic shock. Our preliminary findings demonstrated that rVlla
appeared to improve markers of global haemostasis in a model of
large volume fluid replacement. This follow up study assessed
what effects rVlla had on global haemostasis and the electron
microscopic appearances of clot formation when haemaccel or
sodium chloride were used as diluents to create a model of large
volume fluid replacement.
Methods: One hundred whole blood samples from normal donors
were tested undiluted, or diluted to 50% and 80% using haemaccel
or sodium chloride (NaCl).Each sample was tested with and without
addition of 90 µg/kg of rVlla. Global haemostasis was assessed
using thrombelastography (TEG). Parameters measured were: Time
to initial fibrin formation (R), Time to 20 mm clot amplitude (K),
Rapidity of fibrin build up and cross-linking (α), Maximum clot ampli-
tude (MA), Time to MA (TMA), and Clot firmness (G). Haemostatic
testing was terminated when maximum clot amplitude was reached
and samples were then examined by electron microscopy.
Results: One hundred samples analysed. Twenty samples for each
of five fluid groups. Each sample tested ± rVlla. Without addition of
rVlla, an intrinsic effect with worsening of TEG parameters was
noted with increasing dilution in the fluid groups. Addition of rVlla
produced significant improvement in TEG parameters: P < 0.05 R,
K, α, TMA for all fluid groups; P < 0.05 MA and G for 80% Haem,
50% and 80% NaCl. Moreover with increasing dilution there was a
greater relative improvement in TEG parameters in rVlla added
groups. When fluid groups were compared to each other to see if
the beneficial effects of rVlla produced a difference, no significant
difference was found between groups except for 50% haemaccel
compared with 50% NaCl where K, MA and G were significantly
better (P < 0.05) in the haemaccel group. Electron microscopy
demonstrated a reversal of both the dilution and intrinsic inhibitory
effects, with increased fibrin deposition and meshwork with greater
cross-linking following addition of rVlla.
Conclusion: In this in vitro model of large volume fluid replacement
with associated haemodilution, the addition of rVlla appeared to
improve markers of global haemostasis and caused increased
fibrin deposition with a tighter resultant meshwork on electron
microscopy. Further work is required to assess the potential value
of rVlla as a universal haemostatic agent in trauma settings involv-
ing large volume fluid resuscitation.
References:
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P128 Recombinant activated factor VII (rFVIIa-NovoSeven®-NovoNordisk) treatment of bleeding complications in intensive care
unit
A Bonadona, P Pavese, R Hamidfar, G Pernod, T Stouls, C Pison, C Letoublon, D Barnoud
CHU de Grenoble, BP217, 38043 Grenoble cedex 9, France
Recombinant activated factor VII (rFVIIa-NovoSeven®-Novordisk)
was first developed to treat severe bleeding episodes occurring in
patients with haemophilia A or B with inhibitor. Complexed with
tissue factor, it activates the factor × and allows transformation of
prothrombin into thrombin, independently of factors VIII and IX. The
success of rFVIIa in controlling haemophilic bleedings has led to
use it, punctually for other serious bleedings in liver transplantation,
cardiac surgery or in cirrhotic patients.
We report five cases of patients hospitalised in intensive care unit,
with haemorrhagic shock or severe haemostasis disorder. Despite
of massive transfusions and usual resuscitation therapeutics, their
clinical course was pejorative. Then, they were given a 90 µg/kg
rFVIIa intravenous dose. See Table overleaf.
A dramatic improvement occurred in a few hours. The majority of
haemorrhages stopped after one or two rFVIIa doses administra-
tion. The immediate correction of haemostasis disorders allowed a
reduction in blood transfusions amount and a decreasing of amine
support requiring. One patient presented a thrombosis of the
portal venous system quickly corrected, but no other adverse event
could be attributed to rFVIIa.
rFVIIa-NovoSeven® appears to be of great interest in the treatment
of uncontrolled haemorrhage in intensive care units. It can be con-
sidered as an efficient and safe therapy. Nevertheless, because of
its high price and of the very preliminary nature of the data we
report, further investigations are necessary before using this
product as a routine treatment.
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Objectives: To investigate the renal effect of dopamine, norepineph-
rine, epinephrine, or norepinephrine-dobutamine in septic shock.
Design: A prospective clinical study in which each patient acted
as his/her own control.
Setting: Teaching hospital Intensive Care Unit.
Patients: Twenty-two patients with septic shock completed the study.
Intervention: Fluid loading to an optimal left ventricular stroke
work index (LVSWI) whilst treated with dopamine, norepinephrine,
epinephrine, or norepinephrine–dobutamine each in a randomized
order, which was adjusted to maintain mean arterial pressure
> 80 mmHg for 2 hours. After each 2 hours, a complete hemody-
namic parameters and measurement of urine flow rate, creatinine
clearance and sodium excretion were performed.
Measurement and results: All patients fulfilled the therapy goals
after being treated with all kinds of the drugs. No statistical differ-
ences were found for right atrial pressure (CVP), mean pulmonary
arterial wedge pressure (PAWP), mean pulmonary arterial pressure
(PAP), mean systemic arterial pressure (MAP) during dopamine,
norepinephrine, epinephrine and norepinephrine–dobutamine infu-
sions. Epinephrine induced a significant higher cardiac index (CI)
compared with norepinephrine alone and norepinephrine–dobuta-
mine (P < 0.05). Compared with other three groups, cretinine
clearance increased significantly in norepinephrine–dobutamine
(P < 0.05), but urine volume increased in dopamine group as com-
pared with epinephrine group (P < 0.05).
Conclusions: Dopamine, norepinephrine, epinephrine, or norepi-
nephrine–dobutamine could improve systemic hemodynamics in
septic shock, but their renal effects were different, dopamine acted
as a diuretic and did not improve creatinine clearance, norepineph-
rine–dobutamine improved creatinine clearance without a signifi-
cant change in urine output, norepinephrine, epinephrine had no
markedly renal effect.
Table
Sex/age Clinical context Indication Haemostasis rFVIIa PT after rFVIIa
F/23 years Cirrhosis, ARF, liver T Liver T PT: 30%
FV: 36% 90 µg/kg × 3 PT: 100%
M/53 years PAHT, pulmonary T Bleeding post lung T PT: 24%
FV: 13% 90 µg/kg PT: 100%
M/60 years Liver T, aspirin Adverse event in a liver biopsy PT: 35%
FV: 37% 90 µg/kg × 2 PT: 75%
M/58 years Fulminant liver failure Liver T in emergency PT: 19%
FV: 33% 90 µg/kg PT: 100%
M/55 years Cirrhosis, liver T Bleeding post liver T PT: 29%
FV: 41% 90 µg/kg × 2 PT: 100%
ARF, acute renal failure; T, transplantation; PAHT, pulmonary arterial hypertension; PT, prothrombin time.
P129 Renal effect of dopamine, norepinephrine, epinephrine, or norepinephrine–dobutamine in septic shock
HB Qiu, Y Yang, SX Zhou, YZ Huang, RQ Zheng
Department of Critical Care Medicine (ICU), Zhong-Da Hospital and Clinical Medical College, Southeast University, Nanjing, PR China
P130 Effects of epinephrine compared to dobutamine–norepinephrine on gastric perfusion in septic shock
P Seguin*, E Bellissant†, Y Le Tulzo‡, B Laviolle†, R Thomas‡, Y Mallédant*
*Service de Réanimation Chirurgicale, and ‡Service de Réanimation Médicale, Hôpital de Pontchaillou, Rennes, France; †Laboratoire de
Pharmacologie Expérimentale et Clinique, Université de Rennes I, Rennes, France
In septic shock, the effects of catecholamines on gastrointestinal
blood flow remain controversial. The aim of our study was to
compare epinephrine (E) to the combination dobutamine–norepi-
nephrine (D–N) on gastric perfusion in septic shock patients.
Methods: The study was prospective, randomized, on two parallel
groups. Systemic and pulmonary hemodynamics, gastric mucosal
blood flow (GMBF, laser Doppler), hepatic function (indocyanine
green clearance) and blood gases were evaluated just before cate-
cholamines infusion and as soon as mean arterial pressure reached
70–80 mmHg. E or N were titrated (from 0.1 µg/kg/min with
0.2 µg/kg/min increases every 5 min). D was continuously infused
at 5 µg/kg/min.
Results: Twenty-two patients were included (11 in each group). At
randomization, there was no significant difference between groups.
At time of evaluation, mean arterial pressure was 78 ± 3 and
77 ± 5 mmHg in E and D–N groups, respectively. There was no
significant difference between groups whichever the systemic and
pulmonary hemodynamic or blood gas variable considered. Never-
theless, compared to D–N, E tended to induce greater values of
cardiac index (5.0 ± 1.6 vs 4.2 ± 1.5 l/min/m2,  P = 0.078) and
oxygen transport (617 ± 166 vs 481 ± 229 ml/min/m2, P = 0.068),
induced significantly greater values of GMBF (662 ± 210 vs
546 ± 200 units, P = 0.011) but did not modify indocyanine green
clearance.
Conclusion: In septic shock patients, at the same mean arterial
pressure, E enhances more GMBF than the combination of D at
5 µg/kg/min and N (see Fig. overleaf). This effect, which probably
results from higher cardiac index, emphasizes the crucial impor-
tance of doses in the pharmacodynamic profile of catecholamines.Figure
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P131 Terlipressin in the treatment of catecholamine resistant septic shock
GM Auzinger, PG O’Callaghan, RA Harry, JA Wendon
Institute of Liver Studies, Liver Intensive Care Unit, King’s College Hospital London, Denmark Hill, London SE5 9RJ, UK
Introduction: Vasopressin plasma levels are low in advanced
septic shock and treatment with low dose vasopressin can reverse
catecholamine resistance [1]. Terlipressin, a vasopressin analogue
with long half life time, was found to exert less gastrointestinal and
myocardial side effects in patients with acute variceal hemorrhage
compared with vasopressin. Little is known about effects and side
effects of terlipressin administration in patients with septic shock.
Methods: Retrospective study of 14 patients with acute liver
failure and septic shock treated with terlipressin for norepinephrine
resistant shock. Seven patients were monitored with gastric
tonometry during terlipressin therapy. Hemodynamic and metabolic
parameters as well as liver function tests were measured sequen-
tially over a 72 hour period and compared to base line levels with
ANOVA for repeated measurements.
Results: One to 3 mg of terlipressin were administered in divided
doses over 24 hours. There was an increase in blood pressure
(MAP) accompanied by a significant decrease in norepinephrine
(NE) requirements over time. Nine patients were weaned off cate-
cholamine support. Cardiac index, stroke volume (SVI) and meta-
bolic parameters as well as liver function tests remained
unchanged. The mucosal-arterial Pco2 gap increased significantly
over time indicating impaired gastric mucosal perfusion. There was
no improvement in the severity of organ failure (SOFA) during terli-
pressin treatment (Table).
Conclusion: Terlipressin can reverse vasopressor resistant septic
shock. The increase in mucosal-arterial Pco2 gradient during terli-
pressin treatment raises concerns of significant gastrointestinal
side effects associated with this novel therapy.
Reference:
1. Landry DW, Levin HR, Gallant EM, et al.:  Vasopressin deficiency
contributes to the vasodilation of septic shock. Circulation 1997,
95:1122-1125.
Table
Pre 1 hour post 4 hours 12 hours 24 hours 48 hours 72 hours
n/nTono 14/7 14/7 14/7 14/7 12/6 11/6 10/5 
MAP 69 ± 5 81 ± 12† 81 ± 15* 73 ± 10 71 ± 7 74 ± 9 73 ± 10
NE‡ 0.48 ± 0.41 0.41 ± 0.38 0.34 ± 0.35 0.33 ± 0.33 0.25 ± 0.25 0.20 ± 0.22 0.19 ± 0.31
SVI 63 ± 21 63 ± 26 64 ± 19 55 ± 14 71 ± 26 64 ± 15 65 ± 28
Pco2 r-a 1 ± 0.4 1.5 ± 0.3 1.7 ± 0.6 1.9 ± 0.5 2.7 ± 0.7 2.8 ± 0.2* 3.3 ± 0.5*
Lactate 2.8 ± 1.4 3.1 ± 1.8 3.1 ± 1.9 2.9 ± 1.2 2.9 ± 2.2 3.3 ± 2.8 3.8 ± 3.1
SOFA 18 ± 4 18 ± 2 18 ± 3 17 ± 3
All values mean and SD. * P < 0.05, † P < 0.01, ‡ P < 0.05 for all time points compared to base line.
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P132 Arginine vasopressin compromises gut mucosal microcirculation in septic rats
M Westphal, H Freise, K Eicker, HG Bone, JH Hilpert, H Van Aken, AW Sielenkämper
Department of Anaesthesiology and Operative Intensive Care Medicine, University of Münster, Albert-Schweitzer-Str. 33, 48149 Münster,
Germany
Background: Arginine vasopressin (AVP) is increasingly used in
the therapy of septic patients with hypotension [1]. In a prospec-
tive, controlled laboratory experiment we studied AVP-associated
changes in the villus microcirculation of the septic rat ileum.
Methods: Twenty-four hours after caecal ligation and perforation to
create sepsis, moderately hypotensive rats (average decrease in
mean arterial pressure [MAP] 20% from pre-septic values) were
anaesthetized. Next, intravital video-microscopy was performed on
6–10 villi of ileum mucosa (M0). The treatment group then received a
continuous infusion of AVP to increase MAP by 20 mmHg (M1) and
40 mmHg (M2) from M0, while the control group received only normal
saline. Measurements were repeated at M1 and M2. Video recordings
were analysed by a blinded investigator. Diameter of terminal arteri-
oles (Artd) were determined and stopped flow across the villus micro-
circulation (total arrest of villus blood flow > 1 s) was quantified.
Statistics: ANOVA with post-hoc test (Student–Newman–Keuls).
Data are mean ± SD.
Results: AVP infusion was associated with a clear increase in
stopped flow time at M1 and M2, while no change was observed
for Artd (Table).
Conclusion: These preliminary data demonstrate severe abnormal-
ities in gut mucosal blood flow following AVP infusion in septic
rats. Because no change occurred in terminal arteriolar diameters,
the observed flow abnormalities could be due to either activities of
AVP on larger arterioles or to a concomitant reduction in cardiac
output [1].
Reference:
1. Holmes CL, et al.: Chest 2001, 120:989-1002.
Table
Control (n = 5) AVP (n = 5)
M0 M1 M2 M0 M1 M2
MAP (mmHg) 114 ± 7 109 ± 14 104 ± 11 108 ± 4 128 ± 5* 149 ± 4*
Artd (µm) 8.04 ± 0.78 7.63 ± 1.15 8.1 ± 0.71 7.12 ± 0.38 7.29 ± 0.59 7.42 ± 0.71
Stopped-flow (s min–1) 8 ± 3.5 6 ± 5.8 7 ± 5.2 11 ± 4.3 36 ± 11.2*† 41 ± 9.4*†
* P < 0.001 vs M0, † P < 0.001 AVP vs control.
P133 Effect of a maldistribution of microvascular blood flow on capillary O2 extraction in sepsis
RM Bateman*, MD Sharpe†, WJ Sibbald‡, R Gill§, CG Ellis*
*Department of Medical Biophysics, and †Department of Anaesthesia, University of Western Ontario, London, Ontario, Canada N6A 5C1;
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Inherent in remote organ injury caused by sepsis is a profound
maldistribution of microvascular blood flow [1]. Using a 24-hour rat
cecal ligation and perforation model of sepsis, we studied oxygen
transport in individual capillaries of the extensor digitorum longus
(EDL) skeletal muscle. We hypothesized that erythrocyte oxygen
saturation (SO2) levels within normally flowing capillaries would
provide evidence of either a mitochondrial failure (increased SO2) or
an oxygen transport derangement (decreased SO2). Using a spec-
trophotometric functional imaging system [2] we found that sepsis
caused (1) an increase in stopped flow capillaries (from 10% to
38%, P < 0.05); (2) an increase in the proportion of fast flow to
normal flow capillaries (P < 0.05); and (3) a decrease in capillary
venular-end SO2 levels from 58.4 ± 20.0% to 38.5 ± 21.2%, while
capillary arteriolar-end SO2 levels remained unchanged compared
to sham group. Capillary oxygen extraction increased three-fold
(P < 0.05) and was directly related to the degree of stopped flow in
the EDL. Our results support the hypothesis that tissue capacity to
increase O2 extraction in early sepsis is impaired by a maldistribu-
tion of O2 delivery and not a failure to utilize O2.
References:
1. Bateman RM, et al.:  Erythrocyte deformability is a nitric oxide-
mediated factor in decreased capillary density during sepsis. Am J
Physiol Heart Circ Physiol 2001, 280:H2848-H2856.
2. Ellis CG, et al.: Determination of red cell oxygenation in vivo by
dual video densitometric image analysis. Am J Physiol Heart Circ
Physiol 1990, 258:H1216-H1223.
P134 Changes in complement cascade during continuous hemodiafiltration (CHDF) in patients with sepsis
K Ikeda, T Ikeda, T Onizuka, H Suzuku, Y Ouhashi, J Sakurai
Division of Critical Care and Emergency Medicine, Hachiouji Medical Center of Tokyo Medical University, Tatemachi 1163 Hachiouji shi,
Tokyo, Japan
Introduction: Sepsis results from activation to complement
cascade, an appropriate and necessary response to infection.
Some studies have demonstrated that CHDF could be an effective
therapy for removing inflammatory cytokines for systemic inflamma-
tory response syndrome (SIRS). The aim of this study is to evaluate
the changes in the complement cascade during CHDF and to
determine the effect of CHDF on sepsis.Methods: Ten patients with sepsis underwent CHDF for at least
3 days in our ICU. Patients with chronic renal failure or receiving
steroid therapy were excluded. We assessed complement function
and concentrations or activities of CH50, C1q, C3a, C3-proactiva-
tor, C3, C4, albumin and C-reactive protein (CRP). Blood samples
were obtained from an arterial catheter before and 3 days after the
start of CHDF. Blood samples from both membrane sites and the
CHDF filtrate were obtained at 2, 6 and 12 hours after the start of
CHDF. Statistical analysis was performed on the changes during
CHDF and both sites of the membrane (P < 0.05).
Results: Six patients survived (S-group) and four patients did not
survive (N-group). Levels of C3a before CHDF were extremely high
and decreased significantly during CHDF in survived group. The
levels of CH50 and C3 before CHDF were low, but did not change
significantly during CHDF. The levels of C1q, C4, and C3 pro-acti-
vator were within their normal ranges, and did not change during
this study. CH50 and C3a were detected in CHDF filtrate. Only the
levels of C3a increased significantly through the dialysis membrane.
Conclusions: It was thought that high levels of C3a indicated activa-
tion of the complement cascade and low levels of CH50 and C3
occurred due to consumption during sepsis. CHDF can be an effec-
tive therapy for sepsis because C3a (chemotactic factor) decreased
significantly during CHDF. The complement cascade except for C3a
did not change during CHDF in this study. However CHDF may have
the potential to activate the complement cascade because the levels
of C3a increased through the dialysis membrane.
P135 Arterio- and veno-venosus hemofiltration in the treatment of sepsis and septic shock
Zs Marjanek, M Faludi
Intensive Care Unit and Nephrologic Department, Bajcsy-Zsilinszky Hospital, Maglodi ut 89-91, 1106 Budapest, Hungary
Many inflammatory agents are known to be released in huge quan-
tities in septic shock. The level of the agents could be decreased
by the continuous arterio-, and veno-venosus hemofiltration (CAVH
and CVVH).
Our study was conducted to remove the inflammatory mediators
from the circulation by the assistance of the CAVH and the control
of the hemodynamic stability.
Method: Forty-eight patients was applied on the study. The hemo-
dynamic parameters were measured with the thermodilution tech-
nique. The mean arterial pressure (MAP), the pulse (F), the cardiac
output (CO), the pulmonary wedge pressure (PCWP), the systemic
vascular resistance (SVR), the left and right ventricule work-index
(LVSWI, RVSWI) were measured, The oxygen delivery and con-
sumption (DO2, VO2), the serum lactate level were estimated. The
inflammatory parameters — C-reactive protein, procalcitonin, white
blood cell — were controlled daily. The laboratory tests of fluid
balance and inonogram (Na, K in the urine), the clinical signs (tem-
perature, consciousness, APACHE II score) were assessed daily.
Results: The hemodynamic parameters were stable: CO:
9.6–7.8 l/min, SVR: 541–789 dyns cm–5, the tissue oxygenation
was improved (DO2 7.5–16.7 ml/min/kg, VO2 1.24–3.4 ml/min/kg).
The temperature of patients were decreased (39.2–37.4°C), the
urine increased (22.4–43.5 ml/kg/die), the APACHE II score
decreased (28.4–19.7) and the GCS (7.8–11.4) increased. The
inflammatory parameters were on the normal level after 2 days of
the CAVH (CRP: 261–61. PCT: 10–0.5 ng/ml).
The hemodynamic effect of the CAVH or CVVH was favourable,
the heart function was improved, the fluid-, and ion-balance could
have been controlled well.
References:
1. Bellomo R: Blood Purif 1995, 13:246.
2. Bellomo R, et al.: Continous renal replacement therapy. Int J Inten-
sive Care 2000, 7:22.
3. Rogiers P: Hemofiltration treatment for sepsis. Is it time for control
trial? Kidney Int Suppl 1999, 72:S99.
P136 Coupled plasmafiltration-adsorption (CPFA) in septic shock with normal renal function
S Livigni*, M Formica†, G Cesano†, C Olivieri*, CA Castioni*, M Meucci*, E Visetti*, V Tessore‡, C Tetta‡
*ICU, and †Nephrology, Torino Nord Emergenza San Giovanni Bosco Hospital, Italy; ‡Clinical & Laboratory Research Department, Bellco,
Mirandola, Italy
Multi-organ dysfunction syndrome (MODS) is the most frequent
cause of death in patients admitted to intensive care units. Severe
sepsis and septic shock are the primary causes of MODS and
develop as a result of the host response to infection and to bacter-
ial wall components, such as the lipid-A containing lipopolysaccha-
ride (LPS). The host response involves both the cellular and
humoral arms of the immune system and the generation of pro- and
anti-inflammatory molecules. The anti-inflammatory response may
lead to a state of ‘immunoparalysis’. Continuous renal replacement
therapies (CRRT) remove several soluble pro- and anti-inflamma-
tory mediators simultaneously, albeit at low rates. However, large
pore membranes, such as those used for plasmafiltration, may
enhance cytokine removal and clearance. We recently observed
that the use of coupled plasma filtration adsorption (CPFA)
improved survival in a rabbit model of septic shock [1]. The
outcome was not correlated with single cytokines or mediators
(such as TNFα, platelet-activating factor or endotoxin), but rather
with a global sepsis severity score. The results of this study sug-
gested that a non-selective removal of various septic mediators
was beneficial. A pilot, prospective, cross-over study tested the
hypothesis that CPFA combined with hemodialysis might exert
similar beneficial effects on hemodynamics and leukocyte respon-
siveness in humans with established septic shock and that it might
prove superior to continuous veno-venous hemodiafiltration
(CVVHDF) alone [2].
Objective: To assess the effect of continuous plasmafiltration
adsorbtion (CPFA) on biochemical markers of inflammation,
cytokines, organ dysfunction, haemodynamic and 28-day mortality
in human sepsis.
Design: Prospective.
Setting: Intensive care unit.
Patients: Five patients (3 males and 2 female; mean age 52 ±
19.9 years) with clinical evidence of infection and septic shock
were enrolled. Three patients had normal renal function.
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Interventions: All patients received protocol-driven supportive
intensive care, and those randomized to CPFA received intermit-
tent plasma treatment (10 hours a day) for 10 days using a two-
step, modular system made of plasma separation and adsorption
on a hydrophobic resin, with final reinfusion of the plasmafiltrate
into the patient’s line before the hemofilter.
Measurements and main results: Illness severity and risk of
death were calculated with the Acute Physiology and Chronic
Health Evaluation II (adults) scales. Plasma samples were assayed
for acute-phase proteins (C-reactive protein and cytokines [inter-
leukin-6, interleukin 10]). The Apache II score before treatments
was 26 ± 5.6, after 14 ± 3.5. Statistically significant improvements
were recorded about the differences pre/post treatments concern-
ing Mean Arterial Pressure 78 ± 14.9 vs 86 ± 18.3 mmHg
(P < 0.0001), Cardiac Index 3.88 ± 1.03 vs 3.24 ± 0.86 l/m2/min
(P < 0.001), Systemic Vascular Resistances 1423 ± 552 vs
1862 ± 657 dyne × s/cm5 (P < 0.001), PaO2/FiO2 ratio 199 ± 70
vs 244 ± 81 (P < 0.001). Laboratory data showed a sharp decline
of C-reactive protein along the treatment time from 29.7 ± 11.4 to
6.9 ± 4.8 (–77%); data concerning IL-6, IL-10 showed a reduction to
2.8%, 36.6% in respect of starting values. All patients but one were
discharged alive from ICU after 36.8 ± 14.1 days (range 18–57).
Conclusions: CPFA caused a significant attenuation of the acute-
phase response in sepsis. The procedure induced a sort of
immunomodulation process, and showed a reduction of both pro-
inflammatory and anti-inflammatory immunoactive mediators. Our
data suggest that this procedure might be beneficial in septic
shock patients despite the absence of acute renal failure.
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P137 Myocardial efficiency during levosimendan infusion
L-M Voipio-Pulkki*, H Ukkonen†
*Department of Medicine, Helsinki University Hospital, P.O. Box 100, FIN-00029, Helsinki, Finland; †Turku PET Centre, P.O. Box 52, 
FIN-20521 Turku, Finland
Levosimendan (LS) is a novel agent indicated for the treatment of
acute decompensated heart failure. It has a dual mechanism of
action, increasing cardiac contractility without increasing myocardial
oxygen demand as well as demonstrating vasodilator properties.
This double-blind, randomised, cross-over trial was conducted to
assess the effects of LS on myocardial energetics in patients
(n = 8) with New York Heart Association functional class III and IV
heart failure. Patients initially received either placebo or intravenous
LS (18 µg/kg bolus, followed by a continuous infusion of
0.3 µg/kg/min for 5 hours). The following day, patients who had
received LS were given placebo and vice versa. Cardiac loading
conditions and cardiac output (CO) were assessed using a
Swan–Ganz catheter, thermodilution and echocardiography.
Dynamic positron emission tomography (PET) with 11C-acetate
and 15O-H2O was used to measure myocardial oxygen consump-
tion (MVO2) and myocardial blood flow (MBF), respectively.
Myocardial efficiency was calculated as (heart rate × stroke volume
× arterial pressure) / ventricular oxygen consumption.
CO increased by 32% (P = 0.002) in patients receiving LS, mainly
because of an increase in stroke volume. LS significantly reduced
pulmonary capillary wedge pressure by 29% (P = 0.013), systemic
vascular resistance by 26% (P < 0.001) and pulmonary vascular
resistance by 28% (P = 0.025). Mean MBF was 0.76 ml/min/g
with placebo and 1.02 ml/min/g with LS (P = 0.033). LS did not
increase MVO2 significantly (8%). Left ventricular efficiency was
comparable in LS-treated and placebo-treated patients, while right
ventricular efficiency was improved by 24% (P = 0.012) with LS.
In conclusion, LS as well as having beneficial haemodynamic
effects, also has an energetically favourable profile.
P138 Effect of β β-blockade on the haemodynamic responses of levosimendan and dobutamine in the treatment of low-output
heart failure
F Follath*, JGF Cleland†, for the LIDO Investigators
*University Hospital Zurich, Rämistrasse 100, CH-8091 Zurich, Switzerland; †University of Hull, Castle Road, Cottingham, Kingston-upon-
Hull HU16 5JQ, UK
The novel calcium sensitiser, levosimendan (LS), and the β-adreno-
ceptor agonist dobutamine (DO), both improve cardiac haemody-
namics in patients with severe low-output heart failure (HF).
However, co-administration of β-blockers may influence the action
of these inotropic agents.
In a multicentre, randomised, double-blind trial in patients with
severe low output HF (n = 203), the haemodynamic effects of LS
and DO infusions over 24 hours were compared. The influence of
concomitant β-blocker therapy (37% in the LS and 39% in the DO
groups) were analysed separately. Patients were given either LS
(loading dose of 24 µg/kg over 10 min followed by a continuous
infusion of 0.1 µg/kg/min), or DO (continuous infusion of
5 µg/kg/min). The infusion rates were doubled if the cardiac index
did not increase by ≥ 30% after 2 hours of treatment.
Figure 1
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β+ β with -blockersThe use of β-blockers had significant effects on the increase in
cardiac output and the decrease in pulmonary wedge pressure
(P = 0.01 and P = 0.03, respectively) (Fig. 1). β-blockade attenu-
ated the effect of DO but did not reduce the effects of LS. There
was even a slight trend for improved haemodynamic benefits of LS
in patients under β-blockade. These findings suggest that LS may
be successfully combined with β-blockers to treat patients with
low-output heart failure.
Mean changes in cardiac output (CO) and pulmonary capillary
wedge pressure (PCWP) in patients given LS (β–  n = 69 and 
β+ n = 33) and DO (β– n = 67 and β+ n = 28).
P139 Effects of levosimendan on cardiac arrhythmia in patients with severe heart failure
J Lilleberg*, L Toivonen†
*Peijas Hospital, Department of Medicine, P.O. Sairaalakatu 1, 01720 Vantaa, Finland; †Helsinki University Hospital, Division of Cardiology,
P.O. Box 340, Helsinki, Finland
Levosimendan (LS) is a novel calcium sensitiser which enhances
cardiac contractility without increasing myocardial oxygen con-
sumption, and induces vasodilation.
The effects of intravenous LS on cardiac arrhythmias in patients
with moderate-to-severe heart failure were examined. The results of
ambulatory electrocardiograms in 386 patients from 10 ran-
domised, double-blind studies have been pooled (254 patients
received LS and 132 patients received placebo).
No significant differences in baseline haemodynamic parameters
were observed between the LS and placebo groups. Furthermore,
mean 24-hour heart rate did not differ significantly between the two
treatment groups (78 beats/min and 74 beats/min in LS and
placebo groups, respectively). There were no differences in the
occurrence or frequency of new supraventricular tachycardia
(SVT), ventricular tachycardia (VT) or an increase in ventricular
complexes (Morganroth’s criteria) (Table 1). One patient in the
placebo group experienced ventricular fibrillation, while no cases of
torsades des pointes were observed with either treatment.
In conclusion, these data suggest that LS has little potential to
induce life-threatening arrhythmias in patients with severe heart
failure.
Table 1
Percentage of patients with supraventricular tachycardia (SVT),
ventricular tachycardia (VT) or increase in premature
ventricular complexes (PCV) after receiving levosimendan or
placebo
SVT VT Increase in PCV
Levosimendan 5% 12% 8%
Placebo 5% 15% 9%
P140 The effects of levosimendan on myocardial oxygen consumption and coronary blood flow early after coronary artery
bypass grafting
J Lilleberg*, M Salmenperä†
*Peijas Hospital, Department of Medicine, P.O. Sairaalakatu 1, 01720 Vantaa, Finland; †Department of Anesthesiology, Helsinki University
Central Hospital, Helsinki, Finland
Levosimendan (LS) is a myocardial calcium sensitiser indicated for
the treatment of acute decompensated heart failure. This ran-
domised, double-blind trial evaluated the haemodynamic effects of
LS in low-risk patients (n = 23) following coronary artery bypass
surgery. The effects of LS on myocardial oxygen (O2) consumption,
coronary blood flow and systemic haemodynamics were measured
by thermodilution. Patients received LS, 8 µg/kg (n = 8), or LS,
24 µg/kg (n = 7), or placebo (n = 8) as a 5-min infusion 1 hour
after surgery. Measurements of systemic and coronary sinus
haemodynamics, myocardial O2 consumption and cardiac sub-
strate utilisation were made, before and after treatment with LS.
Levosimendan, 8 µg/kg and 24 µg/kg, significantly increased cardiac
output (CO) by 0.7 and 1.6 l/min, respectively (P < 0.05), compared
to baseline. Mean arterial pressure and pulmonary vascular resis-
tance decreased significantly with both doses of LS, as did coronary
artery resistance, the latter being indicative of coronary vasodilation
(P < 0.05). Furthermore, an increase in coronary blood flow of
28 ml/min and 42 ml/min with LS, 8 µg/kg and 24 µg/kg, respec-
tively, was obtained (P = 0.054 for both doses combined). Despite
the markedly improved cardiac function seen with LS, neither dose
significantly increased myocardial O2 consumption compared with
placebo. In addition, no significant differences in myocardial free fatty
acid, lactate, pyruvate and glucose utilisation were observed in LS-
treated patients compared to placebo controls.
In conclusion, based on the results of this study, LS may be of sig-
nificant benefit in improving cardiac function in patients with low
CO following coronary artery bypass surgery, with no significant
increase in O2 consumption.
P141 Haemodynamic effects of levosimendan in patients during weaning from cardiopulmonary bypass
R Demeyere*, P Herijgers†, W Flameng†
*Department of Anaesthesia, and †Department of Cardiac Surgery, University Hospital Gasthuisberg, Leuven, Belgium
Levosimendan (LS) is a calcium sensitiser indicated for the treat-
ment of acute heart failure that possesses a novel dual mechanism
of action. It increases both cardiac contractility and induces coro-
nary and systemic vasodilation. In this study the haemodynamic
effects of LS were assessed in nine patients (classified as ‘high
risk’) undergoing combined aortic or mitral valve repair/replace-
ment and multiple coronary artery bypass grafting surgery. Immedi-
ately after weaning from cardiopulmonary bypass LS, 24 µg/kg,
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was given intravenously over 10 min. Haemodynamic data were
recorded for up to 60 min post-infusion using thermodilution, 2-D
transoesophageal echocardiography and pressure/volume analysis
using a Millar 12 pole-conductance catheter with an integrated
pressure sensor.
The results (Table 1) show that the LS infusion increased cardiac
index (CI), mainly through an increase in stroke index (SI) and a
decrease in systemic vascular resistance (SVR). LS treatment
improved left ventricular contractility (+dP/dt) and end-systolic
elastance (Ees), without a significant change in the left ventricular
isovolumic pressure decline time constant (Tau). LS increased
coronary graft flow by 32% (P < 0.05). No arrhythmias occurred
during the 60-min study period.
In conclusion, a 10-min intravenous infusion of LS significantly
improved left ventricular function and contractility without impairing
the rate of ventricular relaxation.
Table 1
Haemodynamic parameters (mean ± SD) before and after the administration of levosimendan
CI (l/min/m2) SI (ml/m2) SVR (dyn/s/cm5)+ d P/dt (mmHg/s) Ees (mmHg/ml) Tau (ms)
Baseline 2.6 ± 0.5 30 ± 7 950 ± 374 766 ± 113 1.1 ± 0.2 42 ± 5
Peak effect 3.9 ± 0.9* 46 ± 10* 669 ± 224* 966 ± 131* 1.5 ± 0.2* 39 ± 5
*P < 0.05 compared with baseline; CI, cardiac index; SI, stroke index; SVR, systemic vascular resistance; +dP/dt, measure of left ventricular
contractility; Ees, end-systolic elastance; Tau, time constant of isovolumic pressure decay
P142 Levosimendan enhances cardiac performance in patients following cardiac surgery and cardiopulmonary bypass
E-P Sandell*, N Nijhawan†, PS Pagel†, DC Warltier†
*Orion Pharma, Preclinical and Clinical Research and Development, Cardiovascular Projects, Espoo, Finland; †Department of
Anesthesiology, Medical College of Wisconsin, Milwaukee, WI, USA
This randomised, double-blind, placebo-controlled trial tested the
effect of the calcium sensitiser levosimendan (LS) on cardiac per-
formance in patients (n = 18) following cardiopulmonary bypass
(CPB) and cardiac surgery.
Patients with normal preoperative left ventricular function received
either placebo or ‘low-dose LS’ (18 µg/kg loading dose followed
by 0.2 µg/kg/min) or ‘high-dose LS’ (36 µg/kg loading dose fol-
lowed by 0.3 µg/kg/min) infusions, starting 15 min prior to separa-
tion from CPB (n = 6 per group). Treatments were continued for
6 hours. Haemodynamic and cardiac output (CO) measurements
were recorded at baseline and following separation from CPB in all
groups.
LS significantly (P < 0.05) increased CO (from 4.2 to 7.9 l/min)
(high-dose) and similarly decreased systemic vascular resistance
(from 1150 to 512 dyn/s/cm5; P < 0.05). Arterial and pulmonary
artery pressures were significantly reduced by LS. Heart rate was
not significantly changed, but stroke volume increased with LS. No
differences in arterial oxygenation and perioperative arrhythmias
(Holter) were seen between groups.
In conclusion, this study suggests that LS enhances cardiac per-
formance in patients with normal preoperative cardiac function fol-
lowing CPB. The ‘low-dose LS’ demonstrated equivalent efficacy
with the ‘high-dose’ group but had the advantage of not increasing
vasoactive drug requirements.
P143 Ibutilide for pharmacological cardioversion of atrial flutter
K Magnusson*, T Othman†, NA Cicco*, EG Vester*
*Department of Cardiology, and †Department of Internal Medicine, Evangelisches Krankenhaus Duesseldorf, Germany
Introduction: Ibutilide an anti-arrhythmic drug (Vaughn Wiliams
Classification Type III) is used to support the cardioversion of atrial
fibrillation and atrial flutter since some years yet. In some countries
ibutilide is also used as an emergency treatment for the pharmaco-
logical cardioversion of new arised atrial flutter instead of electro-
version. In this prospective study the effectiveness and safety of
this emergency treatment were investigated.
Methods: We included all patients with atrial flutter seen in the
emergency department. All patients received a treatment with
1.0 mg ibutilide infusion over 10 min. During this period monitoring
of heart rate and blood pressure was performed. Later on a telemet-
ric observation of ECG was performed over a period of 24 hours.
Results: The procedure was performed in seven patients with a
mean age of 62 ± 12.7 (SD) years. At admission the atrial flutter
was persistent meanly for 5 ± 10.1 days (range 1–28 days). The
mean size of the left atrium was 44 ± 4.2 mm (range 40–49 mm).
In four patients a coronary heart disease was diagnosed. In five
patients a stable sinus-rhythm after solitary treatment with ibutilide
was recorded. Electroversion after the ibutilide infusion had to be
performed in two patients to achieve a stable sinus-rhythm after
recurrent atrial flutter. No complications, especially no ventricular
tachycardia, occurred during the observation period. In all patients
a stable sinus-rhythm could be recorded.
Conclusion: In patients with atrial flutter a pharmacological car-
dioversion with ibutilide should be performed. Also in patients with
chronically atrial flutter and/or dilated left atrium the pharmacologi-
cal cardioversion is promising a safe and minimally invasive alterna-
tive to electroversion.P144 Ibutilide after unsuccessful electric electroversion of atrial fibrillation
K Magnusson*, T Othman†, NA Cicco*, EG Vester*
*Department of Cardiology, and †Department of Internal Medicine, Evangelisches Krankenhaus Duesseldorf, Germany
Introduction: Ibutilide, an anti-arrhythmic drug (Vaughn Wiliams
Classification Type III) is used to support the Cardioversion (CV) of
atrial fibrillation and atrial flutter since some years yet. Under usage
of ibutilide lower energy charges for electroversion and higher
rates of success have been reported.
Methods: In this prospective study all patients with atrial fibrillation
received, after unsuccessful synchronized electroversion with
increased energy charges till 360 J, 1.0 mg ibutilide within 10 min.
After that procedure a new electroversion was performed. The
success-rates have been reported.
Results: The procedure was performed in 18 patients with a mean
age of 62 ± 11.2 (SD) years. At admission the atrial fibrillation was
persistent meanly for 333 ± 934.1 days (range 1–4000 days). The
mean size of the left atrium was 48 ± 7.4 mm (range 30–60 mm).
In four patients a coronary heart disease was diagnosed. In 15
patients a stable sinus-rhythm (SR) could be reported after the ibu-
tilide infusion and further electroversion with 360 J. In two patients
SR could be reported after the ibutilide infusion without any further
electroversion. In one patient the atrial fibrillation was persistent
although he received the therapy with ibutilide. No side-effects,
especially no ventricular tachycardia, occurred.
Conclusion: In patients with atrial fibrillation and unsuccessful
electroversion a new try should be performed after infusion of
1.0 mg ibutilide. Also in patients with chronically atrial fibrillation for
years and/or dilated left atrium this procedure is promising a safe
and minimally invasive help for a successful electroversion.
P145 Acute atrial fibrillation (AAF) in cardiac surgery postoperative period (PP): its influence in mortality, intensive care and
hospital length of stay (LOS) and costs
FG Aranha, JESS Pinto, RV Gomes, LAA Campos, MAO Fernandes, PMM Nogueira, AGR Carvalho, J Sabino, DJS Filho, 
HJ Dohmann
Hospital Pró-Cardíaco, Surgical Intensive Care Unit (SICU), PROCEP, RJ, Brazil
Background: AAF in cardiac surgery postoperative period has
been implicated as a complication that leads to longer ICU and
hospital stay and to augmented costs. However, it has not been
associated with increased mortality rates.
Objective: To determine possible correlation between the occur-
rence of AAF and length of SICU LOS, total hospital LOS, costs
and mortality.
Patients and methods: Three hundred and fifty adult patients con-
secutively admitted in the immediately postoperative period were
prospectively evaluated between June 2000 and November 2001.
Those with previously documented atrial flutter or atrial fibrillation
were excluded. Patients were included in Group (G) A when AAF
did not occur in the PP and in G B when it occurred. Statistical
techniques were: t Student test, Fischer test and linear regression.
Results: G A included 263 and G B 87 patients (24.8%). The
hospital mortality shows no statistically significant difference
(15 patients in G A [5.7%] and 6 in G B [6.8%] — P = 0.7). The
mean SICU LOS was significantly higher in G B (4.47 ± 6.4 days
in G A versus 9.74 ± 12.6 days in G B — P < 0.001), as well as the
hospital LOS (9.26 ± 12.7 days in G A versus 13.69 ± 11.4 days in
G B — P< 0.001). Hospital costs were increased in 61.9% by AAF
occurrence (P  = 0.0025). G A hospital cost was U$8485.23 ±
9509.54 against U$13,740.34 ± 16,849.1 of G B. Linear regression
shows relation between costs and SICU LOS and hospital LOS.
Discussion: AAF was a common complication in these postopera-
tive patients. It was not associated with increased mortality, but it
was shown a positive correlation between its occurrence and
longer SICU LOS and elevated costs. The longer hospital LOS, as
well as the higher cost appear to be related to longer SICU LOS.
Conclusions: It is concluded that AAF in the cardiac surgery post-
operative setting is a frequent complication and that it is an impor-
tant marker of longer SICU LOS and of higher hospital costs.
Hospital costs have been increased in AAF patients due to longer
SICU LOS. Further studies will be needed to determine whether
AAF is the real cause or simply a marker of these findings.
P146 The relationship between plasma urotensin II (hU-II) and pulmonary artery occlusion pressure during cardiac surgery:
further evidence that hU-II is influenced by cardiac filling pressures
M Heringlake*, S Eleftheriades*, L Bahlmann*, S Klaus*, W Eichler*, J Schumacher*, M Heinzinger*, E Kraatz†, P Schmucker*
*Anaesthesiologie, and †Herzchirurgie, Universitätsklinikum Lübeck, Ratzeburger Allee 160, D-23538 Luebeck, Germany
Introduction: The (patho-)physiological role of human urotensin II
(hU-II) — the most potent endogenous vasoconstrictor yet
described — remains to be defined [1]. Preliminary evidence sug-
gests that hU-II levels during cardiac surgery are increased in
patients with myocardial dysfunction [2]. However, it is not known,
if hU-II plasma concentrations are related to pulmonary capillary
wedge pressure (PCWP) as an estimate of left ventricular filling
pressure.
Methods: We investigated 33 consecutive patients during coro-
nary artery bypass (CABG) surgery. Blood was sampled before
induction of anesthesia (t1), 20 min after intubation (t2), 10 and
30 min after aortic cross clamping (t3 and t4) during cardiopul-
monary bypass (CPB), and 30 min after CPB (t5). Hemodynamic
variables (including PCWP) were recorded at t2 and t5. hU-II was
determined by a commercially available ELISA.
Results: hU-II concentrations decreased during CPB and returned
to baseline thereafter (Fig. 1). Plasma hU-II concentrations were
significantly correlated with mean pulmonary artery pressure
(MPAP) and PCWP before and after CPB (Spearman’s rho: range:
0.52–0.62). Patients with a preoperative ejection fraction (EF)
Available online  http://ccforum.com/supplements/6/S1Critical Care    Vol 6 Suppl 1 22nd International Symposium on Intensive Care and Emergency Medicine
≤ 0.45 had higher hU-II levels before (P = 0.02) and immediately
after CPB (P = 0.008) than patients with an EF ≥ 0.5 (Fig. 1).
Conclusions: The correlation between hU-II concentrations, MPAP
and PCWP during CABG surgery and its relation to the preopera-
tive degree of myocardial dysfunction strongly suggest a role of left
ventricular filling pressures in the regulation of plasma hU-II in
patients with ischemic heart disease.
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Figure 1
The course of plasma urotensin II (U-II) during cardiac surgery. For
abbreviations and time points see text.
P147 Intrahepatic interleukin-10 synthesis during hypothermic cardioplumonary bypass inhibits TNFα α synthesis throughout the
STAT-3 pathway
M Qing*, A Nimmesgern†, K Schumacher*, JF Vazquez-Jimenez‡, J Hess*, G von Bernuth§, M-C Seghaye*
*Department of Pediatric Cardiology, German Heart Centre at the Technical University Munich, Munich, Germany; †Department of
Biochemistry, ‡Department of Thoracic and Cardiovascular Surgery, and §Department of Pediatric Cardiology, Aachen University of
Technology, Aachen, Germany
Background and aim: Hypothermic cardiopulmonary bypass stim-
ulates the synthesis of the anti-inflammatory cytokine IL10 and
decreases that of TNFα in the organs. This study was intended to
analyze the signaling pathways involved in the suppressive effects
of IL10 on intra-hepatic TNFα gene expression
Methods: Twelve young pigs were assigned to a temperature (T°)
regimen during standardized CPB: normothermia (T° 37°C; n = 6)
and moderate hypothermia (T° 28°C; n =6). Six hours after termi-
nation of CPB, liver tissue was sampled. Intra-hepatic gene expres-
sion and synthesis of TNFα IL10, and of the suppressor of cytokine
signalling SOCS-3 were detected and quantified by competitive
RT-PCR and by Western blot. DNA binding activity of the tran-
scription factors NF-κB and STAT-3 was detected by
eletrophoretic-mobility-shift assay (EMSA) and super shift, and
phosphorylation of IκB-α and STAT-3 by Western blot. Cellular
origin of TNFα and IL10 was assessed by immunohistochemical
staining.
Results: Synthesis of IL10 and SOCS-3 were significantly higher,
while that of TNFα was significantly lower, in pigs that were in
moderate hypothermia during cardiac surgery than in the others.
Hepatocytes themselves produced IL10 but not TNFα after
cardiac surgery with CPB. Pigs under moderate hypothermia also
showed significantly higher phosphorylation of STAT-3 and DNA
binding activity of STAT-3 6 hours after CPB but no lower phos-
phorylation of IκB-α and DNA binding activity of NF-κB than
animals operated on in normothermia.
Conclusion: Suppression of TNFα synthesis during moderate
hypothermic CPB by IL10 is dependent on the activation of the
transcription factor STAT3- and of the activity of the regulatory
SOCS-3, but not on the suppression of the activity of NF-κB.
P148 Methylprednisolone sodium succinate reduces postoperative hyperthermia but does not affect cardiac function after aortic
valve replacement
R Jara-Rubio*, J Galcerá*, E Serrano†, J Diaz†, LF Carbonell†
*Intensive Care Unit, Hospital Universitario Arrixaca, 30120 Murcia, Spain; †Departamento de Fisiología, Universidad de Murcia, Spain
Objective: Steroids have been used in cardiac surgery for many
years to reduce the inflammatory response associated with extra-
corporeal circulation. However, their clinical benefits have not been
well established. The aim of the present study was to evaluate the
effect of methylprednisolone on body temperature and cardiac
index in the postoperative period of aortic valve replacement with
extracorporeal circulation and aortic clamp.
Patients: Twenty-two consecutive patients undergoing aortic valve
replacement and extracorporeal circulation. The patients received
methylprednisolone (30 mg/kg; n = 11, MP group) or received no
medication (n = 11, no MP group) before cardiopulmonary bypass.
Clinical and demographic characteristics of the patients were
similar in both groups.Measurements and main results: Body temperature (To, oC) and
cardiac index (CI, l/min/m2) were measured in the postoperative
period on admission in the ICU and at 4 hours and 8 hours after
ICU admission. On admission to ICU there were no differences in
temperature between groups. Body temperature was significantly
lower in group MP at 4, and 8 hours after ICU admission
(P < 0.05) (Fig. 1).Cardiac index increased during the postopera-
tive period, with no significant differences between groups
(Fig. 2).
Conclusion: Methylprednisolone sodium succinate reduces hyper-
thermia without affecting cardiac function in the postoperative
period of aortic valve replacement with extracorporeal circulation
and aortic clamp.
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P149 Hemostatic and fibrinolysis markers in serum and shed mediastinal blood after elective coronary artery bypass grafting
AA Peivandi*, M Dahm*, D Peetz†, W Kasper-Koenig*, H Oelert*
*Department of Cardiothoracic and Vascular Surgery, and †Institute of Clinical Chemistry, University Hospital Mainz, D-55131 Mainz,
Germany
Objective: Reduction of homologous blood products in cardiac
surgery is mainly achieved by autologous blood salvage. One of
the most customary methods consists in autotransfusion of shed
mediastinal blood within the first 6 hours after surgery. Aim of this
prospective study was to compare serum and shed mediastinal
blood qualities of hemostatic and fibrinolysis markers early after
elective coronary artery bypass grafting (CABG).
Methods: Forty-seven patients (mean age 68.1 ± 6.9, 15 female/
32 male) underwent first-time elective CABG with extracorporal
circulation via median sternotomy. Activated partial thromboplastin
time (aPTT), prothrombin time (Quick’s value), international normal-
ized ratio (INR), thrombin time, and fibrinogen (factor I) in arterial
blood and shed mediastinal blood were measured after admission
to the ICU and 6 hours after unclamping the aorta.
Results: Mean loss of mediastinal shed blood was 207 ± 127 ml
within the first 6 hours after unclamping the aorta. All tests showed
that the shed mediastinal blood contained significantly elevated
concentrations or activities of all biochemical parameters indicating
blood activation or clotting (Table 1).
Conclusions: Mediastinal shed blood is excessively activated
regarding coagulation and fibrinolysis. In patients undergoing
transfusion of higher quantities of shed blood might cause postop-
erative excessive bleeding.
Table 1
After admission to the ICU 6 hours after unclamping the aorta
Shed blood Serum P Shed blood Serum P
Quick’s value (%) 34 83 < 0.001 22 92 < 0.001
INR 2 1.18 < 0.001 2.12 1.1 < 0.001
APTT (s) > 120 52 < 0.001 > 120 46 < 0.001
Thrombin time (s) > 120 18.6 < 0.001 > 120 14.9 < 0.001
Fibrinogen (mg/dl) 121 70.5 < 0.001 40 281 < 0.001
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P150 Acute atrial fibrillation (AAF) in cardiac surgery postoperative period: evaluation of preoperative and peroperative factors
associated with its higher incidence
FG Aranha, RV Gomes, JESS Pinto, LAA Campos, MAO Fernandes, PMM Nogueira, R Farina, AGR Carvalho, HTF Mendonça, 
H Dohmann
Hospital Pró-Cardíaco, Surgical Intensive Care Unit, PROCEP, Rua Dona Mariana 219, Botafogo, Rio de Janeiro, CEP 22.280-020, 
RJ, Brazil
Background: AAF in cardiac surgery postoperative period is impli-
cated in implements in hospital length of stay and costs. Some pre-
operative and peroperative factors have been associated to a
higher incidence of the arrhythmia. Advanced age, longer surgery
time, mitral valve surgery (MVS) and stopping beta-blockade have
been described.
Objectives: To evaluate some preoperative and peroperative
factors in order to identify those patients with higher probability for
cardiac surgery postoperative AAF.
Patients and methods: Three hundred and fifty adult patients con-
secutively admitted in postoperative period of cardiac surgery were
prospectively followed. Clinical and surgical variables were col-
lected and then compared between patients who developed AAF
in postoperative period and those who did not. Statistical tech-
niques were: Student t-test and Fischer test.
Results: In the patients submitted to cardiac arterial by-pass
surgery (CABS), the mean age in the two groups were significantly
different (69.98 ± 9.67 years old in AAF patients and
62.89 ± 10.65 years old in no AAF patients — P < 0.0001). Water
retention during surgery was higher in AAF patients (P = 0.05)
while water retention on the first postoperative day was also higher
in AAF patients but P value was 0.07. Left atrial diameter, body
mass index, surgery time, extra corporeal circulation time, aortic
clamping time, diagnostic of diabetes and chronic obstructive pul-
monary disease, lactate and creatinine levels and PaO2/FiO2 ratio
were not statistically different in the two groups. Postoperative
AAF incidence was higher in MVS when compared to non-MVS
(43.4% versus 22.6% with P < 0.01).
Conclusion: Advanced age, water retention and Mitral Valve
Surgery were shown to be predictors for AAF in cardiac postoper-
ative period. The other factors analyzed did not influence the inci-
dence of the arrhythmia but further analyses are needed.
P151 Methemoglobin formation in children with congenital heart disease treated with inhaled nitric oxide after cardiac surgery
MM Hermon*, G Burda*, J Golej*, H Boigner*, E Stoll*, E Kitzmüller†, G Wollenek‡, A Pollak*, G Trittenwein*
*Department of Neonatology and Pediatric Intensive Care, and †Department of Pediatric Cardiology, University Children’s Hospital,
University of Vienna, Austria; ‡Department of Cardiothoracic Surgery, University Hospital of Vienna, University of Vienna, Austria
Background: Inhaled nitric oxide is used as a therapy of pulmonary
hypertension in children after cardiac surgery. Hemoglobin binds to
nitric oxide with great affinity and forms methemoglobin by oxida-
tion in the erythrocyte. Once produced, methemoglobin is unable
to transport and unload oxygen in the tissues. The amount of avail-
able hemoglobin in the body for oxygen transport is thereby
reduced. Anemia, acidosis, respiratory compromise, and cardiac
disease may render patients more susceptible than expected for a
given methemoglobin level. The goal of the present study was to
investigate the effect of inhaled nitric oxide on methemoglobin for-
mation in critical ill children. We therefore measured methemoglo-
bin levels in children with congenital heart disease after cardiac
surgery who where treated with inhaled nitric oxide in a range of
5 to 40 ppm.
Methods: We enrolled 38 children with congenital heart disease
after cardiac surgery into a retrospective chart review study. We
extracted demographic data and physiological measurements at
the following time points: (1) T0 = before starting inhaled nitric
oxide therapy, (2) T1 = 24 hours after begin of inhaled nitric oxide
therapy, (3) T2 = half-time therapy, (4) T3 = end of therapy, 
(5) T4 = 24 hours after finishing inhaled nitric oxide therapy.
Results: Median duration of inhaled nitric oxide therapy was
5.5 days (quarter percentiles 3/9, range 2–29), nitric oxide con-
centration at T1 and T2 was 16 ppm (10/20, 5–40) and 12.5 ppm
(7.7/20, 2–40) respectively. Median cumulative dose of inhaled
nitric oxide was 1699 ppm (809/3122, 193–7018). Methemoglo-
bin levels increased moderately but significantly during therapy 
(T0 vs T1, P < 0.05 and T0 vs T2, P < 0.001). Comparing methe-
moglobin levels during therapy showed a significant difference
between: T1 vs T3 (P < 0.05), T1 vs T4 (P < 0.001) T2 vs T3 and
T4 (P < 0.001). The highest measured methemoglobin level was
3.9%. Methemoglobin levels correlated positively with the applied
inhaled nitric oxide doses at T1 (r2 = 0.4086; P < 0.01) and at 
T2 (r2 = 0.5477; P < 0.01). At T1 methemoglobin level was nega-
tively correlated with T1 blood pH value. The overall mortality rate
was 13.2% (five of 38 study patients died).
Conclusion: This study extends the findings of previous reports
that methemoglobin levels did not cause toxic adverse effects in
children with congenital heart disease after cardiac surgery treated
with inhaled nitric oxide. We recommend the use of the minimal
effective dose of inhaled nitric oxide and continuous monitoring of
methemoglobin levels especially in cases of anemia or sepsis.
P152 Fibrinolytic activity in patients with atrial arrhythmias during acute myocardial infarction, treated with streptokinase
A Sinkovic*, V Urlep-Salinovic†
*ICU, and †Department for Transfusiology, General Hospital Maribor, Ljubljanska 5, 2000 Maribor, Slovenia
Background: Increased level of plasminogen-activator-inhibitor-1
(PAI-1) reflects impaired fibrinolytic activity and is associated with
increased risk for failed fibrinolysis with fibrinolytic agents, includ-
ing with streptokinase (STK). Atrial arrhythmias (AA) in patients
with acute myocardial infarction (AMI) are associated with heart
failure and increased mortality. The prognostic role of pre-treat-
ment PAI-1 activity in patients with AA and AMI, treated with STK
was evaluated.Methods: In patients with AMI, treated with streptokinase, pre-
treatment PAI-1 levels were estimated by chromogenic method
(normal levels 0.5–3.5 U/ml) and the presence or absence of AA
assessed. Included were atrial fibrillation and/or flutter and/or
tachycardias. We compared pre-treatment variables (PAI-1
included) and in-hospital events in patients with and without AA.
Results: AA were found in 22.4% (26/116) of patients. Among
pre-treatment variables, the only statistically significant difference
between patients with and without AA was observed in mean pre-
treatment PAI-1 levels (P = 0.0017). PAI-1 level over 7 U/ml was
the most significant independent risk factor for AA (P < 0.05, OR 3.5,
95% CI 1.15–10.6). AA were significantly associated with cardio-
genic shock, pulmonary edema, cardiopulmonary resuscitation
after STK, conduction disturbances and mortality. In-hospital mor-
tality of patient with AA was 23% and 4% without them (OR 6.45,
95% CI 1.66–25.017). Among in-hospital events, cardiogenic
shock was the most significant independent predictor of AA.
Conclusions: AA in patients with AMI, treated with streptokinase,
were associated with elevated mean pre-treatment PAI-1 levels
and increased mortality due to heart failure. Pre-treatment PAI-1
over 7 U/ml was the only independent significant risk for AA during
AMI.
P153 Predictive role of plasminogen-activator-inhibitor-1 (PAI-1) in non-ST-segment elevation acute coronary syndrome
A Sinkovic*, V Urlep-Salinovic†
*ICU, and †Department for Transfusiology, General Hospital Maribor, Ljubljanska 5, 2000 Maribor, Slovenia
Background: Increased plasma activity of plasminogen-activator-
inhibitor-1 (PAI-1) is associated with increased risk for coronary
thrombosis, but its role in predicting adverse events in non-ST-
segment elevation acute coronary syndrome (ACS) is not yet
defined. Therefore, we studied prospectively the role of PAI-1
activity for the 30-days composite endpoint of death and new
myocardial infarction (MI) in patients with ACS.
Methods: Fifty-one patients with chest discomfort, but no ST-
segment elevation on ECG were admitted to the ICU. PAI-1 levels
were estimated at admission and every 12 hours in the first 48 hours
by chromogenic method (normal range 0.5–3.5 U/ml), as well as
Troponin T (TnT) by electrochemiluminescence immuno method at
admission and 8 hours later (normal level up to 0.1 µg/l). After initial
medical therapy, in case of recurrent ischemia and/or haemodynamic
and/or rhythmic instability, percutaneous interventions (PCI) were
performed. Thirty-days mortality and new MI were registered.
Results: The composite 30-days endpoint of mortality and/or new
MI was 13.1% (7/51). Between patients with and without compos-
ite death and/or new MI statistically significant difference was
observed in mean admission PAI-1 levels (5.3 ± 4.2 vs
3.0 ± 2.4 U/ml, P < 0.05), highest mean PAI-1 levels in the first
48 hours (5.98 ± 4.1 vs 3.2 ± 2.4 U/ml, P < 0.05), mean ICU stay
(7.8 ± 7.0 vs 3.1 ± 1.4 days, P < 0.001), but nonsignificant differ-
ence in mean admission TnT (0.5 ± 0.7 vs 0.4 ± 7.3 µg/l,
P > 0.05) and highest in-hospital TnT levels (1.4 ± 1.8 vs
0.9 ± 1.5 µg/l, P > 0.05). The risk for 30-days mortality and/or new
MI was significantly increased only in patients with PAI-1 levels
over 5.0 U/ml in the first 48 hours of therapy (OR 17.5, 95% CI
2.05–149.1).
Conclusions: PAI-1 level > 5.0 U/ml during first 48 hours of
therapy was the only significant risk for composite 30-days death
and/or new MI of patients with non-ST-segment elevation ACS.
P154 Fibrinogen, ejection fraction and Killip classification as mortality prediction factors in acute coronary syndrome
W Del Cid, M Lopez, V Segura
Unidad de Medicina Crítica, Hospital Médico Quirúrugico (ISSS), Alameda Juan Pablo II, San Salvador, El Salvador
Background: In patients with acute coronary syndrome, there is a
relation between the patient’s outcome and multivariate group of
coronary risk factors. The aim of this investigation is to develop a
predictive equation of mortality in patients with acute coronary
disease, taking those factors with mortality risk significantly higher
to predict acute coronary disease’s outcomes.
Methods:  Patients: Between April to September 2001, were fol-
lowed 53 patients with acute coronary disease (18 unstable anginas
and 35 acute myocardial infarcts). Ninety-two variables between clini-
cal, laboratory and echocardiography were analyzed. Statistical analy-
sis: Database was analyzed using SPSS 9.0 for Windows. Forward
stepwise logistic regression model was used to analyze the joint
association of multiple covariates with overall mortality. No missing
covariate data was found. The result constant and B coefficients was
include in the equation (Z function) to predict the patient’s outcome.
Values of P < 0.05 were considered statistically significant.
Results: Mortality risk: Logistic regression analysis was used to
examine the effects of multiple covariates (92) on the overall mor-
tality risk and we found this major cardiovascular mortality risk
factors: age, heart rate, pain duration, blood nitrogen ureic, fibrino-
gen, Killip and ejection fraction. A new logistic regression analysis
was applied to these covariates (8) with the objective to obtain
those with prediction power higher to explain the patient’s
outcome. In this step were included: blood fibrinogen, Killip classi-
fication and ejection fraction.
During follow-up, eight of 53 patients died of cardiac causes
(15%). The mortality rates of death increased with a fibrinogen
≥ 333 mg/dl (Fig. 1 overleaf; P  = 0.001, with a mean valor of
405 mg/dl). Likewise the mortality rates increased with Killip classi-
fication increases (Fig. 2 overleaf) and with ejection fraction ≤ 48%
(Fig. 3 overleaf; P = 0.001, with a mean valor of 40.1%).
With these predictors was developed a mortality predictive equa-
tion (Z function) using a constant (K = –11.4997) and the B coeffi-
cients of each covariate (fibrinogen: 0.0268, Killip: 1.947 and
ejection fraction: –0.0974). The equation obtained was: death
probability (P)= (–11.49) + (0.268 × fibrinogen) + (1.971 × Killip)
+ (–0.974 × FE%).
The death probability increases when P value increases from 0.5 to
1. The prognostic of patient’s outcome was tested and compared
with the real patient’s outcome. It shows a sensibility 71% and
specificity 97%.
Conclusions: Blood fibrinogen, ejection fraction and Killip classifi-
cation were major independent covariates that predict patient’s
outcome in acute coronary disease.
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Figure 1
Fibrinogen seric concentrations in patients
with non-fatal acute coronary disease (ACD)
and cardiovascular (CV) death.
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Figure 3
Ejection fraction in patients with non-fatal
acute coronary disease (ACD) or
cardiovascular (CV) death.
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Figure 2
Mortality rates by Killip classification.
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Thrombosis on top of an atheromatus unstable plaque is now
accepted as the most common mechanism underlying acute
ischemic syndromes (ACS), and in that process platelet dysfunc-
tion plays a central pivotal role through interaction with the vessel
wall. The present study is an attempt to highlight and re-evaluate
the role of platelets in the pathogenesis of ACS via the combined
approach of aggregometry and flow cytometry techniques before
applying any reperfusion therapy.
Methods: For this purpose we studied 44 individuals who were
classified into three groups, group (1): 24 patients (pts) with acute
myocardial infarction (AMI) (21 M, 3 F, mean age: 49 ± 11 years),
group (2): 10 pts with unstable angina pectoris (UAP) (6 M, 4 F
mean age: 49 ± 7 years), and group (3) 10 normal individuals who
served as controls (9 M, 1 F, mean age: 27 ± 2 years). All cases
were selected in such a way as to be free from gross liver and
kidney impairment and were subjected to clinical examination, ECG
and echocardiography. Coronary angiography was performed to
assess the extent of CAD (the number of lesions in the coronary
arteries with more than 50% stenosis as well as the patency of the
infarct-related artery according to TIMI flow grading system).
Blood samples were withdrawn from pts on admission to the criti-
cal care department of Cairo University before any intervention.
Specific lab investigations to assess the platelet activity included
measurement of platelet aggregation with ADP, collagen, and risto-
cetin using the four channels chronolog aggregometer whereas
the flow cytometry was employed to assess surface expression of
glycoprotein IIb/IIIa receptors.
Results: Compared to healthy control subjects, pts with AMI and
UAP had significantly greater aggregatory response to ADP
(102%, 105% vs 75%, P < 0.001) to collagen (88%, 91% vs
74%, P < 0.001) and to ristocetin (77%, 90% vs 71%, P < 0.001)
and substantially greater number of glycoprotein IIb receptors: (91,
90% vs 73%, P < 0.001) and gp IIIa (94, 96% vs 67%, P < 0.001)
respectively. Platelet aggregatory response to ADP, collagen, and
ristocetin had no significant correlation with the number of coro-
nary vessels affected (P = 0.4), nor the patency across the culprit
vessel (P = 0.33).
Conclusion: Compared to the healthy controls and prior to reper-
fusion therapy, pts with ACS exhibit a significant platelet aggrega-
tory activity. Contrary to our expectations our data clearly show no
correlation between platelet activity neither with the number of
coronary vessels affected nor with different grades of TIMI flow.
P155 Platelet dysfunction in acute coronary syndromes: diagnostic aspects and relation to angiographic patency
HK Nagi, A El-Naggar, AA El-Aziz, A Rizk, M El-Desouky, S Mokhtar
Critical Care Medicine Department, Cairo University, Egypt
P156 Acute myocardial infarction in patients older than 80 years: 3 years later
L Lorente, MM Martín, R Medina, J Valencia
Intensive Care Unit, Clínica La Colina, Santa Cruz de Tenerife, Spain
Objective: To analyze the survival and functional capacity 3 years
after an acute myocardial infarction in patients older than 80 years.
Methods: It is a retrospective study. We studied all patients admit-
ted from 1 January 1994 to 31 December 1997 with a myocardial
infarction who were older than 80 years. The analysis of functional
capacity was realized through telephone interview. We analyzed
mortality during hospital stay and 3 years after. Used was a daily
activity scale (DAS) compounded by five actions (walking, dressing,
bathing, cleaning and eating). Each action had a punctuation from 0
to 2 (0 = total dependence, 1 = partial dependence and 2 = inde-
pendence). The total punctuation had a range from 0 to 10. The sta-
tistical analysis was realized by Student t-test and values P < 0.05
were taken to establish a statistically significant difference.
Results: Studied were 112 patients (48.21% were male). The
localization of the myocardial infarction was anterior in 63.39%
cases and 77.67% developed Q wave. During hospital stay 41patients died (36.60%), at the end of the first year 53 patients
were dead (50.89% accumulate mortality), and after 3 years 65
patients were dead (the accumulate mortality was 58.03%). The
47 survivors had a mean DAS 8.42 ± 3.01. There were significant
differences on comparing the development of Q-wave (8.81 with
Q-wave vs 8.22 without Q-wave) and the sex (8.95 males vs 7.86
females). None had significant differences according to the local-
ization of myocardial infarction (8.25 anterior vs 8.69 inferior).
Conclusions: Patients older than 80 years with a myocardial
infarction had an acceptable functional capacity 3 years later,
although the accumulate mortality was elevated.
P157 Diabetes mellitus worsens the prognosis of an acute myocardial infarction in patients older than 80 years
L Lorente, MM Martín, J Valencia, R Medina
Intensive Care Unit, Clínica La Colina, Santa Cruz de Tenerife, Spain
Objective: To evaluate the influence of diabetes mellitus in the
prognosis of an acute myocardial infarction in patients older than
80 years.
Methods: This was a retrospective analysis. We studied a period of
time of 10 years (from 1 July 1989 to 30 June 1999). Analyzed were
all patients older than 80 years admitted with an acute myocardial
infarction. The statistical analysis was realized by Chi-square test.
Values P < 0.05 were considered statistically significant.
Results: Analyzed were 235 patients (51.06% males) and 26.38%
had diabetes mellitus. They had the following pathological
antecedents: arterial hypertension 39.14%, coronary disease
34.04%. Myocardial infarction was anterior in 69.78% cases and
80.85% patients developed Q wave. Patients had several compli-
cations: 14.04% supraventricular tachycardia, 5.95% complete
atrioventricular block, 59.14% left ventricular failure, 34.89% car-
diogenic shock and dead 39.14%. Patients with diabetes mellitus
developed more left ventricular failure (67.74% vs 53.17%), car-
diogenic shock (46.77% vs 32.36%) and had more incidence of
exitus (50% vs 35.26%). We did not find significant differences in
the sex, antecedents of arterial hypertension, antecedents of coro-
nary disease, localization of myocardial infarction and development
of Q wave. Neither were significant differences noted in the
appearance of supraventricular tachycardia and complete atrioven-
tricular block.
Conclusions: Diabetes mellitus had a negative influence in the
evolution of an acute myocardial infarction in patients older than 80
years.
P158 Cardiac troponin I and T in patients with impaired renal function after heart surgery
AA Peivandi*, M Dahm*, D Peetz†, U Hake*, H Oelert*
*Department of Cardiothoracic and Vascular Surgery, and †Institute of Clinical Chemistry and Laborator Medizin, University Hospital Mainz,
D-55131 Mainz, Germany
Objective: Cardiac troponins are specific markers of myocardial injury
but the effects of renal dysfunction on postoperative levels remain
unclear. In a prospective study postoperative troponin concentrations
were evaluated in patients with normal or high serum-creatinine.
Methods: One hundred and ninety-one patients after elective heart
surgery without myocardial infraction were divided into two groups
according to serum creatinine. Group I included patients with
serum creatinine < 1.3 mg/dl (n = 106), group II patients with
serum creatinine ≥ 1.3 mg/dl (n = 85). CTnI and cTnT serum levels
were measured before, and 6, 12, 24, 48 and 120 hours after the
operation. Serum creatinine and urea concentrations as well as
12-lead electrocardiograms were recorded preoperatively, on the
ICU and on day 1, 2 and 5. Levels and variability of troponin con-
centrations were expressed by median, first and third quartiles and
analyzed by non-parametric methods.
Results: Pre-operative concentrations of both troponins were
normal, but increased after surgery in all patients. Maximal slope of
cTnI in group I ranged between 1.2 and 4.9 µg/l (Xmed = 2.1 µg/l)
and in group II between 2.1 and 5.9 µg/l (Xmed = 2.9 µg/l). Maximal
slope of cTnT ranged between 0.145 (I) and 0.474 µg/l (Xmed =
0.274 µg/l) and 0.212 and 0.650 µg/l (Xmed = 0.406 µg/l) (II).
Serum concentrations of cTnI and cTnT in group II were signifi-
cantly higher (P = 0.003 [cTnI], P = 0.002 [cTnT]).
Conclusions: In all patients cardiac troponin concentrations post-
operatively increased, but patients with pre-operatively normal cre-
atinine presented lower serum concentrations of both troponins
than those with high creatinine values. These results indicate that
for postoperative interpretation of troponins the status of renal
function must be taken into account.
P159 The use of cardiac troponin I to diagnose myocardial dysfunction in the critically ill
A Chiu
Intensive Care Unit, United Christian Hospital, 130 Hip Wo Street, Kwun Tong, Kowloon, Hong Kong
Background: Myocardial dysfunction in the critically ill is character-
ized by decreased contractility, increased compliance and progres-
sive ventricular dilatation. The phenomenon is global but the clinical
consequences are demonstrated predominantly by the left ventricle.
The condition is most commonly seen in patients with sepsis and
acute neurologic events, but has also been recognized in patients
with trauma and other diseases giving rise to systemic inflammatory
response syndrome. The pathophysiology is uncertain, but myocyte
damage attributed to either micro-ischemia or circulating myocardial
depressant substances are prevailing postulations. Electrocardio-
gram and conventional cardiac markers like CK-MB are modalities
of low sensitivity and specificity to diagnose this condition. Cardiac
troponin I (cTnI) is a highly tissue specific protein that is detectable
in circulation even with minor myocardial injury. Given these proper-
ties, it appeared reasonable to use a biochemical assay of cTnI to
detect myocardial dysfunction in these patients.
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Objective: The purpose of the present study is threefold: to
address the incidence of abnormal cTnI levels in critically ill
patients; to evaluate the association of cTnI elevation with left ven-
tricular dysfunction; and to assess whether cTnI elevation
presages a poorer clinical outcome.
Methods: A prospectively designed study that recruited all admissions
to our intensive care unit from June 2000 through September 2000.
Patients suffered from myocardial infarction or undergone cardio-
pulmonary resuscitation was excluded. Blood samples for measure-
ment of cTnI levels were obtained on admission and upon 72 hours.
Transthoracic echocardiogram was performed within the first 3 days
of admission to assess left ventricular ejection fraction using method
described by Simpson. Extensive clinical evaluations and electrocar-
diograms were also obtained. In-ICU mortality was documented and
surviving patients were followed up for a 6-month period.
Results: Fifty-one patients (30%) of 170 admissions in the final
cohort had elevated cTnI levels. The median cTnI level on admission
was 3.0 ng/ml (1.2–6.0 ng/ml) and the median level at 72 hours
was 3.7 ng/ml (1.5–8.8 ng/ml). Patients with elevated cTnI levels
had lower systolic arterial pressure, higher creatinine levels, worse
oxygenation index, greater APACHE II scores as well as more fre-
quently suffered from sepsis (P < 0.05 in all conditions). Multiple
logistic regression demonstrated cTnI status to be an independent
predictor of left ventricular dysfunction with an adjusted odds ratio
of 10.34 (2.31–46.21) and a P value of 0.002. Cumulative survival
at 6 months revealed significant difference in mortality rates
between cTnI-positive and cTnI-negative patients (log rank 4.55,
P = 0.03). cTnI status however was not shown to be an indepen-
dent predictor for in-ICU mortality by multivariate analysis.
Conclusion: There is a high incidence of cTnI elevation in the
intensive care unit setting. cTnI is a surrogate marker for myocar-
dial dysfunction and is also useful for risk stratification in those that
are critically ill.
P160 Troponin I as expression of myocardial damage after major vascular surgery
G Consales*, G Olivo†, G Borsotti*, V Natale*, A Sardu*, AR De Gaudio*, GF Gensini†
*Department of Critical Care Medicine Section of Anaesthesia and Intensive Care, University of Florence, Italy; †Department of Critical Care
Medicine Section of Internal Medicine, University of Florence, Italy
Introduction and methods: In the perioperative period different
levels of Troponin I (TnI) increase allow the identification of differ-
ent severity degrees of myocardial damage [1]. Aim of the present
study was to verify the correlation of TnI increase with clinical,
ECG and Echo TT data and with the stratification of risk in patients
submitted to major vascular surgery. A prospective observational
study was performed on 51 patients submitted to major vascular
surgery and then admitted to ICU. Preoperative measurements of
TnI, CK-MB isoform, ECG and Echo TT were obtained. Then blood
samples for TnI and CK-MB were obtained every 6 hours for 72
hours after surgery and then once daily. Twelve-leads ECG was
registered daily. A new echocardiogram was obtained 48–72
hours after surgery. According to our laboratory and to NACB [2],
two cut-off values for TnI were used as follows: normal values =
< 0.11 ng/ml; > 0.11 to < 1.5 ng/ml; > 1.5 ng/ml. Patients were
then subdivided into three groups in relation to TnI levels: Group
T0 = normal values (< 0.11 ng/ml); Group T1 = > 0.11 to
< 1.5 ng/ml; Group T2 = > 1.5 ng/ml. In every group TnI values
were related to CK-MB, ECG and echo TT results. Patients were
reassessed 3 months after surgery by means of telephone survey,
ECG, echo TT and clinical evaluation.
Results and discussion: In the T0 group TnI and CK-MB levels
were normal, as ECG traces and echocardiography. In the T1
group TnI levels were higher than the first cutoff value, although
CK-MB levels were normal as ECG and echocardiography. Finally,
in four out of eight patients of the T2 group, with TnI > 6 ng/ml and
CK-MB values > 3.6 ng/ml, an acute myocardial infarction was
diagnosed. Two of these patients died. The 3 months follow-up did
not detect any cardiac adverse events in survivors. Our results
demonstrate a high incidence of TnI increase in the perioperative
period after major vascular surgery. In the vast majority of cases
serum TnI increase is limited. In our opinion a mild increase of TnI
individuates a group of patients at low risk of cardiac adverse
events. In the acute phase these patients with minimal myocardial
cellular damage do not need any invasive diagnostic or therapeutic
procedure nor any aggressive pharmacological treatment. Never-
theless, it is mandatory to re-evaluate this issue in a greater number
of patients in order to establish a new and more reliable cutoff
value of TnI in the perioperative setting of major vascular surgery.
References:
1. Circulation 2000, 102:1221-1226.
2. Clin Chem 1999, 45(7):1104-1121.
P161 Effect of IV amiodarone on CPR haemodynamics and outcome: experimental study in dogs
EF Paiva*, MBM Perondi*, L Factore†, KB Kern‡, R Berg‡, S Timerman*, LF Cardoso*, JAF Ramires*
*Heart Institute, and †Clinical Hospital, University of São Paulo School of Medicine, Rua Cristiano Viana, 765 apt 141, CEP 05411-000 São
Paulo, SP, Brazil; ‡Department of Medicine, University of Arizona College of Medicine, Tucson, AZ, USA
Amiodarone has been shown to be superior to placebo in improv-
ing admission to hospital for victims of out-of-hospital ventricular
fibrillation. There is no data about haemodynamics induced by
amiodarone alone or associated with epinephrine. This study com-
pared outcome and haemodynamics of amiodarone alone, epi-
nephrine alone, and the association of these two drugs in a model
of resistant ventricular fibrillation in dogs (30 dogs were random-
ized; 10 to the epinephrine group, 10 to the amiodarone group and
10 to the association group). There were no differences among the
groups in baseline variables. Compared to the association, epi-
nephrine produced a better rate of ROSC, resuscitation, and
1-hour survival. There were no differences in outcome between
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P < 0.05Introduction: Survival after CPR with epinephrine therapy is disap-
pointing. Increasing evidence from laboratory and clinical studies
suggests that vasopressin may be a promising alternative vaso-
pressor during cardiac arrest and resuscitation.
Methods and patients: We performed our study in the prehospital
setting in Prehospital Unit Maribor after approval of The Ethical review
board of The Ministry of Health. Patients were eligible if they had a
cardiac arrest and required epinephrine according to ERC ACLS pro-
tocols for refractory VF. We gave patients one intravenous dose of
vasopressin (40 U) after 3 × 1 mg epineprine. If there was no return of
pulse after vasopressin, patients as before received epinephrine 1 mg
every 3 min during CPR. We excluded patients who were younger
than 18 years, had a documented terminal illness, had a traumatic
cardiac arrest, were in severe hypothermia (< 30°C), had PEA or
asystole as initial rhythm or received drugs via endotracheal tube.
Results: See Table 1. During the trial (from November 2000 to
October 2001) we successfully followed up 20 patients and com-
pared them with 20 patients with equal characteristics from retro-
spective study. Our preliminary study shows a significantly better
results in patients treated with vasopressin for ROSC and 24 hour
survival, additional doses of epinephrine were less needed
(P < 0.05). Respectively more patients treated with vasopressin
were discharged from hospital (P = 0.18).
Conclusion: These results suggest possible indication for vaso-
pressin in refractory out-of-hospital VF, after initial application of epi-
nephrine. Based upon our preliminary study larger and prolonger
studies of vasopressin in treatment of out-of-hospital VF are needed.
P162 Vasopressin in refractory out-of-hospital ventricular fibrillation: preliminary results
Š Grmec*, B Kamenik†, Š Mally*, P Klemen*, K Lah*, S Piberl*, T Schaubach*, M Golub†
*EMS–PHU Maribor, Slovenia; †Teaching Hospital Maribor, Slovenia
Table 1
Baseline and treatment characteristic and survival outcomes
Epinephrine 
only Vasopressine P value
Sex (M/F) 9/11 9/11 1*
Age 60.8 ± 11.2 59.6 ± 10.9 0.90†
Time collapse to CPR 7.2 8.1 0.81†
Additional epinephrine  20 10 < 0.05†
(number of patients)
Any ROSC (Y/N) 9/11 (45%) 16/4 (80%) < 0.05*
Hospitalization (Y/N) 8/12 (40%) 13/7 (65%) 0.26*
24 hour survival (Y/N) 5/15 (25%) 12/8 (60%) < 0.05*
Discharge of hospital (Y/N) 3/17 7/13 0.18*
* Chi square test; † Student t-test.
P163 Continuous insufflation of oxygen (CIO) during cardiopulmonary resuscitation (CPR): preliminary results of a randomised
controlled trial
C Bertrand, JM Saïssy, E Sorel, F Hemery, M Rüttimann, G Boussignac, Ph Duvaldestin, L Brochard, P Carli
Hôpital Henri Mondor, SAMU 94, Créteil; SAMU 75, Paris, AP-HP, Paris, France
Introduction: The use of CIO through a special ‘Boussignac’ endotra-
cheal tube during CPR for out-of-hospital cardiac arrest has been
shown to be as efficient as standard manual ventilation and chest com-
pression in terms of immediate resuscitation [1]. A multicentre trial was
therefore undertaken to compare the outcome associated with CIO-
CPR versus standard CPR. We report the preliminary results concern-
ing the respective efficacy of the two techniques on oxygenation.
Methods: An independent Ethics Committee has approved the proto-
col. All patients were randomised to receive either CIO-CPR with no
intermittent ventilation or standard CPR. Pulse oximetry (SpO2) was
recorded every 5 min until recovery or death. The number of patients
with a reliable SpO2 signal and the mean values of SpO2 were com-
pared between the two groups (Chi-square and Student’s t-test).
Results: Between August 2000 and April 2001, 430 patients with
a mean age of 64 ± 14 years have been included in the study, with
208 patients in the standard-CPR group and 222 in the ICO-CPR.
The Table shows the percentage of patients with measurable SpO2
values, significantly larger in the ICO-CPR group (*P < 0.05).
The measured values were always significantly higher in the ICO-
CPR group (T 10: 78 ± 29 vs 68 ± 27%, T 15 78 ± 22 vs
71 ± 26%).
Conclusion: In out-of-hospital cardiac arrest, the CIO-CPR tech-
nique offers an attractive alternative to standard CPR since it does
not need any intermittent ventilation and allows a better oxygena-
tion. The study is still ongoing with a lack of difference in outcome.
Reference:
1. Saïssy J-M, Boussignac G, Cheptel E, Rouvin B, Fontaine D, Bargues
L, Levecque J-P, Michel A, Brochard L: Efficacy of continuous insuf-
flation of oxygen combined with active cardiac compression-
decompression during out-of-hospital cardiorespiratory arrest.
Anesthesiology 2000, 92:1523-1530.
Table
SpO2 signal T 5 T 10 T 15 T 20 T 25 T 30
Standard-CPR(%) 38 42 41 37 34 29
CIO-CPR (%) 50* 51* 50* 49* 41* 39*
amiodarone and epinephrine or amiodarone and association. Aortic
systolic and diastolic, and coronary perfusion pressures were
lower in the amiodarone than in the other two groups. Associated
to epinephrine, amiodarone produced pressures similar to epineph-
rine alone. Amiodarone may be used during cardiac arrest, if asso-
ciated with a vasoconstrictor like epinephrine.
Available online  http://ccforum.com/supplements/6/S1Critical Care    Vol 6 Suppl 1 22nd International Symposium on Intensive Care and Emergency Medicine
P164 Efficacy of in and out of hospital CPR
P Myrianthefs, M Kalafati, E Minasidou, C Lemonidou, E Boutzouka, G Baltopoulos
Athens University School of Nursing ICU at ‘KAT’ Hospital, Athens, Greece
Introduction: The aim of the study was to examine the efficacy of
in-hospital (wards, ICU), and out of hospital (Emergency Medical
System, EMS) cardiopulmonary resuscitation (CPR) application.
Materials and methods: We enrolled 193 patients (134 males,
69.4%) mean age (59.1 ± 1.4) who developed cardiac arrest
either out of hospital (24 pts, 12.4%) or in-hospital (wards: 45 pts,
23.3%, ICU: 116, 60.1%). We examined underlying disease,
current diagnosis and place of arrest, application or not of CPR,
and outcome.
Results: Patients characteristics are shown in the Table.
CPR (basic and advanced cardiac life support) was performed in
137/193 patients (71%) by a CPR team. Cardiac function was
restored in 106/137 (77.4%) of the patients within 5 min. Six, 
12 and 24 hour survival was 29/106 (27.4%), 14 (13.2%) and
10/106 (9.4%) respectively.
Conclusions: CPR was performed in an accepted percentage
(71%) of patients and was followed by higher percentage of auto-
matic cardiac function (77.4%) compared to international data.
However, 24 hour survival was lower than that expected.
Aknowledgement: Supported by the University of Athens.
Table
Underlying disease Current diagnosis Place of arrest
Cancer: 60 (31.1%) Sepsis: 55 (21.8%) Wards: 45 (21.8%)
Cardiac: 15 (7.8%) MI-Arrhythmia: 32 (12.4%) Operating Theater: 1 (0.5%)
Surgical: 10 (5.2%) Hemorrhage: 36 (13.9%) Emergency Room: 7 (3.1%)
Pulmonary: 29 (15%) Metastasis: 19 (7.3) ICU: 116 (56.5%)
CNS: 27 (14%) Respiratory failure: 43 (17.1) Home: 2 (1%)
Burns: 8 (4.1%) DIC: 3 (0.5%) Public place: 20 (9.8%)
Head injury: 21 (10.9%) ARN: 5 (2.1) Work place: 2 (1%)
Orthopedic: 23 (11.9%)
P165 Brazilian heartsaver program: ‘Time is Life’ campaign
MF Canesin, MA Moretti, CMC Grion, LTQ Cardoso, AE Soares, C Fuganti, N El Sanadi, LA Factore, S Timerman, JAF Ramires, 
V Nadkarni
Heart Institute (InCor), University of São Paulo Medical School, Brazil
The cardiac arrest by ventricular fibrillation (VF) is the main cause
of sudden death. Its acknowledgment, followed by cardiopul-
monary resuscitation (CPR) initiation and early defibrillation, before
the arriving of advanced cardiac life support (ACLS) experts, are
directly related with the survival chances. For this reason, the
bystanders participation in performing the CPR is as important as
the medical assistance in this event.
In Londrina, a city with a population of 610,000 and 1200 physi-
cians, a campaign was held aiming to educate people about the
importance of basic life support (BLS) instructions and the employ
of automatic external defibrillators (AED).
Entitled ‘Time is Life’, the campaign was held in a site of great
public concentration. It took 3 days and was widely covered by the
media. 86,700 people attended the event site. It was a pioneer
campaign, which called the attention and interest of the people to
this subject. We could measure the impact of this campaign,
through 1900 signatures of people who got straight knowledge in
the event site and also for countless phone calls (about 1300) from
people who looked for more information about the BLS course in
the training center of the Londrina Medicine College. However, one
data specially called our attention: 31 people had already attended
the BLS course in 1999, before the campaign, and 168 in the year
of 2000, after the campaign. Five physicians, in downtown area,
attended the ACLS in 1999, before the campaign and 308
attended this course in 2000, after the campaign was held. An sta-
tistic analysis using the X2 method, found this difference significant.
We figured out that campaign like this should be held systemati-
cally, in order to educate people, to motivate authorities to develop
continuous education programs in BLS and that an educated and
informed population may positively interfere in sensitizing the
medical community to improve the qualifying in CPR performance.
P166 Ultrastructural alterations in myocardial, pulmonary and cerebral tissues after resuscitation by closed chest
cardiopulmonary bypass (CPB)
PZ Huang*, GH Zou†, AQ Chen† KJ Hu†, GR Gu*, JY Gu*, Z Wang†, ZY Liu†, YC Li*
*Emergency Department, and †Cardiology Surgery Department, Fu Dan University, Zhong Shan Hospital, Shanghai 200032, China
Objective: To observe ultrastructural changes in myocardial, pul-
monary and hippocampal tissues after resuscitation by closed
chest CPB with mild and deep hypothermia following 15 min
cardiac arrest in dogs.Methods: After 15 min cardiac arrest by KCl-induced 10 dogs
were resuscitated with the use of mild hypothermia (33–34°C)
chest closed CPB in group 1 (n = 5) and with deep hypothermia
(26–27°C) in group 2 (n = 5). The mean arteral pressures were
maintained higher than 80 mmHg during CPB. The hippocampal,
myocardial and pulmonary tissues were studied by light and elec-
tromicroscopy after 3 hours of CPB in group 1 and in group 2, in
group 3 (n = 3) which was controlled after 15 min cardiac arrest.
Results: There are no significantly pathological injury in group 3.
The numbers of oligodendrocytes at the light microscopy level
were 4.6 ± 0.9 in group 1, less than 13.6 ± 5.2 in group 2
(P < 0.01) and 8.3 ± 4.7 in group 3. The average diameters of
nuclei of oligodendrocytes at electromicroscopy were
4.563 ± 1.035  µm in group 3, more than 3.944 ± 0.90 µm in
group 2 (P < 0.05) and less than 5.086 ± 0.80 µm in group 1
(P < 0.05), in group 1 more than in group 2 (P < 0.01).
In group 1, the broken cell membranes, the swollen nuclei and
mitochondria in oligodendrocytes were found by electro-
microscopy, whereas the cell membranes and nuclei were intact in
group 2. In group 2, intra-aoveolar pulmonary surfactants showed
by electromicroscopy were increased, whereas in group 1 were
decreased. The swollen endoplasmic reticulum in type II pulmonary
epithelial cells were found, and pulmonary vascular endothelium
were showed weak intercellular connections in group 1, but in
group 2 were closed. In group 2, the smaller and structurally
altered mitochondrial, the thinned and fragmentation of myogenic
fibrils, decrease of content in glycogen granules in the swollen
myocardial cell were found, but in group 1 were no significantly
pathological future.
Conclusions: The pathological changes were found during reperfu-
sion after 15 min cardiac arrest in dogs,. The ultrastructure changes
of reperfusion injury in pulmonary and hippocampal tissues was
more severe by mild hypothermia CPB than by deep hypothermia
CPB, but in myocardial tissues were no significantly injury. This sug-
gests that resuscitation by mild hypothermia CPB with head deep
hypothermia or by deep hypothermia CPB with myocardial protec-
tion may be more effective after prolong cardiac arrest.
P167 Epidemic poisoning with methanol in Estonia: experience of intensive care
S Sarapuu, M Eerme, N O’Konnel, A Reintam, A Sipria, R Suik, A Ööpik, J Sütt, A Talonpoika, A Kõrgvee, J Starkopf
Department of Intensive Care, Tartu University Clinics, 8 L. Puusepa Str, 51014, Tartu, Estonia
In September 2001, 147 patients were admitted to Pärnu county
hospital in Estonia with suspicion of acute methanol poisoning
due to consumption of illegal alcohol. From these patients, 35 (22
male and 13 female, age from 19 to 74, mean 41 years) were
transferred into Tartu University Clinics for further intensive care,
particularly for hemodialysis. Most of the transferred patients
appeared in coma, 29 were in shock. First-line therapy (before
and during transport) consisted of artificial ventilation, fluid resus-
citation, vasopressors, if needed, and i.v. infusion of 10% ethylal-
cohol as an antidote. Arterial pH prior to transport was in range
from 6.49 to 7.29, and base excess from –12 to –30. In average
690 mmoles (from 200 to 1700 mmoles) of sodium bicarbonate
was administered before dialysis for management of acidemia. In
our department, 30 patients were treated with single hemodialysis
for 6 hours, while three patients underwent continuous veno-
venous hemodialysis for 12 to 16 hours. The blood level of
methanol was in range from 0.24 to 5.9 (mean 1.67) mg/dl before
dialysis. After discontinuation of the dialysis, the methanol level
remained between 0.05 and 1.6 (mean 0.59) mg/dl, and infusion
of 10% ethyl alcohol was continued until methanol level below
0.3 mg/dl was detected. Neurological impairment was evident in
seven patients after dialysis. In CT-scans, intracerebral haemor-
rhages, white-matter lesions, and severe brain oedema were the
common findings. Four patients, who complained visual distur-
bances in immediate post-dialysis period, were treated with hyper-
baric oxygenation, and in three of them the symptoms were
effectively reversed. Overall, from 35 patients six died (mortality
17%), two remained with persistent neurological disability
(encelopathy, coma), while 27 patients (77%) were discharged
from hospital in normal health status.
In conclusion, our experience demonstrates the importance of
intravenous ethanol administration, hemodialysis, and hyperbaric
oxygenation in the management of acute methanol poisoning.
P168 Acute in-hospital hyponatremia in children: an observational study
EJ Hoorn*†, M Robb‡, D Geary§, ML Halperin¶, E van der Voort†, D Bohn*
*Department of Critical Care Medicine, ‡Department of Emergency Medicine, and §Department of Nephrology, The Hospital for Sick
Children, University of Toronto, Toronto, Canada; ¶Division of Nephrology, St. Michael’s Hospital, University of Toronto, Toronto, Canada;
†Department of Pediatric Intensive Care, Sophia Children’s Hospital, Erasmus University Rotterdam, Rotterdam, The Netherlands
Introduction: To develop hyponatremia (plasma sodium concen-
tration (PNa) < 136 mM), there must be a source of electrolyte free
water (EFW) and actions of antidiuretic hormone (ADH) to prevent
its excretion. A low PNa is the most common electrolyte disorder in
hospitalized children and it makes them more prone to neurological
damage.
Objectives: To establish the incidence of and to identify risk
factors for the development of hospital-acquired hyponatremia in a
tertiary care hospital.
Methods: We included all children (n = 432) who had two or more
PNa-measurements in the Emergency Department in a 3-month
period and in hospital over the first 48 hours.
Results: The incidence of hyponatremia was 22.5% of whom
14.4% were hyponatremic on presentation and 9.3% developed
hyponatremia in hospital (five patients fell in both groups). ADH
was likely elevated due to disease (7.9%; e.g. bronchiolitis), symp-
toms (47%; e.g. nausea) and treatment (45.1%; e.g. surgery).
Eighty-three percent of the EFW responsible for the falls in PNa
was administered as either hypotonic intravenous (66%) or oral
fluids (34%) and was excessive in 53% of the cases. Those who
did not seem to receive excessive EFW had an occult source of
water, hyperglycemia (16%), mannitol (8%) and/or excreted hyper-
tonic urine (62%).
Conclusions: The most important factor for hospital-acquired
hyponatremia is the administration of hypotonic fluids. Hospital-
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acquired hyponatremia is iatrogenic and therefore preventable. It
unnecessarily puts children at risk of neurological damage. The
practice of IV-fluid therapy should be re-evaluated.
Reference:
1. Halberthal M, Halperin ML, Bohn D: Acute hyponatraemia in chil-
dren admitted to hospital: retrospective analysis of factors con-
tributing to its development and resolution. BMJ 2001,
322:780-782.
P169 Predictive factors of mortality in polytrauma patients with life threatening pelvic hemorrhage after transarterial
embolization (TAE)
A Hagiwara, K Yamada, H Fukushima, A Murata, H Matsuda, S Shimazaki
Department of Traumatology and Critical Care Medicine, Kyorin University School of Medicine, 6-20-2 Shinkawa Mitaka-shi, 
Tokyo 181-8611, Japan
Objective: To determine the predictive factors of mortality in
patients with severe pelvic trauma after transarterial embolization
(TAE).
Methods and materials: We developed a protocol for the man-
agement of patients with severe pelvic trauma with stressing the
roles of TAE, and performed a study according to it between
January 1996 and December 2000. When patients with unstable
pelvic fracture and without hemoperitoneum were in shock on
admission, angiography was immediately performed after admis-
sion. In case of hemodynamically stable patients, angiography was
performed only when contrast-enhanced CT showed hematoma in
the pelvic cavity. For patients with stable pelvic fracture and
without hemoperitoneum, angiography was performed when they
were in shock and had CT evidence of hematoma in the pelvic
cavity. When patients in shock with stable or unstable pelvic frac-
ture had hemoperitoneum, we first chose either of angiography or
laparotomy according to our previously reported protocol. All the
patients who had angiographic evidence of extravasation of con-
trast medium underwent TAE. In addition, all the patients with
unstable pelvic fracture immediately underwent external fixation
after TAE.
Result: TAE was successfully performed to all the 61 patients with
the angiographic evidence of extravasation of contrast medium.
Forty-eight patients survived and 13 died. To analyze the predictive
factors of mortality on admission, the damages that the patients
sustained were divided into two types; anatomical and physiologi-
cal. Tile’s classification, the positions of arterial injury, ISS, and
head injury (AIS ≥ 4) were used as anatomical damage parameters.
For the physiological damage parameter, APACHE II score was
used. Multivariate analysis was performed for these five factors
inclusive of anatomical and physiological parameters. The arterial
injury in the posterior position and APACHE II score had a signifi-
cantly high odds ratio, 16.3 and 26.2, respectively. The items that
were statistically significant among the APACHE II parameters
were age, mean arterial blood pressure (MAP), core temperature
and pH. Volume of positive water balance (ml/kg/hour) during the
period from admission to TAE, total units of blood transfusion, time
from onset to TAE, and numbers of surgery for complicated injuries
(AIS ≥ 4) were examined using multivariate analysis for the predic-
tive factors of mortality after admission. Among these four factors,
only the positive water balance had significantly high odds ratio
(8.3).
Conclusion: MAP, core temperature, pH, and volume of positive
water balance were hemodynamic factors. Therefore, the predic-
tive factors of mortality could be said to be determined by the loca-
tion of arterial injury which should be the posterior position, age,
and degree of deterioration of hemodynamics.
P170 Changing the practice of blood transfusion in intensive care
N van Heerden, S Rau, CB Groba
Department of Anaesthesia & Intensive Care, University Hospital Lewisham, Lewisham High Street, London SE13 6LH, UK
Optimal red blood cell (RBC) transfusion in critically ill patients
remains controversial and, amongst other complications, transfu-
sion induced impaired immune response has been postulated. We
modified our transfusion practice in ICU after Herbert et al.’s Cana-
dian multi-centre trial, compared a liberal (10–12 g/dl) to restrictive
(7–9 g/dl) RBC transfusion strategy [1]. They concluded that
restrictive RBS usage was at least equivalent, and possibly supe-
rior, to a more liberal transfusion strategy.
Aim: Before and after change in transfusion practice, we docu-
mented ICU RBC usage, admission severity of illness (APACHE II),
and ICU and hospital mortality.
Method: Retrospective study of RBCs transfused in two 6 month
periods (135 patients in 1997 and 171 patients in 1998).
Results: Demographics were similar in the two groups. Average
admission Hb in 1997 was 11.3 g/dl and in 1998 10.8 g/dl. Dis-
charge Hb in 1997 was 10.9 (g/dl) and 10.0 (g/dl) in 1998.
Average APACHE II was 20.5 in 1997 and 20.4 in 1998. ICU
mortality was 28.8% in 1997 compared to 29.8% in 1998. Hospi-
tal mortality in 1997 was 34.8% compared to 37.4% in 1998. The
average length of ICU stay in 1997 was 6.5 days compared with
5.6 in 1998. Standardised mortality ratio was 1.0 in 1997 and
1.02 in 1998. 586 RBC units were transfused in 1997 compared
to 483 in 1998. This equates to 4.3 units per patient in 1997 and
2.8 units per patient in 1998 (35% reduction in RBC usage).
30.1% of patients received no blood in 1997, compared to
51.7% in 1998. In untransfused surgical patients in 1997 average
APACHE II was 8.6 and in untransfused medical patients it was
18.5, compared to 12.2 and 20.3 respectively in 1998. In 1997
the medical patients received 230 RBC units, compared to 200 in
1998. 68.4% of medical patients were transfused in 1997 versus
60.5% in 1998. Average APACHE II for transfused medical
patients in 1997 was 26.5 versus 29.1 in 1998 and for untrans-
fused patients 18.5 in 1997 versus 20.3 in 1998. The surgical
patients received 356 RBC units in 1997 compared to 283 in
1998. 20% of vascular patients remained untransfused in 1997
versus 39.3% in 1998. Average APACHE II of vascular patients
was 13.3 in 1997 (average total surgical APACHE II 18.1) versus
15.0 in 1998 (average total surgical APACHE II 17.6). The
average admission and discharge haemoglobins of vascular
patients were 12.3 g/dl and 10.1 g/dl in 1997 versus 10.1 and
9.9 g/dl in 1998.Conclusion: Restrictive blood transfusion strategy appears to be
safe practice, even in patients with relatively high APACHE II
scores. There was a reduction of 106 units of RBCs in 1998 com-
pared to 1997. This translates into a considerable financial saving
for the hospital (approximately £17,000 p.a.) and a better balanced
use of vital blood products, in a time of national shortage.
Reference:
1. Herbert P, Wells G, Martin C, Tweedale M, et al.: Variation in red cell
transfusion practice in the intensive care unit: a multi-centre
study. Crit Care 1999, 3:57-63.
P171 Hypoalbuminemia in the acutely ill — risks and rationale for treatment: a meta-analysis
RJ Navickis*, J-L Vincent†, M-J Dubois†, MM Wilkes*
*Hygeia Associates, 17988 Brewer Road, Grass Valley, CA 95949, USA; †Department of Intensive Care, Université Libre de Bruxelles,
Hôpital Erasme, Brussels, Belgium
Hypoalbuminemia is associated with poor outcome; however, the
causal role of low serum albumin concentration and appropriate-
ness of albumin therapy are controversial. We conducted a meta-
analysis focusing on two types of evidence: (1) cohort studies with
multivariate analysis capable of more accurately assessing whether
serum albumin is a direct contributor to poor outcome rather than
merely a marker for other pathological processes; and (2) controlled
trials of albumin therapy for hypoalbuminemia reporting data on mor-
bidity, which may afford a comparatively sensitive endpoint. The
meta-analysis included 66 cohort studies with 171,654 total
patients evaluating hypoalbuminemia as an outcome predictor by
multivariate analysis and seven prospective controlled trials with
449 total patients on correcting hypoalbuminemia. The pooled
results of the included cohort studies revealed hypoalbuminemia to
be a potent, dose-dependent, independent predictor of poor
outcome. For each 10 g/l decline in serum albumin concentration
the odds of mortality increased by 124% (OR, 2.24; CI,
1.83–2.74), morbidity by 78% (OR, 1.78; CI, 1.45–2.18), prolonga-
tions in intensive care unit and hospital stay respectively by 22%
(OR, 1.22; CI, 1.06–1.41) and 64% (OR, 1.64; CI, 1.26–2.14), and
increased resource utilization by 18% (OR, 1.18; CI, 1.03–1.35).
These effects were independent of both nutritional status and
inflammation. In controlled trials, albumin therapy reduced complica-
tions in hypoalbuminemic patients (OR, 0.79; CI, 0.36–1.72),
although the overall effect was not statistically significant. However,
there was a strong and significant (P = 0.019) inverse relationship
between morbidity and attained serum albumin level during therapy,
which suggested that complication rate may be diminished by
exogenous albumin sufficient to elevate serum albumin level above
30 g/l. The value of albumin therapy for hypoalbuminemia needs to
be investigated further in well-designed trials. At present, the evi-
dence suggesting a causal link between hypoalbuminemia and poor
outcome and a dose-dependent effect of exogenous albumin in
reducing complications provides a logical basis for albumin therapy,
and there appears to be no compelling argument for withholding
albumin therapy if deemed clinically appropriate.
P172 HES 130 kD, but not crystalloid volume support reduces leukocyte–endothelial cell interaction during endotoxemia
JN Hoffmann, B Vollmar, M Laschke, D Inthorn, FW Schildberg, MD Menger
Klinikum Grosshadern Ludwig Maximilians University of Munich, Marchioninistraße 15, 81377 Munich, Germany
Background: Increased leukocyte/endothelial cell interaction and
deterioration of capillary perfusion represent key mechanisms of
septic organ dysfunction. Despite ongoing debate, however, the
type of volume support to be used during septic disorders remains
controversial. Using intravital microscopy we, therefore, studied
microcirculatory effects of different clinically relevant volume
therapy regimens, i.e. the synthetic colloid hydroxyethyl starch
(HES, 160 kD) and a crystalloid regimen with isotonic saline solu-
tion (NaCl) in a new model of normotensive endotoxemia.
Methods: In Syrian hamsters, normotensive endotoxemia was
induced by i.v. application of E. coli lipopolysaccharide (LPS,
2 mg/kg). The microcirculation was analysed in striated muscle of
skinfold preparations. HES (Voluven®, 16 ml/kg, n = 7) or isotonic
saline (NaCl, 66 ml/kg, n = 6) were infused 3 hours after LPS
exposure over a 1-hour period (post-treatment mode). Animals,
receiving LPS without volume therapy served as controls (n = 8,
control). Leukocyte–endothelial cell interaction and functional cap-
illary density (FCD, indicator of capillary perfusion quality) as well
as macromolecular leakage were repeatedly analysed by intravital
fluorescence microscopy in the awake animals during a 24 hour-
period after LPS exposure.
Results: HES significantly attenuated LPS-induced arteriolar and
venular leukocyte adherence (P < 0.05), whereas NaCl volume
resuscitation had no effect when compared with non-treated con-
trols. In parallel, the LPS-induced decrease in FCD and the
increase in macromolecular leakage were significantly attenuated
by HES, but not by NaCl.
Conclusions: Thus, our study indicates for the first time a protec-
tive effect on the microcirculation by HES volume resuscitation
during endotoxemia, even when used in a clinically relevant post-
treatment mode.
P173 Large-dose hydroxyethyl starch (HES) 130/0.4 in elective coronary artery bypass surgery
SM Kasper*, P Meinert*, C Görg*, U Mehlhorn†, C Diefenbach*
*Department of Anesthesiology, and †Department of Cardiothoracic Surgery, University of Cologne, 50924 Cologne, Germany
Objective: To test the hypothesis that, in elective coronary artery
bypass surgery, HES 130/0.4 at a dose of up to 50 ml/kg does not
increase blood loss and transfusion requirements over the levels
with HES 200/0.5, 33 ml/kg, plus gelatin.
Patients and methods: One hundred and twenty adult patients
were randomized to receive up to 50 ml/kg of 6% HES 130/0.4
(Voluven®; Fresenius Kabi, Bad Homburg, Germany) or up to
33 ml/kg of 6% HES 200/0.5 (Haes-steril® 6%; Fresenius Kabi)
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plus gelatin for volume replacement during elective coronary
artery bypass surgery and until 24 hours thereafter. The first
33 ml/kg of HES 130/0.4 or HES 200/0.5 were administered in a
double-blind fashion. Colloids (HES, gelatin) were given at the
discretion of the attending physicians. Erythrocyte transfusions
were administered per protocol. Outcome variables were 
(1) chest tube output during the first 24 hours after surgery, and
(2) erythrocyte transfusion requirements until postoperative day 7.
Data were compared using the Mann–Whitney test. A two-sided
P < 0.05 was considered significant.
Results: One hundred and sixteen patients (58 patients from each
group) completed the study according to protocol. Four patients
(two from each group) required re-exploration for bleeding, which
was confined to specific sites with no observation of generalized
bleeding. These four patients were excluded from the analysis. The
median (interquartile range) dose of HES administered was 
49 (5.5) ml/kg and 33 (0) ml/kg in the HES 130/0.4 and HES 200/0.5
groups, respectively (P < 0.0001). The two groups (HES 130/0.4
vs HES 200/0.5) did not differ in postoperative (0–24 hours) chest
tube output (635 [365] ml vs 705 [408] ml, P = 0.48), the hemat-
ocrit of the drainage fluid (0.17 [0.09] vs 0.18 [0.11], P = 0.53),
and erythrocyte transfusion requirements until postoperative day 7
(1 [2] units vs 1 [2] units, P = 0.62).
Conclusion: In elective coronary artery bypass surgery, HES
130/0.4, 49 ml/kg, did not increase chest tube output and erythro-
cyte transfusion requirements over the levels with HES 200/0.5,
33 ml/kg, plus gelatin.
P174 Effects of three different resuscitation regimens on jejunal tissue oxygen supply after hemorrhagic shock
W Pajk, H Knotzer, A Mayr, M Dünser, W Hasibeder
Division of General and Surgical Intensive Care Medicine, Department of Anaesthesia and Critical Care Medicine, University of Innsbruck,
Anichstraße 35, A-6020 Innsbruck, Austria
Introduction: In this study we evaluated effects of blood (B; n =7 ) ,
gelatine (G; n = 8) and Ringer’s lactate (R; n = 8) resuscitation on
jejunal microvascular blood flow (PU), tissue microvascular hemo-
globin oxygen saturation (HbO2t) and jejunal mucosal tissue
oxygen tension (PO2muc) after severe haemorrhage (50% of esti-
mated blood volume) in pigs.
Methods: Animals were anaesthetised, paralysed, and normoventi-
lated. A small segment of the jejunal mucosa was exposed by
midline laparotomy and antimesenteric incision. PO2muc was mea-
sured using Clark-type surface oxygen electrodes. HbO2t and PU
were determined by tissue reflectance spectrophotometry and
laser doppler velocimetry. Systemic hemodynamics, mesenteric-
venous acid base and blood gas variables as well as systemic acid
base and blood gas variables were recorded. Measurements were
performed after a resting period, after a 50 min period of haemor-
rhage (H) and after resuscitation with B, G and R to achieve base-
line pulmonary capillary wedge pressures at 70, 90, 110 and
130 min, respectively. ANOVA was performed to analyse differ-
ences in mean values between and within groups. Multiple com-
parisons were done by two tailed Dunnett’s t-test followed by
Bonferoni correction. P ≤ 0.05 was considered significant. Data
are presented as means ± SD.
Results: H resulted in significant hypotension and decreased sys-
temic blood flow which was reversed after resuscitation in all
groups. At baseline we observed no differences in PO2muc 
(B: 29 ± 5.9 mmHg), HbO2t (B: 48.5 ± 6.7%) and microvascular
blood flow (B: 253 ± 66 PU) between groups. H equally and sig-
nificantly decreased PU, PO2muc and HbO2t in B, G, R animals.
However, after resuscitation R animals had significantly lower
HbO2t (time point 130 min; R: 25 ± 9%) when compared with B
and G animals (time point 130 min; B: 39 ± 9%; G: 33 ± 10%).
PO2muc decreased similar in B and R animals after resuscitation
(time point 130 min; B: 15 ± 6 mmHg; R 14 ± 7 mmHg). However,
in G animals a trend towards higher PO2muc values (time point
130 min; G: 20 ± 9 mmHg) was observed during resuscitation.
There were no differences concerning microvascular blood flow
during resuscitation.
Conclusion: Resuscitation after severe haemorrhage using whole
blood, Ringer’s lactate or gelatine results in distinct changes of
jejunal tissue oxygen supply. Whole blood resuscitation favourably
preserved HbO2t without affecting PO2muc while use of gelatine
only, demonstrated a trend towards higher PO2muc values when
compared with R and B animals. Therefore type of resuscitation
fluid seems to have some impact on tissue oxygen supply within
the gastrointestinal tract.
Supported by a Lorenz Böhler Fonds 2000
P175 The prognostic value of gastric tonometry in severe polytrauma patients
J Calvete*, L Schonhorst*, DM Moura*, G Friedman†
*Hospital São Vicente de Paula, University of Passo Fundo, Passo Fundo, Brazil; †School of Medicine, Federal University of Rio Grande do
Sul, 90035-091, 181 Fernandes Vieira, Porto Alegre, RS, Brazil
Objectives: First, to evaluate the prognostic value of gastric intra-
mucosal pH (pHi) and pCO2 gap during intensive care unit (ICU)
and hospital stay. Second, to compare the prognostic value of
gastric tonometry parameters with APACHE II, SOFA score and
blood lactate levels.
Design: Prospective cohort of trauma patients in the first 24 hours
after admission to ICU.
Setting: General ICU in a university hospital.
Patients: Forty consecutive severe polytrauma patients admitted to
a General ICU.
Methods: A gastric tonometer (Trip NGS Catheter, Tonometrics,
Finland) was introduced into the patients’ stomach. Continuous air
tonometry (Tonocap, Datex Engestrom, Finland) was used to
measure gastric pCO2. Gastric pHi, pCO2 gap, arterial blood
gases and lactate levels were measured at admission and 6, 12,
24 hours after admission. Organ dysfunction was evaluated using
SOFA score at admission and 3, 7, 10, 14, 21 and 28 days afteradmission. The patients were followed until death or discharge
from the ICU.
Results: The mean age was 35 (14–79) years. Thirty-six were male
(90%). Mortality rate was 35% (14/40). There were differences
between survivors (S) and non-survivors (NS) on admission for
APACHE II (13 ± 5 vs 21 ± 7, P = 0.001) and pHi (7.33 ± 0.11 vs
7.21 ± 0.20, P = 0.02). After 24 hours, pHi (7.33 ± 0.13 vs
7.15 ± 0.32, P = 0.01), pCO2 gap (12 ± 16 vs 28 ± 25 mmHg,
P = 0.03), blood lactate levels (1.4 ± 0.9 vs 3.2 ± 3.4, P = 0.01)
and HCO3 (24.4 ± 2.3 vs 19.3 ± 5.5, P = 0.001) were different
between S and NS. First day SOFA score (5.4 ± 4.0 vs 12.1 ± 6.4,
P = 0.001) was different for S and NS. Kaplan–Meir surviving
curves showed significant differences for S and NS whenever
gastric intramucosal acidosis (pHi > 7.32 or pCO2 gap
≤ 15 mmHg) was present at admission or 24 hours later. Gastric
acidosis was associated both at admission and after 24 hours with
a greater ICU stay (10 vs 16 days, P = NS and 4 vs 19, P = 0.02),
hospital stay (22 vs 40 days, P = 0.05 and 17 vs 28, P = NS) and
SOFA score (4.3 vs 8.7, P = 0.01 and 4.9 vs 10.4, P = 0.002).
Conclusions: In severe trauma patients, gastric pHi and pCO2 gap
are reliable predictors of outcome. Inadequate regional oxygena-
tion as detected by gastric intramucosal acidosis, but not by sys-
temic measures as blood lactate, is an important contributor to
morbidity and mortality in this group of patients.
P176 The effects of a single dose of furosemide on urine flow, fluid balance, and the course of plasma creatinine during cardiac
surgery
M Heringlake, S Klaus, L Bahlmann, U Gosch, J Schumacher, P Schmucker
Universitätsklinikum Lübeck, Klinik für Anaesthesiologie, D-23538 Lübeck, Germany
Introduction: Urine flow rate during cardiac surgery is frequently
augmented with diuretics. Recent evidence has shown that a con-
tinuous  infusion of low dose furosemide — starting before car-
diopulmonary bypass (CPB) — has detrimental effects on renal
function [1]. It is not known, if this does also apply to a single dose
of a diuretic.
Methods: We performed a study to determine the effects of a
single dose of furosemide — given immediately before or during
CPB — on urine flow (UV), fluid balance and the course of plasma
creatinine as a crude measure of renal function in patients sub-
jected to coronary artery bypass grafting (CABG) procedures with
CPB. Anesthesia charts from 1/01 to 3/01 were analysed retro-
spectively in alphabetical order until 24 patients had been selected
that fulfilled the criteria: (a) isolated CABG procedure; (b) normal
left ventricular function, and (c) no need for inotropes during
surgery.
Results: Urine flow (UV), infused fluids and plasma creatinine
values PCREA (mean ± SEM) are given in Table 1. Three patients —
all in the diuretics group — received transfusion of packed red cells.
Subgroup analysis excluding these patients revealed that relative
PCREA was significantly higher (P < 0.05) after CPB in the diuretics
group in comparison with control.
Conclusions: These retrospective data suggest that a single dose
of furosemide during cardiac surgery does have no beneficial
effects on the course of PCREA and UV but conversely may lead to a
greater need of fluids and to a trend to more blood transfusions
and a deterioration of renal function.
Reference:
1. Lassnigg A, et al.: J Am Soc Nephrol 2000, 11:97-104.
Table 1
PCREA
UV (ml/min) Fluids (ml) (µmol/l) (% baseline)
No diuretics (n = 12; control)
Before CPB 1.5 ± 0.5 1458 ± 498 86 ± 12 100
During CPB 7.1 ± 3.6
After CPB 5.7 ± 2.9 1333 ± 443 81 ± 13 95 ± 47
Furosemide (n = 12), mean dose: 12 ± 9 mg
Before CPB 1.8 ± 1.1 1333 ± 325 74 ± 10* 100
During CPB 9.0 ± 5.2
After CPB 6.5 ± 2.5 1708 ± 541* 76 ± 15 106 ± 17
* P < 0.05 vs control.
P177 Continuous versus bolus furosemide therapy in critically ill patients with fluid overload
M Ostermann*, G Alvarez*, M Sharpe†, CM Martin‡
*Department of Medicine, †Department of Anesthesia, and ‡Department of Physiology, Division of Critical Care, London Health Sciences
Centre, University of Western Ontario, London, Canada N6A 5G4
Loop diuretics are commonly used in critically ill patients with fluid
overload and/or renal failure. Our objective was to compare the
effects of furosemide administered by intermittent intravenous (i.v.)
boluses versus continuous i.v. infusion on urine output and
furosemide requirement. In an open randomised controlled fashion,
59 fluid overloaded adult patients in two University hospital mixed
intensive care units were randomised to a treatment algorithm
using either continuous (n = 32 patients) or bolus (n = 27 patients)
furosemide to achieve a minimum hourly urine output. At baseline
there was no significant difference in age, gender, hourly urine
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output, creatinine clearance, APACHE II score and number of ven-
tilated patients between the two groups. Algorithm-driven diuresis
was equally efficacious using bolus or infusion furosemide but the
total dosage of furosemide required was significantly less using
continuous infusion therapy (Fig.). There were no significant differ-
ences in hospital mortality and the need for renal replacement
therapy.
We conclude that continuous infusion of furosemide may be easier
to manage and expose patients to a lower dose, potentially avoid-
ing or reducing adverse events.
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P178 Plasma-lyte® as dialysate for CRRT: institution of a new therapy and initial evaluation
M McCunn, HN Reynolds
R Adams Cowley Shock Trauma Center, University of Maryland, 22 S. Greene Street, Baltimore, MD 21403, USA
Introduction: At the R Adams Cowley Shock Trauma Center,
dialysate for CRRT has traditionally been 0.9% saline with 0.5 amp
sodium bicarbonate/l. Replacement fluids were 0.9% saline or
0.45% saline with additives adjusted as indicated by laboratory
results. Plasma-lyte® was suggested as a new dialysate due to its
electrolyte composition.
Methods: Prior to institution of Plasma-lyte® as dialysate, a review
of existing dialysis and replacement fluids and electrolyte additives
was undertaken. Disposables were recorded and a cost review
was done. Dialysate was then changed to P-lyte® with close moni-
toring of laboratory parameters to identify metabolic or electrolyte
abnormalities. Relative costs were compared. ICU nurses were
polled with regard to ease of use.
Results: The average daily cost of all IV fluids for dialysate, replace-
ment fluids with additives and disposables was US$71.00. (Does
not include circuitry/filters.) The cost of P-lyte® is $1.72/l, compared
to $0.70 of 0.9% saline and $0.75 for 0.45% saline. The pH of
P-lyte® is 7.4 and the pH of 0.9% and 0.45% saline is 5.0. The
composition of the various fluids is listed in the Table (in mEq/l).
There were no major metabolic abnormalities identified due to the
use of P-lyte® as dialysate. One patient developed and maintained
a serum K+ > 5.0 and the P-lyte® was discontinued. The nursing
staff consistently rated the use of P-lyte® as superior to the saline
solutions due to: (1) convenience of use, (2) improvement of serum
electrolyte composition (leading to discontinuation of mixing multi-
ple bags of replacement fluids), and (3) less risk of error. The costs
were felt to be comparable, because of a decrease in the need for
numerous electrolyte additives to the replacement fluids (and the
disposables associated with this).
Conclusion: Plasma-lyte® appears to be a safe, cost effective and
physiologic dialysate solution that can be used with ease. Diffusive
losses of magnesium should be minimized with P-lyte®. Hyper-
glycemia is minimized due to a lower glucose content than that
found in Dianeal®. The chloride load presented by isotonic
dialysates should be reduced with the use of Plyte®. P-lyte® is now
the first-choice dialysate and replacement fluid at the Shock
Trauma Center for CRRT.
Table
Na+ K+ Cl– Mg+ Acetate Gluconate
P-lyte® 145 5.0 98 3.0 27 23
0.9% saline 154 – 154 – – –
0.45% saline 77 – 77 – – –
P179 Simplified method of regional citrate anticoagulation for continuous extra renal epuration
O Cointault*, N Kamar*, P Bories*, L Lavayssiere*, O Angles†, P Guittard†, L Rostaing*, M Genestal†, B Cathala†, D Durand*
*Department of Nephrology, Dialysis and Transplantation, CHU Rangueil, 1 avenue J. Poulhès, 31403 Toulouse, France; †Intensive Care
Unit, CHU Purpan, 1 place du docteur Baylac, 31000 Toulouse, France
Background: Regional anticoagulation with trisodium citrate is an
effective form of anticoagulation for continuous renal replacement
therapy (CRRT) for patients with high risk of bleeding complica-
tions and/or with contraindications to heparin. However, this tech-
nique is not used currently because of the metabolic
complications, requiring specialized dialysis solution. We therefore
evaluated the efficacy and safety of a simplified protocol for citrate
regional anticoagulation in 22 critically ill patients treated by contin-
uous venovenous hemodiafiltration (CVVHD).
Methods: A.C.D-A541 (Lab. BRAUN) solution containing
112.9 mmol/l of trisodium citrate (3.22%) was initially delivered at
250 ml/hour (mean, 251 ± 27 ml/hour) via the prefilter port of a
COBE PRISMA with an AN-69 dialyzer, with the rate adjusted tomaintain a post-filter ionized calcium (iCa++) between 0.3 and
0.4 mmol/l. Plasmatic iCa++ was maintained > 1.1 mmol/l by the
infusion of calcium chloride (Calcium element concentration was
45.7 mmol/l) at the mean rate of 1.82 ± 0.36 mmol/hour. The
blood flow rate was 100 ml/min. Replacement solution (Hemosol®
Solution containing, Na+ = 144 mmol/l; HCO3
– = 35 mmol/l;
CA++= 1.75 mmol/l) was delivered at 1000 ml/hour. Dialysate was
a modified Hemosol® Solution (containing, Na+ = 126 mmol/l;
HCO3
– = 17 mmol/l; CA++ = 1.75 mmol/l) and was also delivered
at 1000 ml/hour. Each seance was scheduled for 48 hours. We
assessed the serum pH, serum bicarbonate, serum and post-filter
iCa++ levels every 6 hours.
Results: Mean dialyzer survival was 39 ± 11 hours (median,
41.5 hours). Clotting of the dialyzer was observed in four cases
(13 hours; 16 hours; 18 hours and 40 hours). CVVHD was
stopped voluntarily in nine patients, without technical problems
(median survival was 39 hours). The mean IGS-II score was
69 ± 12. There were neither bleeding events nor coagulation para-
meters modifications. Serum sodium, serum pH and serum bicar-
bonate were similar before and after CVVHD (respectively,
133 ± 8 vs 133 ± 7 mmol/l, P > 0.05; 7.39 ± 0.15 vs 7.38 ± 0.13,
P > 0.05; 25.3 ± 5.5 vs 25.1 ± 6.1, P > 0.05).
Conclusion: Simplified 3.22% trisodium citrate regional anticoagu-
lation for CRRT is efficacy and is not associated with bleeding
complications or citrate toxicity.
P180 Fatal events on chronic hemodialysis (HD) in Croatia
V Gasparovic, R Ostojic
Department of Internal Medicine, University Hospital Center, Rebro, Kiþpatiåeva 12, 10000 Zagreb, Croatia
Introduction: In the year 2000, 2719 chronic renal failure patients
in Croatia underwent chronic HD, the reported mortality was
10.3% which was not different from other countries. From 8 to 13
October 2001, 23 sudden and unexpected deaths during HD or
within several hours thereafter were recorded.
Patients and methods: All dead 23 patients  were dialyzed on cel-
lulose diacetate membrane P15 (15 patients ) and P18 (8 patients
) in six dialysis centers. One patient suffered from metastatic
uterine cancer with ascites, but was still ambulatory and in satisfac-
tory condition. She died at home, within 2 hours of the termination
of her HD. Another patient had a history of a coronary incident 8
days prior to death which occurred 37 hours after dialysis. In these
two patients  we must appreciate comorbidities but the clinical
picture still pointed to a sudden death related to the HD. In all
other 21 patients , the death was unexpected and associated with
the above mentioned dialyzers. All other materials were different.
All P15 dialyzers had the control number 2001F07 P, and all P18
dialyzers had the control number 2001B17R.
Discussion: Sudden death on HD is infrequent, and mostly cardio-
vascular events are reported as causes. Death occurred within
2 hours of the onset of HD or in the first hours after completion of
dialysis. The clinical presentation was dominated by sudden wors-
ening of the general condition accompanied by suffocation, chest
pain, sweating, and in some cases generalized convulsions.
Despite resuscitation in the hospital all 16 patients  died. The other
seven pts died at their homes. Autopsy findings pointed to foaming
of blood. Effluent samples from incriminated dialyzers showed dif-
ferent gas chromatography findings (perfluorocarbon?) compared
to other control cellulose diacetate dialyzers.
Conclusion: Sudden deaths during HD or in the first hours after
dialysis are in causal relationship with dialyzers of cellulose diac-
etate manufactured by Baxter, distributed by Pliva, under designa-
tions P15 and P18. After withdrawal of the incriminated dialyzers
no new lethal events were recorded.
References:
1. Gasparovic V, Ostojic R, Gjenero-Margan I, Kes P: Sudden deaths of
Croatian hemodialysis patients in October 2001.  Croat Med J
2001, 42(6):606-610.
2. Canaud B, Aljama P, Locatelli F, Tielmans C, Gasparovic V, Hoerl W,
Baldamus C, Gutierrez A, Henrich W, Lameire N: Performance liquid
test as probable cause for sudden deaths of dialysis patients is
perfluorohydrocarbon a previously unrecognized hazard for 
dialysis patients? Nephrol Dial Transplant (in press).
P181 Outcome of patients with acute renal failure treated with intermittent or continuous renal replacement therapy depending
on the initial diagnosis: a retrospective analysis
TH Schroeder*, K Dinkelaker*, R Vonthein†, R Fretschner*, K Unertl*, M Hansen*
*Department of Anaesthesiology and Critical Care Medicine, and †Department of Biometry, Tuebingen University Hospital, Hoppe-Seyler-
Str. 3, D-72076 Tuebingen, Germany
Introduction: The mortality of patients with acute renal failure
(ARF) remains high (50–60%). Predictive variables of outcome
include, age, altered previous health status, severity of illness, mul-
tiorgan failure, oliguria, cause of ARF [1]. We retrospectively ana-
lyzed all patients without pre-existing renal insufficiency, admitted
to the surgical ICU between 1993 and 2000, who developed ARF,
that was treated with renal replacement therapy (RRT).
Methods: Three hundred and six (2.9%) of a total of 13,191 admit-
ted patients were included in the study. Age, sex, APACHE II
score, renal function parameters, initial diagnosis (hemorrhargic
shock, trauma, post-liver transplantation, post-cardiac surgery,
sepsis/MODS, other) were recorded as independent variables.
Renal replacement therapy (intermittent, continuous, both), days in
the ICU, emergency admission, and treatment with vasoactive
drugs were recorded as dependent variables. Primary outcome
variables were death in the ICU, poor renal recovery (poor
outcome) or favorable renal recovery. Statistical analysis was per-
formed by multiple logistic regression.
Results: A total of 51% of patients with ARF died after the initia-
tion of RRT (mortality of patients without ARF 7%). Patients with
sepsis/MODS who developed ARF had a significantly higher mor-
tality (68%) compared to all ARF patients (OR 0.18 [0.06–0.49]).
A significantly better outcome, was noted for patients after liver
transplantation (mortality 28%; OR 6.50 [1.50–33.58]). Besides
the initial diagnosis, APACHE II score and length of ICU stay were
significantly correlated with mortality of these patients. The pro-
gression of creatinine clearance during RRT was predictive for
mortality during ICU stay and was 4.5 times lower at the end of
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therapy compared to surviving patients with initially comparable
clearance values. However, poor (death, no renal recovery requir-
ing dialysis post-ICU) or favorable (full renal recovery) outcome
was independent of the type of RRT. The predictors were validated
by a receiver operating characteristics (ROC) curve (AUC: 0.74).
Discussion: The overall incidence of patients with ARF, treated
with RRT, and mortality of those patients was comparable to pub-
lished data. Mortality was highest in patients with sepsis/MODS
and post-cardiac surgery patients. Of those patients who survived,
renal recovery was best after liver transplantation and hemorrhagic
shock and worst in patients with sepsis/MODS and trauma. The
progression of creatinine clearance predicted the outcome. Renal
recovery was independent of the type of renal replacement
therapy, as treatment was not randomized.
Reference:
1. Brivet FG, et al.: Crit Care Med 1996, 24:192-198.
P182 Renal function impairment (RFI) in the ICU: a 1-year prospective study
F Kodonas, V Nalbanti, C Iasonidou, F Christidou, G Bamichas, A Lahana, V Tsiora, D Riggos, K Sombolos
ICU and Renal Unit, ‘G. Papanikolaou’ General Hospital Exohi, Thessaloniki 57010, Greece
We studied prospectively the characteristics and the outcome of
patients with RFI in the ICU. RFI was defined as a serum creatinine
concentration (sCr) remaining ≥ 1.6 mg/dl, for at least two consec-
utive days during hospitalization in the ICU (sCr normal value
≤ 1.5 mg/dl). From 1 October 2000 until 30 September 2001,
among 362 adult patients (247 M, 115 F, aged 52.4 ± 19 years)
who were admitted and remained into the ICU for at least 2 days
(mean 13.2 ± 17.3 range 2–143), 60 patients, 16.5%, (42 M,
18 F, aged 58.5 ± 18.1 years) fulfilled the criteria for RFI. They
were divided into two groups, A and B according to the timing of
RFI development. Group A included 27 patients (19 M, 8 F, aged
60.5 ± 15.4 years) who developed RFI after their admission into
the ICU. APACHE II score, BUN and sCr at admission were
18.5 ± 5.8, 23.3 ± 17.9 mg/dl and 1.2 ± 0.2 mg/dl respectively.
The mean time to fulfill the criteria of RFI in these patients was
8.4 ± 6.2 days. Group B included 33 patients (23 M, 10 F, aged
56.8 ± 20.1 years, P = NS comparing to group A), who were
admitted into the ICU with a sCr ≥ 1.6 mg/dl, which remained there
at least for 2 days. APACHE II score, BUN and sCr at admission
were 25.1 ± 7.4, 66.4 ± 43.7 mg/dl and 3.6 ± 2.9 mg/dl respec-
tively (P < 0.001 for each parameter, comparing to group A). The
mean time of ICU hospitalization was 21.5 ± 26.2 days in patients
of group A and 25 ± 30.9 days in patients of group B (P = NS).
Oliguria during ICU hospitalization (defined as 24 hour urine output
< 450 ml/day) was observed in seven patients (25.9%) of group A
and in 15 patients (45.4%) of group B (P = NS). Seven patients of
group A and 13 patients of group B were treated finally with CVVH
(P = NS). Among the 60 patients with the RFI 44 died (23/27 in
group A and 21/33 in group B, P = 0.055). Among the rest 302
patients, without RFI, 76 patients died (P < 0.0001 comparing to
the patients with RFI).
We conclude that in ICU patients a sCr which remains ≥ 1.6 mg/dl,
for at least two consecutive days, constitute a bad prognostic factor.
P183 Factors affecting mortality from acute renal failure in the ICU
ME Ostermann, RW Chang, for the Riyadh ICU Program Users Group (RIPUG)
Department of Nephrology and Transplantation, St George’s Hospital, London SW17 0QT, UK
Acute renal failure (ARF) in the Intensive Care Unit (ICU) is per-
ceived as associated with a high mortality. We retrospectively
analysed the RIPUG database of 26,689 patients admitted to 21
ICUs in the UK between June 1989 and September 1996. The
incidence of ARF was 9%. Patients who were admitted with ARF
(n = 1393) had a lower mortality than those who developed ARF
Table
Maximum OFs at any time OFs within 48 hours of death/discharge
Type of OF n ICU mortality (%) Pn ICU mortality (%) P
Any 1 OF 737 16.3
ARF 608 9.4 517 11.6 < 0.05
CVS N/A N/A 20 45.0 < 0.001
RESP N/A N/A 123 34.2 < 0.001
2 OFs 713 35.6 555 55.0
CVS + RESP 23 43.5 NS 30 73.3 < 0.05
CVS + ARF 183 47.5 < 0.01 320 87.8 < 0.001
RESP + ARF 297 36.0 NS 371 85.2 < 0.001
GI + ARF 89 13.5 < 0.001 94 70.2 < 0.01
GI + RESP 28 35.7 NS 30 60.0 NS
NEURO + ARF 36 41.7 NS 31 45.2 NS
3 OFs 685 66.0 482 83.4
CVS + RESP + ARF 345 78.8 < 0.001 243 91.0 < 0.01
CVS + RESP + GI 10 80.0 NS 11 100 NS
CVS + NEURO + ARF 40 77.5 NS 36 86.1 NS
RESP + NEURO + ARF 38 65.8 NS 38 81.6 NS
CVS = cardiovascular failure; RESP = respiratory failure; GI = gastrointestinal failure; HAEM = haematological failure; NEURO = neurological
failure; N/A = not applicable. (Only Groups with 10 patients included.)(n = 1001) during their stay in the ICU (40.8% versus 50.7%,
P < 0.001). We determined the maximum number and specific
combinations of organ failures (OF) at any time and the number
and specific combinations within 48 hours of death or discharge
and the associated outcomes (Table). The mortality rates of all
patients with any single, two or three OFs served as references for
comparison with the mortality rates of specific types or combina-
tions. Forty-four percent of patients who died in the ICU had a
serum creatinine of < 200 µmol/l.
Patients with ARF alone had a significantly lower mortality than
patients with any other single OF. This superior outcome was abol-
ished when ARF occurred in combination with other failed organ
systems. The majority of patients die with ARF rather than from ARF.
P184 Need for renal replacement therapy in ICU is a marker of morbidity
ME Ostermann, RW Chang, for the Riyadh ICU Program Users Group (RIPUG)
Department of Nephrology and Transplantation, St George’s Hospital, London SW17 0QT, UK
Patients in the intensive care unit (ICU) with acute renal failure
(ARF) who need renal replacement therapy (RRT) have a high mor-
tality. There is a widely held view that RRT per se is the reason. The
aim of our study was to verify this hypothesis. We retrospectively
analysed the RIPUG database of 26,689 patients admitted to 21
ICUs in the UK between June 1989 and September 1996. 2394
patients (9%) had ARF of whom 650 (27.2%) were treated with
RRT. We compared the ICU mortality rates of patients who
needed RRT with outcome of patients in ARF without RRT and the
impact of the number of associated failed organ systems (Table).
ICU mortality of patients with ARF was higher in patients who
needed RRT. Four hundred and twenty-seven (66%) of patients
with ARF who needed RRT suffered from at least two additional
failed organ systems, compared to 590 (36.7%) amongst patients
with ARF who did not need RRT. There was no significant differ-
ence in mortality between patients with or without RRT if the same
number of associated organ failures were accounted for. We
looked at the temporal relationship between onset of systemic
inflammatory response syndrome (SIRS) and start of RRT. Of all
353 patients who suffered from ARF for more than 3 days and
required RRT, 335 patients fulfilled the criteria for SIRS either
before or at time of initiation of RRT. ICU-mortality in this group
was 54.3% compared to 44.4% amongst the 18 patients who
developed SIRS after starting RRT (hospital mortality 63.3%
versus 44.4%). This difference was statistically not significant. In
patients with ARF the need for RRT should be viewed as a marker
of severity of illness and not as a cause of death.
Table
Patients in ARF with RRT Patients in ARF without RRT
Number of OFS n ICU mortality (%) n ICU mortality (%) P
Total 650 57.5 1742 40.3 < 0.001
ARF alone 60 10 552 9.2 NS
ARF + 1 other 163 38.7 551 34.7 NS
ARF + 2 other 266 64.3 419 67.1 NS
ARF + 3 other 121 79.3 150 80 NS
ARF + 4 other 37 94.6 63 81 NS
ARF + ≥ 5 other 3 100 7 100 NS
OFS = failed organ systems.
P185 Use of Molecular Adsorbent Recycling System (MARS) treatment in severe liver failure: initial clinical experience
R Gaspari*, S Mensi*, L D’Amato*, C Di Campli†, A Gasbarrini†, R Proietti*
*Department of Anaestesiology and Intensive Care Medicine, and †Department of Medical Pathology, Catholic University of Rome, 
Largo F. Vito, 8-00168 Rome, Italy
Introduction: Despite significant advances in intensive care man-
agement, patients with severe liver failure (SLF) still have a high
mortality rate and the orthotopic liver transplantation (OLT) remains
the only effective treatment. Stange et al. [1] have introduced a
new, cell-free, extracorporeal, liver assistance method for the selec-
tive removal of albumin-bound substances using a specific mem-
brane and an albumin-enriched dialysate, namely Molecular
Adsorbent Recycling System (MARS).
Methods: Eleven patients (mean age 46, range 23–71 years; 4 M,
7 F) affected by SLF, admitted to our ICU, were treated with
MARS. Seven patients were candidates to OLT, while the other
four patients were excluded from the list because of the sepsis.
Patients were divided in three groups. Group I was composed of
patients (n = 7) with acute exacerbation of chronic liver disease;
Group II of patients (n = 3) with acute liver failure and Group III
(n = 1) of one patient with delayed nonfunction after OLT. Thirty-
one MARS sessions, lasting 6 hours each, in addiction to standard
therapy, were performed. Laboratory parameters, Fischer’s ratio
and hepatic encephalopathy (HE) were evaluated before and after
each MARS treatment in our three groups.
Results: No hemodynamic variations, technical problems or signifi-
cant adverse reaction occurred during MARS sessions. In the
three groups a statistically significant decrease in total and conju-
gated bilirubin, ammonia and bile acids levels was observed after
MARS (P < 0.01). Bun and creatinine levels markedly decrease
(P < 0.01 in Groups I and III; P < 0.05 in Group II). In the three
groups HE was successfully reduced at least one point. The Fis-
cher’s ratio improved in all groups. Four patients having liver trans-
plantation after MARS showed favourable outcome. One was
discharged with improved condition, while six patients died.
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Conclusions: MARS seems to be an effective depurative system
and could be proposed as a bridge to OLT. Nevertheless, further
studies will be necessary to know the optimal timing and
favourable indication of MARS in SLF.
Reference:
1. Stange J, Mitzner SR, Risler T, et al.: Molecular Adsorbent Recycling
System (MARS): clinical results of a new membrane-based blood
purification system for bioartificial liver support. Artif Organs 1999,
23(4):319-330.
P186 Renal blood flow in cirrhotic patients and hepatorenal syndrome (HRS)
HK Nagi, A Rasmy, S Hadad, S Mokhtar, H Mowafy
Critical Care Medicine Department, Cairo University, Egypt
Aim: To assess the effect of liver cirrhosis and ascites on the renal
blood flow.
Methods: A prospective study that includes 40 consecutive
patients with liver cirrhosis divided into two groups according to
presence of renal dysfunction (group B) or its absence (group A).
Another 10 normal volunteers were considered as control (group
C). All patients were subjected to clinical, laboratory, ultrasono-
graphic, Duplex study on renal artery and isotopic study for the
estimation of total effective renal plasma flow (ERPF). The renal
fraction of cardiac output (CO) was also estimated (ERPF/CO). By
renal Duplex, the renal vascular resistances were estimated using
resistivity index (RI) and pulsitility index (PI).
Results: Mean total ERPF was significantly lower in-group B
(HRS) compared to group A (cirrhotics) (330 ± 61 ml/min vs
708 ± 144 ml/min, P = 0.00). The mean (ERPF/CO) was signifi-
cantly lower in-group B (HRS) than group A (cirrhotics).
(4.02 ± 0.53% vs 9.5 ± 1.2%, P = 0.00). Both groups A&B had
lower mean total ERPF & ERPF/CO than group C,
(862 ± 130ml/min and 16.5 ± 0.8%, P = 0.00).
Both RI and PI were higher in group B and A than group C
(0.73 ± 0.06, 1.3 ± 0.2 in group B, 0.66 ± 0.7, 1.2 ± 0.3 in group
A vs 0.59 ± 0.05, 1.00 ± 0.3 in group C, P = 0.00). PI was similar
in group A&B, while RI was significantly higher in group B than A,
P = 0.03.
Conclusion: Patients with HRS showed marked diminution in total
ERPF & ERPF/CO when compared with normal volunteers, while
cirrhotics only showed mild diminution in total ERPF & ERPF/CO
compared with volunteers. However, renal blood flow when mea-
sured by duplex showed similar elevation in the renal vascular
resistance in both HRS & cirrhotics.
P187 The effect of induced hypernatraemia on intracranial pressure in patients with acute liver failure: a randomised controlled
clinical trial
ND Murphy, G Auzinger, W Bernel, J Wendon
The Institute of Liver Studies, King’s College Hospital, Dulwich, London, UK
Introduction: Acute liver failure (ALF) is a rare condition charac-
terised by the development of encephalopathy. This is complicated
by the development of cerebral oedema and intracranial hyperten-
sion (IH) in up to 80% of cases that reach grade IV encephalopa-
thy and is a common cause of death. Preliminary work in patients
with traumatic brain injury suggests that inducing and maintaining
hypernatraemia can limit the severity of IH. We examined the effect
of induced hypernatraemia in patients with ALF on the incidence of
clinically significant IH in a prospective randomised clinical trial.
Patients and methods: Thirty patients with acute or hyperacute
liver failure and grade III or IV encephalopathy were randomised.
Group 1 (15 patients) received normal standard of care (SOC).
Group 2 (15 patients) received SOC and hypertonic (30%) saline
(HS) by infusion. The aim was to maintain serum sodium between
145 and 155 mmol/l in the HS group. The primary end point was
IH. Intracranial pressure (ICP) was monitored in all patients with a
subdural catheter (Camino Systems). ICP, measured continuously,
was noted at 6 hourly intervals. An ICP of > 25 mmHg was consid-
ered to be clinically significant. Patient’s data was examined for up
to 72 hours following inclusion. Case censoring occurred following
death or liver transplantation.
Results: The risk of developing clinically significant IH was greater
in the control group (P = 0.04, Breslow test) over the study period
(see Fig.).
Conclusion: Inducing and maintaining hypernatraemia can
reduce the incidence and severity of IH in patients presenting
with ALF.
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gP188 Plasma separation and bilirubin adsorption for excessive hyperbilirubinemia before and after liver transplantation
E Mancini*, S Faenza†, E Mambelli*, A Santoro*
*Malpighi Hospital Nephrology and Dialysis Department, via. P. Palagi 9, Bologna, Italy; †Department of Anaesthesia and Intensive Therapy,
Policlinico S. Orsola-Malpighi, via Massarenti 9, Bologna, Italy
Severe hyperbilirubinemia is known to exert multiple toxic effects,
but there are very little tools against the bilirubin intoxication.
Plasma separation and bilirubin adsorption by an anion-exchange
adsorbent column (BR-350) were performed in 13 patients with
severe jaundice and multiple organ failure developed either before
or after orthotopic liver transplantation. Forty-four sessions were
performed and in 30% of them the plasma procedure was com-
bined with hemodialysis treatment.
Three to four liters of plasma were separated by membrane plasma
separation, then perfused to a rate of 20–30 ml/min through an
anion exchange adsorbent and returned to the venous blood line of
the plasma separator.
The bilirubin removal rate for total bilirubin was 24.8 ± 12.9% for
conjugated bilirubin and 25.2 ± 14% for the non-conjugated form.
The final values of plasma bilirubin were directly related to the initial
ones (r = 0.824, P < 0001). The mean adsorption rates on the
BR-350 column were 72.6% in the first 30 min and 39% after per-
fusion of 500 and 1000 ml of plasma respectively. A rebound in the
bilirubin levels was present from the very first minutes after the end
of the procedure; 24 hours later the rebound recorded in 18 treat-
ment was 34.9 ± 38.7% compared to the end of the treatment.
In patients undergoing four or more repeated sessions of plasma
separation and bilirubin adsorption, the level of seric bilirubin
decreased from 57 ± 12 to 17 ± 10 mg/dl.
In conclusion, extracorporeal anion exchange plasma perfusion/
bilirubin adsorption is a safe and effective treatment and it should
be considered as a supportive therapy for excessive hyperbilirubi-
menic side effects in cholestatic disorders.
P189 Non-invasive measurement of carboxyhemoglobin (COHb) by new pulse oximeter in human volunteers
Y Sato*, K Ikegami*, Y Kuno*, N Kobayashi†, T Usuda†
*Trauma and Critical Care Center, Koshigaya Hospital, Dokkyo University School of Medicine, 2-1-50 Minami-Koshigaya, Koshigaya,
Saitama, 343-8555, Japan; †R&D Center, Nihon Kohden Corporation, Tokyo, Japan
Introduction: Carbon monoxide is the most commonly encoun-
tered and pervasive poison in our environment. However, conven-
tional pulse oximeters cannot detect the presence of
carboxyhemoglobin (COHb) and overestimate arterial oxygenation
in patients with severe carbon monoxide poisoning. We developed
a new pulse oximeter utilizing three wavelengths which can dis-
criminate three species, oxyhemoglobin (O2Hb), deoxyhemoglobin
(RHb) and COHb. We previously demonstrated that increases in
COHb concentration measured by the new pulse oximeter (SpCO)
highly correlated with increases in COHb concentration measured
by a CO-oximeter (SaCO) in pigs. The present study determined
whether COHb was detected by the pulse oximeter with three
wavelengths in human.
Methods: The study was approved by the hospital Ethics Commit-
tee. Eight human healthy volunteers were tested in this study. They
were ventilated with 100% oxygen. Probes of the new three wave-
length pulse oximeter were attached to the finger. Then 50 ml of
carbon monoxide gas was inhaled by human volunteers. SpCO
was non-invasively and continuously measured by the new pulse
oximeters. SaCO was also measured by a CO-oximeter after 3 min
of inhalation. The same amount of carbon monoxide gas was
repeatedly inhaled until SaCO reached 15–20%. Then they were
ventilated with 100% oxygen until SaCO reached 5%. SpCO was
compared with SaCO.
Results: COHb was non-invasively and continuously detected by
the new pulse oximeter. There is a strong correlation between
SpCO and SaCO (r = 0.92, P < 0.001).
Conclusion: The results of this study demonstrated that the new
pulse oximeter might be useful for non-invasive diagnosis of carbon
monoxide poisoning.
P190 Helicobacter pylori antigen scanning in stools in the patients and in the staff of the intensive care unit
S Özkan, M Metin, HV Acar, O Öncül, O Çakir, S Poçan, M Gökben
Department of Anaesthesiology, GATA Haydarpasa Training Hospital, 81327-Kadikoy, Istanbul, Turkey
Background and goal: The pathogenesis of acute gastric ulcera-
tion of the ICU patients is still unclear and whether Helicobacter
pylori (HP) plays a role in pathogenesis is not known [1,2]. In this
study, we aimed to detect the presence of HP colonization in
stools and the importance of the HP positivity of the ICU staff in
spread of infection.
Materials and methods: The study included 52 patients, treated
in the ICU and 40 healthcare staff from ICU of Department of
Anaesthesia and 40 from the ICU of the other departments. Pres-
ence of HP antigen was assessed by using Helicobacter pylori
Stool Antigen (HpSA) test (Primer Platinum HpSA; Meridian Diag-
nostic, Cincinnati, USA) in the first 24–48 hours and at the end of
a week after admission for the patients and only once from the
medical staff. The antigen titers were compared between the ICU
staff and others based on the multiple factors.
Results and discussion: The hospitalization in ICU was a signifi-
cant factor in HP antigen positivity. The incidence of HP positivity
in ICU staff was higher than the others (P < 0.05). The antigen
titers were also higher in ICU staff than the other staff and this dif-
ference was statistically significant (P < 0.05). The antigen titers
were also well correlated with their duration of working in ICU
(P < 0.05). Presence of a high incidence of HP infections in ICU
patients lead us to the thought that HP might be suggested as one
of the causative agents in nosocomial infections. High antigen
titers in ICU staff suggested that transmission by oral–oral or
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fecal–oral routes might be possible because they often exposed to
secretions of patients such as feces, urine and saliva [1,3].
Conclusion: In the critically ill patients, acute ulcer prophylaxis was
caused by HP infection. This study also showed the importance of
knowledge of a new nosocomial causative agent for ICU staff and
its probable spreading ways of oral–oral or fecal–oral.
References:
1. Robertson MS, Cade JF, Clancy RL: Crit Care Med 1999, 27:1276-
1280.
2. Hawker FH: Crit Care Med 1999, 27:1385-1386.
3. Vaira D, Malfertheiner P, Megraud F, et al.: Lancet 1999, 354:30-33.
P191 A comparison of two immediate-early genes, c-fos and c-jun in rat brain after occlusion of superior mesenteric artery
(SMAO)
T Hase, T Tani, S Nishimura, S Matuno, M Terada, M Matsuda
Section of Emergency and Critical Medicine, First Department of Surgery and Section of General Int. Medicine, Shiga University of Medical
Science, Otsu 520-2192, Japan
Changes in level of consciousness and/or emotion are frequently
experienced in the lethal gut necrosis. However, little is yet known
about what a mechanism is underlying beneath the alteration of
neuronal function. The aim of the present study was to investigate
how the brain was influenced by massive gut necrosis. In an
attempt to examine functionally activated neuron, we applied
immunohistochemistry (IHC) for c-Fos and c-Jun, cellular transcrip-
tional factors encoded by immediate early genes c-fos and c-jun,
respectively, and widely used as metabolic markers for neuronal
activity.
Materials and methods: Adult male Wistar rats (n = 30) were
used. Under general anesthesia, 25 rats underwent celiotomies.
Twenty of them received SMA clipping and the others were used
as control. Control and treated rats at 2, 4, 8 hours were perfused
and fixed. The brain were sectioned in 20 µm thick every 200 µm
and stained by avidine–biotin-complex method using anti-c-Fos
and c-Jun antibodies.
Results and discussion: c-Fos IHC: Very low or absent c-Fos
immunoreactivity (IR) in control rat brain. In treated rat, c-Fos IR
was increased in time course. The predominant c-Fos IR were
demonstrated in the specific nuclei including the hypothalamus
(PVN; paraventricular nuc.), amygdala (CeA; central amygdaloid
nuc.), locus ceruleus and nucleus tractus solitarii. These areas
were congruent with c-Jun IR.
c-Jun IHC: Basal c-Jun IR was evident in most brain site and
higher than c-Fos IR. There were several notable differences from
c-Fos IR: (1) in the treated rat, intense c-Fos IR was observed in
the habenula, circumventricular organ (area postrema, subfornical
organ) but c-Jun IR was very low; (2) c-Jun IR was very high in the
hippocampus, cerebellum and cingulum, but c-Fos IR was very
subtle. The congruent sites of both IR could be interpreted that the
hypothalamus, brain stem and limbic system are activated in
response to extensive gut necrosis, and participating in neuroen-
docrine, autonomic or behavioral responses.
P192 Cardiac output determination during experimental hemorrhage and resuscitation using a transesophageal Doppler monitor
LF Poli de Figueiredo*†, E Silva*†, RJ Cruz Jr†, SG Sakamoto†, E Knobel*, M Rocha e Silva†
*ICU Hosp. Israelita Albert Einstein, Av. Albert Einstein, 627, Sao Paulo, SP 05651-901, Brazil; †Heart Institute, InCor, University of Sao
Paulo School of Medicine, Av. Eneas de Carvalho Aguiar, 44 Sao Paulo, SP 05403-000, Brazil
Introduction: Transesophageal Doppler (TED) has been consid-
ered a noninvasive and accurate alternative to pulmonary artery
catheter for volume replacement and cardiac output measurement
in patients undergoing major surgeries.
Objective: To test the hypothesis that TED can accurately predict
cardiac output during hemorrhage, shock and resuscitation, by
comparing it to total pulmonary artery blood flow (PABF), the gold
standard for cardiac output estimation and to standard intermittent
bolus cardiac output (ICO).
Methods: In eight anesthetized dogs (18 ± 1.0 kg), PABF was
measured with an ultrasonic flowprobe while ICO and mixed
venous O2 saturation (SvO2) were measured through a Swan–
Ganz catheter. A TED probe (CardioQ™), designed for adult use
(minimum 30 kg, 16 years), was placed in midesophageous to
evaluate stroke volume. A graded hemorrhage (20 ml/min) was
produced (H5–H35) to a mean arterial pressure (MAP) of
40 mmHg and maintained by additional blood removal for 30 min
(S1–S30). Total shed blood volume was retransfused
(541 ± 54.2 ml) over 30 min (T5–T30), after which a massive hem-
orrhage, 100 ml/min rate, was produced over 10 min (M5–M10).
Results (see Fig. overleaf): In general, TED overestimated PABF
(r2 = 0.3472), but changes in TED paralleled PABF throughout the
experimental protocol, principally during massive hemorrhage
(r2 = 0.9001).
Conclusion: We conclude TED measures precisely cardiac output
during massive hemorrhage. Probes designed for lower weights
and smaller aortas may improve its accuracy in medium size animal
models under less dramatic alterations induced by hemorrhage,
shock and resuscitation.P193 Is the blood velocity beat-to-beat variation in the descending aorta similar to the arterial pulse pressure variation?
M Feissel*, JL Teboul†, A Cariou‡, I Mangin*, S Darfin*, O Ruyer*, JP Faller*
*Service de Réanimation et Maladies Infectieuses, Centre Hospitalier, 90000 Belfort, France; †Réanimation Médicale CHU Bicêtre, 94275
Le Kremlin-Bicetre Cedex, France; ‡Réanimation Médicale CHU Cochin, 75679 Paris Cedex 14, France
Introduction: The beat-to-beat analysis of the arterial pulse pres-
sure (PP) [1] and of the maximal aortic velocity measured by the
transesophageal echocardiographic Doppler technique (TEE) [2]
have been demonstrated as good predictors of volume responsive-
ness in patients with circulatory failure. However, the PP analysis
requires an invasive procedure for arterial catheter placement and
TEE does not allow long-term continuous analysis. Therefore, we
have tested the hypothesis that the beat-to-beat variation of the
peak of velocity of blood in the descending aorta (PV Ao), mea-
sured by a transesophageal echo-doppler device (a less invasive
monitoring technique using a small probe) was of the same degree
as the beat-to-beat PP variation measured by an arterial catheter.
Patients and methods: In 12 patients receiving mechanical venti-
lation, the arterial pressure curve (arterial catheter) and the
descending aorta velocity signal (transesophageal echo-doppler;
HemoSonic100 — Arrow Intl.) have been recorded simultaneously
on a computer allowing beat-to-beat analysis of the PP and PV Ao
values.
Results: Three hundred and sixty measurements were obtained
(30 per patient). Six patients had atrial fibrillation, three had a sinus
rhythm with numerous supraventricular extra systoles and three
had a regular sinus rhythm. There was an excellent correlation
between beat-to-beat PP and PV Ao variation in every patient
(r = 0.85, 0.88, 0.89, 0.90, 0.92 [three times], 0.94, 0.95 [two
times], 0.96 and 0.98).
Conclusion: The beat-to-beat variation of blood velocity in the
descending aorta obtained by the minimally invasive trans-
esophageal echo-doppler method is quite similar to the beat-to-
beat variation of the pulse pressure. This may open a large field of
clinical investigation in the perspective of detecting cardiac
preload dependence and fluid responsiveness in patients under
mechanical ventilation.
References:
1. Michard, et al.: Am J Respir Crit Care Med 2000, 162:134-138.
2. Feissel, et al.: Chest 2001, 119:867-873.
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P194 Is it feasible to monitor total hepatic blood flow by use of transesophageal echography? A validation in patients
P Kiefer, R Meierhenrich, R Koch, M Georgieff, P Radermacher, W Schütz
Universitätsklinik für Anästhesiologie, Universität Ulm, Steinhövelstr. 9, D-89070 Ulm, Germany
Objective: In critically ill patients total hepato-splanchnic blood
flow is usually determined using a primed continuous infusion of
indocyanine green (ICG) with hepatic venous sampling [1]. The
hepatic venous catheterisation, however, is an invasive procedure
and we could recently demonstrate in an animal model that hepato-
splanchnic blood flow could be reliably determined with trans-
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esophageal echocardiography (TEE) [2]. In this study we investi-
gated whether transesophageal echocardiography is a noninvasive
method for bedside assessment of hepatic venous blood flow in
clinical practice.
Patients and Methods: Thirteen anesthetized and ventilated criti-
cally ill patients in whom hepato-splanchnic blood flow was aug-
mented by a dobutamine infusion were studied.
Hepatic venous blood flow values were derived with TEE using the
following calculations: Diameter (d) and velocity time integral (VTI)
of all three hepatic veins were determined by TEE, heart rate (HR)
was derived from ECG and flow subsequently calculated as
Q = π (d/2)2 0.57 VTI HR [2]. These values were compared with
hepato-splanchnic blood flow (Qspl) measurements using a
primed (12 mg) continuous (0.5 mg/min) infusion of indocyanine
green with hepatic venous sampling as described before in detail [1].
Parameters were determined at baseline as well as after modulat-
ing splanchnic blood flow by the infusion of dobutamine.
Results: A significant increase in splanchnic blood flow could be
determined with TEE (438 [387–555] vs 559 [495–709]
ml/min/m2) as well as using the ICG-method (889 [370–2285] vs
1098 [684–3479] ml/min/m2). The Spearman correlation coeffi-
cient between both methods, however, was 0.77 at baseline and
0.63 after dobutamine-infusion.
Conclusion: The values of splanchnic blood flow determined by
the two different methods had a great variance. TEE, hence, does
not seem to offer a noninvasive approach for monitoring changes in
hepato-splanchnic blood flow in critically ill patients.
References:
1. Cardiovasc Res 1995, 30:106-112.
2. Intensive Care Med 2001, 27:580-585.
P195 Assessment of the agreement between cardiac output measured by thermal filament continuous thermodilution (CCO)
and noninvasive partial CO2 rebreathing (NICO) with particular reference to ETCO2 levels
AS Crespo, C Galhardo, CG Silveira, HJ Dohmann
Hospital Pro-Cardíaco, Rua Gal. Polidoro 192, Rio de Janeiro, RJ, Brazil
Introduction: Cardiac output (CO) is an important hemodynamic
parameter and its continuous measurement has the potential to
enable early recognition of hemodynamic trends and provide earlier
therapeutic response. NICO is a new noninvasive cardiopulmonary
monitor that provides an alternative to invasive CCO for measure-
ment of CO. NICO uses a differential form of the Fick equation
(change in CO2 excretion and end-tidal CO2, in response to a brief
period of partial rebreathing) to provide noninvasive estimates of
CO [1]. The accuracy and reliability of NICO as a function of the
end-tidal CO2 (ETCO2) levels of the patient has not been studied.
The purpose of this study was to determine if ETCO2 levels affect
the degree of agreement between NICO and CCO.
Methods: Matched sets of CO measurements from NICO
(Novametrix Medical Systems, Wallingford, CT, USA) and CCO
(Vigilance, Baxter-Edwards, Irvine, CA, USA) were collected in 25
patients undergoing elective cardiac surgery. The NICO sensor
(consists of on-airway flow sensor, mainstream CO2 sensor,
adjustable dead space tubing, and a pneumatic valve) was
attached between the endotracheal tube and the breathing circuit
of the patient. The two measures, NICO and CCO were assessed
for agreement by using methods proposed by Bland and Altman at
different levels of ETCO2.
Results: One hundred and fifty-four data points were obtained
indicating variations in the difference of cardiac output compared
with the variations of ETCO2 of the patient. The range for CCO
measures was 2.0–8.4 l/min and for NICO measures
2.5–8.3 l/min. The mean bias in CO between the two techniques
for the entire protocol was 0.24 l/min and the precision (1 SD) was
0.77 l/min. The difference in CO was independent of the ETCO2
levels of the patient (Fig.).
Conclusion: The agreement between the NICO and CCO is clini-
cally acceptable and is unaffected by ETCO2.
Reference:
1. Haryadi DG, et al.: Partial CO2 rebreathing indirect Fick technique
for non-invasive measurement of cardiac output. J Clin Monit
2000, 16:361-374.
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P196 Comparison of cardiac output (CO) measurement before and after cardiopulmonary bypass: bolus thermodilution (TDco)
and noninvasive partial CO2 rebreathing (NICO)
AS Crespo, C Menezes, C Galhardo, ON Barbosa, LA Diego
Instituto Nacional de Cardiologia Laranjeiras, Rua das Laranjeiras 374, Rio de Janeiro, RJ, Brazil
Introduction: NICO is a noninvasive cardiopulmonary monitor that
provides an alternative to invasive TDco for measurement of CO.
NICO uses a differential form of the Fick equation (change in CO2
excretion and end-tidal CO2, in response to a brief period of partial
rebreathing) to provide noninvasive estimates of the CO [1]. The
objective of this study was to compare the degree of agreement inmeasurements of CO using NICO and TDco, at predetermined
intervals in patients undergoing coronary artery bypass graft
surgery (CABG).
Methods: Matched sets of CO measurements from a standard PA
Catheter and NICO (Novametrix Medical Systems Inc, Wallingford,
CT, USA, software version 4.2) were collected in 10 patients (age
35–62 years, weight 32–68 kg) undergoing elective CABG. Mea-
surements were made at predetermined intervals during the
surgery (during pre-cardiopulmonary bypass and post-cardiopul-
monary bypass; chest wall open and closed). The NICO circuit
was attached between the endotracheal tube and the breathing
circuit of the patient. An average of three consecutive bolus (10 ml)
TDco measurements made during end-expiration was compared
with corresponding NICO measurements. Bland–Altman analysis
was performed to compare the degree of agreement between the
two methods.
Results: Bias, precision (1 standard deviation), and limits of agree-
ment between the NICO and TDco during pre-CPB vs post CPB
are shown in the Table.
Conclusion: The overall agreement between NICO and TDco was
–0.03 (bias) and ± 0.80 (precision) l/min. There was no statistical
difference in the CO measured by the two techniques neither
during pre-CPB nor during post-CPB (P < 0.01) with the chest
open or closed. The degree of agreement between NICO and
TDco is within the recommended value [2] for NICO to be a clini-
cally acceptable method for CO measurement during CABG.
References:
1. J Clin Monit 2000, 16:361-374.
2. J Clin Monit 1999, 15:85-91.
Table
Precision (l/min),  Limits of 
1 SD  agreement 
Study phase Bias (l/min) deviation (bias ± 2 × SD)
Pre-bypass (chest closed) +0.25 0.59 –0.93 to 1.43
Pre-bypass (chest open) +0.10 0.81 –1.53 to 1.73
Post-bypass (chest open) –0.31 0.92 –2.15 to 1.54
Post-bypass (chest closed) –0.23 0.68 –1.58 to 1.13
P197 Monitoring of intrathoracic blood volume in early septic patients: its correlation with survival
F Turani, DF Colella, F Leonardis, G Andreozzi, G Celeste, G Pilia, G Gianni, PF Dauri, D Curatola, AF Sabato
ICU Ospedale S. Eugenio Rome, Anesthesiology and Intensive Care University of Rome, Tor Vergata, Piazzale Umanesimo, Rome 00100, Italy
Introduction: Early goal directed therapy improves survival in
sepsis, trough optimisation of contractility, oxygen balance and
correction of fluids deficit [1]. Aim of the study is to investigate
whether optimisation of ITBV (intrathoracic blood volume) an index
of preload, could be a therapeutic end point in early sepsis, as pre-
viously demonstrated in burns patients [2].
Methods: Sixty septic patients (Bone criteria) were monitored with
a central vein catheter and an artery femoral catheter connected to
a fiberoptic system (Cold Z-02; Pulsion Medizintechnic) Patients
were submitted to a fluid management protocol to obtain MAP
≥ 75 mm/Hg, maintaining ITBVI 800–1000 ml/m2 and EVLWI
< 7.5 ml/kg. At T0 (basal) and after 24 (T1), 48 (T2) 72 (T3) and
96 hours (T4) main volumetric, hemodynamic data were studied.
ANOVA test was used to compare changes over time. A Fisher
test was used to compare categorical data.
Results: Thirty-two patients survived (Group A) and 28 died at 28
days (Group B). ITBVI was higher in Group A than Group B at T1
and T2 (Fig. 1). And ITBVI > 800 ml/m2 at T1 and T2 was predic-
tive of survival.
Comment: (1) ITBVI improves earlier in survivors then non sur-
vivors during a reanimation period. (2) This improvement has a pre-
dictive value. (3) Optimisation of ITBVI during early sepsis should
be evaluated in further trials.
References:
1. N Engl J Med 2001, 345:1368-1377.
2. J Trauma 2000, 48:728-734.
Table
ITBVI > 800 ml/m2 95% CI
P 0.02
Sensitivity 0.44 0.25–0.66
Specificity 0.84 0.67–0.94
RR 1.97 1.188–3.288
Positive predictive value 0.70 0.44–0.89
Negative predictive value 0.64 0.48–0.78
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P198 Preload index: pulmonary artery occlusion pressure and intrathoracic blood volume monitoring during lung transplantation
G Della Rocca, MG Costa, C Coccia, L Pompei, F Pierconti, P Di Marco, P Pietropaoli
University of Rome ‘La Sapienza’, Viale del Policlinico n°155, 00161 Rome, Italy
Introduction: We analyzed two preload variables, pulmonary artery
occlusion pressure (PAOP) and intrathoracic blood volume index
(ITBVI), with respect to cardiac index (CIpa), obtained from pul-
monary artery catheter (PAC) during lung transplantation. The
reproducibility and precision of all transpulmonary single indicator
dilution technique (CIart) and CIpa measurements were also
evaluated.
Methods: Measurements were made in 48 patients monitored with
PAC and with PiCCO System at six specific stages through the
study. The relationship between the two different preload variables
(PAOP and ITBVI) and the CIpa were analyzed by linear regres-
sion. Agreement between CI measurements obtained by PAC and
PiCCO system was analyzed using the analysis suggested by
Bland and Altman.
Results: Linear regression between ITBVI-CIpa was r2 = 0.40
(P < 0.0001) while PAOP poor correlated to CIpa (r2 = 0.004) (Figs
1 and 2). Mean bias between CIart and CIpa was 0.15 l min–1 m–2
(1.37).
Conclusion: ITBVI, rather than PAOP, is a reliable indicator of
cardiac preload in patients undergoing lung transplantation.
References:
1. Bindels, AJGH, et al.: Critical Care 2000, 4(3):193-199.
2. Sakka, SG, et al.: Intensive Care Med 2000, 26(2):180-187.
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P199 Continuous and intermittent cardiac output measurement: pulmonary artery catheter vs aortic transpulmonary technique
G Della Rocca, MG Costa, C Coccia, L Pompei, P Di Marco, F Pierconti, P Pietropaoli
University of Rome ‘La Sapienza’, Viale del Policlinico n°155, 00161 Rome, Italy
Introduction: We compared two methods of intermittent cardiac
output measurements: pulmonary artery catheter (COpa) (Vigi-
lance system SvO2/CCO, Baxter Edwards Laboratories, Irvine, CA,
USA), regarded as the current clinical standard, and an aortic
transpulmonary thermodilution technique (COart) performed with
the PiCCO System (Pulsion Medical System, Munich, Germany),
and also compared the continuous thermodilution technique
(CCO), the continuous pulse contour analysis cardiac output
(PCCO) versus COpa in patients during lung transplantation,
Methods: Measurements were made in 49 patients at six stages
between the induction of anaesthesia and the end of surgery. Sta-
tistical analysis used the method described by Bland and Altman.
Results: We found close agreement between the techniques.
Mean bias between COart and COpa was 0.21 l min–1 (2 SD of
differences between methods = 1.6 l min–1). Mean bias between
CCO and COpa and PCCO and COpa was 0.16 l min–1 (2 SD =
1.40 l min–1) and 0.09 l min–1 (2 SD = 1.39 l min–1) respectively
(see Fig. overleaf).
Conclusions: Measurements with the aortic transpulmonary ther-
modilution technique give continuous and intermittent values that
agree with the pulmonary thermodilution method. Anyway, continu-
ous CO data obtained with PAC reflect accurately the clinical stan-
dard thermodilution COpa.
References:
1. Sakka SG, et al.: Intensive Care Med 1999, 25:843-846.
2. Rödig G, et al.: Br J Anaesth 1999, 82:525-530.Figure
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P200 Prognostic value of indocyanine green-plasma disappearance rate in critically ill patients
SG Sakka, A Meier-Hellmann, K Reinhart
Department of Anesthesiology and Intensive Care Medicine, Friedrich-Schiller-University, Jena, Germany
Background: Monitoring of regional organ blood flow and function
is often crucial for guiding therapy in critically ill patients. In particu-
lar, indocyanine green-plasma disappearance rate (ICG-PDR) has
been proposed for the assessment of liver function and its value
has been demonstrated in evaluation of donor organs [1] and as
prognostic marker in 39 critically ill patients [2].
Methods: We retrospectively analyzed 336 critically ill patients
(120 female, 216 male, age 10–89 years, mean 53 ± 19 years)
who were treated in our ICU between 1996 and 2000. All these
patients were hemodynamically monitored by the transpulmonary
double indicator (thermo-dye) dilution technique. Statistical analy-
sis for ICG-PDR in survivors (n = 168) and non-survivors (n = 168)
was based on the lowest value of ICG-PDR in each individual.
Results: ICG-PDR was significantly lower in non-survivors than in
survivors (median 6.4 vs 16.5 [%/min]) (P < 0.001). Mortality was
about 80% in patients with ICG-PDR below 8 (%/min) and survival
about 80% in those with ICG-PDR above 16 (%/min). Within three
different sub-groups of patients (sepsis, ARDS, and others) sur-
vivors had significantly higher ICG-PDR than non-survivors (Fig.).
Conclusion: ICG-PDR correlates well with survival of critically ill
patients. For the future, measurement of ICG-PDR seems to be a
promising clinical tool, particularly since accurate and non-invasive
transcutaneous assessment at the bedside has become possible.
References:
1. Wesslau C: Clinical investigations using indocyanine green clear-
ance for evaluation of liver function in organ donors. Transplantol-
ogy 1994, 5:1-3.
2. Kholoussy AM: Prognostic significance of indocyanine green clear-
ance in critically ill surgical patients. Crit Care Med 1984, 12:115-
116.
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P201 Arterial blood pressure monitoring during whole body hyperthermia
T Kerner*, M Deja*, O Ahlers*, B Hildebrandt†, I Frerking*, H Riess†, P Wust‡, H Gerlach*
*Department of Anesthesiology and Critical Care Medicine, †Department of Hematology and Oncology, and ‡Department of Radiology,
Charité Medical Center, Virchow Hospital, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany
Background: For monitoring of arterial blood pressure (ABP)
during induced whole body hyperthermia (WBH) different methods
have been recommended. This investigation was performed to
evaluate the agreement of invasive measurements at various sites,
and to compare invasive and non-invasive methods of ABP moni-
toring under conditions of a heat-induced extreme vasodilation.
Methods: In 19 patients, 48 treatments with WBH were per-
formed. Measurements of ABP in radial and femoral artery, by
oscillometry and sphygmomanometry, were taken at four tempera-
ture-levels during WBH (at 37°C, 40°C, 41.8°C and 39°C).
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Results: For systolic ABP significant differences were seen
between invasive and non-invasive methods with higher values for
non-invasive measurements. For diastolic blood pressures sphyg-
momanometry gave higher and oscillimetry lower values when
compared to both invasive measurements. Sphygmomanometry
also showed higher values for mean ABP compared to all other
techniques, while measurements in radial and femoral artery and by
oscillometry differed only by about 5 mmHg.
Conclusion: The hemodynamic management during WBH should
be guided by mean arterial pressure instead of the systolic and/or
diastolic pressure. The sphygmomanometric technique is not rec-
ommended for use during hyperthermia.
P202 Monitoring of intrathoracic volumes in induced supranormal cardiac output
T Kerner*, I Frerking*, M Deja*, B Hildebrandt†, O Ahlers*, H Riess†, P Wust‡, H Gerlach*
*Department of Anesthesiology and Critical Care Medicine, †Department of Hematology and Oncology, and ‡Department of Radiology,
Charité Medical Center, Virchow Hospital, Humboldt University, Augustenburger Platz 1, 13353 Berlin, Germany
Background: Induced whole body hyperthermia (WBH) up to
42°C leads to hypercirculation, large fluid shifting and a high
demand of intravascular fluids. This study was performed to evalu-
ate several parameters of systemic and intrathoracic hemodynam-
ics during such a condition of hypercirculation with high cardiac
output and low vascular resistance.
Methods: A combination of reflexion photometry and thermodilu-
tion (COLD Z-021-System, Pulsion, Germany) was used to obtain
mean arterial pressure (MAP), cardiac output (CO), global end-
diastolic volume index (GEDVI), intrathoracic blood volume index
(ITBVI), total blood volume index (TBVI), right ventricular end-dias-
tolic volume index (RVEDVI), right heart end-diastolic volume index
(RHEDVI), left heart end-diastolic volume index (LHEDVI), pul-
monary blood volume index (PBVI) and extravascular lung water
index (EVLWI) at 37°C, 41.8°C and 39°C in 26 patients with
metatased cancers during 51 WBH treatments. WBH was
induced by infrared radiation (Iratherm 2000). Hemodynamics at
41.8°C and 39°C were compared with the initial values using
Wilcoxon rank sum test for linked random samples.
Results: Compared with the initial values at 37°C significant
increases of CO, GEDVI, ITBVI, TBVI, RVEDVI, RHEDVI and PBVI
and a significant decrease of MAP could be found at 41.8°C. For
LHEDVI and EVLWI no significant changes were observed. Some
of these parameters were still significantly changed during the
cooling-down phase at 39°C, but, with exception of EVLWI, all
parameters showed a clear tendency to pre-treatment levels. Only
EVLWI showed a slight tendency to further increase during the
cooling-down phase.
Conclusions: Induced hyperthermia results in significant changes
of cardiac output, intracardial and intrapulmonary volumes. There-
fore monitoring of these parameters seems to be useful in risk
patients and in other conditions of hypercirculation.
P203 Is the degree of multiple organ dysfunction related to severity of capillary leakage?
H Knotzer, W Pajk, A Mayr, M Dünser, W Hasibeder
Division of General and Surgical Intensive Care Medicine, Department of Anaesthesia and Critical Care Medicine, University of Innsbruck,
Anichstraße 35, A-6020 Innsbruck, Austria
Introduction: Multiple organ dysfunction syndrome (MODS) is
believed to result from microcirculatory failure in surgical intensive
care patients. We hypothesised that degree of MODS is mirrored
by severity of capillary leakage assessed by venous congestion
plethysmography.
Methods: Twenty-two patients with MODS [1] (moderate MODS
group: less and equal 8 points, n = 13; severe MODS group:
greater and equal 9 points, n = 9) were studied. All patients were
monitored including a pulmonary artery catheter and a gastric
tonometer during the study. Fluid filtration capacity and isovolumet-
ric venous pressure were assessed using a electromechanical
sensor with automated calibration for strain-gauge plethysmogra-
phy (Filtrass 2001, Domed GmbH, Germany). In addition, arterial
lactate concentrations, arterial-, mixed venous blood gas analysis
and systemic hemodynamics were measured and systemic oxygen
transport variables calculated. For statistical analysis paired Stu-
dent’s t-test and in cases of non-normal distribution the Wilcoxon
signed-ranked test was performed. P-values < 0.05 were consid-
ered significant. Data are given as means ± SD.
Results: There were no differences in age, systemic oxygen deliv-
ery, consumption and oxygen extraction ratio between groups.
Mortality in patients with moderate MODS was 15.4%, in patients
with severe MODS 55.6% (P = 0.049). Patients with high MODS
demonstrated significantly higher arterial lactate concentrations
(4.5 ± 3 mmol/l) when compared with moderate MODS
(1.7 ± 0.9 mmol/l; P = 0.04). There was a trend towards higher capil-
lary filtration coefficients in patients with severe MODS
(5.33 ± 2.04 ml/min/100 ml/mmHg × 10–3) when compared to mod-
erate MODS (4.02 ± 1.48 ml/min/100 ml/mmHg × 10–3; P = 0.062).
Conclusion: Patients with severe MODS have a tendency towards
higher capillary filtration coefficients suggesting increased capillary
leakage. Neither systemic oxygen transport parameters nor tono-
metrically derived variables demonstrated any differences between
MODS-groups despite significant differences in patients mortality.
Reference:
1. Goris RJA, Te Boekhorst TPA, Nuytinck JKS, Gimbrere JSF: Multiple-
organ failure. Arch Surg 1985, 120:1109-1115.
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2000.P204 Microvascular bed volume evaluated by near infrared spectroscopy in healthy and critically ill subjects
RA De Blasi, A Morelli, D Alampi, PF Bucci, R Pinto, C Berritta
Cattedra di Anestesiologia e Rianimazione, I Università, II Facoltà di Medicina e Chirurgia, Roma, Italy
Introduction: The microvascular tone regulation can be very useful
to be assessed to titrate therapy in critical conditions. In the
present study, we use near infrared (NIR) spectroscopy in the fre-
quency domain on critically ill patients and healthy subjects, to
obtain the measurement of microcirculatory compliance and the
regulation of vascular tone.
Methods: Two groups of subjects have been studied: the first
group was composed by 17 healthy subjects (H) at rest, in the
second group five critically ill patients were treated with noradrena-
lin infusion (N). In the N group the measurements have been per-
formed at different noradrenalin doses: the first dose (d1) was
established by the head physician, then the dose was doubled (d2)
and finally reduced at the half of the first dose (d3).
The probe of the spectrometer used in this study (ISS incorpo-
rated, Urbana, IL, USA), have been applied on the forearm skin, in a
zone corresponding to brachioradial muscle. A serial of a pneu-
matic cuff compressions have been performed at the arm. Mea-
surements of the total hemoglobin [Hbt] in tissue and blood
volume, derived from [Hbt] have been obtained. The linear coeffi-
cient correlating blood volume to cuff compressions was consid-
ered as a measurement of venous and capillary compliance.
Results: The [Hbt] and Hb in the blood of the two groups are
shown in Table 1, the Hb content in the blood was lower in N than
in H group. There was no difference about [Hbt] between the
groups. In the H group in no subject [Hbt] change, at cuff pressure
of 10 mmHg, was evidenced while only five subjects out of 17
showed a [Hbt] increase at 20 mmHg. In the N group, three sub-
jects out of five (60%) showed a [Hbt] increase at 20 mmHg pres-
sure. The capillary and venular bed compliance is shown in
Table 1.
Conclusions: From our results is shown clearly that in critically ill
subjects the microvascular bed volume rose, in fact even if the Hb
in blood was low the [Hbt] in tissue did not change.
References:
1. De Blasi RA, Ferrari M, Natali A, et al.: A non invasive measurament
of forearm blood flow and oxygen consumption by near–infrared
spectroscopy. J Appl Physiolol 1994, 76(3):1388-1393.
2. Fantini S, Franceschini MA, Maier JS, et al.: Frequency domain multi-
channel optical detector for non-invasive tissue spectroscopy and
oxymetry. Opt Eng 1995, 34:32-42.
3. Shrier I, Magder S: Pressure–flow relationship in a vitro model of
compartment syndrome. J Appl Physiolol 1995, 79:214-221.
Table 1
Group H N
Hb (g 100 ml–1) 14.21 ± 1.1 8.64 ± 1.79
d1 d2 d3
[Hbt] µM l–1 58.28 ± 16.63 51.3 ± 19.01 53.16 ± 20.67 52.62 ± 19.19
Compliance (µl.mmHg–1.100 g–1T) 20 ± 10 5.4 ± 4.5 3.9 ± 2.6 5.0 ± 3.2
Hb, blood hemoglobin; [Hbt], tissue hemoglobin.
P205 Utility of mixed venous vs central venous oximetry following cardiac surgery in infants
SM Tibby, K Sykes, A Durward, C Austin, IA Murdoch
Guy’s Hospital, London SE1 9RT, UK
Objective: Mixed venous oxygen saturation (PAsat) has been used
as a surrogate marker for trends in cardiac output and oxygen utili-
sation:supply ratio following cardiac surgery in infants. We wished
to ascertain whether superior vena cava oxygen saturation (CVsat)
would provide similar trend-related information.
Method: Twenty infants were studied following cardiac surgery,
median age 2 weeks (range: 2 days–18 weeks). Operations
included complete correction of the following: transposition of the
great arteries (n = 10), ventricular septal defect (n = 7), atrioven-
tricular septal defect (n = 2), and total anomalous pulmonary
venous drainage (n = 1). All patients had absence of postoperative
anatomical shunt on colour Doppler echocardiography. Single-
lumen pulmonary artery lines were placed intraoperatively, and
position of the preoperatively placed percutaneous central venous
lines was checked by chest X-ray. Oxygen saturation was mea-
sured by co-oximetry. Cardiac index was estimated using a typical
oxygen consumption of 9 ml/min/kg, and adjusted by 10% for
every degree of temperature change from 37°C. Analysis was by
two-way, repeated measures ANOVA.
Results: PAsats were generally higher than CVsats (group effect
P = 0.02), with a mean difference of 6.7% 1-hour post operatively
(Fig.); however this had dropped to 2.6% at 12 hours, and 0.4% at
24 hours. This did not produce a significant difference in estimated
cardiac index (group effect P = 0.16, interaction P = 0.94).
On sequential readings, PAsats and CVsats trended in the same
direction on 75% occasions; however the greatest discrepancy
was between the 4 and 8-hour readings, when concordance was
only found 55% of the time.
Conclusion: PAsats and CVsats provide similar quantitative and
qualitative haemodynamic information in the absence of anatomical
shunts following cardiac surgery. Consistent differences between
the two readings in the first 12 hours may be due either due to
Available online  http://ccforum.com/supplements/6/S1Critical Care    Vol 6 Suppl 1 22nd International Symposium on Intensive Care and Emergency Medicine
regional perfusion and/or oxygen consumption differences
between the upper and lower body, or may reflect a transient, small
anatomical leak across sites of shunt correction which is missed by
echocardiography.
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P206 Intraoperative correction of low cardiac output to normal values improves outcome in patients with elective abdominal
surgery
R Kula*, P Szturz*, I Petras
vovic
vová*, P Sklienka*, L Martínek†
*Department of Anesthesiology and Intensive Care, and †Department of Surgery, University Hospital, Ostrava, Czech Republic
Introduction: Clinically unrecognised hypovolemia [1], low stroke
volume and/or cardiac output [1,2] during the intraoperative period
represent risk factors for unfavourable postoperative outcome.
Several prospective randomized clinical studies have shown a
decreased postoperative morbidity and mortality linked to perioper-
ative cardiac output or DO2 stimulation to so-called supranormal
values (CI > 4.5 l/min/m2 or DO2I > 600 ml/min/m2) [3]. The objec-
tive of our study was to find out whether intraoperative mainte-
nance of at least normal values of cardiac output (i.e. 5–7 l/min)
would influence postoperative outcome in a group of elective
abdominal surgery patients. The reason to choose normal range of
cardiac output as a therapeutic goal was the observation, that
average values of intraoperatively measured cardiac output are fre-
quently found in a range lower than normal values in a group of
patients with unfavourable postoperative outcome [2].
Methods: Forty-nine consecutive adult patients, undergoing exten-
sive elective abdominal surgery with expected duration of more
than 90 min, were included in this prospective observational study
(37 male and 12 female; average age: 61.6 ± 11 years; 84% —
abdominal surgery for tumour, 14% — bowel resection for inflam-
matory disease, 2% — abdominal aortic surgery; average length of
surgery: 172 ± 64 min). They were divided into two groups: the
first group of consecutive 24 patients managed with oesophageal
doppler and the second consecutive group of 25 patients
managed according to usual intraoperative monitoring. In the first
group of patients (doppler group [D]; n = 24, male: 67%, female:
33%; average age: 61.4 ± 13 years; 79% — abdominal surgery for
tumour) intraoperative hemodynamic management was based on
the continual CO monitoring using oesophageal doppler
(HEMOSONIC™ 100, Arrow International, Inc.). Doppler probe
was inserted on an average 15 min after induction of general anes-
thesia. Whenever during surgery there was a drop in cardiac
output below 5 l/min, usual diagnostic and therapeutic intervention
were carried out to reach its normal range 5–7 l/min. Cardiac
output values, for data processing, obtained from oesophageal
dopplerometry, were collected in 30 min interval (Fig. 1). Intraoper-
ative hemodynamic management in the second group of patients
(non-doppler group [ND]; n = 25, male: 84%, female: 16%;
average age: 61.8 ± 9 years; 84% — abdominal surgery for
tumour) was based on the monitoring of commonly used parame-
ters: ECG, non-invasive blood pressure or invasive pressures (arte-
rial blood pressure, central venous pressure), ETCO2, SpO2.
Operating theatre staff, both anesthesiologic and surgical person-
nel, were blinded to patients’ study inclusion. The postoperative
management of both patient’s groups was carried out in the
Department of Surgery. Likewise the operating theatre staff, staff of
the surgical department was also blinded to patients’ study inclu-
sion. In both D and ND group of patients we analysed and com-
pared these data: ASA score, duration of surgery, blood units
administered and fluid management intraoperatively, hemodynamic
or respiratory instability occurrence during surgery, need for post-
operative artificial ventilation longer than 24 hours, length of ICU
stay, occurrence of postoperative complications (cardiovascular,
respiratory, renal, gastrointestinal, coagulation, CNS and wound
complication) total length of hospital stay and mortality. For statis-
tic data processing following tests were used: Wilcox,
Mann–Whitney and χ2-test. Statistical significance was deter-
mined as P < 0.05. Values are shown as mean ± SE.
Results: Significantly lower frequency of postoperative complica-
tions (number of patients with complications: D: 5/24 vs ND: 14/25;
total frequency of complications: D: 8/186 vs ND: 31/175; average
frequency of complications per patient: D: 0.33 ± 0.63 vs ND: 1.24
± l.69; the greatest difference in occurrence of complications was
found for gastrointestinal and wound complications), shorter ICU
stay (D: 3.9 ± 1.8 days vs ND: 5.8 ± 3.2 days) and total hospital stay
(D 14.8 ± 7.3 days vs ND: 19.4 ± 8.1 days) were found in the groupof patients with intraoperative cardiac output maintained in normal
range (46% of cases needed beyond fluid administration also
inotropic support with dobutamin and 25% of cases needed admin-
istration of isosorbid-dinitrate). In the rest of observed parameters
there was found no significant difference (Table 1).
Conclusion: Intraoperative correction of low cardiac output to
normal range is linked to improvement of postoperative outcome in
elective abdominal surgery patients. Randomly collected data with
high comparability between both groups of patients (namely age,
ASA score, duration of surgery, intraoperative blood units adminis-
tered and fluid management, frequency of intraoperative complica-
tions), allow us to state that clinically unrecognised low cardiac
output or drop of cardiac output during intraoperative period partici-
pates, in a crucial way, in postoperative unfavourable development.
References:
1. Webb AR: The role of the oesophageal Doppler in the prevention
of postoperative complications. Int J Intensive Care 1997, 4:96-
104.
2. Shoemaker WC, et al.:  Hemodynamic patterns of survivors and
nonsurvivors during high risk elective surgical operations. World J
Surg 1999, 23:1264-1271.
3. Boyd O: The high risk surgical patient — where are we now? Clin
Intensive Care, 2000 (special issue):3-10.
Table 1
Average values of parameters that did not reach statistical
significance
Group D Group ND
ASA score 2. 4 ± 0.9 2.2 ± 0.7
Duration of surgery 171 ± 69 min 172 ± 60 min
Fluids intraoperatively 2896 ± 1409 ml 2958 ± 1223 ml
Blood units 10/24 9/25
FFP, colloids 740 ± 743 ml 742 ± 713 ml
Crystalloids 1972 ± 859 ml 2094 ± 668 ml
Hemodynamic instability  4/24 (17%) 6/25 (24%)*
during surgery
Respiratory instability  1/24 (4%) 2/25 (8%)
during surgery
Artificial ventilation for  0/24 2/25 (8%)
> 24 hours postoperatively
Mortality 0/24 2/25 (8%)
*Fluid administration and in three patients also dopamine was used in
management of hemodynamic instability. Note: dobutamine and/or
isosorbid-dinitrate was not used in any patient from ND group.
Figure 1
Average CO values during surgery in doppler group. , Initial CO
value (15 min after general anesthesis induction). *P < 0.05, compared
with initial CO value
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P207 The cost-effectiveness of preoperative optimisation of high risk surgical patients
AN Chamberlain, N Harper, S Morris
The Whittington Hospital NHS Trust, Highgate Hill, London N19 5NF, UK
Aims: This study aimed to determine the cost-effectiveness of a
London National Health Service Hospital Trust providing preoptimisa-
tion with intravenous fluids, oxygen, and inotropes to High Risk Surgi-
cal Patients with the aim of reducing postoperative complications.
Design: A cost-effectiveness study.
Method: The cost of usual care for a 5 month cohort (n = 40) of
High Risk Surgical patients was calculated by using the standard
Health Resource Group costs provided by the NHS Executive
which gives average costs for Hospital Stay based on procedures
and treatment. Intensive care bed days were added at a local rate
(£1072) multiplied by number of days spent in ITU. Group average
costs were calculated for those who suffered postoperative com-
plications (n = 13, £7751) and those that did not (n = 27, £2983).
The cost of preoptimisation was estimated by including preopera-
tive and postoperative costs such as Intensive care and HDU bed
usage, equipment, and the time of a Consultant Anaesthetist (total
cost per patient = £1328). Predicted reductions of morbidity were
taken from a published randomised controlled trials. Sensitivity
analysis was performed on a range of costs and effects.
Results: Results showed that preoptimisation is cost-effective as it
dominates in comparison to usual care. Sensitivity analysis also
showed that the treatment remained cost-effective even if the inter-
vention gives a reduced effect.
Conclusion: Preoptimisation would be cost-effective for the
London NHS Trust as it would reduce cost of hospitalisation care
by reducing the recovery period of High Risk Surgical Patients.
P208 Outcome of hemodynamic instability therapy guided by pulmonary artery catheter in immunocompromised ICU patients
FVC De Marco, A Higa, RG Silva, JOM Pestana, OFP Santos
Intensive Care Unit, Kidney and Hypertension Hospital ‘Oswaldo Ramos Foundation’, Rua Borges Lagoa 960, Vila Clementino, CEP
04038-002, São Paulo, Brazil
Objectives: The aim of this study is to evaluate the outcome of the
therapy guided by pulmonary artery catheter (PAC) in immunocom-
promised ICU patients.
Setting: A kidney transplant specialized ICU in a 90-bed public
hospital.
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Methods: We prospectively followed (from May 2000 to Novem-
ber 2001) kidney transplant recipients admitted to ICU who devel-
oped hemodynamic instability which required vasoactive drugs
administration and PAC insertion in order to optimize therapy. After
catheter insertion, based on hemodynamic profile, the patients
were classified in one of the following types of shock: distributive,
cardiogenic, obstructive and hypovolemic. ICU resource utilization,
catheter-related complications and 28-day mortality were
recorded.
Results: In the period of study, our institution had 2021 kidney
transplant recipients in ambulatory management, performed 690
kidney transplant surgeries and the ICU admitted 289 kidney trans-
plant recipients (not in postoperative period). There were 13 con-
secutive patients (3 F/10 M) who fulfilled inclusion criteria. The
mean age was 45.4 ± 10.3. Of these patients 12 (92%) were in
the first year of transplantation and all patients were receiving
immunosuppression therapy at ICU admission. The mean Apache II
score was 22 ± 8. The PAC was inserted within 24 hours of the
beginning of hemodynamic instability in all patients. There were
nine (70%) patients classified as distributive shock (sepsis) and
the mortality in this group was 78% (n = 7). There were two (15%)
patients with cardiogenic shock (acute myocardial infarction) and
the mortality was 50% (n = 1). There were two (15%) patients with
hypovolemic shock (acute drug-induced pancreatitis, nephrotic
syndrome) and the mortality was 50% (n = 1). The mean perma-
nence of CAP was 4.5 ± 2.6 days. In one (7.5%) patient there
were complications related to catheterization procedure (pneumo-
hemothorax). The mean length of ICU stay was 12.9 ± 15.1 days
and of mechanical ventilation was 10.5 ± 15.6 days. In nine (70%)
patients there was need for renal replacement therapy.
Conclusion: Based on these preliminary results, distributive shock
associated with sepsis is more frequent and carries a higher mor-
tality than cardiogenic and hypovolemic shock in immunocompro-
mised patients.
Objective: In this prospective study, indirect calorimetry (IC) and
Harris–Benedict equation were compared to find out the daily
energy consumption of the patients who have severe head injury
and ventilation support.
Methods: The inclusion criteria were; head injury with Glasgow
Coma Scale score (GCS) ≤ 8, peripheral oxygen saturation over
95% with inspired oxygen concentration lower than 0.5. Thirty-six
patients who met these criteria and were admitted to our intensive
care unit (ICU) between March and October 2000 were included
in the study. The Injury Severity Score (ISS), Revised Trauma
Score (RTS), Acute Physiology and Chronic Health Evaluation II
(APACHE) score, Glasgow Outcome score (GOS), and intensive
care stay of the patients were determined. The indirect calorimetric
measurements were performed by Vmax 6200 Metabolic Measure-
ment Cart (Sensor Medics, Yorba Linda, CA, USA) in the first
48 hours following admission of the patients to the ICU. Fifty-five
measurements were carried out in 36 patients and after each
measurement which lasted 12 hours the mean values of resting
energy expenditure (REE), O2 consumption, and CO2 production
were noted. All of the patients were in steady-state during the
measurements. Moreover, the daily nitrogen balance of all patients
were determined.
Results: The basal energy expenditure calculated with Harris–
Benedict equation was 1674.6 ± 317.5 kcal, and daily average
resting energy expenditure (REE) measured with IC was 1881.2 ±
465.0 kcal. The energy consumption measured with IC was 12.4%
higher than the value which was calculated with Harris–Benedict
equation (P < 0.05). Average daily nitrogen loss was 21.6 ± 16 g.
Conclusion: The energy consumption calculated with Harris–
Benedict equation had no correlation with trauma severity.
The REE measured with IC was higher in the patients who had
GCS 6 or higher, RTS over 5, and ISS 25 or lower compared with
the other.
There was no correlation between nitrogen loss of the patients and
trauma severity.
P210 Oxygen consumption in critically ill children
V Sapiega, SH Havalad, MA Quaid, EA Bello, BP Chalikonda
Lutheran General Children’s Hospital, 1775 Dempster Street, Park Ridge, IL 60068, USA
Measurement of oxygen consumption (VO2) in the critically ill patient
has become an important tool because of its prognostic value and
therapeutic implications. If oxygen delivery does not match VO2,
tissue hypoxia ensues followed by organ failure. It is well known that
critically ill patients have increased VO2, however what has not been
fully explored is whether different disease categories have varying
degrees of VO2. The purpose of this study was to determine if VO2
differs between subgroups of critically ill children.
Methods: Ninety patients between the ages of 5 weeks and 16
years who were mechanically ventilated were included in this
study. Patients were excluded if: air leak around the endotracheal
tube was > 5%, FiO2 was > 0.6, or catecholamine infusion was
required. VO2 was measured within the first 24 hours of admission
to the pediatric intensive care unit. A Deltatrac metabolic monitor,
which uses a paramagnetic oxygen analyzer, was used to measure
VO2. Measurements were obtained over 20 min and standardized
to body surface area. Patients were categorized into medical, sur-
gical, trauma, sepsis or cardiac surgery subgroups. Mean VO2 in
the medical subgroup was compared to the other subgroups.
Data was analyzed using one-way ANOVA and Bonferroni Multiple
Comparisons test.
Results: There was a statistically significant difference in the mean
VO2 between patients in the medical subgroup and patients in
sepsis subgroup (P < 0.001), surgery subgroup (P < 0.01), and
cardiac surgery subgroup (P < 0.001). There was no significant
difference in the mean VO2 between patients in the medical sub-
group and trauma subgroup.
ç
P209 Assessment of energy consumption by indirect calorimetric method and Harris–Benedict equation in patients with severe
head injury
F Gürpinar, M Yilmaz, L Dösemeci, M Cengiz, A Ramazanog
vlu
Department of Anaesthesiology and Intensive Care, Hospital of Akdeniz, University Antalya, TurkeyDiscussion: We have demonstrated that VO2 varies based on the
category of critical illness. This finding is significant given the
importance of optimizing and matching oxygen delivery to a
patients’ VO2.
Table
Medical (n = 23) Trauma (n = 30) Sepsis (n = 16) Surgical (n = 8) Cardiac surgery (n = 13)
Mean VO2 (ml/m2) (SD) 135.26 (20) 145.23 (18) 163.94 (19) 165.25 (19) 180.08 (22)
P211 Nutritional status in hypercatabolic patients with acute renal failure
V Pavoni*, L Gianesello*, L Paparella*, P Pavarin*, N Todesco*, CA Volta†, G Gritti*
*U.O. di Anestesia e Rianimazione Università di Padova, Via Giustiniani, 1, 35100 Padova, Italy; †Sez. di Anestesiologia e Rianimazione
Università di Ferrara, Italy
Introduction: In spite of optimized artificial nutrition, the develop-
ment of malnutrition is often rapid in critically ill patients with acute
renal failure undergoing a continuous venovenous hemofiltration
(CVVH) [1].
Methods: In this prospective-observational study we evaluated all
patients with hypercatabolic status during a period of 15 days. A
Hospal Prisma blood pump at a ultrafiltrate rate of 1.2 l/h and poly-
acrylonitrile AN69HF hemofilters were employed. Daily caloric
support and nitrogen intake as well as urinary nitrogen loss were
recorded. Specimens of ultrafiltrate (200 ml) were collected every
48 hours from a 5 l pool ultrafiltrate. Daily nitrogen losses were cal-
culated by multiplying the nitrogen concentration measured in each
specimen by the total amount of ultrafiltrate produced over a 24-
hour period and by adding to this the standard estimate for insensi-
ble nitrogen losses (15 mg/kg/day). Nitrogen balance was
estimated as the difference between intake and losses after taking
changes in total urea body pool into account. The evaluation of
nutritional status was assessed collecting lost body weight every-
day and lymphocyte count, serum albumin, serum pre-albumin,
transferrin, at least twice a week. Comparison of nutritional para-
meters between the beginning of the treatment and after 15 days
was made using Student’s t-test (P < 0.05).
Results: Twelve critically ill patients (four burnt and eight septic)
were studied. Their mean SAPS II was 48.6 ± 15.5 and the mean
of SOFA was 11.1 ± 3.1. They received a mean amount of
43.4 kcal/kg/day. The protein intake was of 1.8 g/kg/day, in spite
of fact that more aggressive renal replacement therapy was
used to achieve adequate control of uremia (mean plasma urea
15.4 ± 7.2 mM/l). The mean nitrogen losses in the ultrafiltrate were
25.4 ± 5.4 g/day and the nitrogen balance was –9.8 ± 0.3 g/day.
During the period of study the lost body weight was
0.53 ± 0.1 kg/day. The nutritional parameters measured (beginning
vs 15th day) are shown in the Table.
Conclusion: Hypercaloric and hyperprotein diet, considering stan-
dard nutritional protocols, does not assure adequate nutritional
status in hypercatabolic patients with acute renal failure undergo-
ing renal replacement therapy. Increase in lymphocyte count could
be correlated with improvement of septic condition.
Reference:
1. Bellomo R, et al.: A prospective comparative study of moderate
versus high protein intake for critically ill patients with acute renal
failure. Renal Failure 1997, 19(1):111-120.
Table
Lymphocyte count (lymph/mm3) 0.60 ± 0.29 vs 0.84 ± 0.3, P < 0.05
Albumin (g/dl) 26.7 ± 3.5 vs 26.3 ± 3.5, NS
Prealbumin (mg/l) 90 ± 33 vs 111 ± 29, NS
Transferrin (g/l) 0.96 ± 0.15 vs 0.77 ± 0.1, P < 0.05
P212 The incidence and immediate respiratory consequences of pulmonary aspiration of enteral feed
PJ Young, U Roy, J Watson
Critical Care Unit, Queen Elizabeth Hospital, King’s Lynn, PE30 4ET, UK
Introduction: The cause of a respiratory deterioration in a critically
ill patient frequently remains unknown. Pulmonary aspiration of
enteral feed during tracheal intubation may be recognised at the
bedside by the appearance of feed in the tracheal aspirate but is
commonly unrecognised. To reduce aspiration it is important to be
able to detect it at the bedside and hence alter management to
reduce risk factors. Techniques to detect feed aspiration using
food colouring have poor sensitivity and are linked with mortality in
septic patients [1]. The standard glucose oxidase strip method for
detecting aspiration is also insensitive because the glucose levels
in feeds are similar to those of normal tracheal aspirates. We have
previously described a modified glucose oxidase test strip method
with an improved sensitivity [2] whereby the glucose concentration
of the feed is markedly increased.
Method: The glucose concentration of the feed was increased by
adding 10 g of glucose to 500 ml of feed. This increased the car-
bohydrate load by only 14% from 68 g to 78 g, but markedly
increased the glucose concentration by 1000% from 11 mmol/l to
120 mmol/l. Testing tracheal secretions with standard glucose
oxidase strips allowed the detection of tracheal aspiration (when
tracheal glucose exceeds blood glucose). Ten patients were
studied and PaO2/FiO2 data were collected prospectively prior to
and after each aspiration episode.
Results: Five of the 10 patients aspirated enteral feed on one or
more occasion (incidence 50%). There were seven episodes of
aspiration detected in 55 patient days studied (prevalence 13%
per day ventilation). Following an aspiration there was a fall in
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PaO2/FiO2 from a mean of 29.2 to 20.7 kPa (Fig. 1; P < 0.017;
Wilcoxon rank sum test).
Conclusion: Aspiration of feed in the critically ill is common and is
associated with a fall in PaO2/FiO2.
References:
1. Maloney JP, Halbower AC, Fouty BF, Fagan KA, Balasubramaniam V,
Pike AW, Fennessey PV, Moss M: Systemic absorption of food dye
in patients with sepsis. N Engl J Med 2000, 343:1047-1048.
2. Young PJ: A spoon full of sugar. Anaesth Intensive Care 2001,
29:539-543.
Figure 1
Deterioration in gas exchange associated with feed aspiration 
(mean/2 SEM).
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P213 The effect of preoperative immunonutrition on postoperative immune system and cytokine release in the cases
undergoing major abdominal surgery
HV Acar, S Özkan, M Özsoy, S Poçan, O Çakir, M Gökben
Department of Anaesthesiology, GATA Haydarpasa Training Hospital, 81327-Kadikoy, Istanbul, Turkey
Background and goal: We aimed to investigate the effects of
use of preoperative and early postoperative standard and
immunonutrient products on immune system and acute inflamma-
tory response in the patients undergoing gastrointestinal malig-
nancy surgery.
Materials and methods: Ninety patients of ASA II-III, were ran-
domly divided into three groups. All patients were started to be
given enteral nutrition in 1000 kcal/day in addition to standard oral
nutrition on 5th preoperative day. Enteral nutrition was restarted
with 30 kcal/kg/day via nasojejunal tube or jejunostomy at 12th
hours of surgery. Group I patients (n = 30) received isocaloric,
isonitrogenic standard oral nutrition (Osmolyte®, Abbott), Group II
patients (n = 30) received oral immunonutrition (Impact®, Novar-
tis), whereas Group III patients (n = 30) received enteral or oral
nutrition (Supportan®, Fresenius Kabi). Studies of immune func-
tion and evaluation of nutritional parameters were made for all
patients on 5th (T1) and 1st (T2) days preoperatively and 1st (T3)
and 5th days (T4) postoperatively. For nutritional assessment;
albumin, prealbumin, retinol binding protein (RBP) and transferrin
levels were determined. For immunologic assessment; IL-2 and
IL-6 levels, IgG, IgM, total lymphocytes, T-lymphocytes, B-lympho-
cytes were studied. Postoperative complications, ICU and hospi-
tal length of stay, duration of antibiotherapy were also compared
between groups.
Results and discussion: In all groups nutritional parameters were
significantly decreased on T3 (P  < 0.05). Prealbumin and RBP
levels (i.e. early stage nutritional parameters) increased in group II
on T4 (P < 0.05). IL-6 and CRP measurements (i.e. predictors of
acute systemic inflammatory response), increased significantly in
all groups (P < 0.05) but this increase was lower in group II than
the others. IL-2 levels (i.e. the cellular component of immune
system) increased significantly on T3 and T4 in group II (P < 0.05).
T-lymphocytes decreased in group I and III on T3 and T4. This
decrease was not seen group II. The duration of antibiotherapy,
ICU and hospital length of stay was significantly longer in group I
than the others. The incidence of postoperative infection was less
in group II.
Conclusion: Early enteral nutrition with arginin in hypercatabolic
state after major operations results a decrease in severity of acute
inflammatory reaction, augmentation in cellular immunologic
support, and a decrease in ICU and hospital length of stays.
P214 Influence of muscle relaxants on the mass of intercostal and upper arm muscles in COPD patients during mechanical
ventilation
M Moukas*, A Amygdalou*, E Kontaki*, C Leontaridi†, MP Vassiliou†, K Mandragos*, SH Constantopoulos†, PK Behrakis‡
*Intensive Care Unit, Red Cross Hospital, 1 Athanassaki Street, Ampelokipi, 11526, Athens, Greece; †Pneumonology Department, School
of Medicine, University of Ioannina, Greece, 45150, Ioannina, Greece; ‡Department of Experimental Physiology, School of Medicine,
University of Athens, Greece, 75 Mikras Asias Street, Goudi, 11527, Athens, Greece
Purpose: The aim of the study is to assess the degree of inter-
costal and upper arm muscles atrophy in COPD patients requiring
ventilatory support and muscular relaxants.
Methods: Twenty-four mechanically ventilated patients hospi-
talised in the ICU for 18.6 ± 3.6 days, were included in the study.
Twelve patients with COPD exacerbation and 12 patients admitted
in the ICU for various reasons (control group) received atracurium
(0.3–0.6 mg/kg/h) for 2.8 ± 0.4 days. The groups did not differ
significantly for age (62.5 ± 6.4 versus 65.6 ± 5.9 years, respec-
tively). Both groups were under the same nutritional schedule.
Muscular mass (MM) of intercostals and upper arm muscles were
measured in cm by U/S at the 1st and the 5th ICU hospitalisation
day. A 10 MHz linear transducer was used and the same inter-
costal space was scanned in all patients. Measurements were also
done at the same position of the right upper-arm. All scans wereperformed by the same sonographer. The corresponding differ-
ences (∆MM) were compared between the two groups of patients
with the aid of the Student t-test (P < 0.05).
Results: Our results concerning measurements of muscle mass (in
cm) are presented in the Table as mean values ± standard deviations.
Intercostal and upper arm MM was significantly greater in the
control group than in the COPD group in the 1st as well as in the
5th hospitalization day. MM thickness was significantly reduced
between the 1st and the 5th hospitalization day in both the COPD
and the control groups. Nevertheless, the ∆MM difference between
COPD and controls was significant for intercostals (P < 0.03) and
not significant for upper arm muscles.
Conclusions: MM is significantly lower in COPD mechanically ven-
tilated patients in comparison to other patients under ventilatory
support. Muscle relaxants reduce significantly the MM in COPD
patients requiring assisted ventilation. Nevertheless, the MM
changes are not uniform in various muscles as indicated by the
comparison of the COPD to the control group, concerning the
intercostals and the upper arm muscles. It seems that a more
precise and complete information for the reduction of MM should
be estimated at different muscle groups.
Table
Intercostal muscle mass Upper arm muscle mass
Group 1st day MM 5th day MM ∆MM 1st day MM 5th day MM ∆MM
COPD 0.28 ± 0.01 0.20 ± 0.01 0.07 ± 0.02 2.13 ± 0.33 1.65 ± 0.27 0.47 ± 0.33
Control 0.42 ± 0.04 0.31 ± 0.03 0.10 ± 0.03 3.03 ± 0.21 2.33 ± 0.36 0.70 ± 0.21
P215 Bombesine in critically ill patients receiving enteral and total parenteral nutrition
M Moukas*, A Amygdalou*, E Palli*, G Giannopoulou*, K Mandragos*, YA Dalavanga†, P Behrakis‡, M Vassiliou†
*Intensive Care Unit, Red Cross Hospital, 1 Athanassaki Street, Ampelokipi, 11526, Athens, Greece; †Pneumonology Department, School
of Medicine, University of Ioannina, Greece, 45150, Ioannina, Greece; ‡Department of Experimental Physiology, School of Medicine,
University of Athens, Greece, 75 Mikras Asias Street, Goudi, 11527, Athens, Greece
Purpose: Bombesine (BN) is a hormone with a critical role on
the control of the secretory gastrointestinal (GI) function and the
immunological sufficiency of the human body. The aim of this
study is to evaluate the influence of nutritional schedule (enteral
vs total parenteral) on BN levels, during the first 5 days of ICU
hospitalization.
Methods: Twenty-one sedated and mechanically ventilated
patients were randomly divided into two groups. Group A con-
sisted of 11 patients, who received continuous nasogastric nutri-
tion, and Group B consisted of 10 patients, who received
continuous Total Parenteral Nutrition (TPN). Serum hormone levels
were measured on the 2nd, 3rd and the 5th day of patients admis-
sion with radioimmunoassay method. BN levels were compared
between the three measurements with the aid of ANOVA for each
group, while the corresponding measurements between the two
groups were compared with the aid of Wilcoxon test.
Results: Values of BN (ng/ml) as mean values ± standard devia-
tions during subsequent measurements in the two groups of
patients are presented in the Table.
No statistically significant changes between hormone levels are
observed in each group for the three different measurements
(P > 0.05). The corresponding differences between the two
groups are also not significant (P > 0.05). Despite the non-signifi-
cance of the differences it should be noted that BN is increased
through measurements in the enteral nutrition (EN) group whereas
a decrease is observed in the TPN group on the 5th day.
Conclusions: The administration of either enteral or parenteral
nutritional formulas for a short period of hospitalization in the Inten-
sive Care Unit does not affect the levels of BN. The extra-gastroin-
testinal presence of BN might explain the non-significant
differences observed in our study between the EN and TPN
groups. The results of the present study refer to a short-term appli-
cation of the tested nutritional schedules. BN showed a clear ten-
dency to increase, during EN. A longer follow up of the
gastrointestinal hormones profile seems necessary.
Table
Days of hospitalization EN TPN
Day 1 11.8 ± 9.8 9.4 ± 10.5
Day 2 12.0 ± 8.2 9.9 ± 9.9
Day 3 15.8 ± 11.7 6.2 ± 7.8
P216 Intravenous total parenteral nutrition elevates oxidant production in critically ill patients
GA Richards, M Gulumian, C Ramoroka, H White, M Hopley, GK Schleicher
ICU, Johannesburg Hospital; University of the Witwatersrand Medical School, South Africa
Introduction: Critical illness is associated with increased oxidant
stress. This is manifested by reduced antoxidant potential and an
increase in measured oxidant species (ROS). ROS have the capac-
ity to cause cellular injury and to activate NFKB in inflammatory cells.
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TPN provides a source of lipid for systemic peroxidation particu-
larly in the presence of reduced antoxidant potential. TPN generally
contains inadequate nutrient-antoxidants and precursors to glu-
tathione. Total parenteral nutrition (TPN) is also a source of lipid
peroxides which are pro-inflammatory.
Materials and methods: This study was approved by the Commit-
tee for Research on Human Subjects of the University of the Wit-
watersrand. Patients were recruited sequentially if they required
TPN. Blood was taken 1 hour pre initiation of TPN, at the time of
and 1 hour and 2 hours post initiation of TPN. Urine was also col-
lected at the same times. Vitamin C, glutathione, IL6 and F2-iso-
prostanes were measured in the urine.
Results: There were no changes in the vitamin C levels and no
definite trend was seen with IL6. The F2-isoprostanes in the urine
remained constant for the –1, 0 and 1 periods, then increased sig-
nificantly by 4.24 units (95% CI, 0.03–8.21) at time +2. This was
significant (Friedman ANOVA P < 0.01).
Conclusions: Administration of TPN is associated with an increase
in lipid peroxide formation which may itself be proinflammatory and
account for adverse outcomes of patients on TPN.
P217 Patients after acute pancreatitis benefit from long-term home enteral nutrition
P Tesinsky, Z Rusavy, Z Jankovec, K Kolarova
Department of Medicine I, Div Metabolism, Charles University Hospital, Plzen, Czech Republic
Background: Stimulation of exocrine pancreatic function by oral
intake impairs resolving of necrotic peripancreatic masses after
severe acute pancreatitis. A long-term parenteral or enteral nutri-
tion may be beneficial in the therapy of postpancreatitic complica-
tions. Aim of the study was to verify efficacy and safety of long-term
home enteral nutrition for therapy of pancreatic pseudocysts after
severe acute pancreatitis.
Patients and methods: Eighty-nine patients with severe acute
pancreatitis were evaluated in the prospective clinical study:
females 38, males 51, mean age 53.2 years (18–80). After initial
period of total parenteral nutrition (TPN) and early enteral nutri-
tion (EEN) with mean duration 13.2 days (5–23), patients were
matched into two groups with either enteral or oral nutrition,
matching in Ranson’s score, age, and size of peripancreatic
pseudocysts. Fifty-nine patients (enteral group) were adminis-
tered an enteral oligopeptide formula, 30 patients (oral group)
were administered a pancreatic diet. Criteria of effectiveness of
home enteral nutrition were disappearance or substantial regres-
sion of the peripancreatic necrotic masses. The results were
compared between both groups and evaluated by the paired Stu-
dent’s t-test.
Results: A significant regression of pseudocysts was reached in
65 patients (73.0%) overall: in 48 (81.4%) patients in the group
treated with enteral nutrition, and in 17 (50.9%) patients with oral
intake. The difference was statistically significant (P < 0.01).
Number of severe complications within the enteral group was 1
(1.7%). Mean period of enteral nutrition was 28.9 days, mean
period of controlled oral diet was 27.4 days (n.s.).
Conclusions: The results indicate that the long-term home enteral
nutrition was a potent method in the therapy of pancreatic pseudo-
cysts and it was superior to oral diet. Its effectiveness is similar
with total parenteral nutrition, which has been tested in our previ-
ous study [1].
Reference:
1. Tesinsky P, Rusavy Z, Staudinger T: Enteral nutrition: an effective
method of treatment of pancreatic pseudocysts [abstract 45]. J
Parenter Enteral Nutr 1999, 23(1):S12.
P218 Investigation of the factors which influence insulin sensitivity in septic patients with glucose intolerance: analysis with
glucose clamp method by means of artificial pancreas
M Hoshino*, Y Haraguchi†, M Sakai*, H Saegusa*
*Department of Intensive and Critical Care Medicine, Tokyo Police Hospital, Fujimi 2-10-41, Chiyoda-ku, 102-8161 Tokyo, Japan; †Tokyo
Disaster Medical Center, Tokyo, Japan
Purpose: Insulin Sensitivity (IS) is often impaired in septic patients
and its evaluation is important in terms of the nutritional support for
those patients. However, accurate measurement of IS is not easy,
partly because Insulin Clearance (IC) is usually increased in septic
patients as we reported at this congress last year. We investigated
IS excluding the influence of IC and the factors which affect IS in
septic patients with glucose intolerance.
Method: Twenty-one septic patients without diabetes mellitus
were investigated. IS was measured by Glucose Clamp method
(GC) by means of bedside-type artificial pancreas (STG-22: manu-
factured by NIKKISO corporation in Japan). GC was performed
twice for each patient basically (first measurement was done in
acute condition or within 3 days after admission, and second mea-
surement was done 1 week after the first measurement). GC was
performed with clamped blood glucose level of 80 mg/dl and
Insulin Infusion Rate (IIR) of 1.12 and 3.36 mU/kg min. I1/I3 and
M1/M3 indicates the blood insulin level (µU/ml) and glucose dis-
posal rate: M value (mg/kg min), when IIR is 1.12/3.36 mU/kg min
respectively. IC was calculated from the following formula: 
IC = (3.36 – 1.12) × 1000/(I3 – I1) (normal value of IC: 10–15 ml/kg
min). M/I: M1/I1 (M1/I1 × 1000) and M3/I3 (M3/I3 × 1000) 
(ml l/kg min µU) were calculated as the parameter of IS. Relationships
between M/I and the following factors were investigated: (1) blood
stress hormone levels (SH) (adrenaline, noradrenaline, glucagon,
cortisol, growth hormone), (2) serum fat levels (SF) (triglyceride,
free fatty acid, total cholesterol), (3) blood endotoxin and β-D
glucan levels, (4) degree of organ dysfunction/failure (MOF score:
calculated from the MOF criteria of Japanese Association for Criti-
cal Care Medicine), and (5) blood IL-6 level.
Results: The results are as follows (shown in mean ± SD [n]). 
(1) (maximum, minimum, mean) of I1, I3, and IC were I1 (133, 23,
62 ± 31 [28]), I3 (705, 19, 209 ± 121 [36]), IC (26, 4, 16 ± 6
[27]) respectively. (2) Mean of M3/I3 of the patients with MOF
score more than 7 was significantly lower than that of the patients
with MOF score = 0 (29 ± 18 [10] vs 57 ± 20 [7], P < 0.025).
The same tendency was found as for M1/I1 (44 ± 54 [12] vs
102 ± 76 [7], P < 0.10). (3) Platelet count was positively corre-
lated with M3/I3 (n = 35, r = 0.62, P < 0.002) and M1/I1 (n = 35,r = 0.45, P < 0.006). (4) As IL-6 increased, M/I decreased in one
patient, but increased in another patient. (5) There was no definite
relationship between M/I and SH, SF, endotoxin, and β-D glucan.
Interpretation and conclusions: M/I seemed to be one of the
useful indicators of IS in septic patients, because IC was variable in
those patients. Multiple organ dysfunction and coagulopathy with
thrombocytopenia were the factors which decreased IS. Difference
of the influence of blood IL-6 level to M/I among the patients might
be related to the balance of the type of glucose transporters
affected by the inflammatory cytokines (ex. activation of glucose
transporter-1, suppression of glucose transporter-4, etc.).
P219 Glucagon processes on intestines in surgically stressed patients
K Tanjoh*, R Tomita†, K Shinohara*, T Kohri*, K Mera*, K Shirai*, S Mimura*, N Hayashi*
*Department of Emergency and Critical Care Medicine, Nihon, University School of Medicine, 30-1 Ohyaguchi, Kamimachi, Itabashi-ku,
Tokyo 173-8610, Japan; †First Department of Surgery, Nihon University School of Medicine, 30-1 Ohyaguchi, Kamimachi, Itabashi-ku,
Tokyo 173-8610, Japan
Introduction: Although insulin/glucagon molar ratio (I/G) in serum
is one of the most important factor to regulate the energy meta-
bolic status of critically ill patients, the kinetics of I/G, especially
glucagon, is still not well known. In this study, we investigated the
I/G and the kinetics of glucagon related peptides and discuss the
glucagon processes in pancreas and intestine in surgically
stressed patients. Furthermore, we investigated the energy meta-
bolic status and discuss the correlation between these results and
the glucagon processes.
Subjects and methods: Sixteen patients with acute abdomen
or trauma who had undergone emergency surgeries served as
the subjects. At the 2nd and 7th days after surgeries, the follow-
ing items were estimated. Serum I/G and glucagon related pep-
tides were assessed using N-terminal and C-terminal specific
RIA. Molecular forms of the glucagon related peptides were also
estimated using gel filtration chromatography method. Further-
more the energy metabolic status were assessed using indirect
calorimetry.
Results: On the 2nd days, 75% of patients showed lower I/Gs
compared to those of normal subjects and the very peculiar pep-
tides similar to the glicentin in molecular weights which were not
seen in normal subjects and supposed to be produced by peculiar
glucagon processes in intestines, were observed. Furthermore, in
these patients, carbohydrates were well utilized as energy sources,
while, in the residual 25% of patients who did not show the pecu-
liar glicentin like peptides in chromatographies, carbohydrates
were not sufficiently utilized, and lipid metabolism were increased.
Conclusion: The I/G and the processes of glucagon, especially in
the intestine in surgically stressed patients were much different
from those of normal subjects and must influence the energy meta-
bolic status.
P220 Corticoids and ACTH test in septic shock: a prospective study over 15 months
S Abdellatif*, H El Ghord*, R Nasri*, S Alaya*, S Ben Lakhal*, M Fkih†, N Kaabachi†, A Mbazaa†
*Intensive Care Unit, and †Laboratory of Biochemistry, Hospital La Rabta, Tunis
Introduction: Inflammatory and vascular manifestations have a
considerable physiological role during septic shock. The place of
corticoids is discussed since 30 years.
Aim: To determine the interest of the use of corticoids in septic
shock.
Patients and methods: During a period of 15 months (June
2000–August 2001), are enrolled all the patients presenting a
septic shock requiring high and/or increasing doses of vaso-active
agents because of the obstinacy of a low blood pressure in spite of
a satisfactory colloid infusion. A test with ACTH is realized in all
patients, then treatment with 300 mg daily Hydrocortisone
(3 × 100) is administered.
Results: Twenty-one patients are enrolled. Their mean age is
46 ± 17 years. The mean severity score (IGSII) is 42 ± 14. The
etiology is pneumonia in 62% of cases. Nosocomial infection is
found 13 times (62%). The administration of corticoids is begun at
the 10th hour on average. Evolution is favorable in 17 patients
(81%), judged on the increase of blood pressure, the beginning of
weaning or the stabilization of necessities in vaso-active agents.
This occurs in 21 ± 16 H.
The result of the ACTH test allowed to distinguish three groups of
patients.
Six patients have adequate adrenal response: high basal serum cor-
tisol level which increase after ACTH’s injection. Hydrocortisone is
stopped. Evolution in this group is always favorable (100%).
Thirteen patients have a relative adrenal insufficiency: normal or
high serum cortisol level but with a weak increase after the test.
Hydrocortisone is maintained for 5 days. Evolution is favorable in
nine patients (69%).
Two patients with very high serum cortisol level, had quickly fatal
evolution.
Conclusion: The ACTH test must be realized at the patients in
state of septic shock to discover those that can benefit from a con-
tribution of corticoids.
P221 Reduced cortisol in acute liver failure is not due to pituitary failure or reduced binding proteins
R Harry, G Auzinger, J Wendon
Institute of Liver Studies, Kings College Hospital, London SE5 5RS, UK
Reduced cortisol is common in patients with acute liver failure (ALF).
The aetiology of this phenomenon is unclear, relating potentially to
reduced levels of cortisol binding proteins, pituitary or adrenal dys-
function. We examined the relative importance of these factors.
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Methods: Twenty patients with ALF, admitted to a 10 bedded spe-
cialist liver intensive care unit, were investigated. We sampled
blood at 9:00 a.m. and measured total cortisol, ACTH and the two
main binding proteins CBG and albumin as well as standard bio-
chemistry. Cholesterol was measured as precursor of cortisol syn-
thesis. From these data, the unbound cortisol was calculated.
Normal ranges are: cortisol > 250 nmol/l, CBG 39.7 ± 6.3 µg/l for
males and 42.2 ± 5.6 µg/l for females, ACTH 39 pg/ ml (range
< 25–65), albumin 35–50 g/l. Absolute values are given as median
and interquartile range. Comparisons were performed using the
Mann–Whitney U test and correlations using the Spearman Rank
Correlation coefficient.
Results: All patients had CBG below the normal range (BNR) and
albumin was BNR in 19/20 patients. Fifty percent of patients had a
total cortisol BNR all of whom also had a free cortisol BNR. All
patients with normal cortisol had normal free cortisol. Cholesterol,
albumin, and CBG were all significantly lower in patients with corti-
sol BNR (Table). The CBG was significantly correlated with total
cortisol (R = 0.519, P < 0.05). ACTH is above normal range in
18/20 patients and was higher in those with cortisol above
250 nmol/l (Table).
Conclusion: In ALF, reduced total cortisol is accompanied by
reduced free cortisol despite reduced CBG and albumin. The
ACTH results suggest adrenal dysfunction rather than pituitary
failure as the cause of the reduction in total cortisol seen in these
critically ill patients. The low cholesterol in those with suboptimal
cortisol levels may suggest lack of this precursor is of importance
and requires further study.
Table
Total cortisol BNR Normal total cortisol P
Cholesterol 1.05 (0.4–2) 1.9 (2–3) < 0.005
Albumin 13.5 (9–17) 18.5 (17–23) < 0.025
CBG 12.85 (10–15) 22.4 (17–30) < 0.005
ACTH 41 (31–61) 60 (52–169) 0.025
P222 Review of the use of hydrocortisone in intensive care patients with sepsis
SJ Russell*, CA McKenzie*, AC Davidson†
*Pharmacy Department, and †Intensive Care Unit (ICU), Guy’s and St Thomas’ NHS Trust, London SE1 7EH, UK
Introduction: Corticosteroids may be beneficial in septic shock.
Hydrocortisone (HC) has been the most widely studied steroid and
is used on our ICU.
Aim: The aim of the study was to review the use of HC on the ICU,
adherence to evidence-based guidelines, and the effect on
inotrope (INO) and vasopressor (VP) requirements.
Method: Prescriptions were reviewed daily to identify patients (pts)
on INO/VPs. Pts were excluded if corticosteroids were adminis-
tered for other indications. Pt demographics, details of the HC pre-
scription, INO/VP doses, and markers of sepsis were recorded.
Results: Twenty-five pts fulfilled the trial criteria for shock in the
time period of this audit and 17 were prescribed steroids. However
three were in cardiogenic rather than septic shock. Norepinephrine
(NE) was used in 23, dobutamine (DB) in four and epinephrine (EPI)
in three pts whilst five pts received more than one INO/VP. The
median time to introduction of HC was 76 hours and 12 (17) did
not adhere to ICU guidelines. The dose (expressed as mean dose
per day, MDD) of NE fell from 0.30 µg/kg/min to 0.15 µg/kg/min
over the following 48 hours (P < 0.02). The MDD for DB and EPI
also decreased following HC administration. At the same time
points, the MDD of NE in pts not receiving HC was lower, with a
non-significant reduction in MDD over the same time frame. HC pts
were on INO/VPs longer than the non-HC group (166 hours vs
112 hours) and had higher TISS scores (58.6 vs 49.8).
Conclusion: This audit confirms the beneficial effect of steroids on
VP/INO requirements in septic shock. Non-adherence to the
therapy guidelines in prescribing was common, probably due to
anxieties surrounding the perceived detrimental effects of steroids
in early sepsis and lack of prescription review.
Table 
Mean daily inotrope and vasopressor doses
Mean daily dose (µg/kg/min)
52–76 hours 77–100 hours 101–125 hours Students t-test
HC Non-HC HC Non-HC HC Non-HC HC P Non HC P
Norepinephrine 0.30 0.06 0.22 0.07 0.15 0.09 < 0.02 0.24
Epinephrine 0.70 – 0.48 – 0.37 – < 0.03 –
Dobutamine 11.40 – 11.23 – 9.42 – 0.44 –P223 Adrenal function in protracted critical illness: evaluation with the low-dose (1 µ µg) corticotropin stimulation test
I Dimopoulou*, I Ilias†, P Roussou‡, A Gavala*, A Malefaki*, E Milou*, M Pitaridis*, C Roussos*
*Department of Critical Care Medicine, Evangelismos Hospital, 4 Marasli street, 106 75 Athens, Greece; †Department of Endocrinology,
Alexandra Hospital, Athens, Greece; ‡Third Department of Internal Medicine, Athens Chest Hospital, Medical School, National &
Kapodistrian University of Athens, Athens, Greece
To investigate the adrenocortical function in protracted critical
illness, 43 patients (29 men and 14 women), having a mean (± SD)
age of 55 ± 21 years were studied. First, a morning blood sample
was obtained to determine baseline plasma cortisol. Subsequently,
1  µg of corticotropin (ACTH, synacthen) was injected intra-
venously and a second blood sample was drawn 30 min following
the injection to measure stimulated plasma cortisol. Patients having
a stimulated cortisol level of at least 18 µg/dl were defined as
responders. In 36 patients, morning interleukin-6 (IL-6) concentra-
tions were also measured. Mean baseline and stimulated plasma
cortisol were 16.8 ± 4.1 µ/dl and 21.2 ± 5.1 µg/dl respectively.
The median increment in cortisol was 4.1 µg/dl. Median IL-6 was
high (39.3 pg/ml, interquartile range 24.9–86.6 pg/ml). There was
a negative correlation between IL-6 and stimulated plasma cortisol
(r = –0.40, P = 0.01). Of the 43 patients, 31 patients (72%) were
responders, and 12 patients (28%) were non-responders to the
low-dose synacthen test. Non-responders had significantly higher
IL-6 levels compared to responders (76.6 vs 37.3 pg/ml,
P = 0.01). Overall, 18 patients died and 25 patients survived to
hospital discharge. Non-survivors had significantly lower baseline
(15.1 ± 2.9 vs 18.0 ± 4.5 µg/dl,  P = 0.02) and stimulated
(19.1 ± 3.3 vs 23.0 ± 5.6, P = 0.01) cortisol levels compared to
survivors. In conclusion, patients with protracted critical illness may
have an altered adrenal responsiveness to stimulation by ACTH.
This finding is in part explained by an increase in the production of
IL-6 and carries a poor prognosis.
P224 Time-dependence of dehydroepiandrosterone (DHEA), dehydroepiandrosterone-sulfate (DHEAS), and cortisol in survivors
and non-survivors of severe sepsis
C Marx*, S Petros†, SR Bornstein‡, M Wendt*, L Engelmann†, G Hoeffken*
*Department of Internal Medicine I, University Hospital C.G. Carus, Fetscherstraße 74, 01307 Dresden, Germany; †Medical ICU, University
of Leipzig, Germany; ‡Department of Endocrinology, Heinrich-Heine-Universitat Düsseldorf, Germany
Objective: The adrenal-derived androgens dehydroepiandros-
terone (DHEA) and dehydroepiandrosterone-sulfate (DHEAS) have
important immunoactivating properties. They show a considerable
decrease with increasing age. In contrast, cortisol is an endoge-
nous immunosuppressing hormone. Both activation and suppres-
sion of immune responses are crucial events during sepsis.
Patients: Twenty-eight non-surgical patients with severe sepsis
(ACCM/ SCCM criteria, 15 survivors (mean age 53 ± 17,
APACHE III score 63.5 ± 7.5) and 13 non-survivors (61 ± 15
years, APACHE III score 64.3 ± 10.4) were included. Hormones
were compared at fulfillment of sepsis criteria and time of recov-
ery/death intra-individually as well as between survivors and non-
survivors.
Results: During early sepsis, cortisol levels (nmol/l) were higher in
survivors than non-survivors (761 ± 120 vs 356 ± 78, P < 0.02)
and they decreased in survivors (P < 0.009) during late sepsis.
During early sepsis, DHEAS levels (% of age-matched normal
levels) were significantly higher in survivors than non-survivors
(80 ± 21 vs 18 ± 5, P  < 0.009). They decreased in survivors
(P = 0.0002) but remained low in non-survivors during late sepsis.
In contrast, during early sepsis, DHEA levels (% of age-matched
normal levels) were significantly elevated in survivors compared to
non-survivors (289 ± 46 vs 123 ± 31, P < 0.007). They decreased
in survivors (P = 0.002) but increased in non-survivors (P < 0.04)
during late sepsis. ACTH levels did not significantly change.
Conclusions: (1) The observed hormonal changes during course
of sepsis seem to be linked to immunoactivation during early and
immunosuppression during late sepsis, thus underlining the impor-
tance of time-dependence. (2) The changes have prognostic
importance and integrate the component of age to prognosis. 
(3) The concept of relative adrenocortical insufficiency is extended
to changes of adrenal androgens. (4) The results may help to
define subgroups which benefit from hydrocortisone substitution.
P225 High incidence of decreased cortisol reserve in brain-dead potential organ-donors
I Dimopoulou*, A Anthi†, E Milou*, I Ilias*, C Stavrakaki*, M Tzanela‡, S Orfanos*, M Christoforaki‡, K Mandragos†, C Roussos*, 
S Tsagarakis‡
*Department of Critical Care Medicine, Evangelismos Hospital, 4 Marasli street, 160 75 Athens, Greece; †Department of Critical Care
Medicine, Hellenic Red Cross Hospital, Athens, Greece; ‡Department of Endocrinology, Evangelismos Hospital, Medical School, National &
Kapodistrian University of Athens, Athens, Greece
To investigate the adrenocortical function in brain-dead, poten-
tial organ donors, 36 patients (27 men, 9 women) with severe
brain injury (BI), having a mean age of 42 ± 18 years were
studied. Group A, consisted of 20 BI patients who did not
develop brain-death (BD), and group B, was comprised of 16 BI
patients who became brain-dead. Of these, seven patients were
admitted in the hospital after clinical BD. In all patients (group A
and group B), a morning blood sample was obtained upon
admission in the ICU to determine baseline plasma cortisol
levels. Subsequently, 1 µg of corticotropin (ACTH, synacthen)
was administered intravenously and a second blood sample was
drawn 30 min following the injection. In group B patients, the
same procedure was repeated the morning following the confir-
mation of BD. Patients having a cortisol level of at least 18 µg/dl
following the administration of ACTH were defined as respon-
ders. After the occurrence of BD, group B patients had signifi-
cantly lower values for baseline (8.8 ± 6.3 vs 17.0 ± 6.6 µg/dl,
P < 0.001) and stimulated (16.8 ± 6.5 vs. 23.9 ± 5.7 µg/dl,
P = 0.001) plasma cortisol levels compared to group A patients.
Hormonal data of the nine brain-dead patients studied
upon admission in the ICU and after the occurrence of BD
were the following: baseline plasma cortisol 23.8 ± 12.0 vs
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7.1 ± 4.3 µg/dl,  P = 0.008, and stimulated plasma cortisol
28.9 ± 10.5 vs 16.0 ± 4.4 µg/dl,  P = 0.01. Thirteen group B
patients (81%) and two group A patients (10%) were non-
responders to synacthen (P < 0.0001). In group B patients,
baseline and stimulated cortisol concentrations were signifi-
cantly related (r = 0.72, P = 0.002), whereas there was no cor-
relation between baseline cortisol and the increment in cortisol
(r = –0.33, P = 0.21). In conclusion, adrenal cortisol secretion
following dynamic stimulation is deficient in a substantial propor-
tion of brain-dead patients. This finding calls for reconsideration
of corticosteroid replacement therapy, at least in a subset, of
brain-dead potential organ donors.
P226 Unlicensed drug use on ICU
C Goldsmith, R Shulman
University College Hospital London, Pharmacy Department, Mortimer Street, London W1T 3AA, UK
Introduction: The use of medicines outside the terms of the
product licence is a common occurrence on the ICU. While the
extent of unlicensed prescribing has been quantified in paediatric
practice [1], no studies have so far addressed this in the adult ICU
setting. There are various types of unlicensed drug use including
an unlicensed drug or a licensed drug used in an unlicensed
manner. Identifying unlicensed drug use is important because the
prescriber is responsible for any adverse effects suffered by the
patient.
Aims: To assess unlicensed drug use in the Intensive Care Unit of
the Middlesex Hospital.
Method: Specific drug charts were selected at random over a 14
day period. Details of each administered drug was compared with
the product licence of the drug. Aspects of use examined included
indications, route, dose, dilution, diluent and compatibility. For
generic drugs, the parent branded drug’s product licence was
used, where applicable, to define the licensed use.
Results: Eighteen out of the 20 patients (90%) received at least
one unlicensed drug administration. Of the 176 drugs prescribed,
41% were ‘unlicensed’ due to: unlicensed indication 13%, unli-
censed route 51%, unlicensed dose 11%, unlicensed dilution/
diluent 21%, unlicensed drug 4%.
Conclusion: In this sample 41% of drug use was ‘unlicensed’ and
90% of patients received medication administered in an ‘unli-
censed’ manner. All nasogastrically administered drugs, adrenaline
and morphine infusions were considered ‘unlicensed’. Although
licensed drugs for licensed uses should be used where possible,
ICU doctors are generally unaware of licence specifics despite
being potentially legally responsible for any adverse effects that
arise from this use.
Reference:
1. Turner S, et al.: Use of ‘off–label’ and unlicensed drugs in paedi-
atric ICU. Lancet 1996, 347:549-550.
P227 Look-alikes favor emergency drug administration errors: a national survey in Belgium
Ph Baele*, S Aunac*, P Mols†
*Anesthesiology Department, Cliniques Université St-Luc (UCL), Avenue Hippocrate 12, B-1200 Brussels, Belgium; †Emergency
Department, CHU St-Pierre (ULB), Rue Haute 322, B-1000 Brussels, Belgium
Errors in drug administration have been identified as a possible
cause of serious morbidity or even patient death. Emergency situa-
tions increase the chances for human error. The Belgian Society of
Anesthesia and Resuscitation (BSAR), the Belgian Society of Emer-
gency and Disaster Medicine (BESEDIM), and The Belgian Society
of Intensive Medicine and Emergency Medicine (SIZ) performed a
joint survey among 1404 Belgian specialists in these fields about
errors in drug administration in their daily practice. Among the 441
responders 64.6% ever drew a drug for another, and 43.5% ever
injected one for another (themselves); 96.4% yet experienced such
an error, made by themselves or by somebody else; 91.4% said
they ever found ampoules in the wrong drawer or box. Among the
89 drugs cited as involved in such errors, the most frequent where
atropine (107 times, 24% of responders), adrenaline (94 times,
21%), ephedrine (75 times, 17%), NaCl vs KCl vs aqua pro injec-
tione (17%), xylocaine (11%) and morphine (7%). The major cause
of confusing was likeness. Almost everyone involved in a drug error
(91.8%) evoked look-alike ampoules (for different drugs), 71.2%
look-alike labels and/or packaging, and 56% poor legibility of labels
or printing on ampoules. The need to dilute emergency drugs (like
inotropes) on the field was cited as a cause of calculation error by
22.9%. Sound-alike names (e.g. epinephrine vs ephedrin, levorenin
vs levophed) were also cited. For 23.1%, look-alike i.v. bags con-
taining different solutions caused problem. Among responding MDs
63.5% wore glasses or lenses for one vision impairment, 3% for
more than one, and 2% were color-blind.
We conclude that there is an obvious and major problem with legi-
bility of drugs labels, particularly emergency drugs. There is a
demand from practitioners to standardize the names, concentra-
tions and designs of emergency drugs. We propose minimal stan-
dards or norms to be defined at the European level for emergency
drugs, concerning their design, (e.g. pre-diluted drugs in pre-filled
ready to use glass syringes), their concentrations, their names,
their packaging and labeling, and concerning the legibility of what
is printed on ampoules or syringes.
P228 Optimization of morphine ampoules for injection
J Douchamps*, J Andris†, V Douchamps‡, S Mirza*, E Gilbart*, D Jacob*, I Louviaux*
*CHU André Vésale, 6110 Montigny-Le-Tilleul, Belgium; †Diffu-Sciences, R. de Rixensart 18, 1332 Genval, Belgium; ‡Faculty of
Psychology, University of Liège, 4020 Liège, Belgium
Confusion between two drugs or dosages is a major risk in the
hospital. One major cause of confusion is similarity between
ampoules. Beside this aspect, the cost/quality ratio has to be con-
sidered for economical reasons. Thus, efforts should be made by
producers to provide ampoules with a perfect and easily recogniz-
able identification at the lowest price. Wishing to increase safetyof our medication use system, we asked a team of 23 different
users (doctors, pharmacists and nurses) to compare four different
systems of identifying and labelling ampoules containing
injectable morphine, a drug typically used in almost all wards, and
especially in anaesthetics, emergency medicine and intensive
care. Two of the examined ampoules were from the same pro-
ducer, DENOLIN, who wished to test a new prototype (DN)
beside his ampoule currently available (DO). The two other mor-
phine ampoules available on the Belgian market were from two
other producers, STEROP (ST) and STELLA (SE), respectively.
The 10, 20, 30 and 40-mg dosages were examined when avail-
able. Twenty-one subjective criteria were evaluated using a five-
point Likert scale (from 1 = unsatisfying to 5 = excellent): five
criteria concerned global packaging, nine evaluated unit-dose
packaging and seven scored the ampoule itself. No criteria con-
cerned the content supposed equivalent for all producers. Each
participant provided an individual evaluation for all criteria and all
drugs. Data were analysed by ANOVA with Newman–Keuls post-
hoc tests (P < 0.05). For the DN, DO, ST and SE products, global
quality was rated 3.99, 3.61, 2.30 and 2.20, respectively. External
packaging scored 3.55, 3.49, 2.82 and 2.61. Similarly, unit-dose
packaging was 4.27, 4.00, 1.89 and 1.99 while ampoule was
rated 3.94, 3.20, 2.48 and 2.19. Quality/cost ratios were 4.2, 3.1,
2.1 and 1.8, respectively. The DN prototype was thus the first-
choice product, as confirmed by statistical tests. Suggestions
were made to still improve its quality and safety.
P229 The incidence and mortality rate of ventilator-associated pneumonia in elderly patients
P Katsoulis, B Grammatikopoulou, G Bourikis, A Tasiou, P Tselioti, A Giannakopoulou, S Fournogerakis, E Chantzi, A Prekates
Critical Care Department, Tzanio Hospital, Athens, Greece
Objective: Elderly critically ill patients are in high risk for pneumo-
nia acquired in the intensive care unit. The aim of our study is to
investigate the incidence and the mortality rate of Ventilator-Asso-
ciated Pneumonia (VAP) in elderly patients.
Design: Prospective consecutive study in a six bed medical-surgi-
cal ICU of a general hospital.
Materials and methods: We examined 91 (54 men and 37
women) postoperative and/or multiple trauma patients. Patients
older than 60 years old and mechanically ventilated for ≥ 48 hours
were included in this study. We considered that a patient devel-
oped VAP when he had (i) a new infiltrate on chest X-ray, for ≥ 24
hours, (ii) fever > 38.3°C, and (iii) one or more microorganisms in
concentrations  ≥ 105 cfu/ml in the samples of bronchoalveolar
lavage through fiberoptic bronchoscope.
Results: Twenty-five out of 91 (27%) patients developed VAP.
Age was 73 ± 8, Apache II score 24 ± 8, duration of mechanical
ventilation 31 ± 15 days and 72 ± 6 in patients with VAP and
without VAP respectively (P  < 0.05). Sixteen out of 25 VAP
patients (64%) and 33/66 patients (50%) without VAP died
(P < 0.05). Additionally bivariate analysis, using age > 60 years as
independent variable, showed significant difference in: ARDS
(P < 0.01), enteral nutrition (P < 0.05), flail chest (P < 0.01), tra-
cheotomy (P = 0.001), and neuromuscular blocker drugs
(P < 0.01) between patients with and without VAP.
Conclusions: Our findings suggest that one fourth of elderly
patients developed VAP and that there is no difference in the mor-
tality rate between patients with and without VAP.
P230 Profile and outcome in elderly patients requiring mechanical ventilation
FS Dias, N Almeida, D Fricke, PB Nery
Hospital São Lucas da PUCRS, Av. Ipiranga 6690, CEP 90610-000 Porto Alegre, RS, Brazil
Purpose: To describe the profile and outcome in elderly requiring
mechanical ventilation (MV) in ICU.
Methods: This cohort study included all consecutive patients with
age ≥ 80 years admitted to the ICU between January 1998 and
November 2001. All patients had age, gender, APACHE II at
admission, MODS score on day 1, need of MV, length of stay
(LOS) in ICU and hospital, occurrence of sepsis and septic shock,
and ICU and hospital outcomes collected. Statistical analysis com-
paring patients who required mechanical ventilation or not were
done by Mann–Whitney and chi-square, as indicated.
Results: There were 1769 admissions in the ICU during the study
period, of whom 167 (9.4%) met age criteria for inclusion in the
study. A group of 116 (70%) patients required MV. The mean age
was 84.2 ± 4 years, ranging from 80 to 96 years. One hundred
and five (63%) patients were females. The mean APACHE II score
was 18 ± 7, mean total MODS score was 4.1 ± 3 on day 1. There
were 80 (48%) patients with sepsis, of whom 49 (61%) had septic
shock. The mean LOS in ICU and hospital was 10 ± 12 and
28 ± 28 days, respectively. Clinical causes were responsible for
117 (70%) admissions. The ICU and hospital mortality were 55%
(n = 92) and 67% (n = 111). The Table compares the characteris-
tics of the patients, regarding with the use of MV.
Table
MV group  No MV 
Variable (n = 116) (n = 51) P
Age (years) 84.4 ± 4.2 83.8 ± 3.7 0.46
Females  73 (69.5%) 32 (30.5%) NS
Clinical admission 81 (69%) 36 (31%) 0.54
APACHE II 20 ± 7.2 14.8 ± 5 < 0.0001
MODS total 4.9 ± 3.1 2.4 ± 2.2 < 0.0001
Central nervous system 0.9 ± 1.4 0.65 ± 1.2 0.5
Cardiovascular 1.2 ± 1.3 0.5 ± 0.9 < 0.0001
Respiratory 1.5 ± 1.2 0.4 ± 0.7 < 0.0001
Renal 0.9 ± 1.1 0.45 ± 0.8 0.007
Hematologic 0.26 ± 0.65 0.2 ± 0.5 0.6
Hepatic 0.25 ± 0.6 0.2 ± 0.5 0.9
Sepsis 68 (85%) 12 (15%) < 0.0001
Septic shock 47 (96%) 2 (4%) < 0.0001
Length of stay — ICU (days) 12 ± 13 5.5 ± 5.2 0.002
Length of stay — hospital (days) 27.3 ± 26 30.5 ± 33 0.64
ICU mortality 91 (78%) 1 (1.8%) < 0.0001
Hospital mortality 100 (86%) 11 (20%) < 0.0001
Available online  http://ccforum.com/supplements/6/S1Critical Care    Vol 6 Suppl 1 22nd International Symposium on Intensive Care and Emergency Medicine
Conclusion: The elderly requiring MV had a higher mortality, which
could be explained by the severity of their illness expressed by
higher scores APACHE II and MODS on admission and the occur-
rence of sepsis and septic shock. Our patients who needed MV in
the elderly had a high incidence of septic shock, LOS in ICU and
poor outcome.
P231 Comparison of three scoring systems for mortality risk assessment among retrieved children
SM Tibby*, M Festa*†, M Hatherill*, G Jones*, P Habibi†, IA Murdoch*
*Guy’s Hospital, London SE1 9RT, UK; †St Mary’s Hospital, London W2 1PG, UK
Objective: A variety of mortality risk assessment tools exist for pae-
diatric intensive care unit (ICU) patients. Over the last decade
there has been a move towards transportation of children to
regional ICUs utilising specialised retrieval teams. The impact of
this on the validity of commonly used scoring systems is unknown.
Method: Data were prospectively collected on all children
retrieved by two teaching hospitals in the South-East of England
over a 21-month period (December 1997–September 1999).
Three scoring systems were compared: (1) PIM, a point of care
score encompassing eight variables from time of first patient
contact by the retrieval team up until 1 hour after physical ICU
admission; (2) PRISM II, a physiological based system incorporat-
ing 14 variables over the first 24 hours of physical ICU admission;
and (3) pre-ICU PRISM, which includes variables collected up to
24 hours before and after ICU admission.
Results: Data were available on 929 retrieved patients (hospital A
593, B 336). The median (interquartile) age was 15 months
(3–54), with a crude mortality of 7.8% (72/929). Seventy-six
percent were mechanically ventilated. Accurate data collection was
verified by an intraclass correlation coefficient of > 0.80 on all
scoring systems for 50 randomly selected patients.
Disease categories differed between the two hospitals, with A
having a higher proportion of respiratory and cardiac illness, and B
a greater degree of sepsis (P = 0.002). Distribution of patients
across mortality risk bands (< 1%, 1–5%, 5–15%, 15–30%,
> 30%) was similar between hospital A and B using PRISM II
(P = 0.27) and pre-ICU PRISM (P = 0.82), but not with PIM
(P = 0.006).
Conclusion: All three scoring systems produce acceptable dis-
crimination. PRISM II appears to be best calibrated. PIM however,
is easiest to collect, and with recalibration may represent a more
attractive alternative.
Table
Pre-ICU PRISM PIM PRISM II
Median % risk (interquartile) 6.1 (2.9–17.5) 6.9 (4.1–12.6) 3.3 (1.4–10.8)
AUC (95% CI) 0.83 (0.78–0.89) 0.86 (0.81–0.91) 0.86 (0.81–0.92)
SMR (95% CI) 0.54 (0.41–0.67) 0.68 (0.52–0.84) 0.71 (0.53–0.89)
Hosmer–Lemeshow χ2 59.4 20.6 14.2
Hosmer–Lemeshow P < 0.0001 0.008 0.08
AUC = area under receiver operating characteristic curve; SMR = standardised mortality ratio.
P232 Comparison of three scoring systems for mortality risk assessment among retrieved children with meningococcal sepsis
SM Tibby*, M Festa*†, M Hatherill*, G Jones*, P Habibi†, IA Murdoch*
*Guy’s Hospital, London SE1 9RT, UK: †St Mary’s Hospital, London W2 1PG, UK
Objective: Scoring systems assess mortality risk following inten-
sive care unit (ICU) admission. They may also be used as risk strat-
ification tools, both to assess severity of illness between ICUs, and
as a screening tool to select patients who may benefit from novel
therapies. The latter is particularly relevant to meningococcal
sepsis (MNS), as mortality is highest in this condition in the first
24 hours. With the advent of paediatric retrieval teams, ICU care
now essentially begins with the arrival of the team, prior to physical
admission of the patient to the ICU. The effect of this practice on
mortality risk assessment in MNS is unknown.
Method: Data were prospectively collected on all children with
MNS retrieved by two teaching hospitals in the South-East of
England over a 21-month period (December 1997–September
1999). Three scoring systems were compared: PIM, a point of care
score encompassing eight variables from time of first patient
contact by the retrieval team up until 1 hour after physical ICU
admission; PRISM II, a physiological based system incorporating
14 variables over the first 24 hours of physical ICU admission; and
pre-ICU PRISM, which includes variables collected up to 24 hours
before and after ICU admission.
Results: One hundred and sixty-four children were evaluated (hos-
pital A 62, B 102), with a crude mortality of 7.23%. Accurate data
collection was verified by an intraclass correlation coefficient of
> 0.80 on all scoring systems for 15 randomly selected patients.
Scoring performance is shown in the Table.
Distribution of patients across mortality risk bands (< 1%, 1–5%,
5–15%, 15–30%, > 30%) was similar between hospital A and B
using PIM (P = 0.42) and pre-ICU PRISM (P = 0.40), but not with
PRISM II (P = 0.006).
Conclusion: PIM, pre-ICU PRISM and PRISM II provide similar dis-
crimination for mortality in retrieved children with MNS, however
PIM exhibits superior calibration. In addition, distribution of patientsacross mortality risk bands varies between hospitals according to
the scoring technique used. Scores which take into account vari-
ables collected prior to ICU admission (PIM and pre-ICU PRISM)
appear to be least affected by retrieval team practice, and are thus
preferable for risk stratification.
Table
Pre-ICU PRISM PIM PRISM II
Mean % risk (standard deviation) 18.5 (22.9) 15.2 (16.2) 12.4 (19.6)
Median % risk (interquartile) 8.8 (3.5–22.9) 11.4 (5.6–18.0) 4.8 (1.5–11.9)
AUC (95% CI) 0.93 (0.88–0.98) 0.90 (0.80–1.00) 0.97 (0.95–1.00)
Hosmer–Lemeshow χ2 22.02 11.44 76.04
Hosmer–Lemeshow P 0.005 0.18 < 0.0001
AUC = area under receiver operating characteristic curve.
P233 Norepinephrine requirement is not an independent variable to predict outcome in severe septic shock patients
E Silva, FS Machado, EF Sousa, AG Garrido, E Knobel
Hospital Israelita Albert Einstein, Avenida Albert Einstein 627, Sao Paulo SP 05651-901, Brazil
Introduction: Although no ideal vasopressor agent is currently avail-
able, norepinephrine has been used to stabilize arterial pressure in
euvolemic patients with septic shock. Few studies have suggested
an association between norepinephrine dose and poor outcome.
Objective: To verify if norepinephrine dose requirement in severe
septic shock is an independent variable to predict outcome.
Methods: We built a database, including demographic, hemody-
namic and oxygen-derived variables, from 43 consecutive septic
shock patients treated with norepinephrine, after fluid replacement,
according to our institutional protocols. APACHE II at admission
and daily LODS and SOFA scores were obtained to assess multi-
ple organ dysfunctions. We chose standard prognostic variables
including age, gender, mean arterial pressure (MAP), arterial pH,
base excess, lactate levels and, norepinephrine dose requirements
during 5 days after admission. We developed models to predict in-
ICU mortality using univariate and multivariate analysis with step-
wise regression. Consecutive variables were expressed as means
± SD. The best cut-off value was chosen using Youden’s Index;
P < 0.05 was considered significant. All statistical analyses were
conducted using statistical software (SAS, Cary, NC, USA).
Results: There were 29 males (67%) and 14 females (33%), with
a mean age of 61 ± 2 years. Mean APACHE II score was
22.1 ± 1.1, with an overall mortality rate of 53.5%. ICU length of
stay was 14.8 ± 1.2 days. Twelve variables were identified through
univariate analysis, including age, SOFA (1st day), LODS (1st and
2nd days), arterial pH (1st and 2nd days), base excess (1st and
2nd days), norepinephrine dose (1st and 2nd days) and the
highest norepinephrine dose in 5 days. Only two variables retained
statistical significance following multivariate analysis with stepwise
regression. They were LODS (2nd day) and arterial pH (2nd day).
LODS (2nd day) ≥ 5 and arterial pH (second day) ≤ 7.33 were
associated with a 29.6 and 19.9 times odds to death, respectively.
Conclusion: Although norepinephrine dose is associated with
mortality by univariate analysis, it is not an independent variable in
severe septic patients. The importance of the severity condition
(LODS) is greater than the norepinephrine dose requirement.
P234 Low urine output in acute renal dysfunction (ARI/ARFS) diagnosis
V Sramek, P Suk, J Hruda, V Zvonicek
Department of Anesthesia and Intensive Care, St Ann’s University Hospital, Pekarska 53, 65691 Brno, Czech Republic
Introduction: Low urine output (UO) has been recently suggested
to define acute renal dysfunction/failure (ARI/ARFS) in addition to
urea/creatinine levels [1]. We tested how inclusion of UO would
change the incidence of ARI/ARFS in long term ICU patients.
Patients and methods: Medical records of long term ICU patients
(> 3 days) hospitalised in 2000 were analysed for UO during the
first 8 days of ICU stay. When low UO (< 200 ml/6 hours or
800 ml/24 hours minimal) was found scoring for ARI/ARFS was
performed. In case creatinine was not available urea was consid-
ered sufficient for ARI/ARFS diagnosis. Furosemide medication
was also recorded.
Results: Out of 189 admissions in 2000, 90 patients (62 males,
28 females), in age of 59 years (median; range 16–85 years) were
hospitalised > 3 days. Altogether 98 hospitalisations were
analysed (eight re-admissions in seven patients). APACHE II on
admission was 25.4 ± 7.7. Four patients died within the period
analysed and one was discharged from the ICU. Thirty-nine ICU
days when seven patients required renal replacement therapies
were also excluded from the analysis. Altogether 735 ICU days
were subject to analysis.
Based on decreased UO 66 ARI/ARFS days in 34 patients were
recorded. Twenty five ARI/ARFS days were found in nine patients
with normal urea/creatinine values (14 in a single patient). In three
cases classification of ARI/ARFS including UO would lead to a
more severe classification of renal dysfunction. Eight patients
would have been missed if ARI/ARFS was based on urea/creati-
nine values only. In all but one patient where an episode with low
UO was recorded no furosemide was given.
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Conclusion: When diuretics are not given, inclusion of low urine
output into an acute renal dysfunction definition significantly
increases the number of ARI/ARFS patients.
Reference:
1. Belomo R, et al.: Acute renal failure: time for consensus. Intensive
Care Med 2001, 27:1685-1688.
P235 Long-term outcome and IL-6 levels in critically ill septic patients: results from the sepsis longitudinal epidemiological
outcomes tracking study (SELECT I)
DB Chalfin*, D Edbrooke†, R Sterz‡, T Ashraf‡, W Holtbruegge§, N Victor¶
*Maimonides Medical Center and the Albert Einstein College of Medicine, 4802 10th Avenue, Brooklyn, NY 11219, USA; †The Royal
Hallamshire Hospital and the Medical Economics and Research Centre, Glossup Road, Sheffield S10 2JF, UK; ‡Abbott Laboratories, 
100 Abbott Park Road, Abbott Park, IL, USA, and Abbott Gmbh & Co KG, Knollstraße 50, D-67061 Ludwigshafen, Germany; 
§STATIS, Lampertheim, Germany; ¶Institute for Medical Biometrics and Informatics, University of Heidelberg, Institute for Medical
Biometrics and Informatics, Im Neuenheimer Feld 305, D-69120 Heidelberg, Germany
Methods: The SELECT I study is a prospective, multi-center,
observational study to assess the long-term clinical and economic
outcomes in patients with sepsis from presumed infectious etiol-
ogy during and beyond their acute care hospitalization, along with
the clinical, economic, and prognostic relevance of baseline IL-6
levels, as measured by a dichotomous rapid test (SEPTEST™: ST-
positive and ST-negative readings with a cut-off at about
1000 pg/ml [1]). All eligible patients with standard clinical criteria
for severe sepsis were enrolled from ICUs in 52 centres in six
European countries during the study period (May 1998–October
2000). The SEPTEST™ was administered within 24 hours after
inclusion in the study. Patients received usual care and were
observed in the ICUs until death or discharge. After discharge the
vital status and the functional and general health status
(EuroQol 5D) were collected at days 30, 60, 90 and 180 following
study entry. The main focus of the analysis reported here is the
comparison of the survival rates in the ST-positive and ST-negative
groups (Kaplan–Maier curves).
Results: Data was derived from the initial 350 patients of a total of
433 enrolled patients. Of these, 113 (32.3%) were ST-positive,
237 (67.7%) were ST-negative. There was no evidence of an asso-
ciation between IL-6 status and either gender, age, co-morbid con-
dition upon admission, major interventions during hospitalization, or
participation in a clinical trial. Table 1 shows the survival by group
(ST-negative, overall, ST-positive). The survival difference between
ST-positive and ST-negative is highly significant (P < 0.0001, log
rank test). The difference on day 30 was 17.3% (95% CI: 6.5%,
28.2%) and remains nearly stable during follow-up (day 60:
23.9%, day 90: 1.9%, day 180: 19.8%).
Conclusions: Overall mortality observed in this study is in the range
expected in critically ill patients with severe sepsis/septic shock.
However, a remarkable statistically significant difference between
patients with high (ST-positive) and low (ST-negative) baseline IL-6
titers are observed. The excess mortality in the ST-positive patients
occurs mostly before day 30 (i.e. in the acute phase of the condi-
tion). After this time the hazard of death seems to remain similar in
the two groups over the observation time of 180 days after study
entry. The study confirms the high prognostic value of IL-6 for mor-
tality in severe sepsis as reported by others [1].
Reference:
1. Reinhard, et al.: Crit Care Med 2001, 29(4):765-769.
Funded by a grant from Abbott Laboratories, Chicago, IL, USA.
Table 1
Survival rates
Group/time point Day 30 Day 60 Day 90 Day 180*
All patients 65.7% 55.1% 52% 49.7%
ST positive 54.0% 38.9% 37.2% 36.3%
ST negative 71.3% 62.9% 59.1% 56.1%
Risk difference 17.3% 23.9% 21.9% 19.8%
* P < 0.0001, log rank test.
P236 Brazilian Sepsis Epidemiological Study (BASES): preliminary results from first 439 patients
E Silva, MA Pedro, AMCB Sogayar, T Mohovic, M Janiszewski, CCLO Silva, TP Abe, AM Bento, GF Janot, E Souza, PCS Rocha, 
A Avezum, J Andrade, JD Matos, PCB Vieira, E Knobel
Hospital Israelita Albert Einstein, Avenida Albert Einstein 627, 5th Floor, Sao Paulo, Brazil
Introduction: Severe sepsis is one of the major causes of mortality
in intensive care units (ICUs) around the world. There are few epi-
demiological studies based on ACCP/SCCM consensus confer-
ence criteria. The incidence of severe sepsis is largely unknown in
countries like Brazil.
Objective: To determine the incidence and outcome of sepsis in
Brazilian ICUs.
Methods: This is an observational, prospective, multicenter cohort
study from four adult, general ICUs from two Brazilian regions.
Table 1
Incidence and outcome in 354 patients with more than 24 hours of ICU length of stay, based on ACCP/SCCM conference
definitions
Non-SIRS SIRS Sepsis Severe sepsis Septic shock
Number of patients 33 321 123 121 65
Mortality rate (%) 8.6 20.3 33.3 33.9 53.8From May to October 2001, all patients admitted to those ICUs
were prospectively followed for 28 days or until discharge. Demo-
graphic data, admission diagnosis, associated chronic diseases,
APACHE II score, daily SOFA score, clinical and laboratory SIRS,
sepsis, and septic shock criteria, as well as early and late outcome
were collected. Data management was performed by a TELEform
Elite V6 — Cardiff Software. Data were expressed as mean ± stan-
dard error. The t-test was used to compare mortality rates in differ-
ent diagnostic categories.
Results: Mean age was 63 ± 1 years and overall mortality rate was
20%. Mean ICU length of stay was 4.5 ± 1.7 days. The main
admission diagnoses (by APACHE II diagnosis categories) were
sepsis, cancer, neurologic disturbances, cardiovascular surgery
and metabolic disorders.
Conclusion: In those patients with more than 24 hours of ICU
length of stay, the incidence of sepsis was of 34.7%. ACCP/
SCCM definitions were feasible and were associated with mortality
rates. Expansion of these data to other Brazilian regions is crucial
to estimate the actual incidence of sepsis in our ICUs.
Supported by a grant from Eli Lilly of Brazil.
P237 Application of SOFA score to neurological patients admitted to intensive care unit
LR Abrahão, FVC De Marco, FMB Maciel, M Giudicissi, ACM Bianco, MA Mora
ICU, Hospital Municipal Dr. Arthur Ribeiro de Saboya, Avenida Francisco de Paula Quintanilha Ribeiro 860, Bairro Jabaquara CEP, 04330-
020 São Paulo, Brazil
Objective: To assess the ability of the SOFA score (Sequential
Organ Failure Assessment) to discriminate outcome in neurologi-
cal patients admitted to intensive care unit (ICU).
Setting: A 24-bed general ICU in a 260-bed public hospital.
Methods: We prospectively followed (from May to September 2001)
neurological patients admitted to our ICU measuring daily SOFA
score throughout the first 7-day ICU stay and recording the 28-day
mortality. We compared median scores between survivors and non-
survivors (Mann–Whitney U-test) and calculated risk relative of death.
Admission APACHE II score was calculated for each patient.
Results: We studied 45 patients (29 M/16 F). The mean age was
47.8 ± 13.2 years and mean APACHE II was 14.2 ± 5.1. The mean
LOS was 12.8 ± 8.3 days. The 28-day ICU mortality was 31%
(n = 14).The best cut-off value of SOFA score was 7. Clinical diag-
nosis at admission were: intracerebral haematoma (n = 14),
extradural haematoma (n = 9), subarachnoid hemorrhage (n = 7),
brain swelling (n = 5), subdural haematoma (n = 4), gun shot injury
(n = 3), diffuse axonal lesion (n = 2), meningitis (n = 1).
Conclusions: SOFA score can be used to discriminate outcome in
neurological patients admitted in ICU.
Table 1
Comparison between median SOFA score in survivors and
non-survivors
Survivors Non-survivors P
SOFA
D0 5 (4–6) 6 (6–7) 0.03
D1 5 (3–6) 7 (6–8) 0.006
D2 6 (3–7) 7 (6.5–8) 0.03
D7 4 (3–5) 7.5 (7–9.5) 0.0001
Table 2
Risk relative of death on days 0, 1, 2 and 7
D0 D1 D2 D7
SOFA f 7
RR 2.3 2.6 6.0 14.3
CI 1.03–5.2 1.13–6.2 1.5–24.5 1.9–105
P238 ‘Treatment profile’: a new concept that must be considered when comparing data obtained from physiological severity of
illness scores
A Picts, M Street, O Boyd
The Intensive Care Unit, The Royal Sussex County Hospital, Brighton BN2 5BE, UK
Most of the physiological derangements that contribute to critical
care outcome prediction models are responsive to direct therapy
to correct them. For example K+ infusions for serum K+ levels; and
inotropes for blood pressure changes. The total physiological
score attained by a patient is therefore a product of the patient’s
illness and also the degree of physiological control that is
achieved by critical care therapy. Differences in therapeutic
culture between critical care units (and indeed the same critical
care units over time) may therefore have a major influence on the
final/score outcome prediction. We have assessed the percent-
age of patients in each score band of high abnormal range (+4),
normal (0) and low abnormal range (+4) for each physiological
variable for APACHE II [1] having treatment specifically targeted
to correct that variable to normal, in order to define a treatment
profile for our ICU.
Method: The notes, treatment cards and clinical observations for
100 consecutive patients were reviewed to find the most deranged
of 11 physiological variables using the APACHE II methodology
(i.e. the most deranged variable within the first 24 hours of ICU
admission), and the occurrence of treatment specifically targeted
to correct any derangement. Analysis of Glasgow Coma Scale was
not included.
Results: The results for individual parameters are shown in the
Table and for combined results in the Figure. Most parameters
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have more treatment the further the value from the ‘normal’ range,
but the converse is true for respiratory rate. Within the group of
patients who fall into the zero score band for physiological
derangement, 30% (see Fig.) are being actively treated to maintain
that parameter within that band. Zero percent to 100% of patients
(see Table) are being actively treated depending on the physiologi-
cal parameter.
Conclusion: We have described the ‘treatment profile’ for our ICU
with regard to management of physiological parameters used in
the APACHE II score. We speculate that different ICUs will have
different treatment profiles. Possibilities to explain this include vari-
ations in targets of treatment in different ICUs (e.g. Haematocrit) or
in the expediency that deviations from a defined range are treated.
We suggest that the way patients are treated on different ICUs is
unlikely to be the same altering the physiological score obtained in
different ICUs. These variations may or may not be reflected in
changes in mortality. This precludes meaningful comparisons
between ICUs using data obtained from physiological scoring
systems without also comparisons of ‘treatment profile’.
Reference:
1. Knaus, et al.: Crit Care Med 1985, 13:818-829.
Table
The patients falling into each APACHE II scoring band being actively treated for each physiological parameter (% [n])
+4 +3 +2 +1 0 +1 +2 +3 +4
Temp – 38 (22) na 8 (12) 10 (60) 10 (10) 66 (3) – –
MAP – – – na 12 (26) na 42 (53) na 82 (17)
Heart R 100 (1) 55 (11) 22 (41) na 12 (42) na – – –
Resp R 0 (2) 0 (11) na 3 (32) 60 (15) 29 (14) 50 (2) na 0 (1)
pO2 100 (24) 100 (9) 100 (16) na 100 (30) – na – –
pH – – na 88 (8) 25 (53) na 23 (18) 32 (12) 67 (5)
Sodium – – 0 (2) 0 (4) 16 (79) na – – –
K+ – – na 0 (2) 44 (64) 88 (17) 100 (5) na 100 (1)
Creat 38 (8) 14 (7) 0 (4) na 0 (45) na 0 (25) na na
Hct – na – – 5 (36) na 48 (73) na 88 (8)
WBC 100 (1) na 86 (14) 90 (10) 82 (68) na 100 (1) na 100 (1)
na = not applicable, – = no patients in that group in our data.
Figure
Summary data showing the mean percentage of patients in each score
band being treated for the physiological derrangement.
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P239 Mortality probability model II (MPM0–72) in 1667 patients with acute cardiovascular disorders
U Janssens, J Graf, R Dujardin, A Kersten, J Ortlepp, M Merx, K-C Koch, P Hanrath
Medical Clinic I, University Hospital Aachen, Pauwelsstraße 30, 52074 Aachen, Germany
Objectives: Aim of this prospective study was to evaluate the mor-
tality probability model (MPM II) in terms of outcome prediction
(hospital mortality [HM]) and calibration in patients with predomi-
nantly cardiovascular disorders admitted to a medical intensive
care unit (MICU).
Methods: 1677 patients (pts) (age 64 ± 13 years, 68.9% male,
SAPS II 27 ± 15.9, 418 pts acute myocardial infarction, 337 pts
unstable angina, 217 pts rhythm disturbances, 141 pts heart
failure, 103 pts cardiac arrest, 416 pts other admission diagnosis)
were included between April 1999 and April 2001. SAPS II and
MPM0–72 were determined according to the published guidelines.
Discrimination power of SAPS II and MPM0–72 for survivors (S) and
non-survivors (NS) (HM) was assessed by the area under the
Receiver Operating Characteristic (AUROC) curve, calibration of
the models with the Goodness of Fit H-Test (GOF-H) and stan-
dardized mortality ratio (SMR).
Results: Two hundred and sixty-one (15.6%) pts died. ICU mortal-
ity was 10.9%. AUROC for SAPS II was 0.83 (0.79–0.81), for
MPM0 0.80 (0.76–0.84), for MPM24 0.83 (0.79–0.87), for MPM48
0.82 (0.78–0.86) and for MPM72 0.87 (0.82–0.89). MPM0–72 II
significantly overestimated mortality (Table 1). Moreover stratifying
pts in subgroups according to age, admission process and diag-nostic categories revealed a poor calibration with overestimation of
mortality too.
Conclusion: Discrimination of MPM0–72 II was reliable. However,
all models showed a most significant lack of calibration overesti-
mating mortality mainly in the low risk strata and other pt related
criteria. These results evidence the importance of a difference in
the uniformity of fit and case mix of the present study population
compared to the original population in which the model was 
developed.
Table 1
χ2 value GOF-H and SMR (95% confidence interval)
χ2 value (GOF-H) SMR (95% CI)
SAPS II 6.84 (P = 0.653, df = 9) 1.048 (0.925–1.183)
MPM0 38.63 (P < 0.0001, df = 9) 0.754 (0.665–0.852)
MPM24 65.31 (P < 0.0001, df = 9) 0.691 (0.608–0.782)
MPM48 31.86 (P = 0.0002, df = 9) 0.755 (0.644–0.879)
MPM72 27.40 (P = 0.0012, df = 9) 0.736 (0.615–0.874)
P240 To verify four 5-year-old mathematical models to predict the outcome of ICU patients
A Donati*, V Gabbanelli*, C Scala*, C Carbini*, I Valentini*, M Antognini*, P Pelaia*, P Pietropaoli†
*Istituto delle Emergenze Medico-Chirurgiche, Università di Ancona, Italy; †Istituto di Anestesiologia e Rianimazione, Università ‘La
Sapienza’, Roma, Italy
Background: In 1995 a retrospective study was made on all the
patients admitted in our ICU from 2 April 1990 to 31 December
1995 with a length of stay of at least 24 hours. For each patient
APACHE II score was calculated after 24 hours and, depending on
the length of ICU stay, on the 5th, 10th and 15th day from the
admission. The case mix of 1254 patients was subdivided in two
series. The first series was used for developing the models and the
second series to verify them.
Data of the patients from the first series were used to make four
mathematical models (1st, 5th, 10th, 15th day from the admission)
to predict the outcome from the calculated APACHE II score.
Stepwise logistic regression (BMDP, Los Angeles) was used to
make these four models. For each model calibration was tested
with the Hosmer–Lemeshow Goodness-of-Fit test and discrimina-
tion was tested with the ROC-curve. These four models were vali-
dated for calibration and discrimination also in the second series.
The aim of this study is to verify these four models in patients
admitted in the same ICU during the year 2000 and, in this way, to
make a quality control of ICU care.
Material and methods: A prospective study was made on patients
admitted in our ICU during the year 2000 with a length of stay of at
least 24 hours. On the base of the four old mathematical models
the risk of death was calculated for each of the four days (on the
1st, 5th, 10th, 15th day from the admission) and calibration and
discrimination were tested.
Results: Three hundred and fifty-seven patients with more than
24 hours ICU stay were admitted in the study. The first model, at
24 hours from the admission, had a bad calibration at the
Hosmer–Lemeshow test (P = 0.000088), while area under the
ROC-curve was equal to 0.74 ± 0.32. The model at the 5th day
had a bad calibration too (P = 0.000588), with an area under the
curve equal to 0.83 ± 0.04. At the 10th day from the admission the
model was well calibrated (Hosmer–Lemeshow test:
P = 0.112247) with a ROC = 0.89 ±0.04. Finally at the 15th day
the model was again bad calibrated (P = 0.001422), but with a
very good discrimination (area = 0.91 ± 0.06).
Discussion: A further analysis suggest that to be increased was
outcome of neurosurgical and trauma patients, while outcome of
patients with other pathologies remained unchanged. To be
increased is not the general quality of ICU care, but only the treat-
ment of neurosurgical and trauma patients. Moreover for the neuro-
surgical patients, the introduction of neuroradiological treatment of
cerebral aneurysm with Guglielmi’s coil has contributed to increase
the outcome of these patients.
Conclusion: These self-made models help the physician to under-
stand ICU outcome changes during the years and if increased
amount of money are justified from increased outcome.
P241 Markers of in surgical intensive care unit length of stay in patients submitted to heart surgery: the intensivist point of view
RV Gomes, FG Aranha, LA Campos, MA Fernandes, PM Nogueira, EM Nunes, J Sabino, AG Carvalho, R Farina, H Dohmann
Hospital Pró-Cardíaco, Surgical Intensive Care Unit, PROCEP, Rua Dona Mariana 219, Botafogo, Rio de Janeiro CEP 22.280.020, RJ, Brazil
Background: Postoperative management of heart surgery (HS)
has been changing in the last decade. ‘Fast-track strategy’ has
been proposed, but not for all patients. Markers of length of stay
(LOS) in surgical intensive care unit (SICU) are still needed.
Objectives: To analyze data of preoperative, peroperative and
postoperative period to identify factors that could be correlated to
higher SICU-LOS among patients submitted to HS in our hospital.
Methods: Three hundred and fifty patients submitted to HS in our
hospital, from June 2000 to November 2001 were retrospectively
analyzed from prospective collected data in a Customized Database
System. Applying Cox Regression with stepwise (Likelihood ratio)
of 62 variables obtained preoperative, peroperative and postopera-
tive period, we observed its correlation with higher SICU-LOS.
Results: Variables considered significant under multivariate analy-
sis with respectively odds ratio (OR) and P value were: age (OR = 1.0,
P = 0.02), type of surgery, Emergency (E) HS (OR = 0.7,
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P = 0.01), Urgency (U) HS (OR = 0.6, P = 0.01), need of re-oper-
ation (OR = 2.8, P = 0.0008), occurrence of acute atrial fibrillation
(OR = 1.7, P = 0,0001) and following the first postoperative day
(FPD): LOS in mechanical ventilation (MV) (OR = 0.9, P = 0.01),
use of pulmonary artery catheter (PAC) (OR = 2.2, P = 0.00001)
and intra-aortic balloon (IAB) use (OR = 1.9, P = 0.01).
Conclusion: In our series using preoperative, peroperative and
postoperative variables, we found three preoperative markers of
longer SICU-LOS (Age, U-HS and E-HS), three FPD occurrence
(PAC, IAB, LOS-MV) that could show the severity of hemodynamic
disturbance, also two postoperative markers that were HS compli-
cations (AAF and need of re-operation). The strongest variables to
predict higher SICU-LOS are found in the postoperative period in
our hospital and are supported by highest OR. We need further
step by step (pre, per and FPD) data analyses to format a predic-
tive SICU-LOS model in HS.
P242 The extent and effect of sepsis in the first 24-hours of intensive care in one country
FN MacKirdy, JA Davidson, SJ Mackenzie
Scottish Intensive Care Society Audit Group, Anaesthetic Department, Victoria Infirmary, Langside Road, Glasgow G42 9TY, UK
Introduction: The PROWESS [1] study reported the development
of an apparently successful, but expensive, treatment for severe
sepsis. All but two of the 26 adult, general intensive care units
(ICUs) in Scotland participated in a prospective audit of admis-
sions during 1999 and 2000. We reviewed our data to assess the
extent and effect of sepsis, evident in the first day of intensive care,
in this 2-year period.
Results: Almost 40% of all patients were septic within the first
24 hours of ICU admission, and 44% of these had severe sepsis
(18% of all admissions). This proportion was consistent in both
1999 and 2000. The ICU mortality was 30% in the sepsis group
and 50% in the severe sepsis group, compared to an overall Scot-
tish ICU mortality of 21.5%. A further 9% die before hospital dis-
charge. Although this attrition rate is similar to that in the general
ICU population, it means that patients with severe sepsis are twice
as likely to die before hospital discharge as the general ICU popu-
lation. Patients with severe sepsis have higher APACHE II scores
(mean 25) compared to those with sepsis (21) or the ICU popula-
tion in general (19) and stay in ICU longer (mean increase
1.8 days, median 1.1). The standardised mortality ratio (SMR) of
1.16 in the severe sepsis group is clearly of concern, but is unlikely
to be due to poor quality of care since the SMRs for Scottish ICUs
are known to be in line with expectation [2].
Conclusion: Severe sepsis has important consequences for indi-
vidual patients, ICU resources and community health. There is the
potential for new therapies to make a significant impact on all of
these but close surveillance on a national rather than selective
basis will be required to assess the cost and benefit.
References:
1. Bernard GR, Vincent J-L, Laterre P-F, et al.: N Engl J Med 2001,
344:699-709.
2. Livingston BM, MacKirdy FN, Howie JC, Jones R, Norrie JD: Crit Care
Med 2000, 28:1820-1827.
Table 1
Summary of data collected during 1999 and 2000 in Scottish ICUs
All admissions (n = 16,000) Sepsis (n = 6504) Severe sepsis (n = 2892)
LOS (days) Median/mean 1.8/4.53 2.2/5.26 2.9/6.3
Age (years) Mean 58.3 57.9 61.4
Mortality (%) ICU/hospital 21.5/29.9 29.6/38.6 50.4/58.7
APACHE II Probability (%) 33.0 38.5 50.1
SMR (95% CI) 0.905 (0.884–0.927) 0.990 (0.970–1.01) 1.16 (1.12–1.19)
P243 Predictors of hospital costs in patients submitted to heart surgery: the intensivist point of view
RV Gomes, FG Aranha, HTF Mendonça, LA Campos, B Tura, MA Fernandes, PM Nogueira, R Vegni, DJ Silva, H Dohmann
Hospital Pró-Cardíaco, Surgical Intensive Care Unit, PROCEP, Rua Dona Mariana 219, Botafogo, Rio de Janeiro CEP 22.280.020, RJ, Brazil
Background: Heart surgery (HS) has been considered one of the
most cost consuming procedures in health care, therefore many
strategies has been studied in order to reduce its final costs.
Objective: To evaluate factors collected during preoperative, per-
operative and postoperative period in Surgical Intensive Care Unit
(SICU) that could be correlated to higher hospital costs (HHC) of
patients submitted to HS.
Methods: We retrospectively analyzed prospective collected data
from a Customized Database System. Hospital cost data was avail-
able in 246 of 350 patients submitted to HS from June 2000 to
November 2001. Applying linear regression and goodness-of-fit
statistics to 62 variables obtained preoperative, peroperative and
postoperative period in SICU we observed its correlation with
HHC.
Results: Variables considered significant under multivariate analy-
sis (R = 0.950, R2 = 0.903, R2 adjusted = 0.898) revealed higher
hospital costs in the presence of pulmonary hypertension (PH)
(P = 0.04), increased left atrial diameters (ILAD) (P = 0.013), use
of anti-platelet agents in the previous 7 days (UAPA) (P = 0.006),intra-aortic balloon (IAB) use for extra-corporeal circulation delivery,
admission SICU bicarbonate level (BL) (P = 0.0001), SICU LOS
(P = 0.0001), occurrence of acute atrial fibrillation (AAF)
(P = 0,039), and the following first postoperative day (FPD)
variables: higher serum levels of creatinine (HSLC) (P < 0.003),
fluid imbalance (FI) (P = 0,001), Nor-adrenaline tritation
> 0.1 µg/kg/min (Nor > 0.1) and length of stay (LOS) in mechani-
cal ventilation (MV) (P = 0.012).
Conclusion: In our sample using preoperative, peroperative and
postoperative variables, we had only three preoperative markers of
HHC (PH, ILAD, UAPA) and eight peroperative or postoperative
(IAB, admission SICU BL, HSLC FPD, FI in FPD, FPD Nor > 0.1,
LOS in MV, SICU LOS and AAF). We interestingly showed that in
hospital with our characteristics (high risk and urgency HS) it is dif-
ficult to predict HHC with only preoperative variables. We will need
further step by step (pre, per and FPD) data analysis to format a
predictive HHC for HS.
P244 Comparison of DRG system funding and actual costs for intensive care in Hungary
A Csomós, A Lendvai, B Szedlák, I Ökrös
Intensive Care Unit, Borsod County Teaching Hospital, 3600 Miskolc, Szentpeteri kapu 72, Hungary
Introduction: Since its introduction in 1993, there has been con-
tinuous underfunding of the Heath System in Hungary; it is espe-
cially true for expensive specialties, like Intensive Care. In many
other countries that use DRG costing, there is individual funding
available for ICUs, but it is not the case in Hungary. In this study,
we compared actual ICU costs with reimbursed funds during a 1-
month period.
Methods: We selected 1 month for which the amount of reim-
bursed fund was available (August 2001). Retrospectively, we col-
lected the actual variable costs for every patient during that period,
using nursing and medical records. These variable costs included
drugs, disposables, nutrition, blood and diagnostics. Fixed costs
(non-clinical support and personnel) were then calculated with the
top-down method. We did not include estate costs in our study as
it was proven to show little importance in cost analysis [1]. General
patient data, reason for admission, SAPS-II score, length of ICU
stay and length of mechanical ventilation were assessed as well.
These potential cost indicators were then evaluated to the actual
cost of ICU care and reimbursed DRG funds.
Results: There were 12 patients during August 2001, who had
been admitted to and discharged from our ICU. The overall costs
of these cases were 7.72 M Ft (SD = 0.60 M Ft) and there was
only 7.26 M Ft (SD = 0.61 M Ft) refunded to the unit.
The length of stay correlated very well with actual cost (r2 = 0.98)
and less well with reimbursed DRG funds (r2 = 0.75). The length of
mechanical ventilation showed better correlation with DRG funding
(r2 = 0.86), then with actual costs (r2 = 0.66). However, there was
no correlation between SAPS-II and actual or reimbursed funds
(r2 = –0.54, –0.08).
Conclusion: The actual cost of Intensive Care was significantly
higher then the reimbursed DRG fund given to the unit. In our
Health System, DRG refund is supposed to cover estate costs and
capital equipment as well. There was a negative balance without
including these cost blocks, which highlights the importance of
individual funding for Intensive Care. DRG refund was less than
actual cost for patients who were not ventilated. Our study con-
firmed that SAPS II could not be used as a cost indicator.
Reference:
1. DL Edbrooke, et al.:  Variations in expenditure between adult
general intensive care units in the UK. Anaesthesia 2001, 56:208-
216.
Table
HUF EURO
Drugs/fluids 981,687 3974 12.70%
Disposables 545,566 2209 7.06%
Nutrition/blood 266,212 1078 3.45%
Clinical support 191,537 775 2.48%
Non-clinical support 1,094,840 4433 14.17%
Personnel 4,648,614 18,820 60.15%
Total cost 7,728,456 31,289 100%
P245 Compliance with intensive care admission guidelines on triage
GYS Choi, CD Gomersall, GM Joynt, PNP Leung, SJ Ramsay
Department of Anaesthesia & Intensive Care, The Chinese University of Hong Kong, Shatin, Hong Kong
Introduction: Appropriate utilization of expensive resources has
become an important issue due to limited health budgets. Admis-
sion to the Intensive care unit (ICU) should be reserved for those
patients with reversible medical conditions who have a ‘reasonable
prospect of substantial recovery’ [1]. The Task Force of the Ameri-
can College of Critical Care Medicine, Society of Critical Care
Medicine have introduced guidelines for prioritizing admission.
These define those that will benefit most from ICU (Priority 1) to
those that will not benefit at all (Priority 4). We aimed to test our
compliance to the model and to critically analyze its usefulness as
a triage tool.
Method: We performed a prospective audit of all adult referrals for
admission to our 22 bed multidisciplinary University ICU between
13 November and 13 December 2001. Patients were categorized
according to the guidelines by two investigators not involved in the
triage decision. The proportion of patients admitted in each priority
group was calculated.
Results: The audit consisted of 117 patients. The mean age was
58 and the mean Mortality Prediction Model at admission (MPM II0)
0.37. The results obtained are shown in the Table overleaf.
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Conclusion: Our triage decisions complied well with the guide-
lines. This is evident from the high admission rate in the Priority 1
group and a reducing admission rate in the subsequent categories.
Due to our limited health resources some category 1 patients were
refused. In healthcare systems with limited resources a method of
selecting between category 1 patients may be necessary.
Reference:
1. Guidelines for intensive care unit admission, discharge, and
triage. Task Force of the American College of Critical Care Medi-
cine, Society of Critical Care Medicine. Crit Care Med 1999,
27:633-638.
Table
Number of patients  Number admitted 
Priority category (% of total) (% of admission)
1 84 (72%) 79 (94%)
2 17 (15%) 11 (65%)
3 7 (6%) 3 (43%)
4 9 (7%) 0 (0%)
P246 Clinical outcomes in a controlled trial of early identification and rapid systematic treatment of shock, modeled after the
trauma system
F Sebat, D Johnson, S Moore, K Henry, M Saari
Redding Medical Center, 1100 Butte Street, Redding, CA 96001, USA
Hypothesis: Early identification and rapid systematic treatment of
shock will improve outcomes.
Inclusion criteria: Sustained inadequate tissue perfusion not
responsive to initial volume resuscitation.
Hypotension. SBP < 90, MAP ≤ 60, not corrected with one liter
rapidly infused crystalloid and one or more of the following: or
Normotension. With three of the following: Temperature ≤ 36; Cool
extremities or skin mottling; Altered mental status; RR ≥ 20; Olig-
uria; Lactic acidosis or BE ≤ –5.
Identified to be in shock by the caregiver (i.e. septic, cardiogenic,
hypovolemic).
Exclusion criteria: Trauma, acute MI, patients already receiving
mechanical ventilation/pressors, and patients who are not candi-
dates for ACLS.
Methods: Patients at Redding Medical Center between 1998 and
1 June 2000 in shock (control group) were treated in the standard
fashion. The outcomes of those patients were compared to the
outcome of patients at Redding Medical Center in shock after
1 July 2000 (treatment group). Both groups had the same inclusion
and exclusion criteria and assessed for severity of illness using
APACHE III. During the month of June 2000 intensive education to
all nursing personnel, Emergency Department physicians, inten-
sivists, surgeons, interventional radiologists, and medical staff at
large was undertaken for the purpose of improving earlier identifi-
cation and treatment of shock. Beginning 1 July 2000 standardized
treatment protocols utilizing best practice were implemented for
the EMS, Emergency Department, critical care units and general
nursing units and a ‘shock bed’ in ICU became available at all
times. Activated by a shock alert a shock team comprised of inten-
sivists, Emergency Department physicians, critical care nurse,
nursing supervisor, respiratory therapy, radiology, clinical labora-
tory, electrocardiography, social and pastoral services rapidly
responds to the patient’s bedside and implements the treatment
protocols. The primary care physician is notified.
Discussion: No significant changes in types of therapy or in the
physician mix in the treatment of shock were made from the time
intervals of the historical control group compared to the treatment
group. The severity of illness between the two groups is equivalent.
Therefore, it is likely that the observed changes in the time intervals
for treatment and the mortality outcome are due to the initiation of
the Shock Program at Redding Medical Center.
Conclusion: Early identification of shock and rapid initiation of
treatment reduces the time to the initiation of therapy and mortality.
Table
APS APACHE III Actual mortality
Control 60.4 73.9 40.7%
Tx 61.8 75.1 29.1%
Control Group = 86; treatment group = 103; absolute 
reduction = 11.6%*; relative reduction = 28.5%*.*P < 0.05.
Table
Time intervals (hours:min)
Shock alert ICU admit* 2 l Fluid*** Central line PA line* Abx**
Average for control NA 4:25 5:21 3:29 4:23 6:04
n 75 76 33 53 54
Average for treatment 0:48 2:38 2:31 2:42 3:20 4:18
n 75 103 101 68 61 65
These intervals are from time zero which was the time that signs and symptoms of shock could have first been recognized determined by
retrospective review. * P < 0.1, ** P < 0.05, *** P < 0.001.P247 Reduction in post-ICU, in-hospital mortality following the introduction of an ICU nursing outreach service
C Young, JL Millo, J Salmon
Intensive Care Unit, John Radcliffe Hospital, Headley Way, Headington, Oxford OX3 9DU, UK
Mortality on hospital wards after discharge from intensive care has
been reported to range from 6.1% to 16.3% [1]. At the John Rad-
cliffe hospital a nursing outreach service was introduced to assist
with the post-ICU management of patients discharged to the
wards. Patients received regular outreach nurse review until no
longer causing concern. ICU medical staff were alerted at an early
point to patients at risk of deterioration.
Following introduction of the service, April–September 2001 post-
ICU in-hospital mortality was 7.8% compared with 12.8% for
April–September 1999 and April–September 2000 combined,
P = 0.068. ICU activity and case mix were unchanged. Patients
expected to die on discharge from ICU remain included in the data.
It has been suggested that mortality after discharge from intensive
care may be reduced if patients at risk were to stay in intensive
care a further 48 hours [2]. Whilst outreach does not replace
extended ICU stay, it may have a contribution to mortality reduction
following discharge from ICU.
References:
1. Rowan K, et al.: Outcome comparisons of intensive care units after
adjustment for case mix by the American APACHE II method. BMJ
1993, 307:977-981.
2. Daly K, Beale R, Chang RWS: Reduction in mortality after inappro-
priate early discharge from intensive care unit: logistic regression
triage model. BMJ 2001, 322:1-6.
Table 1
Patients discharged from ICU to hospital wards
April–September April–September 
1999 and 2000 2001
n 421 223
Age, years (SD) 58 (19) 60 (18)
Sex M/F 292/129 149/74
Acute Physiology Score (SD) 23(6) 24(6)
Post-ICU mortality (%)  54 (12.8%) 18 (7.8%), P = 0.068
Post-ICU LOS, days (SD) 19 (40) 15 (17)
P248 Emergency airway service by anaesthetists: a selective referral approach
HL Tan*, T Lew*, A Earnest†
*Department of Anaesthesiology, and †Department of Clinical Epidemiology, Tan Tock Seng Hospital, 11 Jalan Tan Tock Seng, 
Singapore 398433
Introduction: We describe our experience with the provision of an
emergency airway service by specialist-grade anaesthestists to
assist the primary physicians who are the first-line personnel in
airway management and resuscitation in our 1249-bedded multi-
disciplinary, tertiary hospital. A dedicated paging system was set
up to facilitate rapid activation of the designated anaesthetist.
Method: A prospective audit was conducted over 6 months to
assess the demand and effectiveness of the service. A question-
naire was completed for each activation by the anaesthesiologist
involved.
Results: There were 68 activations (average of 11.3/month),
64.7% of which occurred after 16:30 hours. The main locations
were the Neurological Intensive Care Unit (24%), Medical Intensive
Care Unit (11.8%) and Coronary Care Unit (11.8%). In 54.4% of
the activations, endotracheal intubation was already attempted by
the primary physicians, with 19.1% of the patients requiring more
than two attempts. In 19.1% of cases, the involvement extended to
participating in other aspects of resuscitation. Majority of the sce-
narios were clinically challenging, benefiting from a specialist
anaesthetist input. Forty-three percent of the patients had anterior
larynces. One patient required an emergency tracheostomy.
Discussion: Cardiac arrest teams are costly and there remains a
lack of concrete evidence to show that they improve patient
outcome. Recently, medical emergency teams are introduced to
provide rapid response to critically ill patients. However, these
teams face many practical problems, such as limited understanding
of the implication of cardiac arrest and hence, the appropriateness
of resuscitation. While retaining a ‘primary physician team resusci-
tation’ approach, the emergency airway service provided a scope
of care equivalent to both cardiac and medical emergency teams
as required, at a lower cost.
Conclusion: We conclude that this system of emergency airway
management support by anaesthesiologists is effective and opti-
mises manpower resources.
P249 Critical care in internal medicine department: EBM approach and new organizational model for Italian National Health Service
A Puleo, S La Carrubba, C Cicatello, S Di Rosa
Struttura Complessa di Medicina Interna, Azienda Ospedaliera ‘Villa Sofia–CTO’, Palermo, Italy
During the last decade the number of over-60 patients with multi-
ple organ dysfunction admitted in the Departments of Internal Med-
icine in Italy has considerably increased. Many of these patients are
critically ill and needs to be treated by trained medical staff with
experience in internal medicine and an olistic approach. Several
studies carried out in ICUs show that prognosis of elderly patients
affected by multiple organ dysfunction is related to the number and
severity of comorbidity regardless of age. Furthermore many sur-
vived patients dismissed from ICUs cannot reach the previous level
of performance and global quality of life. One randomized con-
trolled trial on chronically critically ill patients compared perfor-
mances of traditional intensive care units with low technology
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‘Special Care Unit’ managed by specialist in internal medicine,
supported by sub-intensive nursing. These units obtained compa-
rable clinical outcomes (mortality, complications) and better value
(economic cost, stay of hospitalization). On the basis of these data
and the characteristics of Italian National Health Service, we
created in our Department of Internal Medicine a ‘protected area’
for critically ill patients affected by internistic diseases with
complex comorbidities needing continuous monitoring of vital para-
meters and therapies. Medical staff working in this area have been
trained in emergency medicine and are supported by nurses ACLS
(Advanced Cardiac Life Support) certified. This unity is constituted
by four beds with monitoring of EKG, non-invasive blood pressure,
pulse, oximetry, body temperature, connected with a central com-
puterized unit. Moreover, in this room are available ABG, ph-metry,
and CPR equipment. Currently in Italy, this kind of patients are
admitted in ICUs, often with unappropriated use of resources or in
Department of Internal Medicine with inadequate quality of care.
We are planning a case–control study to compare the outcomes of
patients admitted in our new ‘protected area’ with those of
matched patients previously admitted in our Department of Internal
Medicine. The results of this investigation could supply data to
support the creation of other ‘protected areas’ in Departments of
Internal Medicine in our country. Furthermore this new approach
could promote the renaissance of the role of Internal Medicine in
Italian National Hospital System and help to release resources for
the ICUs and other specialties.
References:
1. Pettila V, Kaarlola A, Makelainen A: Health-related quality of life of
multiple organ dysfunction patients one year after intensive care.
Intensive Care Med 2000, 26(10):1473-1479.
2. Rudy EB, Daly BJ, Douglas S, Montenegro HD, Song R, Dyer MA:
Patients outcomes for chronically critically ill: special care unit
versus intrensive care unit. Nurs Res 1995, 44:324-331.
3. Ip SP, Leung YF, Ip CY, Mak WP: Outcomes of critically ill elderly
patients: is high-dependency care for geriatric patients worth-
while? Crit Care Med 1999, 27:2351-2357.
P250 Health-related quality of life of multiple organ dysfunction patients: changes and comparison with normative population data
M Wehler*, D Hadzionerovic*, E Aljukic*, U Reulbach†, EG Hahn*, R Strauss*
*Department of Medicine I, and †Department of Medical Informatics, Biometry and Epidemiology, University Erlangen-Nuremberg, 
91023 Erlangen, Germany
Introduction: Few studies analyzing health-related quality of life
(HRQOL) in patients with multiple organ dysfunction (MOD) have
used pre-ICU and follow-up data. Generic HRQOL instruments
allow comparisons with normative population data and have
recently demonstrated good reliability and validity when applied to
intensive care unit (ICU) survivors [1].
Patients and methods: During June 1998 and May 1999 HRQOL
was assessed in 318 consecutive adults admitted for > 24 hours
to our non-coronary medical ICU. Baseline HRQOL measures
were collected by interview during the first 24 hours of ICU stay
and 6 months after admission using the Short Form (SF)-36 Health
Survey, a generic health status measure that evaluates eight health
domains that reflect physical and mental health. MOD was
assessed using daily SOFA scores. MOD was defined as a SOFA
total maximum score (TMS) of ≥ 6 points. Baseline SF-36 data of
ICU patients were compared with age and gender adjusted popu-
lation norms obtained in the German Federal Health Survey 1998
(n = 6964). Changes in individual domains for each patient at
follow-up were measured using normalized standard Z-scores (i.e.
difference between baseline mean and follow-up mean divided by
baseline standard deviation [SD]). A Z-score of 1.0 or more was
used as a cut-off to identify patients with a relevant deterioration of
HRQOL at follow-up.
Results: Mean age of the study cohort (n = 318) was 57 ± 17
(± SD) years, median 59; 58% were male. Mean ICU length of stay
was 11 ± 19 days, median 4.5. Mean APACHE II score after
24 hours was 18 ± 10, mean TISS score was 33 ± 14. One
hundred and seventy patients (53%) had MOD with a mean SOFA
TMS of 11.8 ± 4. Cumulative mortality rates for non-MOD/MOD
patients were 3%/45% in the ICU, 6%/57% in the hospital, and
12%/64% at 6 month follow-up. At follow-up HRQOL data could
be obtained in 118 non-MOD and 53 MOD patients, 19 patients
were lost to follow-up.
Compared with normative population data pre-ICU HRQOL was
significantly (P  < 0.0005) impaired in all ICU patients. MOD
patients demonstrated more severe deteriorated pre-ICU physical
health scores than non-MOD patients (P  < 0.0005), whereas
mental health domains did not differ between the two groups
(P = 0.61). Survivors of MOD showed further deteriorated physical
health scores at follow-up (P  = 0.002) but unchanged mental
health (P = 0.51). Non-MOD patients demonstrated unchanged or
even improved scores in all eight SF-36 domains. The majority of
the survivors (94%) were living at home. Ninety-one percent of
those previously in employment had returned to their former work.
Conclusion: Using age and gender matched population norms MOD
patients demonstrated more severe impaired pre-ICU physical health
scores than non-MOD patients. At follow-up a deterioration in most
areas of physical health was noted in MOD but not in non-MOD
patients, whereas domains of mental health did not differ between the
two groups. The SF-36 seems to have sufficient discriminative validity
when used to measure HRQOL in survivors of MOD.
Reference:
1. Heyland DK, et al.: Crit Care Med 2000, 28:3599-3605.
P251 Are clinical diagnoses prior to death reliable in critically ill patients?
GD Perkins, S Davies, DF McAuley, F Gao
Department of Intensive Care Medicine, Birmingham Heartlands Hospital, Birmingham B9 5SS, UK
Background: European and American studies have recently high-
lighted discrepancies between clinical diagnoses and post mortem
findings in patients who died on the intensive care unit (ICU). This
study set out to determine if similar findings were present in
patients that died on an ICU in the UK.
Methods: Patients that died between January 1998 and June
2001 were identified from a database of ICU admissions. From this
list, patients that had undergone a post mortem were identified and
their medical notes reviewed retrospectively to establish the clini-
cal diagnoses prior to death. These were compared to the postmortem cause of death and classified using the Goldman system.
This system categorises discrepancies between clinical and post
mortem diagnoses into three groups — major, minor and complete
agreement. Major discrepancies were those where the principle,
underlying cause of death was missed. Minor were missed diag-
noses that may have contributed to death or important diagnoses
that were unrelated to the cause of death. Complete agreement
indicated concordance between clinical and post mortem diag-
noses. Differences between the groups demographics were tested
for using repeated measure ANOVA on ranks and chi-squared test.
Results: Nine hundred and thirty-nine patients died during the 3.5
year study period, of which 49 (5.2%) underwent a post mortem
examination. Medical records were available and analysed for 38 of
these patients. Major missed diagnoses were present in 18 cases
(47%). In contrast, less than half of the cases (n = 16, 42%)
showed complete agreement between clinical diagnoses and post
mortem findings. There were no difference in age, admitting spe-
ciality, APACHE II score, predicted mortality or hospital length of
stay between the three groups. Undiagnosed carcinoma, pul-
monary embolism, left ventricular failure or infections represented
the most frequently missed major diagnoses.
Conclusion: This small study has demonstrated that, in the criti-
cally ill, major underlying diagnoses were frequently missed prior to
death. This may have led to unnecessary early death (if known for
reversible causes) or unnecessary prolongation of life where termi-
nal disease was present.
P252 Terminal weaning in critically ill patients
V Cerny, R Parizkova, P Dostal
Department of Anaesthesiology and Intensive Care, Charles University, Hradec Kralove 500 05, Czech Republic
Introduction: The withdrawal of mechanical ventilation as a termi-
nal care process occurs with increasing frequency. The aim of the
study was to analyze patients undergoing terminal weaning (TW) at
ICU in tertiary care hospital during period 1999–2001.
Methods: A prospective, descriptive study of all patients experi-
enced TW during a 3 years period was conducted. Diagnosis,
length of ICU stay (LOS) in days before decision of TW was made,
length of TW (LTW) in minutes, way of TW (SW = step-wise
reduction or VW = ventilator withdrawal), providing information
about TW to the family, adequacy of documentation and difference
in LTW between selected patients subgroups were also evaluated.
Data as mean ± SD (minimum–maximum) or median (25–75%),
t-test or Mann–Whitney Rank Sum Test were used, P < 0.05 was
considered statistically significant.
Results: Thirty-nine patients were studied, age 52 ± 22 years,
LOS 8.7 ± 14 (0.2–84) days, LTW 196 ± 344 (3–1634) min. The
TW procedure was step-wise reduction of ventilatory support
(SW) in 18 patients and ventilator withdrawal (VW) in 21 patients.
There was significant difference in LTW between patients with SW
compared to patients with VW (20, 13–58 min resp. 82, 20–597,
P = 0.04). There were 26 patients with primary brain damage
(group BD) and 13 patients without primary brain damage (group
NBD). Selected results are presented:
Discussion: LOS before decision of TW was significantly longer in
patients without brain damage. The LTW did not differ significantly
between patients with or without brain damage, however LTW was
shorter in patients undergoing ventilator withdrawal compared to
step-wise reduction of ventilatory support.
Reference:
1. Campbell LM, Bizek KS, Thill M: Patients responses during rapid
terminal weaning from mechanical ventilation: A prospective
study. Crit Care Med 1999, 27:73-77.
P253 Ethical attitudes of ICU physicians in Hong Kong
FHY Yap, GM Joynt
Department of Anaesthesia and Intensive Care, Prince of Wales Hospital, Shatin, HKSAR, China
Introduction: Medical practice in HK is based on Western princi-
ples. However, most local doctors and patients are Chinese with a
strong Chinese cultural and religious background. This study
explores the practice and ethical attitudes of ICU doctors in HK,
using a structured questionnaire modified from recent European
ethical questionnaires [1,2].
Results: Of 90 questionnaires distributed to 12 ICUs in HK,
65(72%) were returned.
In HK, 99% of physicians would sometimes withhold and 89%
sometimes withdraw therapy from patients with no chance of
recovery, compared to 93 and 77% in Europe. More respondents
Table
Group BD  Group NBD 
(n = 26) (n = 13)
LOS (days) 2.2 (1–4.5) 13 (9–19)*
Step-wise/ventilator withdrawal 8/18 10/3
Family information about TW given: yes/no 4/22 3/10
Written order of TW: yes/no 23/3 11/2
Respiratory activity before TW: yes/no 11/15 12/1
LTW (min) 24 (15–125) 30 (17–241)
LTW (min) (step-wise) 22.5 (13–690) 161 (30–597)
LTW (min) (ventilator withdrawal) 22.5 (15–49) 12 (7.5–66)
Data as median (25–75%), * P < 0.05.
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in HK involved patients and/or families in decision making (83%
compared to 49%, P < 0.001).
Conclusion: Although demographically different, the ethical behav-
ior and attitudes of ICU doctors in HK and Europe are similar. HK
doctors involve families more often in the discussion of end-of-life
issues.
References:
1. Intensive Care Med 1990, 16:256-264.
2. Crit Care Med 1999, 27:1626-1633.
P254 Life sustaining treatment decisions in Portuguese intensive care units
T Cardoso, T Fonseca, P Campos, A Azevedo, L Lencastre
Intensive Care Unit, Hospital Pedro Hispano, Rua Dr. Eduardo Torres, 4454-509 Matosinhos, Portugal
Objectives: To evaluate current views and practice of Portuguese
intensive care physicians regarding end-of-life decisions, namely
‘do not resuscitate’ (DNR) orders and withhold/withdraw treatment
decisions.
Design and methods: An individual questionnaire was sent to full-
time intensive care physicians working in the intensive care units
(ICUs) registered in the Portuguese Intensive Care Society. High
dependency and specialised units (like burns and coronary care
units) were excluded. A comparison was done between religious
and non-religious, more and less experienced (>10 years or ≤ 10
years of practice in ICU), younger and older (< 45 or ≥ 45 years),
female and male doctors, as well as between doctors working in
small and larger (≤ 8 beds or > 8 beds) ICUs. Chi-square test was
used to compare different groups.
Results: A total of 250 questionnaires were sent in October 2001
and 140 returned (56%) until the end of November. Physicians
from 68% of the country ICUs participated in the study. The vast
majority of physicians answered that DNR orders (100%) and with-
Table
Demographics Europe (%) HK (%) P
Age
< 40 32 89 < 0.001
40–49 47 9
50+ 21 2
Sex
Male:female 6.7:1 1.6:1 < 0.001
Religious background
Yes 78 46 < 0.001
Table
ICU admission limited by bed availability (% of respondents)
Generally Often  Sometimes  Almost 
Country (%) (%) (%) never (%) P
HK 6 25 51 18 0.5
Belgium [2] 7 34 44 14
Table
ICU admission for patients with poor prognosis or poor quality of life (% respondents)
No hope of survival for more than a few weeks Poor QOL according to physician Poor QOL according to patient
Country Admitted Should be admitted Admitted Should be admitted Admitted Should be admitted
HK 69 45 86 66 81 51
Belgium [2] 63 34 91 75 83 53
Table
Application and discussion of DNR orders (% of respondents)
Written DNR orders Discuss with patient Discuss with family
Country Apply Should apply Yes Should Yes Should
HK 61 80 52 88 90 92
Belgium [2] 79 92 16 48 80 80hold and withdraw treatment decisions (98.6%) are made in their
units. Regarding these decisions approximately three-quarters of
the physicians answered that they are made by the medical group
alone and this answer is more prevalent in the group of religious
and less experienced doctors (P < 0.05). Thirteen to sixteen per
cent of the physicians, mainly the more experienced (P < 0.05)
answered that the nurses are involved in the decision. Eleven to
sixteen per cent, mainly the non-religious doctors (P  < 0.05),
involve the patient or relatives in the decision. When asked about
who they think these decisions should involve: 45–50% think that
the patient or relatives should participate — mainly the non-religious
(P < 0.05); 27–36% think that nurses should be involved — mainly
the more experienced doctors (P < 0.05); 43–48% of the doctors
feel that these decisions should be made by the medical group
alone — mainly the religious and less experienced. Regarding docu-
mentation of DNR orders only 2.1% answered that their unit uses a
specific document and 49.3% said that it is just transmitted orally
to the working group. The same applies for withhold and withdraw
treatment decisions, with 43.5% and 38.4% of the physicians
answering that they are just transmitted orally. Probability of sur-
vival to the current episode and the patient wishes were the most
important factors pointed out by the physicians that influence
refusal of ICU admission, DNR orders and withhold or withdraw
treatment decisions. Only 37.9% of the physicians said that a DNR
order precedes a withdraw treatment decision. Eighty-two per cent
continue or start comfort measures like morphine infusion, after a
withdraw treatment decision is made.
Conclusions: End-of-life decisions are a current practice in the
inquired Portuguese ICUs. These decisions are taken by the
medical group alone in most ICUs, although there is a will to
involve the nurses and the patient or relatives in the process. The
experience and religious beliefs of the respondents influence the
way these decisions are taken (but not age, sex or the ICU size).
The practice of writing down these decisions is not done on a
regular basis and needs to be improved.
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